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PREFACE
I
n 2015 the Millennium Development Goals (MDGs) come to the end of their term, 
and a post-2015 agenda, comprising 17 Sustainable Development Goals (SDGs), takes 
their place. We stand on the threshold of a new era. This is an important moment to 
look back at the trends that have defined health-related development under the MDGs, 
noting achievements, highlighting lessons learned, drawing attention to unfinished 
business, and looking forward to the challenges we must now face. 
While progress towards the MDGs has been impressive in many ways, much work 
remains to be done. In health, unprecedented progress has been made in reducing 
maternal and child mortality and in the fight against infectious diseases, even though 
several global and many country MDG targets were not met. The unfinished agenda 
needs to be addressed, but more importantly the dramatic progress paves the way 
for more ambitious achievements by 2030. Similarly important is addressing other 
significant, ongoing public health challenges that were left out of the MDGs altogether, 
notable among them the challengse of acute epidemic diseases, disasters and conflict 
siituations, the burgeoning epidemic of noncommunicable diseases and mental health 
disorders and large inequalities in all parts of the world. 
The SDGs address many of these issues head on, setting a new health goal (“Ensure healthy lives and promote well-being 
for all at all ages”) with a broad set of targets. The SDGs also significantly broaden the scope of action with 17 goals, 
covering a wide range of human activity across the three sustainable development dimensions (economic, social and 
environmental): people, planet, prosperity, peace and partnership, the five Ps of the new agenda, an agenda for all countries. 
Fundamental to achieving the SDGs will be the recognition that eradicating poverty and inequality, creating inclusive 
economic growth, preserving the planet and improving population health are not just linked but interdependent. This has 
profound implications for development strategy, many of which will only be revealed as we move forward. But some seem 
fairly clear at the outset, including the fact that silo-based, vertical approaches to development will have to give way to 
broader, cross-cutting approaches coordinated around and aligned with countries’ needs and priorities.
By taking a more integrated approach to development the SDGs present us with an opportunity to advance, seizing 
opportunities to collaborate and exploit synergies. However, there are clearly challenges too. For example, in order to 
take on cross-cutting issues, it will be necessary to achieve far greater intersectoral coherence and coordination of effort. 
To achieve that end, a new impetus will have to be given to global and regional partnerships and collaborations, with a 
focus on country action. 
A great deal has been achieved since 2000. However, progress can easily be reversed if we do not maintain our commitment 
to making the world a better place for all, leaving no one behind. Key to achieving that vision will be focusing our efforts 
intelligently, and setting clear, measurable goals that national governments and development partners can support. In 
health the target on universal health coverage (UHC) provides the platform for integrated action across all 13 health targets. 
Rather than being seen as one target among many, it is my belief that UHC should be seen as the linchpin of the health 
development agenda, not only underpinning a more sustainable approach to the achievement of the other health targets, 
but allowing for a balance between them. Relevant to all, it can now be monitored within an accepted framework which 
will allow for target setting and measurement of progress. It is, I believe, our way forward. This report is a first step in a 
series of actions that I am taking to make WHO fit to fully support the implementation of the SDG agenda. 
Dr Margaret Chan
Director-General
World Health Organization
iv HEALTH IN 2015: FROM MDGs TO SDGs
3
vii Abbreviations
1 From MDGs to SDGs: general introduction
3 Summary
4 MDGs
5 Health in the MDG: achievements
6 Strengths and limitations of the MDGs
7 SDGs
8 The health goal
9 Health in other goals
10 Follow-up and review
12 Notes and references
15 Economic, social and environmental context  
and health implications
17 Summary
18 Population trends
18 Fertility and population growth
19 The youth bulge
21 Ageing
22 Migration
23 Urbanization
25 Economic determinants of health and financing for development
26 Poverty eradication and income inequality
27 Globalization and trade
28 Development assistance for health
29 Social development
29 Gender equality and rights 
30 Human rights
31 Education
32 Environment and climate change 
32 Climate change 
34 Pollution and contamination
34 Occupational health
35 Intersectoral action
36 Notes and references
39 Universal Health Coverage
41 Summary
43 Trends
44 Positive developments
45 Challenges
47 Strategic priorities
 Snapshots
50 Governance
52 Health financing
1
2
CONTENTS
vHEALTH IN 2015: FROM MDGs TO SDGs
54 Health workforce
56 Medical products 
58 Health information
60 Service delivery
62 Research for UHC
64 Notes and references
69 Reproductive, maternal, newborn, child,  
adolescent health and undernutrition
71 Summary
74 Achievements
75 Success factors
78 Challenges
79 Strategic priorities
 Snapshots
82 Maternal health
84 Newborn health
86 Child health
88 Polio 
90 Undernutrition
92 Adolescent health
94 Sexual and reproductive health and rights
96 Notes and references
99 Infectious diseases
101 Summary
103 Achievements
105 Success factors
107 Challenges
109 Strategic priorities
 Snapshots
112 HIV/AIDS 
114 Tuberculosis
116 Malaria
118 Neglected tropical diseases 
120 Hepatitis
122 Waterborne diseases
124 Cholera
126 Sexually transmitted infections
128 Notes and references
131 Noncommunicable diseases
133 Summary
134 Trends
135 Positive developments
137 Challenges
138 Strategic priorities
 Snapshots
140 Cardiovascular diseases
142 Cancer
144 Diabetes
146 Tobacco use
148 Air pollution
150 Notes and references
4
5
6
vi HEALTH IN 2015: FROM MDGs TO SDGs
153 Mental health and substance use
155 Summary
157 Trends
157 Positive developments
158 Challenges
159 Strategic priorities
 Snapshots
162 Depression and suicide
164 Dementia
166 Substance use and substance use disorders
168 Notes and references
171 Injuries and violence
173 Summary
175 Trends
176 Positive developments
177 Challenges
177 Strategic priorities
 Snapshots
180 Road traffic injuries 
182 Violence and homicide 
184 War and conflict
186 Disasters
188 Notes and references
189 The SDGs: reflections on the implications  
and challenges for health
191 Summary
192 The legacy of the MDGs
192 The birth of the SDGs
193 Children of their time: the SDGs are different
194 Towards a WHO position on health and the SDGs
195 The place of health in the SDGs
196 Health systems are central to the new agenda
197 The SDGs can put health governance centre stage
198 Financing the SDGs
199 Follow-up and review
200 Final reflections
201 Notes and references
202 Annex 1. Regional groupings
204 Photo credits
7
8
9
viiHEALTH IN 2015: FROM MDGs TO SDGs
ACT artemisinin-based combination therapy
AFR WHO African Region
AIDS acquired immunodeficiency syndrome
AMR WHO Region of the Americas
ART antiretroviral therapy 
ARV antiretroviral drug
BCG bacillus Calmette-Guérin
BMI body mass index
CDC Centers for Disease Control and Prevention (USA) 
COPD chronic obstructive pulmonary disorder
CRD chronic respiratory disease
CRVS civil registration and vital statistics
CVD cardiovascular disease
DALY disability-adjusted life year
DHS Demographic and Health Survey
DTP diphtheria, tetanus, pertussis (whooping cough)
ECOSOC United Nations Economic and Social Council
EMR WHO Eastern Mediterranean Region
ENAP Every Newborn Action Plan
EPMM Ending Preventable Maternal Mortality
EUR WHO European Region
FGM female genital mutilation
FP2020 Family Planning 2020
G8 Group of 8 countries
GDP gross domestic product 
GISRS WHO Global Influenza Surveillance and Response System
Global Fund Global Fund to Fight AIDS, Tuberculosis and Malaria
GNI gross national income
GOARN Global Outbreak Alert and Response Network
HAI Health Action International
HBV hepatitis B virus
HCV hepatitis C virus
Hib Haemophilus influenzae type b
HIV human immunodeficiency virus
HLPF High-Level Political Forum
HPV human papillomavirus
HRH human resources for health
IAEG Inter-agency and Expert Group
ICT information and communication technologies
IHP+ International Health Partnership and related initiatives
ABBREVIATIONS
viii HEALTH IN 2015: FROM MDGs TO SDGs
IHR International Health Regulations
IPCC Intergovernmental Panel on Climate Change
ITN insecticide-treated mosquito net
LLIN long-lasting insecticidal net
MCV measles-containing vaccine
MDG Millennium Development Goal
MDR TB multidrug-resistant TB
mhGAP WHO Mental Health Gap Action Programme
MICS Multiple Indicator Cluster Survey
MMR maternal mortality ratio
NCD noncommunicable disease
NMR neonatal mortality rate
NTD neglected tropical disease
ODA official development assistance
OECD Organisation for Economic Co-operation and Development
OWG Open Working Group
PCV pneumococcal conjugate vaccine
PEPFAR United States President’s Emergency Plan for AIDS Relief
POP persistent organic pollutant
PPP purchasing power parity
R&D research and development
RMNCAH reproductive, maternal, newborn, child and adolescent health
RMNCH reproductive, maternal, newborn and child health 
SARS severe acute respiratory syndrome
SDG Sustainable Development Goal
SEAR WHO South-East Asia Region
SSFFC substandard, spurious, falsified, falsely-labelled and counterfeit 
STI sexually transmitted infection
TB tuberculosis
TRIPS Agreement on Trade-Related Aspects of Intellectual Property Rights
U5MR under-five mortality rate
UHC Universal Health Coverage
UN United Nations
UNAIDS Joint United Nations Programme on HIV/AIDS
UNESCO United Nations Education, Scientific and Cultural Organization
UNFPA United Nations Population Fund
UNICEF United Nations Children’s Fund
UNODC United Nations Office on Drugs and Crime
USAID United States Agency for International Development
WASH drinking-water, sanitation and hygiene
WHA World Health Assembly
WHO World Health Organization
WHO FCTC WHO Framework Convention on Tobacco Control
WHO PEN WHO Package of Essential NCD Interventions 
WPR WHO Western Pacific Region
WTO World Trade Organization
YLD years of healthy life lost due to disability 
YLL years of life lost to mortality
  
FROM MDGs TO SDGs: 
GENERAL 
INTRODUCTION
1

SUMMARY
This report aims to describe global health in 2015, looking back 15 years at the trends and positive forces during the 
Millennium Development Goal (MDG) era and assessing the main challenges for the coming 15 years.
The 2030 Sustainable Development Agenda is of unprecedented scope and ambition, applicable to all countries, and goes 
well beyond the MDGs. While poverty eradication, health, education, and food security and nutrition remain priorities, 
the Sustainable Development Goals (SDGs) comprise a broad range of economic, social and environmental objectives, 
and offer the prospect of more peaceful and inclusive societies. 
Progress towards the MDGs, on the whole, has been remarkable, including, for instance, poverty reduction, education 
improvements and increased access to safe drinking-water. Progress on the three health goals and targets has also been 
considerable. Globally, the HIV, tuberculosis (TB) and malaria epidemics were “turned around”, child mortality and 
maternal mortality decreased greatly (53% and 44%, respectively, since 1990), despite falling short of the MDG targets. 
During the MDG era, many global progress records were set. The MDGs have gone a long way to changing the way we 
think and talk about the world, shaping the international discourse and debate on development, and have also contributed 
to major increases in development assistance. However, several limitations of the MDGs have also become apparent, 
including a limited focus, resulting in verticalization of health and disease programmes in countries, a lack of attention 
to strengthening health systems, the emphasis on a “one-size-fits-all” development planning approach, and a focus on 
aggregate targets rather than equity.
The 17 goals and 169 targets, including one specific goal for health with 13 targets, of the new development agenda 
integrate the three dimensions of sustainable development around people, planet, prosperity, peace and partnership. The 
health goal is broad: “Ensure healthy lives and promote well-being for all at all ages”. Health has a central place as a major 
contributor to and beneficiary of sustainable development policies. There are many linkages between the health goal 
and other goals and targets, reflecting the integrated approach that is underpinning the SDGs. Universal health coverage 
(UHC), one of the 13 health goal targets, provides an overall framework for the implementation of a broad and ambitious 
health agenda in all countries.
Monitoring and review of progress will be a critical element of the SDGs. An indicator framework is still being developed 
and is scheduled to be adopted in 2016. 
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On 25 September 2015, the United Nations (UN) 
General Assembly adopted the new development agenda 
“Transforming our world: the 2030 agenda for sustainable 
development”.1 The new agenda is of unprecedented 
scope and ambition, and applicable to all countries. 
The post-2015 framework goes far beyond the MDGs, 
which nevertheless provided an important framework for 
combatting poverty and promoting development in low- 
and middle-income countries during the past 15 years. 
While poverty eradication, health as a basic human right, 
education, and food security and nutrition remain priorities, 
the SDGs comprise a broad range of economic, social and 
environmental objectives, as well as offering the promise 
of more peaceful and inclusive societies. The 17 goals and 
169 targets, including one specific goal for health with 13 
targets, have many linkages and cross-cutting elements, 
reflecting the integrated approach that underpins the SDGs.
This report aims to describe global health in 2015, looking 
back 15 years at the trends and positive forces during the 
MDG era and assessing the main challenges for the coming 
15 years. The following chapter describes the context, 
including population and epidemiological changes, and 
the economic, social and environmental determinants of 
health. The subsequent six chapters present the trends and 
challenges for the main health areas that are prominent in 
the health goal of the SDGs: UHC; reproductive, maternal, 
newborn, child and adolescent health; infectious diseases; 
noncommunicable diseases (NCDs); mental health and 
substance abuse; and injuries and violence. Some chapters 
cover multiple health targets and, where relevant, refer to 
SDG targets that are in other goals. The final chapter reflects 
on the implications of the SDG for health.
Each chapter summarizes the achievements and progress 
towards the health-related MDGs since 2000, or trends 
in areas that were not prioritized in the MDGs. Key 
factors that have contributed to the success of the past 
15 years are identified, ranging from country actions to 
global partnerships, funding increases and scale-up of 
new interventions. The major challenges for health in 2015 
and the next 15 years are also summarized. The last part 
of each chapter puts together the strategic priorities as 
defined in the SDG targets, and links those to World Health 
Organization (WHO) resolutions, global action plans and 
other critical strategic documents. For many areas, the 
World Health Assembly has already laid out what countries 
and the international community should prioritize to make 
significant progress towards the new SDG targets. In many 
other areas, the SDGs offer a new, broader and integrated 
perspective that needs further concretization and impetus 
in regard to UHC and intersectoral approaches.
This introductory chapter starts with a brief review of the 
general health-related MDG achievements, strengths and 
limitations. The second part describes the health-related 
SDG targets, including how health is reflected in other goals 
and targets, and discusses how the monitoring of progress 
towards the health-related SDG can be accomplished.
MDGs
In September 2000, the UN General Assembly adopted the 
Millennium Declaration, establishing a global partnership 
of countries and development partners committed to eight 
voluntary development goals, to be achieved by 2015. 
Representing ambitious moral and practical commitments, 
the MDGs2 called for action to: (1) eradicate extreme 
poverty and hunger; (2) achieve universal primary 
education; (3) promote gender equality and empower 
women; (4) reduce child mortality; (5) improve maternal 
health; (6) combat HIV/AIDS, malaria and other diseases; 
(7) ensure environmental sustainability; and (8) develop 
a global partnership for development. Three of the eight 
MDGs are focused on health, while health is also a 
component of several other MDGs (nutrition, water and 
sanitation).3 
There has been unprecedented mobilization of resources 
around MDG-related activities across a wide spectrum 
of global and national initiatives and the development 
community has convened on a regular basis to assess 
progress. Major global events related to the MDGs include: 
the 2001 and 2011 UN special sessions on HIV/AIDS, 
convened to intensify international activity to fight the 
epidemic;4 the 2005 World Summit,5 which reaffirmed the 
commitments to the Millennium Declaration; the 2008 
high-level event at the UN in New York,6 at which there 
was a call to accelerate progress towards the MDGs; 
the 2010 Millennium Development Goals Summit, which 
concluded with the adoption of a Global Action Plan and 
the announcement of multiple initiatives against poverty, 
hunger and disease, as well as initiatives designed to 
accelerate progress on women’s and children’s health, and 
at which specific MDG-related commitments were made 
by countries and others;7 and, most recently, the 2013 
UN special event to follow up on MDG-related efforts.6 
Many regional and country events have also been held to 
review progress and make new commitments. 
The MDGs have gone a long way to changing the way we 
think and talk about the world, shaping the international 
discourse and debate on development, and stimulating 
popular awareness of moral imperatives such as achieving 
gender equality and ending poverty and starvation. 
The MDGs have also contributed to major increases in 
development assistance,8,9,10 as evidenced by the 66% jump 
in official development assistance (ODA, in real terms) 
between 2000 and 2014 when it reached an unprecedented 
US$ 135 billion.3 More aid has flowed into education and 
public health, while also being directed towards poorer 
countries to supplement the increases in domestically 
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Table 1.1 
Global and WHO regional status of the health-related MDGs
Target Global AFR AMR SEAR EUR EMR WPR
Target 1.C
Halve, between 1990 and 2015, the 
proportion of people who suffer from 
hunger
Percent reduction in proportion of underweight 
children under-five years of age, 1990–2015 50 44 35 63 49 85 39 82
Target 4.A
Reduce by two thirds, between 1990 and 
2015, the under-five mortality rate
Percent reduction in under-five mortality 
rate, 1990–2015 67 53 54 65 64 65 48 74
Measles immunization coverage among 
one-year-oldsa (%), 2014 90 85 73 92 84 94 77 97
Target 5.A
Reduce by three quarters, between 1990 
and 2015, the maternal mortality ratio
Percent reduction in maternal mortality 
ratio, 1990–2015 75 44 44 49 69 63 54 64
Births attended by skilled health personnelb 
(%), 2013 90 73 54 96 59 99 67 95
Target 5.B
Achieve, by 2015, universal access to 
reproductive health
Antenatal care coverage (%): at least one 
visit, 2013 100 88 81 99 84 99 79 95
Unmet need for family planning (%), 2015 0 24 55 19 27 28 42 10
Target 6.A
Have halted by 2015 and begun to reverse 
the spread of HIV/AIDS
Percent reduction in HIV incidence, 2000–2014 >0 45 59 28 50 -16 < -50 27
Target 6.C
Have halted by 2015 and begun to reverse 
the incidence of malaria and other major 
diseases
Percent reduction in incidence of malaria, 
2000–2015 >0 37 42 78 49 100 70 65
Percent reduction in incidence of tuberculosis, 
1990–2014 >0 17 1 49 17 14 12 48
Target 7.C
Halve, by 2015, the proportion of people 
without sustainable access to safe 
drinking-water
Percent reduction in proportion of population 
without access to improved drinking-water 
sources, 1990–2015
50 62 38 62 74 67 39 84
Percent reduction in proportion of population 
without access to improved sanitation, 
1990–2015
50 31 7 47 32 28 54 54
AFR, African Region; AMR, Region of the Americas; SEAR, South-East Asia Region; EUR, European Region; EMR, Eastern Mediterranean Region; WPR, Western Pacific Region.
a Target for measles immunization coverage was set by the World Health Assembly.
b Target for births attended by skilled health personnel was set by the International Conference on Population and Development. 
  Met or on track     Half way     Insufficient progress
sourced development finance.11 The influence on donor 
policies and practices and – more variably – on governments 
in the developing world, has been considerable.12 For 
instance, the MDGs (specifically MDG 6) were integral 
considerations in the policy formation of the Global Fund to 
Fight AIDS, Tuberculosis and Malaria (Global Fund), which 
was created in 2002.
Tracking progress towards the MDGs has required a 
significant investment in measuring the 60 key indicators 
which are used to monitor the 8 MDGs and their 21 targets. 
Annual progress reports are produced by the Inter-agency 
and Expert Group (IAEG) on MDG indicators, coordinated 
by the UN Statistics Division, and based on the contributions 
of technical agencies.3 In 2008, the World Health Assembly 
called for regular monitoring of progress towards the health 
MDGs13 and has conducted annual reviews of progress 
since 2009, based on a report prepared by the Secretariat 
derived from the WHO annual statistical overview and 
WHO Global Health Observatory data.14,15
Health in the MDG: achievements
Progress towards the MDGs has, on the whole, been 
remarkable. With regard to extreme poverty, for example, 
the number of people living on less than US$ 1.25 per 
day has declined by more than half, from 1.9 billion in 
1990 to 836 million in 2015. Similarly, the proportion 
of undernourished people in the developing regions has 
fallen from 23% in 1990–1992 to 13% in 2014–2016. The 
child undernutrition indicator target has almost been met 
(Table 1.1).
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Significant progress has also been achieved with regard to 
education, with the primary school net enrolment rate in 
the developing regions reaching 91% in 2015, up from 83% 
in 2000. Many more girls are now in school compared to 
15 years ago, with developing regions as a whole having 
achieved the target to eliminate gender disparity in primary, 
secondary and tertiary education, which is likely to yield 
considerable maternal and child health benefits.16
Major progress has been made on water and sanitation, 
which has a significant impact on the transmission of 
infectious diseases. In 2015, 91% of the global population is 
using an improved drinking-water source, compared to 76% 
in 1990, thus meeting the MDG target, while the proportion 
of people practising open defecation has fallen almost by 
half. Globally, 147 countries have met the drinking-water 
target, 95 countries have met the sanitation target and 77 
countries have met both.
Progress on the specific health-related goals and targets, 
MDG 4, MDG 5 and MDG 6, has also been encouraging 
(see chapters 4 and 5). Globally, the HIV, TB and malaria 
MDG targets have been met. Child mortality has fallen by 
53% and maternal mortality by 43%. Even though this 
is a cause for celebration, both declines fall well short 
of the MDG targets of two thirds and three quarters 
reductions from the 1990 levels. Regional progress has 
also been uneven, as can be seen in Table 1.1, and substantial 
inequalities remain within and across countries.17 More 
detailed assessments of the progress made are provided 
in chapters 5 and 6.
Strengths and limitations of the MDGs
The MDGs have been more influential than any other 
attempt at international target setting in the field of 
development. The rapid acceleration of global progress 
towards the poverty reduction, gender, health and education 
goals since 2000, and particularly since 2005, is just one 
example of their beneficial impact. The adoption of a simple, 
clear and time-bound framework that is compelling, easy 
to communicate and measurable has been one of the 
MDGs’ great strengths, encouraging donor governments, 
international agencies and country decision-makers to focus 
attention on areas of need, and to measure the results of 
initiatives undertaken. And while it is hard to isolate specific 
causal effects, it seems reasonable to suppose that the 
intensity of focus (and investment) has been a key driver of 
innovation, enabling the scale-up of new interventions, such 
as antiretroviral therapy (ART), long-lasting insecticidal 
nets (LLINs), artemisinin-based combination therapies 
(ACTs), vaccines against pneumonia and diarrhoeal disease, 
and new and better diagnostic tests for multiple diseases.
The emphasis on measuring results has also had a positive 
impact on country data systems. A good example is the 
improvement in country data availability for a subset of 22 
official MDG indicators between 2003 and 2014.3 While 
in 2003, only 2% of developing countries had at least two 
data points for 16 or more of the 22 indicators, by 2014 this 
figure had reached 79%, reflecting the increased capacity 
of national statistical systems to address monitoring 
requirements. Development partners played an important 
role in boosting monitoring capacity, most successfully by 
providing long-term support to national health surveys, 
especially the United Nations Children’s Fund (UNICEF) and 
the United States Agency for International Development 
(USAID). These surveys, mostly conducted by national 
statistical offices in collaboration with ministries of health, 
also generated data on inequalities in health, especially for 
reproductive, maternal and child health indicators.18,19 One 
important benefit of increased monitoring was highlighting 
the importance of accountability involving a cyclical process 
of monitoring, review and remedial action. The importance 
of accountability has been underlined at all levels through, 
for instance, the recommendations of the Commission on 
Information and Accountability for Women’s and Children’s 
Health, and has not only improved monitoring, but is 
also gradually leading to more inclusive and transparent 
reviews of progress involving civil society, politicians and 
the media.20,21
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Despite their overall success, the MDGs have not achieved 
unanimous approval.8 ,22,23,24 For example, it has been pointed 
out that despite their pro-poor focus, the MDGs have, 
by employing almost exclusively aggregate targets and 
indicators, glossed over within-country inequalities, thereby 
undermining efforts required to improve conditions for the 
poorest and hardest-to-reach populations. Figure 1.1 offers 
an example of such disparities, showing the significant 
differences in mortality in children under five living in the 
poorest and richest households, children whose mothers 
were the least educated compared with the most educated, 
and between those living in urban compared with rural areas 
in 49 countries. 
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Figure 1.1 
Under-five mortality in low- and middle-income countriesa by multiple dimensions of 
inequality, 2005–201225
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The MDG framework has also been criticized for focusing 
attention and resources on the attainment of particular 
goals at the expense of others. This is, of course, in the 
nature of focusing, but the criticism raises important issues 
nonetheless. The focusing “problem” has been particularly 
apparent with regard to the health goals, where resources 
and effort have been directed at strengthening certain 
disease-specific or “vertical” programmes, often at the 
expense of broader, cross-cutting investments in health 
systems that can deal with all health issues in a more 
integrated manner. This emphasis on vertical approaches 
has often resulted in separate strategic plans, monitoring 
mechanisms, funding streams and implementation 
efforts, with only limited investment in harmonization 
and alignment across programmes. The MDGs focused 
on the ends (health outcomes), without offering major 
incentives to invest in the more broad-based means – i.e. 
health systems. This has often led to major progress in 
MDG health indicators, while leaving major deficiencies in 
health systems as a whole, such as weak country capacity 
to respond to challenges, for example infectious disease 
outbreaks (the West Africa Ebola epidemic is an obvious 
example) or a rapidly increasing burden of NCDs. 
Doubts have also been expressed about the purposes 
to which the MDGs have sometimes been put. For 
example, the MDGs have been applied as one-size-fits-all 
development planning instruments with targets that every 
country can meet, even though the MDGs were never 
meant as targets for individual countries. Global targets 
are less useful for countries with a low starting point or in 
conflict situations. A greater degree of realism about each 
country’s ability to attain them would have helped guide 
national policy development in certain instances.
SDGs
On 25 September 2015, the UN General Assembly adopted 
the new development agenda “Transforming our world: the 
2030 agenda for sustainable development”.1 The agenda 
builds upon the outcome document of the UN Conference 
on Sustainable Development (Rio+20 conference),26 which 
took place in June 2012 and led to the establishment of 
the Open Working Group on SDGs, a group of Member 
States tasked with preparing a proposal on the SDGs. The 
Open Working Group proposal was welcomed by the UN 
General Assembly in September 2014 and became the 
principal guideline for integrating SDGs into the post-
2015 development agenda.27 Further intergovernmental 
negotiation processes resulted in the final document for 
the Sixty-ninth UN General Assembly in 2014, which also 
included the outcomes of major global meetings such as the 
Sendai Framework for Disaster Risk Reduction 2015–203028 
and the Addis Ababa Action Agenda,29 as well as inputs 
such as the synthesis report of the Secretary-General on 
the post-2015 agenda, “The road to dignity: ending poverty, 
transforming all lives and protecting the planet”, published 
in December 2014.30 
The 17 goals (Table 1.2) of the new development agenda 
integrate all three dimensions of sustainable development 
(economic, social and environmental) around the themes of 
people, planet, prosperity, peace and partnership. The SDGs 
seek to continue to prioritize the fight against poverty and 
hunger, while also focusing on human rights for all, and the 
empowerment of women and girls as part of the push to 
achieve gender equality. They also build upon, and extend, 
the MDGs in order to tackle the “unfinished business” 
of the MDG era. The SDGs recognize that eradicating 
poverty and inequality, creating inclusive economic 
growth and preserving the planet are inextricably linked, 
not only to each other, but also to population health; and 
that the relationships between each of these elements 
are dynamic and reciprocal. For example, with regard to 
health, a fundamental assumption of the SDGs is that 
health is a major contributor and beneficiary of sustainable 
development policies.26
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for family planning, information and education. 
We will equally accelerate the pace of progress 
made in fighting malaria, HIV/AIDS, tuberculosis, 
hepatitis, Ebola and other communicable diseases 
and epidemics, including by addressing growing anti-
microbial resistance and the problem of unattended 
diseases affecting developing countries. We are 
committed to the prevention and treatment of non-
communicable diseases, including behavioural, 
developmental and neurological disorders, which 
constitute a major challenge for sustainable 
development.
One of the 17 goals has been devoted specifically to health, 
and is framed in deliberately broad terms that are relevant 
to all countries and all populations: “Ensure healthy lives 
and promote well-being for all at all ages”. The health 
goal is associated with 13 targets, including four means 
of implementation targets labelled 3.a to 3.d. Overall, the 
SDGs have 169 targets.
Even though the 2030 agenda refers several times to 
the term “human right(s)” (rights to development, self-
determination, an adequate standard of living, food, water 
and sanitation, good governance, and the rule of law), it 
does not specifically mention that health is a human right.
1 End poverty in all its forms everywhere
2 End hunger, achieve food security and improved nutrition and promote sustainable 
agriculture
3 Ensure healthy lives and promote well-being for all at all ages 
4 Ensure inclusive and equitable quality education and promote lifelong learning 
opportunities for all
5 Achieve gender equality and empower all women and girls
6 Ensure availability and sustainable management of water and sanitation for all
7 Ensure access to affordable, reliable, sustainable and modern energy for all
8 Promote sustained, inclusive and sustainable economic growth, full and productive 
employment and decent work for all 
9 Build resilient infrastructure, promote inclusive and sustainable industrialization 
and foster innovation 
10 Reduce inequality within and among countries 
11 Make cities and human settlements inclusive, safe, resilient and sustainable 
12 Ensure sustainable consumption and production patterns 
13 Take urgent action to combat climate change and its impactsa 
14 Conserve and sustainably use the oceans, seas and marine resources for 
sustainable development 
15 Protect, restore and promote sustainable use of terrestrial ecosystems, sustainably 
manage forests, combat desertification, and halt and reverse land degradation 
and halt biodiversity loss 
16 Promote peaceful and inclusive societies for sustainable development, provide 
access to justice for all and build effective, accountable and inclusive institutions 
at all levels 
17 Strengthen the means of implementation and revitalize the global partnership 
for sustainable development 
a Acknowledging that the United Nations Framework Convention on Climate Change is 
the primary international, intergovernmental forum for negotiating the global response 
to climate change.
Table 1.2
The 17 SDGs
The SDGs aim to be universal, integrated and interrelated 
in nature. In order to take on such a wide range of cross-
cutting issues, it will be necessary to achieve far greater 
intersectoral coherence, integration and coordination of 
efforts than has hitherto been in evidence. A revitalized 
global partnership for sustainable development, based on 
a spirit of strengthened global solidarity, informed by a 
readiness to reach across sectors and guided by clear and 
measurable objectives will be critical for the mobilization 
of the means required to implement the SDG agenda, 
focused particularly on the needs of the poorest and most 
vulnerable.
The health goal
Paragraph 26 of the 2030 agenda for sustainable 
development addresses health as follows:1 
To promote physical and mental health and well-
being, and to extend life expectancy for all, we must 
achieve universal health coverage and access to 
quality health care. No one must be left behind. We 
commit to accelerating the progress made to date in 
reducing newborn, child and maternal mortality by 
ending all such preventable deaths before 2030. We 
are committed to ensuring universal access to sexual 
and reproductive health-care services, including 
3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100 000 
live births
3.2 By 2030, end preventable deaths of newborns and children under five years of 
age, with all countries aiming to reduce neonatal mortality to at least as low 
as 12 per 1000 live births and under-five mortality to at least as low as 25 per 
1000 live births
3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical 
diseases and combat hepatitis, waterborne diseases and other communicable 
diseases
3.4 By 2030, reduce by one third premature mortality from noncommunicable diseases 
through prevention and treatment and promote mental health and well-being
3.5 Strengthen the prevention and treatment of substance abuse, including narcotic 
drug abuse and harmful use of alcohol
3.6 By 2020, halve the number of global deaths and injuries from road traffic accidents
3.7 By 2030, ensure universal access to sexual and reproductive health-care services, 
including for family planning, information and education, and the integration of 
reproductive health into national strategies and programmes
3.8 Achieve universal health coverage, including financial risk protection, access to 
quality essential health-care services and access to safe, effective, quality and 
affordable essential medicines and vaccines for all
3.9 By 2030, substantially reduce the number of deaths and illnesses from hazardous 
chemicals and air, water and soil pollution and contamination
3.a Strengthen the implementation of the World Health Organization Framework 
Convention on Tobacco Control in all countries, as appropriate
3.b Support the research and development of vaccines and medicines for the 
communicable and noncommunicable diseases that primarily affect developing 
countries, provide access to affordable essential medicines and vaccines, in 
accordance with the Doha Declaration on the TRIPS Agreement and Public 
Health, which affirms the right of developing countries to use to the full the 
provisions in the Agreement on Trade-Related Aspects of Intellectual Property 
Rights regarding flexibilities to protect public health, and, in particular, provide 
access to medicines for all
3.c Substantially increase health financing and the recruitment, development, 
training and retention of the health workforce in developing countries, especially 
in least-developed countries and small island developing States
3.d Strengthen the capacity of all countries, in particular developing countries, for 
early warning, risk reduction and management of national and global health risks
Table 1.3
Health targets in SDG 3
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The 13 targets that underpin the broad health goal are shown 
in Table 1.3. It is noted that the MDG goals on maternal 
mortality (3.1), child mortality (3.2) and infectious diseases 
(3.3) have been retained in the SDG framework, augmented 
by new and more ambitious targets for 2030, and expanded 
to include neonatal mortality and more infectious diseases 
such as hepatitis and waterborne diseases. The targets on 
access to sexual and reproductive health-care services (3.7) 
and access to vaccines and medicines (3.b) are also closely 
related to the MDG targets. Sexual and reproductive rights 
are addressed under MDG 5 on gender equality.
The SDGs include new targets on NCDs and mental health 
(3.4), substance abuse (3.5), injuries (3.6), health impact 
from hazardous chemicals, water and soil pollution and 
contamination (3.9) and the implementation of the WHO 
Framework Convention on Tobacco Control (WHO FCTC) 
(3.a). Target 3.d addresses reducing and managing national 
and global health risks, and health financing and health 
workforce issues in least-developed countries and small 
island developing states are addressed by Target 3.c.
UHC is also a new target (3.8), which provides an overall 
framework for the implementation of a broad and ambitious 
agenda in all countries. UHC is the only target that cuts 
across all targets of the health goals, as well as addresses 
linkages with health-related targets in the other goals. The 
issue of UHC in the SDGs is addressed in Chapter 3 where 
its importance for all health targets, including notably 
targets for NCDs, is outlined. A simple framework for 
organizing the health targets in a logical manner is proposed 
in Chapter 9.
Health in other goals
Health is linked to many of the non-health goals, reflecting 
the fact that health affects, and is in turn affected by, 
many economic, social and environmental determinants. 
Progress in health is dependent on economic, social and 
environmental progress. Well over a dozen targets in other 
goals can be considered health-related and should be given 
special attention in strategies, policies and plans to achieve 
the health goal and in monitoring progress (Table 1.4). Goal 
17 is about means of implementation and links to the four 
means of implementation targets of the health goal.
One of the strengths of the SDGs is the breadth of their 
embrace,31 which seeks to encompass communicable 
diseases, NCDs and injuries as well as determinants of 
health such as increasing urbanization, pollution and 
climate change. The SDG agenda emphasizes the close links 
between health and sustainable development. Health policy 
can contribute to sustainable development and poverty 
reduction if people have access to the information and 
services they need to promote and protect their health and 
are protected from catastrophic expenditure when they fall ill. 
Sustainable development, in turn, limits the adverse impacts 
1.3 Implement nationally appropriate social protection systems and measures 
for all, including floors, and by 2030 achieve substantial coverage of the poor 
and the vulnerable
2.2 By 2030, end all forms of malnutrition, including achieving, by 2025, the 
internationally agreed targets on stunting and wasting in children under five 
years of age, and address the nutritional needs of adolescent girls, pregnant 
and lactating women and older persons
4.2 By 2030, ensure that all girls and boys have access to quality early childhood 
development, care and pre-primary education so that they are ready for 
primary education
4.a Build and upgrade education facilities that are child, disability and gender 
sensitive and provide safe, non-violent, inclusive and effective learning 
environments for all
5.2 Eliminate all forms of violence against all women and girls in the public and 
private spheres, including trafficking and sexual and other types of exploitation
5.3 Eliminate all harmful practices, such as child, early and forced marriage and 
female genital mutilation
5.6 Ensure universal access to sexual and reproductive health and reproductive 
rights as agreed in accordance with the Programme of Action of the International 
Conference on Population and Development and the Beijing Platform for Action 
and the outcome documents of their review conferences
6.1 By 2030, achieve universal and equitable access to safe and affordable 
drinking-water to all
6.2 By 2030, achieve access to adequate and equitable sanitation and hygiene for 
all and end open defecation, paying special attention to the needs of women 
and girls and those in vulnerable situations
6.3 By 2030, improve water quality by reducing pollution, eliminating dumping 
and minimizing release of hazardous chemicals and materials, halving the 
proportion of untreated wastewater and substantially increasing recycling 
and safe reuse globally
10.4 Adopt policies, especially fiscal, wage and social protection policies, and 
progressively achieve greater equality
11.5 By 2030, significantly reduce the number of deaths and the number of people 
affected and substantially decrease the direct economic losses relative to 
global gross domestic product caused by disasters, including water-related 
disasters, with a focus on protecting the poor and people in vulnerable situations
16.1 Significantly reduce all forms of violence and related death rates everywhere
16.2 End abuse, exploitation, trafficking and all forms of violence against and 
torture of children 
16.6 Develop effective, accountable and transparent institutions at all levels
16.9 By 2030, provide legal identity for all, including birth registration
17.18 By 2020, enhance capacity-building support to developing countries, including 
for least-developed countries and small island developing States, to increase 
significantly the availability of high-quality, timely and reliable data disaggregated 
by income, gender, age, race, ethnicity, migratory status, disability, geographic 
location and other characteristics relevant in national contexts
Table 1.4
Examples of targets in other goals linked to the health SDG 3
of environmental degradation and climate change, which 
have the highest relative impact on the poorest countries 
and the least healthy and poorest groups within countries.
Policies made in all sectors can have a profound effect on 
population health and health equity. The health of people is 
not solely a health sector responsibility; it is also impacted 
by issues such as transport, agriculture, housing, trade 
and foreign policy. To address the multisectoral nature of 
health determinants requires the political will to engage 
the whole of government in health. The health sector 
should promote “Health in All Policies”, an approach to 
public policies across sectors that systematically takes 
into account the health implications of decisions, seeks 
synergies and avoids harmful health impacts in order to 
improve population health and health equity and address 
the social determinants of health.32,33
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Follow-up and review
Tracking progress has been vital in maintaining momentum 
of the MDGs, as well as in identifying areas requiring greater 
efforts. It will be no less important in the context of the 
SDGs. The SDG declaration pays considerable attention 
to the systematic follow-up and review of implementation 
at national, regional and global levels. Globally, the High 
Level Political Forum on Sustainable Development will play 
a critical role in overseeing a network of review processes. 
The reviews will be informed by an annual report prepared 
by the UN Secretary-General in cooperation with the UN 
system.
Follow-up and review processes will be voluntary and 
country-led. The SDG resolution states that national 
governments should “set their own national targets guided 
by the global level of ambition but taking into account 
national circumstances”.1 How this will actually be done 
and what, for instance, the role of regional and global 
mechanisms will have to be worked out as part of the 
indicator framework. 
The UN Statistical Commission will provide a proposal 
for a global indicator framework (and associated global 
and universal indicators) by March 2016 for subsequent 
adoption by the Economic and Social Council of the UN 
General Assembly.34 Monitoring the progress of the 17 
SDGs and their 169 targets will be a challenge, given the 
sheer number of targets and indicators. Furthermore, some 
of the new goals and targets have little track record in terms 
of data and monitoring. 
Among the health agencies and countries, there is 
considerable agreement around the key indicators 
which should be selected from the existing, well-tested 
indicators, included in the Global Reference List of 100 Core 
Indicators.35 However, less-established indicators may be 
required in some targets. One of the biggest challenges 
faced in developing meaningful indicators is the lack of data 
in many countries, even for well-established indicators such 
as those used to monitor cause-specific mortality. Domestic 
and international investments in robust health information 
and statistical systems, including civil registration and vital 
statistics systems, are thus urgently required.36 
As the lead agency for the health SDGs, WHO should 
provide Member States with detailed annual updates of 
progress and inform the overall SDG monitoring process, 
coordinated by the United Nations Statistics Division, with 
regular updates on a small set of core indicators. Optimal 
fulfilment of this task will depend on close collaboration 
with other agencies such as UNICEF, the United Nations 
Office on Drugs and Crime (UNODC), the United Nations 
Population Fund (UNFPA) and the World Bank. The SDG 
health and health-related targets are closely related to 
many of the targets that have been adopted by the WHO 
Member States in the World Health Assembly (WHA). 
Dozens of targets already exist that correspond to the SDG 
health targets, and while some SDG health targets do not 
yet have corresponding, specific WHA health targets, the 
general adoption of the SDG framework makes these targets 
relevant for the WHA.
Monitoring the overarching health goal 
There is a need to monitor the SDGs at the goal level. The 
overall health SDG is to, “Ensure healthy lives and promote 
well-being for all at all ages”. WHO has considered several 
overarching indicators that might serve to monitor that 
goal, including life expectancy, number of deaths before age 
70, and healthy life expectancy.37,38 If it could be measured 
reliably, healthy life expectancy would be a suitable single 
indicator that captures both mortality and years of life 
lived in less than good health (i.e. with a disability). There is 
increasing interest in the accurate measurement of health, 
disability and well-being, especially given the context of 
ageing populations and the growing prominence of chronic 
diseases as causes of disability and premature mortality. 
There is some evidence that life expectancy in high-income 
countries is increasing faster than healthy life expectancy. 
The monitoring efforts being undertaken in the European 
Union are interesting in this regard, setting a target for 
Members States of achieving an additional two healthy 
life years by 2020.39,40 However, while many attempts 
have been made to measure population health status in 
addition to the underlying causes of declines in health, 
challenges remain with regard to the availability of data 
on population level functional status that are comparable 
over time and across populations and collected through 
regular surveys.41,42
Despite the large gaps in coverage of global mortality 
information systems, mortality is more amenable to 
accurate measurement than disease or disability. Several 
cause-specific mortality targets are proposed for the 
post-2015 agenda, many focusing on reducing or ending 
“preventable” deaths.43 Life expectancy is an attractive 
summary measure of mortality rates at all ages, and all 
health and health-related programmes contribute to it. 
Box 1.1 shows the dramatic improvements observed in life 
expectancy during the MDG era. WHO has estimated that 
achievement of the major SDG health targets for child, 
maternal, infectious diseases and NCDs would result in an 
increase of global average life expectancy of around four 
years by 2030. The gap between high- and low-income 
countries would narrow from around 17.5 years in 2015 to 
around 13–14 years.41
Also worthy of consideration is a proposal for a measure 
of premature mortality with a target of reducing the 
number of deaths before age 70 by 40% by 2030 globally 
and in every country.44 Countries at different stages of 
development could achieve such gains by bringing down 
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mortality due to HIV, malaria, TB or child mortality or NCD 
deaths between ages 30 and 70 – depending on their 
relevant priorities. A 40% reduction in premature mortality 
by 2030 would be achievable by: averting two thirds of 
maternal and child deaths; two thirds of HIV, TB and malaria 
deaths; one third of premature deaths from NCDs; and one 
third of deaths from other causes (other communicable 
diseases, undernutrition and injuries). These challenging 
subtargets would halve under-50 deaths, avert one third 
of the (mainly NCD) deaths at ages 50–69, and so prevent 
40% of under-70 deaths. Such a reduction would result in 
a global increase in life expectancy of five years, assuming 
mortality rates at age 70 and over also decline, as projected 
by WHO. Concerted action to reduce NCD deaths before 
age 70 is likely to also reduce NCD death rates for people 
age 70 and over. 
The “promote well-being” component of the overall health 
SDG also presents an interesting monitoring challenge, as 
does health Target 3.5, which refers to “promote mental 
health and well-being”. While health and self-reported 
well-being are intricately related (health status is a critical 
determinant of subjective well-being, for example) they 
are not synonymous.47,48,49,50 Measurement of self-reported 
well-being shares many of problems encountered in the 
measurement of non-fatal health outcomes. The field of 
measuring subjective well-being is rapidly expanding and 
distinguishes different aspects including: (i) evaluative life 
Box 1.1
Life expectancy improvements during the MDG era
Overall trends in life expectancy at birth provide one partial, but important, summary 
of the health improvements since 1990 (Figure 1.2). Life expectancy increased at a 
faster rate in most regions from 2000 onwards and, overall, there was a global increase 
of 6.8 years in life expectancy from 1990 to 2015, with even larger increases of 9.3 
years in the African Region and the South-East Asia Region. This corresponds to an 
average increase in global life expectancy at birth of 2.7 years per decade, which is 
faster than the increases in today’s high-income countries over the past century.45 
The gap between African life expectancy and European life expectancy has narrowed 
by four years in the MDG period.
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Figure 1.2 
Trends in average life expectancy at birth, by WHO region and globally, 
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All major causes of deaths contributed to these huge gains. For instance, WHO 
calculations indicate that compared to the numbers of deaths in 2012 that would have 
been expected if death rates in 2000 had applied, there were 42% fewer maternal 
and child deaths, 36% fewer deaths due to HIV, TB and malaria and around 7% fewer 
due to other causes, including the main NCDs and injuries.  
satisfaction: a reflective assessment on a person’s life or 
some specific aspect of it; (ii) affective or hedonic: a person’s 
feelings or emotional states, typically measured with 
reference to a particular point in time; and (iii) eudemonic: 
a sense of meaning and purpose in life, autonomy and 
self-realization.51 It may, however, be too early to adopt an 
indicator as part of the SDG monitoring.
Monitoring equity
Equity is at the heart of the SDGs, which are founded on 
the concept of “leaving no one behind”. The overall health 
SDG calls for healthy lives for all at all ages, positioning 
equity as a core, cross-cutting theme, while SDG 10 calls 
for the reduction of inequality within and among countries, 
and Target 3.8 calls for the establishment of UHC, founded 
on the principle of equal access to health without risk of 
financial hardship. A movement towards equity in health 
depends, at least in part, on strong health and health 
financing information systems that collect disaggregated 
data about all health areas and health expenditures. This 
fact is recognized in Target 17.8, which calls for efforts to 
build capacity to enable data disaggregation by a number 
of stratifying factors, including income, gender, age, race, 
ethnicity, etc. Disaggregated data enable policy-makers 
to identify vulnerable populations and direct resources 
accordingly. 
MDGs were focused on national progress and on specific 
populations, notably mothers and children and people 
affected by HIV, TB and malaria. In contrast, the health 
SDGs address health and well-being at all ages, including 
in newborns and children, adolescents, adult women and 
men, and older persons. Not only is the goal to be monitored 
much broader, but it is also extended over time, and will thus 
require a comprehensive, life course approach. Needless to 
say, such an approach will also be relevant in monitoring 
progress towards UHC.
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SUMMARY
The SDGs position health as a key feature of human development in a more integrated manner than was the case for the 
MDGs, emphasizing the fact that social, economic and environmental factors influence health and health inequalities and, 
in turn, benefit from a healthy population.
Major population trends impact health. Fertility rates have fallen substantially almost everywhere, but still remain high 
in the African Region. Close to 40% of the population growth in 2015–2030 will come from Africa, and more than one 
quarter of the world’s children will live there by 2030. The population aged 60 and over will increase by 50% in the SDG 
era. This presents many opportunities but will also challenge existing social norms, require a re-aligning of health systems 
and challenge countries to provide sustainable social security and long-term care. By 2030, 60% of the world’s population 
will live in urban areas. 
Poverty eradication is still a priority. The world attained the MDG target – to cut the 1990 poverty rate in half by 2015 – in 
2010. Despite positive trends, one in seven people in developing regions still lives on less than US$ 1.25 per day. In sub-
Saharan Africa, more than 40% of the population still live in extreme poverty in 2015. 
In 2013, total health spending reached US$ 7.35 trillion, more than double the amount spent in 2000. Development 
assistance for health increased dramatically since 2000, but is now flattening and likely to become less prominent in the 
SDG era. The greatest need – as well as the focus of much traditional development finance – will become increasingly 
concentrated in the world’s most unstable and fragile countries.
Gender inequalities in education, employment and civil liberties not only deprive women of basic freedoms and violate 
their human rights, but also negatively affect health and development outcomes for societies as a whole. The SDGs expand 
the focus on gender equity across a range of goals, including health. The right to health has been re-emphasized in terms 
of the achievement of UHC, but is also closely linked to the realization of other human rights, particularly for women and 
vulnerable groups such as migrants and people with disabilities.
Education is strongly linked to better health and the MDG goal of universal primary education has been broadened with 
10 SDG targets addressing all sectors of education. Just over half of countries achieved the MDG goal, and 70% have 
achieved gender parity for primary education, but fewer than half have achieved parity for the secondary level. 
Environmental sustainability is a central concern of the SDGs and is addressed in goals for water and sanitation, energy, 
cities and climate change. Climate change will have increasing consequences for health, ranging from the immediate 
impact of extreme weather events, to the longer term impacts of droughts and desertification on food production and 
malnutrition, and the increased spread of infectious disease vectors for malaria and dengue. The poorest and most 
vulnerable populations are likely to be affected most. 
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Health is central to human development, both as an 
inalienable right in and of itself and as a key contributor 
to the growth and development of communities and 
societies. Health was central to the MDGs, and in the SDGs 
is positioned as a key feature of human development in a 
more integrated manner. One SDG is specifically focused 
on health and several others incorporate actions to improve 
health and to address its broader social, environmental 
and economic determinants. These determinants have 
an impact on health and, in turn, benefit from a healthy 
population. 
While health is still considered an important factor for 
development, it now finds its place alongside many more 
development priorities than was the case during the MDG 
era. This reflects a number of new and growing challenges, 
including: (i) rising inequalities within and between states; 
(ii) profound demographic and epidemiological changes; 
(iii) spiralling conflict, violence and extremism; (iv) increased 
migratory flows; (v) depletion of natural resources; 
(vi) adverse impacts of environmental degradation; and 
(vii) the prospect of irreversible climate change. Needless 
to say, all of these challenges have profound implications for 
health, and the SDGs that seek to address them have health 
concerns woven into their fabric (Table 1.3). This chapter 
examines the principal trends, determinants and risks that 
impact health, including:
• population trends, including fertility decline and 
population growth, changing population structure and 
ageing, migration and urbanization;
• economic and development trends, including poverty 
eradication and equity, globalization and trade, and 
financing for development;
• social determinants such as gender, education and 
income; 
• human rights and equity;
• environmental determinants and other risks, including 
climate change.
In each section, a brief overview is provided on how these 
determinants are reflected in the SDGs, and the possible 
implications for health actions in the coming 15 years are 
outlined.
POPULATION TRENDS
Demographic trends fundamentally influence countries’ 
economic, social and health conditions. Population growth, 
changes in fertility rates, and population structure, all have 
a profound influence, as do migration, which is increasingly 
a cross-border issue, and growing urbanization, which 
may spur economic growth, but also puts strains on food 
and water resources. The SDGs are more explicit about 
population issues than the MDGs. The SDGs outcome 
document references the Programme of Action of the 
International Conference on Population and Development 
and the Beijing Platform for Action,1 and Target 5.6 refers 
directly to this programme of action, calling for efforts 
to: “Ensure universal access to sexual and reproductive 
health and reproductive rights...”. There is one goal on cities 
(Goal 11: Make cities and human settlements inclusive, safe, 
resilient and sustainable) that addresses the challenges 
of rapid urbanization, and two targets specifically refer to 
migrants (SDG Targets 8.8 and 10.7).
Fertility and population growth
Fertility rates are falling globally and, as a consequence, 
population growth is slowing almost everywhere except 
Africa. In mid-2015, the world population reached 7.3 
billion people – almost a tripling of the population in 1950 
– of which 60% lives in Asia. Even as population growth 
rates continue to slow, the world population is projected 
to reach 8.5 billion by 2030.2 Close to 40% of the growth 
in 2015–2030 will come from the African Region (Figure 
2.1). The parts of the world where populations are growing 
fastest are, in many cases, also those most vulnerable to 
climate change. Rising populations may exacerbate some 
of the consequences of global warming, such as water 
shortages, mass migration and declining food yields. 
Figure 2.1 
World population by region, 1950–20502,3 
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Between 1990 and 2015, the average expected number 
of children per woman (total fertility rate) fell close to 
or below replacement level (2.1 children) in all regions 
except the African Region and the Eastern Mediterranean 
Region (Figure 2.2). The fertility rate is now at or below 
replacement level in 44% of countries, including Brazil, 
China, the Russian Federation and the United States of 
America. The total fertility rate for the African Region is 
projected to remain high until after 2030.2 
Projections indicate that approximately 2.1 billion babies 
will be born worldwide during 2015–2030, an increase of 
almost 3% of the total number of births in the previous 15 
year period. Half of these babies will be born in Asia and 
one third in Africa. Over the same period, the total number 
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of women of reproductive age is projected to increase by 
9% and reach 2.0 billion in 2030. Even though the average 
births per woman is projected to decline in Africa, the 
number of reproductive age women is projected to increase 
by 47% by 2030, which yields a projected increase in 
numbers of births of 24%.2
High fertility has multiple consequences for health and 
health-related issues. Continued rapid population growth in 
low- and lower-middle-income countries, along with higher 
fertility rates in the poorest segments of the population, 
is likely to make it harder for those countries to eradicate 
poverty and inequality, combat hunger and malnutrition, 
invest in education and health, improve access to basic 
services, plan and develop cities, protect local ecosystems 
and promote peaceful and inclusive societies. 
Global reproductive, maternal, newborn and child health 
programmes will remain focused on Africa and Asia, 
which together account for more than four fifths of global 
fertility. Especially in Africa, high fertility rates and rising 
numbers of women of reproductive age have considerable 
implications for the efforts to achieve the SDG targets for 
ending preventable child and maternal deaths. Investments 
in reproductive health, especially in family planning, are 
needed to ensure that all women and men can achieve their 
desired family size. In addition, reducing child mortality and 
poverty are critical to reducing fertility and accelerating the 
demographic and epidemiological transitions.
Interventions before school age have very substantial 
benefits for children throughout schooling and life.4 The 
continued high fertility of Africa makes it more difficult 
to implement low-cost but effective early childhood 
development interventions for countries with limited 
financial and human resources.
For countries in demographic transition, where age 
structures change rapidly, a reorientation of the health 
sector is critical. For example, in countries where fertility 
and mortality levels have fallen, progressively greater 
resources need to be committed to adult health and ageing 
 1990    2015    2030    Replacement level   
Figure 2.2 
Trends in fertility by region, 1990–20302,3
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populations as opposed to maternal and child health and 
to infectious diseases. The demographic transition is 
accompanied by an epidemiological transition where NCDs, 
mental health disorders and injuries become much more 
prominent as a cause of death and disability than infectious 
diseases. Figure 2.3 shows where countries are in the 
epidemiological transition, using years of life lost (YLL) due 
to reproductive, maternal, child health and undernutrition 
and infectious diseases – the MDG conditions – on the one 
hand (y-axis), and NCDs and injuries on the other hand 
(x-axis). At the top, there are 22 African countries where 
the poverty-related conditions are still responsible for more 
than 70% of all YLL. At the other end of this epidemiological 
shift, there are 48 countries where NCDs and injury-related 
conditions cause at least 90% of all YLL.
The youth bulge
Globally, the total number of young people is at an all-time 
high, with 1.8 billion people between the ages of 10 and 
24 in 2015 and nearly 2.0 billion projected by 2030. The 
number of adolescents and youth between ages 10 and 24 
in the African Region will increase from 315 million in 2015 
to 453 million in 2030.2
The youth bulge, where a large proportion of the total 
population is youths or adolescents between ages 10 and 24 
or 15 and 24 (showing a “bulge” in the population pyramid), 
19ECONOMIC, SOCIAL AND ENVIRONMENTAL CONTEXT OF HEALTH
Figure 2.3 
Countries at different stages of the epidemiological transition from MDG conditions to NCDs and injuries as the main causes of years of life lost (YLL), 20125
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has been a common phenomenon in many countries during 
the MDG period (Figure 2.4). High fertility and, to a lesser 
extent, declines in child mortality are the main causes. 
A rapid fertility decline, such as occurred in the Western 
Pacific Region, may also give rise to a temporary increase 
of the youth bulge. In the African Region, more than 30% 
of the population is between ages 10 and 24, and this 
proportion will not change much in the coming 15 years. 
The youth bulge is projected to decline in the Eastern 
Mediterranean Region, although the proportion of the 
population between ages 10 and 24 will still be over 30% 
in 2030 for several countries, including Afghanistan, Iraq, 
Somalia and Yemen.2 
In a country with a youth bulge, if most young adults 
entering the workforce can find productive employment, 
then the level of average income per capita should 
increase, producing a “demographic dividend”. However, 
if many young people cannot find employment or earn a 
satisfactory income, then the youth bulge may become 
a potential source of social and political unrest,6 while 
young people themselves may become more susceptible 
to mental disorders such as depression. Globally, the youth 
unemployment rate is nearly three times higher than the 
adult rate, and highest in the Middle East.7 
The prominence of youth in the population and the 
importance of improving health behaviours and services for 
adolescents needs much more attention in many countries. 
This includes extending the improvements in maternal and 
child health to adolescents, a focus on health promotion and 
preventive measures, and on intersectoral approaches.8 For 
example, reducing road injuries, the top cause of mortality 
in 10–19-year-olds, will require action across a range of 
services, from education to transportation. Furthermore, 
investing in health during adolescence can have critical 
benefits for health throughout the life course, influencing, 
for example, behaviours associated with an increased risk 
of NCDs.
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Trends in proportion of youth age 10–24, by region, 1990–20302,3
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Ageing
Populations around the world are rapidly ageing.9 These 
older populations are a significant human and social 
resource, and this demographic transition therefore presents 
enormous opportunities to society. However, it will also be 
accompanied by a number of serious challenges. Global life 
expectancy increased, from 64 to 71 years between 1990 
and 2015, an unprecedented rate of increase (see Chapter 
1, Box 1.1). The number of people 60 and older reached 901 
million in 2015 and will increase by 56% in the SDG era to 
around 1.4 billion people in 2030, of whom over 650 million 
will be 70 or older.2 The dramatic increases will occur in all 
regions except the African Region, where a modest increase 
can be expected (Figure 2.5). By 2030, 71% of older people 
will live in low- and middle-income countries. China will 
have almost the same proportion of older people as the 
United States.
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Figure 2.5 
Trends in proportion of population age 60 and older, by region, 1990–20302,3
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Population ageing will increase the proportion of the older 
population relative to the younger population, and will 
challenge the traditional framing of the life course around a 
defined working age, followed by retirement. The projected 
trends of the ratio of people over age 65 compared to those 
aged 15–64 years show the large differences in population 
age structure between regions. During the MDG period, the 
ratio increased only slightly or not at all in most developing 
regions (Figure 2.6). However, the situation is projected to 
change drastically during the SDG period, with substantial 
increases in the ratio in all regions except in the African 
Region.
Despite the fact that many middle-income countries 
and even some low-income countries have expanded 
pension coverage through a mix of contributory and non-
contributory schemes, nearly half of all older people do not 
receive any form of pension and, for many of those who 
do, the level of support is inadequate.10 Large numbers of 
older people are entering retirement age in countries where 
significant social support systems have yet to be put in 
place. There is thus an urgent need to expand coverage, 
both in countries that have yet to put systems in place 
and in countries that already have such systems. Clearly, 
this presents fiscal challenges. However, inadequate social 
protection constitutes a major obstacle to sustainable 
development, as it is associated with high and persistent 
levels of poverty and inequality.
Declining mortality rates at older ages in the last three 
decades suggest that with appropriate interventions it 
is possible to sustain longevity gains in all countries.11 
However, it is not at all clear if these gains in life expectancy 
at older ages have been coupled with increasing years 
of life gained in good health, mainly because of chronic 
NCDs such as musculoskeletal conditions and dementia.12 
A recent analysis shows that patterns of limitations in 
functioning vary across countries and within countries 
over time to a significant extent, with some suggestion in 
high-income countries that subsequent generations may 
live longer in better health than those preceding them.13 
However, recent studies from high-income countries have 
raised questions regarding these health gains, given rises 
in obesity and related risk factors in the baby boomer 
cohort.14,15,16,17 While health declines as we grow older, this 
fall is even more significant in the oldest group, the most 
rapidly growing segment of the older population. The health 
status of this group is worse in poorer countries, among 
women, those with lower education and those with lower 
levels of income across all countries.
The health SDG of ensuring healthy lives and promoting 
well-being for all at all ages cannot be achieved without 
attention to the health of older adults, which is now 
an important agenda for all countries. This will require 
major shifts in the way health systems are designed. The 
strategy should include a focus on primary prevention as 
well as on managing declines in functioning. Poor health 
is not an inevitable outcome of ageing, and many of the 
health problems that confront older people are associated 
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Figure 2.6 
Trends in the population age 65 and older as a percentage of the population age 
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with chronic conditions that can be prevented, delayed 
or managed. Increasingly, medicine and technology also 
provide assistive devices that compensate for sensory and 
motor disabilities. Environmental interventions can ensure 
that even those with significant losses in capacity can still 
get where they need to go and do what they need to do.
In general, health systems will need to find effective 
strategies to extend health care and respond to the needs 
of older adults. In order to meet the target on UHC, the 
specific needs of older adults, often with complex, multiple 
chronic health conditions, will have to be addressed by 
health systems.18,19 This will also require financial protection 
against catastrophic health spending to ensure that health 
interventions produce equitably distributed health gains. All 
societies also need sustainable models of long-term care 
and support that allow everyone to maintain lives of dignity 
and meaning, even in the presence of significant losses in 
functioning. The number of people requiring long-term care 
and support is forecast to double by 2030.9
Migration
We live in an era of great human mobility, with more people 
on the move today than ever before. The total number of 
international migrants is estimated to be 232 million or 
3.2% of the global population for 2013. Half of international 
migrants who were born in the developing regions (the 
“global South”) moved to the developed regions (the “global 
North”) in 2013 (Figure 2.7).20 
While no substitute for development, migration can be 
a positive force for development when supported by the 
right set of policies. For example, migration could help 
harmonize the very different economic and demographic 
conditions across countries as the world moves towards 
its peak population. At the same time, the emigration of 
highly skilled workers such as doctors and nurses can have 
considerable negative impact.21
Migration could also re-emerge as both a cause and result 
of conflict within and between countries. Some high-
income countries are already drastically limiting the rights 
of refugees to seek asylum. The rise in global mobility, the 
growing complexity of migratory patterns and their impact 
on countries, migrants, families and communities have all 
contributed to international migration becoming a priority 
for the international community. 
The factors promoting cross-border migration are likely to 
remain strong or intensify and international migration is set 
to grow even faster than it did in the past quarter-century.23 
Determinants of migration levels include disparate age 
structures and income inequalities between richer and 
poorer countries, easier transportation at lower cost, 
the presence of migrant networks that link sending and 
receiving countries, and improved communications. Internal 
migration affects much larger numbers of people, and 
generally takes the form of rural to urban migration in low- 
and middle-income countries. 
Conflict and persecution also drive migration and, in 2014, 
the total number of people displaced by war, conflict or 
persecution reached a record high of nearly 60 million 
globally, an increase of 8.3 million from the previous year24 
(Figure 2.8). Of these 60 million displaced persons, almost 
20 million are refugees, 38 million are displaced inside their 
own countries and 1.8 million are awaiting the outcome of 
claims for asylum. The global number of refugees, asylum 
seekers and internally displaced people had ranged between 
38 and 43 million for most of the past decade, but started 
to increase in 2012, due to conflicts in the Central African 
Republic, Iraq, South Sudan, the Syrian Arab Republic and 
Ukraine among others.
In some countries, towards the end of the SDG timeframe, 
environmental factors and climate change may play a 
greater role as a driving force, as they will almost certainly 
have greater adverse impacts in poorer countries of Africa 
and Asia.
Many migrants, especially victims of human trafficking, 
run increased health and mortality risks. For instance, over 
2700 migrant deaths have been recorded in the first half of 
2015, the majority of these in the Mediterranean Region.25 
Migrants often have little or no access to health and social 
services, although they have much greater health risks 
related to exploitation, dangerous working circumstances 
and substandard living conditions. Eliminating human 
trafficking is a priority task for the global community. 
Figure 2.7 
South–South migration is as common as South–North migrationa,20,22
a Based on migrant stock data, 2013; North: developed regions; South: developing regions
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The recent influx of refugees into Europe is a vivid reminder 
for all countries of the importance of preparedness. All 
countries will need to have measures in place to minimize 
the potential adverse health consequences of migration, 
including protective laws and policies and health services 
in refugee settings. Health issues associated with migration 
present key public health challenges faced by governments 
and societies, as was reflected in a resolution on the health 
of migrants that was endorsed by the Sixty-first World 
Health Assembly in May 2008.26 Many migrants do not 
have access to health care and longer-term migrants may 
also face difficulties in getting legal identity and citizenship. 
It will be important to ensure that UHC is interpreted as 
relating to all de facto residents, not just citizens.
Figure 2.8 
Trends in number of people displaced by conflict, 2005–201424 
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The SDGs include several targets relating to migration 
generally (8.1, 10.7, 10.c) as well as one (3.c) explicitly 
relating to the health worker “brain drain” from low- and 
middle-income countries to high-income countries, a 
phenomenon that has increased with globalization. The 
2010 WHO Global Code of Practice on the International 
Recruitment of Health Personnel27 highlighted these issues, 
drawing attention, in particular, to the problem of richer 
countries recruiting from poorer nations that are struggling 
with health worker shortages. The Code was voluntarily 
adopted in 2010 by all of the then 193 WHO Member 
States, but thus far implementation has been disappointing. 
Greater collaboration among state and non-state actors is 
needed to raise awareness of the Code and reinforce its 
relevance as a potent framework for policy dialogue on 
ways to address the health workforce crisis.28 The Code 
links directly with SDG Target 3.c.
Urbanization
Since the MDGs were adopted in 2000, urban areas have 
grown by more than 1 billion new inhabitants. The urban 
proportion of the global population increased from 43% in 
1990 to 54% in 2015, and it is projected that by the time the 
SDG draw to a close in 2030, 60% of the world’s population 
will live in urban areas. The world’s rural population is 
expected to reach its peak in a few years and will gradually 
decline to 3.2 billion by 2050 (Figure 2.9).29 This leaves 
virtually all of global population growth in the projectable 
future in urban areas. This is still due in greater part to cities’ 
natural growth, where fertility outpaces replacement level,30 
but is also explained by migration. More than 1 billion people 
on the planet are, or were migrants, the majority of which 
settle in urban areas.31 
Figure 2.9 
Trends in urban and rural population of the world, 1950–205029 
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Urbanization is occurring across all world regions. Africa and 
Asia, where urbanization is just below 50%, are projected 
to experience the most rapid urbanization in coming years. 
The number of cities with a population of 1 million or more 
increased from 270 to 501 during the MDG period, and is 
projected to increase to 662 by 2030. The number of mega 
cities of more than 10 million people will increase from 29 
in 2015 to 41 in 2030, and more than half of these cities 
will be in Asia.29 
Urbanization has been accompanied by an increase in urban 
slums. Slums are characterized by overcrowding, poor 
access to safe drinking-water or sanitation, poor housing 
conditions and lack of secure tenure. In 2000, the number 
of slum dwellers in developing countries was estimated to 
be 767 million; by 2010 it rose to an estimated 828 million, 
and by 2020 is projected to reach 889 million. More than 
60% of sub-Saharan Africa’s urban inhabitants and more 
than 30% of urban populations of Southern Asia and South-
East Asia live in slums.32
Urban health inequalities are a growing concern.33,34 For 
example, Figure 2.10 shows that in urban areas of selected 
46 countries, children in the poorest quintile were more 
than twice as likely to not survive till their fifth birthday 
compared to children in the richest quintile. In only one 
country was the national MDG target for reducing under-
five mortality achieved for children in the poorest wealth 
quintile. 
About half of urban dwellers live in smaller cities of less than 
half a million. It is in these cities that most urban growth will 
occur as they expand along highways and coalesce around 
crossroads and coastlines, often without formal sector job 
growth and without adequate services. 
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The provision of health services for the urban poor is a 
critical part of the SDG health targets, including UHC, 
and of SDG Target 11.1: “By 2030, ensure access for all to 
adequate, safe and affordable housing and basic services 
and upgrade slums”. Urbanization brings opportunities for 
health, through the concentration of people, resources and 
services, which results in better access to health services 
and more scope for public health interventions. However, 
rapid unplanned urbanization may also increase the risks 
of infectious disease transmission, promote adverse trends 
in NCD risk factors such as obesity and increase the risks 
of road injury and violence, and exacerbate environmental 
degradation with impacts on health such as air pollution, 
poor water quality, and unavailable sanitation. Therefore, 
special attention will need to be given to better monitoring 
of the health situation of the urban poor, and to establishing 
Figure 2.10 
Socioeconomic inequality in under-five mortality between richest and poorest 20% of households in urban areas35
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and implementing policies and programmes that reduce the 
risks of illness and death due to unsafe water and sanitation, 
violence and injuries, poor housing conditions and air 
pollution. Strong health promotion (e.g. for HIV and NCDs) 
and affordable health services will be an important part of 
any response, and need to be driven by local governments 
and communities. 
ECONOMIC DETERMINANTS 
OF HEALTH AND FINANCING 
FOR DEVELOPMENT
The MDGs mobilized the collective efforts of countries 
and the development community to end extreme poverty, 
reduce hunger, promote gender equity and improve 
education and health. Despite substantial progress in 
reducing the numbers of people living in extreme poverty, 
many millions of people around the world continue to suffer 
from deprivation. Some countries, especially those affected 
by conflict and civil strife, remain trapped in a vicious spiral 
of underdevelopment, inequity and grinding poverty. 
The social gradient in health that runs from top to bottom 
of the socioeconomic spectrum is a global phenomenon 
that is seen in low-, middle- and high-income countries. 
Specific examples of this phenomenon, relating to child 
and maternal health outcomes, are presented in Chapter 4. 
The world has changed, and no longer consists of a large 
group of poor countries and a small group of rich ones. Today, 
many low-income countries have “graduated” from the 
World Bank Group’s low-income classification group to reach 
middle-income status. In fact, between 2000 and 2013, the 
number of low-income countries fell from 63 to 34 such that 
there are now 105 middle-income countries. This group of 
countries are very diverse and include populous countries 
such as China and India and many small island states, 
as well as countries with stable economies and countries 
in conflict.36 Moreover, progress for many socioeconomic 
development targets in relation to health and development 
vary widely across these countries. This means that extreme 
poverty is no longer concentrated in poor or fragile states 
but in richer middle-income countries. While only relatively 
few countries are the main contributors to levels of extreme 
poverty (i.e. India, Nigeria, China, Bangladesh and the 
Democratic Republic of Congo) – poverty also continues 
to persist among the most disadvantaged within several 
high- and middle-income countries. As a result, around three 
quarters of the world’s absolute poor live in middle-income 
countries that are today less dependent on (and no longer 
eligible for) development assistance.37
As such, an approach to poverty reduction based on 
externally financed development is becoming rapidly 
outdated. Rather than thinking about poor countries 
perhaps the approach should focus on poor individuals. In 
other words, attention to reducing poverty in low-income 
countries should be expanded to middle-income countries 
and concerns for the distribution of poverty internationally 
should consider the distribution of poverty within national 
boundaries. In addition, provision of “traditional” aid in the 
form of transferring resources could increasingly adapt to 
today’s global context and take the form of supporting the 
development of national policies and institutional structures 
to use available resources well, regardless of the source.
The SDGs reflect this change by emphasizing a much 
broader approach to poverty reduction strategies to improve 
not only health, but also to enhance progress across the full 
range of SDGs relating to health and nutrition, education, 
governance, economic reform, marginalized populations, 
gender discrimination, and violence and conflict. The first 
MDG was to eradicate extreme poverty and hunger, and had 
three targets, including one on nutrition. In contrast, there 
are several SDG targets that focus directly on eradication 
of poverty and hunger, and many other targets that will 
also contribute to poverty reduction and development. 
Moreover, inequality is more central in the SDGs than in 
the MDGs, especially in SDG 10, which calls for efforts “to 
reduce inequality within and among countries”. Similarly, 
while globalization and trade-related issues were addressed 
as part of MDG 8, they have a more prominent position in 
the SDGs, reflected in the multiple targets on economic, 
social and environmental issues (e.g. Target 17.10 on 
trade and Target 3.b on research and access to essential 
medicines and vaccines). 
This next section focuses on poverty eradication and income 
inequality, globalization and trade, and global financing for 
health and development.
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Poverty eradication and income inequality
The world attained the MDG target – to cut the 1990 
poverty rate in half by 2015 – in 2010, and the target was 
met in all regions, except sub-Saharan Africa. In 2015, 
836 million people globally live on less than US$ 1.25 per 
day, compared with 1.9 billion in 1990. In the developing 
world, 14% of the population live on less than US$ 1.25 
per day in 2015, down from 47% in 1990.38 Progress has 
been harder won at higher poverty lines, such as US$ 2 
per day. The world’s most populous countries, China and 
India, have played a central role in the global reduction of 
poverty (although India still has 30% of the world’s extreme 
poor; Figure 2.11) and most of that reduction is related to 
growth in labour-intensive sectors of the economy. Direct 
income transfers to the poor, remittances and changes 
in demographic patterns have contributed much less.39 
Despite positive trends, about one in seven people in 
developing regions still lives on less than US$ 1.25 per day. 
In sub-Saharan Africa, more than 40% of the population still 
lives in extreme poverty in 2015.38 Middle-income countries 
are home to 73% of the world’s poor people.40 
Figure 2.11 
Top 10 countries with largest share of the global extreme poor,a 201141
India
30%
Nigeria
10%
China
8%
Democratic Republic 
of the Congo
5%
Rest of the world 
28%
Bangladesh
6%
Indonesia
4%
United Republic of 
Tanzania 
2%
Madagascar
2%
Ethiopia
3%
Pakistan 
2%
a People living on less than US$ 1.25 per day. 
Poor people become “trapped” in poverty for a number of 
reasons, including the inability to access credit or own land, 
governance failures, and because low levels of education, 
skills or health hinder their ability to seize opportunities 
arising from a general expansion of economic activity. The 
poor also tend to be more vulnerable to economic “shocks” 
– mainly due to health events as well as weather-related 
natural disasters and broad economic crises – that push 
households below the poverty line and keep them there.42 
While globalization is associated with increasing average 
incomes in many countries, there is concern that it is also 
causing widening income inequality between and within 
countries.43,44,45 Income inequality affects all countries 
around the world, and there is clear evidence that people 
with lower income have worse health outcomes across a 
broad range of indicators.46,47 In developed and developing 
countries alike, the poorest half of the population often 
controls less than one tenth of the country’s wealth.48 
Failure to address income inequality is likely to reduce the 
sustainability of economic growth, weaken social cohesion 
and security, and increase risk of conflict.
MDG Target 1.C, which called for a halving of the proportion 
of people who suffer from hunger was almost achieved, 
with a reduction from 23.3% in 1990–1992 to 12.9% in 
2014–2016 (projected).38 This occurred despite major 
global challenges such as natural disasters and adverse 
weather events, volatile commodity prices, higher food 
and energy prices, rising unemployment and economic 
recessions in the late 1990s and in 2008–2009. There 
has also been significant progress on the child nutrition 
indicators (underweight and stunting in children under 
five years), an issue that is presented in Chapter 4. The 
current trends and projections indicate the importance of 
continued targeting of programmes for the poor, whether 
directed at the poorest countries, poorest regions or poorest 
populations within countries. Progress needs to be measured 
based on disaggregated health and nutrition indicators. 
The 2001 report of the Commission on Macroeconomics 
and Health made a valuable contribution to global and 
country dialogues regarding the economic benefits of better 
health and the costs of achieving it,49 showing, among 
other things, the large economic returns to be derived 
from investing in health. It is estimated that reductions in 
mortality account for about 11% of recent economic growth 
in low- and middle-income countries as measured by 
their national income accounts.50 Subsequently, the 2008 
report of the Commission on Social Determinants of Health 
complemented this message, by adding to evidence on the 
health returns, in particular in relation to reducing health 
inequalities from optimizing policies in other sectors.51 
A common theme related to optimizing policies in other 
sectors was to address inequalities in power, money 
and resources, which was one of the three overarching 
recommendations. It is estimated that health gains from 
policies in other sectors have been considerable. Of 
improvements in child under-five mortality rates between 
1990 and 2010, 50% were attributed to non-health sector 
investments.52 Also, reducing inequalities in NCDs requires 
substantial non-health sector investments, especially for 
cardiovascular diseases and lung cancer.53 Policies and 
programmes addressing income inequalities, such as cash 
transfers and active labour policies, have demonstrated 
benefits for health and the economy.54
Ensuring that investing in health is perceived as a necessary 
and effective way to combat poverty and ensure economic 
progress requires an ongoing dialogue between health and 
finance executive bodies. One way to open and maintain 
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that dialogue is to demonstrate an awareness of fiscal 
constraints to establish credibility by generating and 
using evidence to show that we can make efficient use of 
resources to deliver optimal services. To deliver, in other 
words, “more health for the money”.55 
Globalization and trade
In the past few decades, and in all parts of the world, 
there has been an increase in global economic, financial, 
political and social integration and cooperation, as attested 
by the KOF index of globalization, which combines a set 
of relevant economic, social and political indicators in a 
synthetic index on a scale of 0 to 100 (Figure 2.12).56,57 
High-income OECD countries have experienced the highest 
levels of globalization, and the African Region and Eastern 
Mediterranean Region the lowest. 
Increasing global economic integration is associated with 
the development of global forms of governance related to 
trade and intellectual property, as well as transnational 
standards and actions in the political, social, human rights 
and environmental spheres. Globalization comprises, 
among other things, growing integration of markets and 
nation states, receding geographical constraints on social 
and cultural arrangements, broader dissemination of ideas 
and technologies, growing threats to national sovereignty 
by transnational actors and the transformation of the 
economic, political and cultural foundations of societies. 
Globalization has both positive and negative implications 
for global health. It is likely that the growth in world trade 
has also led to job and income growth, and has stimulated 
the growth in labour-intensive sectors of developing 
country economies that have been responsible for much 
of the progress in poverty reduction. On the other hand, 
global connectedness helped spread the impact of the 
global financial and economic crisis of 2008–2009 to 
countries that had nothing to do with it. Many governments 
underwent expenditure contractions, which dragged down 
economic growth prospects and cast doubts on the ability 
of markets to generate new and decent jobs.59 In 2014, 
201 million people were unemployed worldwide; this is 31 
million more people than before the global crisis in 2008. 
Global unemployment is expected to continue to increase 
by 3 million in 2015 and another 8 million over the next 
four years.60 Youth unemployment is a matter of particular 
concern (see also the section on population trends in this 
chapter), and prominent in SDG 8 on sustained inclusive 
growth and employment.
The new century has also seen a transformation in the 
relative power of the state on the one hand, and markets, 
civil society and social networks of individuals on the other. 
The role of the private sector as an engine of growth and 
innovation is not new, often transcending borders through 
multinational companies. Governments retain the power 
to steer and regulate, but it is now difficult to imagine 
significant progress on issues of global importance, such as 
health, food security, sustainable energy and climate change 
mitigation, without the private sector playing an important 
role. Similarly, in low-income countries, resource flows 
from foreign direct investment and remittances far outstrip 
development support and, in the case of remittances, have 
often proved to be more resilient than aid in the face of an 
economic downturn.61
Globalization also has implications for epidemiology, 
notably by facilitating the spread of communicable diseases 
and associated risks due to increased movement of people 
and goods around the globe – for example, through 
international travel and migration and trade in animals 
and goods. In addition, the globalization of markets (and 
marketing) supports the spread of NCDs by changing diets 
and lifestyles. Globalization may also have mixed impacts 
on health and health systems. For instance, low-income 
countries may lose health workers, but globalization may 
enable faster, coordinated action against health threats.
The World Trade Organization (WTO) was established 
in 1995 to govern global trade, including areas that have 
direct and indirect implications for public health. Around 
the same time, the emerging agreement on Trade Related 
Aspects of Intellectual Property Rights (TRIPS) established 
minimum standards of protection for each category of 
property rights and stimulated debate on pharmaceutical 
patents. In 2001, the Doha Ministerial Declaration on the 
TRIPS Agreement and Public Health granted increased 
flexibility for Member States to take measures to protect 
public health and promote access to medicines in certain 
circumstances.62
In 2003, the World Health Assembly expressed concerns 
about access to medicines in developing countries and the 
implications of the current patent protection system, and 
urged Member States to adapt national legislation to exploit 
the flexibilities contained in the TRIPS Agreement. In 2004, 
Member States were further encouraged to ensure that 
bilateral trade agreements take into account the flexibilities 
contained in the WTO TRIPS Agreement as recognized by 
the Doha Declaration. 
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The main outcome of these various initiatives and 
discussions was a significant drop in the price of certain 
drugs. For example, the 100-fold reduction in the price of 
antiretroviral medicines against HIV/AIDS since 2000 and 
the global effort to increase access to such therapies, notably 
in sub-Saharan Africa, was made possible by the successful 
implementation of the TRIPS Agreement, including the 
production of much cheaper but nevertheless high-quality 
generics (see Chapter 5). However, the failure to complete 
the Doha Round, and the increase in mega-regional trade 
agreements such as the Trans-Pacific Partnership (TPP) 
and European Union–United States agreements, could 
strengthen intellectual property protection in ways that 
could undermine access to medical products.
Within the SDG health goal, Target 3.b reiterates the 
importance of access to affordable essential medicines 
and vaccines, in accordance with the Doha Declaration 
on the TRIPS Agreement and Public Health. Reducing the 
costs of essential medicines, vaccines and technologies in 
developing countries continues to be a major priority as 
globalization and trade liberalization continue.
Development assistance for health
Much of the improvement in the availability and use 
of services and in health and development outcomes 
since 2000 was facilitated by a substantial increase in 
development financing, including for health. In 2013, 
total health spending reached US$ 7.3 trillion, more than 
double the amount spent in 200063 and the increase in 
development assistance for health has been one of the 
features of the MDG era. Disbursements for development 
assistance for health tripled after 2000 (Figure 2.13), 
growing at a faster rate than domestic health spending, 
although the rate of growth has slowed since the financial 
crisis of 2008–2009. This external financial support for 
health was targeted particularly at initiatives related to the 
three health goals highlighted in the MDGs, representing 
an estimated 61% of all development assistance for health 
disbursed from 2000 to 2014.
Domestic spending – both government and private – 
also increased substantially and, despite growing more 
slowly than development assistance for health, remains 
the dominant source of health financing even in low-
income countries, where it represented 75% on average 
in 2013. This growth in domestic spending was facilitated 
by continued strong economic growth in most low- and 
middle-income countries despite the economic crisis.
Nevertheless, total health spending from domestic and 
external sources combined remained below a proposed 
target of US$ 86 per capita65 in 39 countries in 2013, and 
included six countries that spent less than US$ 20 per 
capita.63 On the other hand, the dependence of health 
systems on out-of-pocket spending has also fallen during 
this period. At the population-level, this facilitates people’s 
ability to use needed health services and reduces financial 
catastrophe and impoverishment. However, this spending 
remains high for many individuals in many countries, so still 
constitutes a barrier to access for many, and poses a risk 
of impoverishment and long-term financial problems for 
those who do get care.
The contributions from public–private partnerships, such 
as GAVI and the Global Fund, and nongovernmental 
organizations (including foundations) have expanded.66 
This has brought in new funding, while also supporting 
innovative approaches and the large-scale introduction 
of new technologies into routine systems at affordable 
prices; but it has also focused resources on vertical 
disease programmes, in some instances unbalancing and 
fragmenting health systems, leaving multiple gaps such 
as weak disease surveillance and response systems – as 
were exposed by the recent Ebola epidemic in West Africa 
– or inadequate resources to meet the rapidly growing 
NCD epidemic.
The SDGs present an opportunity for a shift in emphasis 
away from the funding of vertical programmes towards 
more system-wide, cross-cutting support, consistent with 
the aim of UHC. For example, health Target 3.c specifically 
calls for efforts to “substantially increase health financing 
and the recruitment, development, training and retention 
of the health workforce in developing countries, especially 
in least developed countries and small island developing 
states”. There are also multiple targets under other goals 
that are relevant in this context that encourage states 
to commit funds according to their own priorities such 
as Target 10.b to “encourage ODA and financial flows, 
including direct investment, to States where the need is 
greatest, in particular least developed countries, African 
countries, small island developing States and landlocked 
developing countries, in accordance with their national 
plans and programmes”. Other references, such as Target 
17.2, encourage high-income countries to maintain their 
commitment to ODA. 
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Development assistance for health by health focus area, 2000–201464
 HIV/AIDS    TB, malaria and other infectious diseases    
 Maternal, newborn and child health    Other
a Preliminary estimates.
20
14
a
20
13
a
20
12
20
11
20
04
20
03
20
02
20
01
20
09
20
08
20
07
20
06
35
30
25
20
15
10
5
0
28 HEALTH IN 2015: FROM MDGs TO SDGs
One of the challenges we face as we move into the SDG era is 
the increasingly complex and fragmented institutional global 
health landscape; and incentives that favour the creation 
of new organizations, financing channels and monitoring 
systems over the reform of those that already exist risk 
exacerbating tendencies to overlap, duplicate and interfere. 
Financing for development is also diversifying beyond 
ODA, and sources of development financing of growing 
importance include funds and foundations, nongovernmental 
organizations, civil society organizations and direct giving 
platforms. For instance, the contribution of philanthropic 
organizations to development increased by a factor of 10 
between 2003 and 2012, notably among them the Bill 
& Melinda Gates Foundation. In the context of the Paris 
Declaration on Aid Effectiveness and the Accra Agenda for 
Action, health has had a combined leadership and tracer 
role. It was also demonstrated, through initiatives such as 
the International Health Partnership and related initiatives 
(IHP+)67 and Harmonization for Health in Africa, that despite 
the many different players, coordination around national 
health strategies can be improved. Such approaches extend 
beyond the UN to include bilateral development agencies, 
development banks and nongovernmental organizations, and 
can show increases both in efficiency and in health outcomes.
Global revenue flows for health financing are likely 
to continue to change50 as the principles underlying 
development aid shift from an emphasis on donor–recipient 
relations based on financial contributions to reflect concepts 
of cooperation and partnership, involving diverse types of 
support and exchanges.68 After a period of dramatic growth 
in development assistance since 2000, it is possible that 
the lower growth rates evident since 2009 will continue. 
More importantly, the economic growth in many low- and 
middle-income countries has provided, and will continue to 
provide, major opportunities for increasing domestic health 
investments. Increased domestic efforts to mobilize more 
government revenues and increase the priority for health 
in public resource allocation, alongside efforts to improve 
efficiency in the use of funds, would accelerate this progress. 
As part of the Addis Ababa Action Agenda,69 countries 
agreed on a broad package of over 100 measures that 
draw upon all sources of finance, technology, innovation, 
trade and data to support the implementation of the SDGs. 
Notable among these measures are the promotion of more 
efficient government revenue collection and a reduction in 
tax avoidance and illicit financial flows. These measures 
are essential for expanding the fiscal space and thus vital 
to making progress on the health goal and targets in the 
SDGs, and in particular UHC. Strengthening domestic 
resource mobilization in low- and middle-income countries 
should enable ODA to be focused on mainly the poorest 
countries.68 However, for other low- and some lower-
middle-income countries, the need for external financial 
assistance will not be eliminated.
The composition of development assistance for health also 
needs to adapt to the rapidly changing epidemiological 
transition away from infectious diseases towards NCDs 
and injuries, and the complex socioeconomic patterns of 
disease and risk factors that appear in different countries. 
It also needs to address emerging global threats such as 
antimicrobial resistance, emerging infections and climate 
change. The world must ensure that global public goods 
such as health research and development for diseases that 
affect developing countries and the setting of global norms 
and standards are adequately financed.50
Many of the world’s poorest people will remain dependent 
on external financial and technical support. It is, therefore, 
likely that the greatest need – as well as the focus of much 
traditional development finance – will become increasingly 
concentrated in the world’s most unstable and fragile 
countries, which are often unpopular with donors in terms 
of fiduciary risk. As a result, donors are likely to favour their 
own parallel systems over national ones and thus limiting 
their contribution to strengthening national capacity. This 
also raises important questions about how the work of 
the UN in other, less poor, countries will be financed. The 
Busan Partnership for Effective Development Co-operation, 
which was formed after the meeting on development in 
the Republic of Korea in 2011, signalled that a framework 
based on “aid” has given way to a broader, more inclusive, 
international consensus that emphasizes partnership 
approaches to cooperation, particularly South–South and 
triangular relationships.70 
SOCIAL DEVELOPMENT
In addition to the direct continuation of MDGs 2 and 3 
in the SDGs 4 and 5, on education and gender equality, 
respectively, the SDGs also give much greater weight to 
human rights and to equity – particularly with Goal 10 to 
reduce inequality – than was the case with the MDGs.
Gender equality and rights 
Gender inequality is expressed in a variety of ways, 
including mistreatment of one sex by another, differences 
in power and opportunities in society, and differences in 
access to health services. Gender inequalities in education, 
employment and civil liberties carry a cost. They not only 
deprive women of basic freedoms71 and violate their human 
rights, but also negatively affect development outcomes 
for societies as a whole. Gender inequities have adverse 
impacts on health, especially for women. In many countries 
and societies, women and girls are treated as socially 
inferior. Behavioural and other social norms, codes of 
conduct and laws perpetuate the subjugation of females 
and condone violence against them. Unequal power 
relations and gendered norms and values translate into 
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differential access to and control over health resources, 
both within families and beyond. Across a range of health 
problems, girls and women face differential exposures and 
vulnerabilities that are often poorly recognized.72 
The MDGs included a gender equality goal focused on 
gender disparity in education, although it also included 
indicators for female workforce participation and female 
representation in parliament. The SDGs also target gender 
equality (Goal 5) and gender equality is specifically referred 
to in several targets of other goals, including education, 
economic and other rights, as well as targets related to 
violence against women (see Chapter 8) and sexual and 
reproductive rights (see Chapter 4).
During the MDG era, substantial gains were been made 
on several fronts. Gender parity in school enrolment for 
primary education in the developing regions as a whole was 
reached by 2015. Women’s access to paid employment in 
non-agricultural sectors increased globally from 35% in 
1990 to 41% in 2015, with increases, although unequal, 
observed in almost all regions. The average proportion of 
women in parliament has nearly doubled over the past two 
decades, but still only one in five members is a woman.38 
Despite these gains, much remains to be done as we 
move forward into the SDG era, as was underlined by 
the Commission on the Status of Women in 2015, which 
concluded that progress since the 1995 Beijing Declaration 
and Platform for Action had been slow and uneven, with 
major gaps remaining.73 Similar conclusions were reached by 
the Commission on Population and Development in a 2014 
review of the implementation of action of the International 
Conference on Population and Development.74,75
The strong relationship between the status of women and 
health forms the basis for integrated action. Actions for the 
health sector include:
• Enhancing data and statistics: Disaggregation of key 
statistics by gender is critical for monitoring progress, 
identifying key gaps, targeting, etc.,76 including health 
data.72 This includes targets on infectious diseases (3.3), 
NCDs and mental health (3.4), substance abuse and 
harmful use of alcohol (3.5), injuries (3.6) and UHC 
(3.8). 
• Increasing access to quality health care: Comprehensive 
strategies to target gender inequality in health care 
and put into practice policies to ensure equal access 
for women, adolescents and youth to affordable and 
adequate health-care services, including primary health 
care and basic nutrition. 
• Supporting caregiving roles: Approaches to strengthen 
human resources for health must acknowledge the 
critical role played by women as informal caregivers in 
the home and community, whether it concerns HIV/AIDS 
in low-income countries or elderly care in high-income 
countries.72
• Eliminating harmful practices: Policies and strategic actions 
that transform discriminatory social norms and gender 
stereotypes, and eliminate harmful practices including, 
child, early and forced marriage, honour crimes and 
female genital mutilation. 
• Combating violence against women: Violence against 
women remains a substantial obstacle to reaching 
gender equality, and the health sector plays a key role 
in violence prevention and in treating the consequences 
of violence.
• Introducing gender-sensitive policies: Improvement and 
strengthening of gender responsive national policies, 
programmes and strategies.
Human rights
The right to the enjoyment of the highest attainable standard of 
physical and mental health was first articulated in the 1946 
Constitution of WHO,77 and has been echoed in many other 
legally binding human rights conventions.78,79 In 2000, 
the United Nations Committee on Economic, Social and 
Cultural Rights adopted a General Comment on the Right 
to Health, stating that this right extends beyond timely and 
appropriate health care to the underlying determinants of 
health, such as: access to safe drinking-water and sanitation; 
adequate supply of safe food, nutrition and housing; health 
occupational and environmental conditions; and access to 
health-related education and information, including sexual 
and reproductive health.80 
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Most recently, the right to health has been re-emphasized in 
terms of the achievement of UHC (see Chapter 3), while the 
SDG declaration stresses the importance of the Universal 
Declaration of Human Rights (as well as other international 
instruments relating to human rights and international 
law) in a number of places, as a key underlying principle. 
The right to health is closely related to and dependent 
upon the realization of other human rights, as contained 
in the International Bill of Rights, such as the right to food, 
housing, work and education. Human rights, including 
the right to health, are especially important for vulnerable 
groups, such as women, migrants or people with disabilities, 
who may be more likely to face discrimination, stigma and/
or socioeconomic hurdles. 
People with disabilities are a particular matter of concern, 
often facing discrimination and barriers that restrict them 
from participating in society on an equal basis. WHO 
estimates that about 1 billion people worldwide live with 
disability or impairment with a larger proportion living in 
low- and middle-income countries.81 Disability was not 
mentioned in the MDGs, but is implicitly included in SDG 
Goal 3, which is concerned with the health and well-being 
for all, at all ages. Disability is also specifically mentioned 
in other targets on education (4.a), social, economic and 
political inclusion (10.2), sustainable cities (11.7), and equity 
monitoring (17.18). In addition, people with disabilities 
are obviously included in the UHC target, since people 
with disabilities are more likely to have higher health-
care expenditures with higher out-of-pocket payments.82 
The explicit recognition that people with disabilities 
need to have access to appropriate health interventions, 
including interventions for rehabilitation and assistive health 
technologies and products, as part of the goal of moving 
towards UHC provides a major impetus for disability-related 
health initiatives. 
The main strategy going forward is to accomplish the 
objectives of the WHO Global Disability Action Plan 2014-
2021 as agreed by all countries and implement the actions 
required.83,84 The objectives of the action plan are threefold: 
(i) to remove barriers and improve access to health 
services and programmes; (ii) to strengthen and extend 
rehabilitation, assistive technology, assistance and support 
services, and community-based rehabilitation; and (iii) to 
strengthen the collection of relevant and internationally 
comparable data on disability and support research on 
disability and related services.
Education
Education is strongly linked to health and other determinants 
of health, contributing directly and indirectly to better 
health.54 For example, education has an independent and 
substantial causal effect on adult mortality and morbidity,85 
and also affects health indirectly through proximate 
determinants such as nutrition, sanitation and prevention 
and treatment practices. Reciprocally, good health permits 
people to fully benefit from education, while poor health 
is directly associated with poor educational attainment. 
Female education is one of the strongest determinants of 
child survival in all societies.86,87,88 Female education is thus 
a key strategy for ending preventable maternal and child 
deaths, as well as reducing fertility and improving child, 
adult and family health and nutrition. 
The completion of basic education is also widely regarded 
as essential to literacy, numeracy and informed citizenship. 
The participation of at least some proportion of adults at 
the more specialized upper secondary and tertiary levels is 
also critical for promoting individual opportunity, economic 
development and societal well-being. Recent evidence also 
shows some direct links between secondary education and 
health, such as protection against HIV risk.89 
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The MDGs contained a single target to achieve universal 
primary education. Primary school net enrolment rate in 
developing regions reached 91% in 2015, up from 80% 
in 1990, which means that more children than ever are 
attending primary school. However, just over half of all 
countries have achieved universal primary enrolment by 
2015; with 10% close and the remaining 38% far or very 
far from achieving it. This leaves 57 million children out 
of school globally and almost 100 million adolescents in 
low- and middle-income countries not completing primary 
education in 2015. A lack of focus on the marginalized has 
left the poorest five times less likely to complete a full cycle 
of primary education than the richest. A high and growing 
proportion of out-of-school children live in conflict-affected 
zones. As a result, completion rates (Figure 2.14) and the 
quality of primary education are regarded as unsatisfactory 
in large parts of the world.4,38
Gender parity has been achieved at the primary level in 
69% of countries by 2015. At the secondary level, only 48% 
of countries will reach the goal. Child marriage and early 
pregnancy continue to hinder girls’ progress in education. 
Girls remain less likely than boys to ever enter school, 
31ECONOMIC, SOCIAL AND ENVIRONMENTAL CONTEXT OF HEALTH
this is even more the case among girls from poor families. 
By contrast, in many wealthier middle- and high-income 
countries, in Europe and the Americas, girls outperform 
boys in some subjects, and boys are at higher risk of failing 
to complete a cycle of secondary education.4
By 2015, lower secondary enrolment increased by 27% 
globally and more than doubled in sub-Saharan Africa 
compared with the levels in 1999. Nonetheless, one third 
of adolescents in low-income countries will not complete 
lower secondary school in 2015. If current trends continue, 
universal lower secondary completion will only be achieved 
towards the end of this century.
While globally the percentage of illiterate adults fell from 
18% in 2000 to 14% in 2015, this progress is almost 
entirely attributed to more educated young people reaching 
adulthood. Women continue to make up almost two thirds 
of the illiterate adult population. Half of sub-Saharan African 
women do not have basic literacy skills. 
The SDGs have substantially expanded the focus on 
education, with nine targets addressing not only primary 
education and literacy, but also access to quality early 
childhood development, care and pre-primary education, 
secondary and tertiary education and vocational training, 
improved access for marginalized groups, and teacher 
supply. The agenda is ambitious, not just in terms of finding 
the resources to meet the additional costs, but also in terms 
of feasibility, given current rates of progress. The United 
Nations Educational, Scientific and Cultural Organization 
(UNESCO) has estimated that an extra US$ 22 billion per 
year is needed on top of already ambitious government 
contributions in order to achieve the new SDG education 
targets for quality pre-primary and basic education for all 
by 2030.4 
ENVIRONMENT AND CLIMATE 
CHANGE
The environment is under pressure from human activity 
and the climate is changing. Driven largely by economic 
activity and population growth, anthropogenic greenhouse 
gas emissions have increased since the pre-industrial era, 
leading to atmospheric concentrations of carbon dioxide, 
methane and nitrous oxide that are unprecedented in at 
least the last 800 000 years. Their effects, together with 
those of other anthropogenic drivers, have been detected 
throughout the climate system and are extremely likely to be 
the dominant cause of the observed warming since the mid-
20th century.91 In many parts of the world, climate change 
will jeopardize the fundamental requirements for health, 
including clean air, safe and sufficient drinking-water, safe 
excreta management, decent work, a secure and nutritious 
food supply, protection from extreme weather events and 
adequate shelter. Addressing the relationship between 
health, climate change and other major environmental 
factors, such as air pollution, will be of growing importance 
in the coming years.92,93
MDG 7 addressed sustainable development and had one 
environmental target that was specific to human health 
– the halving of the proportion of the population without 
sustainable access to safe drinking-water and basic 
sanitation. The target on drinking-water has been met, 
although disparities persist within and between countries. 
With regard to basic sanitation, however, 2.4 billion people 
still lack access to improved sanitation facilities.94
The SDGs include several targets relating to environmental 
sustainability and human health, notably Target 3.9 “By 
2030, substantially reduce the number of deaths and 
illnesses from hazardous chemicals and air, water and soil 
pollution and contamination”, targets relating to water 
and sanitation (SDG 6), energy (SDG 7), exposure to 
chemicals and all wastes (SDG 12), and natural disasters 
and climate change (SDG 13). Environmental determinants 
of health also have a bearing on a number of other SDGs. 
For example, they are an important consideration in the 
poverty/hunger goal (SDG 1) given that environmental 
risks, such as use of solid fuels for cooking or unsafe 
water and sanitation disproportionally affect the poor. The 
same is true regarding gender inequality (SDG 5) since 
women and girls are the ones most likely to be doing the 
cooking. Those already vulnerable to food insecurity will 
be at increased risk of reduced crop yields linked to climate 
change (SDG 2). The link between decent work (included 
in SDG 8) and occupational health and safety is another 
example and, finally, SDG 11 addresses the safety and 
sustainability of cities and settlements, which is related 
to environmental health determinants such as access to 
safe water and sanitation, road traffic, air pollution and 
physical activity. The following section addresses climate 
change and other environmental risks to health not already 
covered in dedicated sections. Safe water and sanitation 
are addressed in Chapter 5, air pollution in Chapter 6, and 
natural disasters in Chapter 8.
Climate change
According to a growing body of evidence, the climate is 
warming. The globally averaged combined land and ocean 
surface temperature data show a warming of 0.85 °C 
(from 0.65 to 1.06) from 1880 to 2012. In the northern 
hemisphere, the 30-year period from 1983 to 2012 was likely 
the warmest of the last 1400 years.95 It is extremely likely 
that human activity has been the dominant cause of the 
observed warming since the mid-20th century. Models now 
reproduce observed continental-scale surface temperature 
patterns and trends over many decades, including the 
more rapid warming since the mid-20th century and the 
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cooling immediately following large volcanic eruptions. 
The Intergovernmental Panel on Climate Change’s (IPCC) 
most recent projections cover a range of scenarios for 
future greenhouse gas emissions, known as representative 
concentration pathways (RCP). These range from RPC 2.6, 
which assumes that global greenhouse gas emissions will 
peak between 2010 and 2020 and decline substantially 
after 2020, to RCP 8.5, in which greenhouse gas emissions 
continue to rise throughout the 21st century. Intermediate 
scenarios RCP 4.5 and 6.0 assume emissions peak in 2040 
and 2080, respectively.96
The global mean surface temperature change for during 
2016–2035 relative to 1986–2005 will likely be in the 
range from 0.3 °C to 0.7 °C. The increase of global mean 
surface temperatures for 2081–2100 relative to 1986–2005 
is projected to range from 0.3 °C to 1.7 °C (RCP 2.6) to 
2.6 °C to 4.8 °C (RCP 8.5) (Figure 2.15). The Arctic region 
will warm more rapidly than the global mean, and mean 
warming over land will be larger than over the ocean. Across 
all RCPs, global mean sea level is projected to rise from 0.26 
to 0.82 metres by the late 21st century.
It is virtually certain that there will be more frequent hot and 
fewer cold temperature extremes over most land areas on 
daily and seasonal timescales as global mean temperatures 
increase. It is very likely that heat waves will occur with 
a higher frequency and duration. Occasional cold winter 
extremes will continue to occur.
Climate variability and climate change has important 
consequences for health, ranging from the immediate 
impact of extreme weather events, to the longer term 
impacts of droughts and desertification on food production 
and malnutrition, and the increased spread of infectious 
disease vectors for malaria and dengue.97 Long-term climate 
change threatens to exacerbate today’s problems, while 
undermining tomorrow’s health systems, infrastructure, 
social protection systems and supplies of food, water and 
other ecosystem products and services that are vital for 
human health. The poorest and most vulnerable populations 
are likely to experience the most severe impacts. These 
may be worsened by rapid and unplanned urbanization, the 
contamination of air and water, and other consequences of 
environmentally unsustainable development.
Successive assessments by WHO98 and the IPCC96 
have concluded that climate change presents significant 
risks to health, but that much of the potential burden 
could be averted through reinforcement of key health 
system functions, including improved management of 
environmental determinants of health such as water and 
sanitation and food security, improved disease surveillance 
and preparedness and response for extreme weather events 
(Figure 2.16). 
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Figure 2.15 
Global average surface temperature change under two scenarios for turning 
around global greenhouse gas emissions, 1950–210096
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Primary prevention is key to protecting from climate risks102
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There is increasing evidence that actions to mitigate climate 
change could also bring immediate health benefits, most 
notably through reductions in the burden of air pollution. 
These include moving towards cleaner sources for 
household energy and electricity generation as well as 
promoting safe public and active transport.99
During the MDG era, climate change risks have become a 
key consideration in the global health agenda. For example, 
WHA resolution 61.19 (2008)100 calls for measures to 
assess the implications of climate change for health and 
health systems, and put in place appropriate response 
measures. This has been reinforced through frameworks 
for action in all WHO regions, the development of health 
sections within national adaptation plans and large-scale 
adaptation projects in low- and middle-income countries. 
WHA resolution 68.8 (2015)101 states that there are 
meaningful opportunities to simultaneously improve air 
quality and reduce emissions of climate-altering pollutants.
According to WHO estimates, climate change will cause 
an additional 250 000 deaths per year between 2030 and 
2050.97 Most will likely perish from malaria, diarrhoeal 
diseases, heat exposure and undernutrition. With regard to 
the last, the greatest impact is expected in Africa and Asia, 
where most lower and lower middle-income countries are, 
and by children, the elderly and vulnerable populations. 
Undernutrition already contributes to almost half of all 
child deaths each year,103 and rising temperatures and 
more variable rainfall patterns are expected to reduce crop 
yields, further compromising food security. Climate change-
driven migration is also most likely to affect Africa and Asia 
because of dependence on agriculture in those regions.
Financial support for adaptation to climate change remains 
much lower than is required by agreed targets or needs, and 
less than 1.5% of multilateral climate adaptation funds have 
gone to health projects.104 In addition, the potential health 
gains from climate mitigation policies are rarely included in 
policy evaluation or design.
Pollution and contamination
SDG Target 3.9 aims to substantially reduce the number 
of deaths and illnesses from hazardous chemicals, and air, 
water and soil pollution and contamination. Indoor and 
outdoor air pollution are jointly responsible for about 7 
million premature deaths annually.105 Chapter 6 provides 
further discussion on the consequences of air pollution 
for health. In some areas there has been progress in the 
past 15 years. For example, since 2002, the number of 
countries using leaded gasoline for vehicles has dropped 
from 82 to 6, including the phase-out of leaded gasoline 
in 48 sub-Saharan African countries between 2002 and 
2005. Lead is a cause of reductions in intelligence and of 
neuropsychiatric disorders, particularly in children, and 
causes an increased risk of cardiovascular diseases. In sub-
Saharan Africa alone, unleaded gas has been estimated to 
result in nearly US$ 100 billion of health benefits.106 
The main health impact of water pollution and contamination 
are associated with increased levels of mortality due to 
waterborne diseases, most notably diarrhoeal diseases 
which are associated with 1.5 million deaths every year. 
More than half of that burden, or 842 000 deaths per 
year, are attributable to unsafe water supply, and lack of 
sanitation and hygiene.107 Chapter 5 deals with waterborne 
diseases in greater detail. The burden of disease due to 
hazardous chemicals and soil pollution and contamination 
is less well known than that due to water and air pollution. 
In 2001, the legally binding Stockholm Convention on 
Persistent Organic Pollutants (POPs), was adopted by most 
countries to protect health and the environment from POPs 
by reducing or eliminating their release. POPs are chemicals 
of global concern due to their negative health impacts, their 
persistence in the environment, potential for long-range 
transport and dispersal, and capacity to accumulate in 
ecosystems. As part of the WHO and the United Nations 
Environment Programme (UNEP) collaboration for the 
global monitoring plan under the Stockholm Convention, 
human milk surveys provide results that indicate success 
in eliminating certain persistent pesticides, such as aldrin, 
dieldrin, mirex and toxaphene, but also the ubiquitous 
presence of unintentional by-products.108
Within the health sector, priority concerns will be ensuring 
access to clean energy for health facilities and lowering 
the climate footprint of the health sector in developed 
countries, for example by reducing energy consumption, 
reducing toxic waste, using safer chemicals and purchasing 
eco-friendly products.
Occupational health
The SDGs have no specific target on occupational health. 
Target 8.8, however, refers to “Protect labour rights and 
promote safe and secure working environments for all 
workers, including migrant workers, in particular women 
migrants, and those in precarious employment”. In 2007, 
Member States endorsed WHA resolution 60.26 Workers’ 
Health: Global Plan of Action to cover all workers with 
essential interventions and basic occupational health 
services for primary prevention of occupational and 
work-related diseases and injuries. A framework for the 
development, implementation and evaluation of healthy 
workplace programmes in different sectors and sizes of 
companies ensures the protection and promotion of the 
health of workers. The Minamata Convention109 was signed 
in October 2013, its main objective being to protect human 
health and the environment from anthropogenic emissions 
and releases of mercury and mercury compounds. The 
Convention includes an article dedicated to health aspects.
While initiatives are being undertaken to improve 
environmental conditions in the workplace generally, many 
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health facilities in low- and lower-middle-income countries 
continue to lack safe water and basic sanitation or, for that 
matter, access to electricity (Figure 2.17). This affects the 
risks of infection for both service providers and clients, as 
well as the quality of services.
Intersectoral action
Addressing the issue of environmental determinants of 
health requires a concerted, intersectoral response, involving, 
at the very least, transport and urban development. The 
main strategy for managing the health risks associated with 
disasters in the post-2015 era is supported by the Sendai 
Framework for Disaster Risk Reduction 2015–2030111, which 
is discussed in Chapter 8. It provides general guidance 
for the reduction of risk and loss through integrated and 
multisectoral actions to prevent new disasters, mitigate 
existing disaster risk, reduce hazard exposure and enhance 
preparedness for response and recovery. In line with the 
Sendai framework, WHO and others should aim to position 
health as a central concern in climate policy, and a prime 
object of technical and financial support mechanisms. More 
generally, climate must be brought into the development 
discourse. The SDGs have made a first step in that direction. 
Progress in this area will require support for a comprehensive 
approach to building health system resilience to climate 
change, including technical support for development of 
the health components of national adaptation plans, an 
operational framework to build climate resilience into 
the core building blocks of health systems, and large-
scale projects, for example, focusing on integrating climate 
change and health into water and sanitation investments. 
Surveillance systems for climate-sensitive infectious 
diseases such as malaria and cholera also need to be 
strengthened. Countries should make better use of early-
warning information to predict the onset, intensity and 
duration of epidemics. Such predictions allow health 
officials to pre-position medicines and vaccines, which 
can reduce the death toll.
Intersectoral actions need to take appropriate account of 
health effects in policies, for example, in the provision of fossil 
fuel subsidies, the reduction of which would be expected to 
significantly reduce both air pollution deaths and emissions 
of greenhouse gases.112 More targeted policies, for example, 
reducing emissions of short-lived climate pollutants such 
as black carbon and methane through cleaner electricity 
generation, household energy and transport policy, would 
slow the rate of global warming, while also saving nearly 
2.5 million lives per year.113 Sustainable, low-carbon urban 
transport – such as cycling or walking – could further lead to 
reductions in heart disease, stroke, breast cancer and other 
ailments. The importance of intersectoral action for health 
has been supported by WHO since the 1978 Declaration 
of Alma-Ata.114 More recently, the 8th Global Conference 
on Health Promotion in Helsinki stressed the importance 
of taking health into account in other policies, what has 
come to be termed Health in All Policies.115,116 Going forward, 
it seems clear that strategies based on such policies will 
play an important part in advancing the SDG agenda in 
this crucial area. 
a Data from most recent survey in each country.
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SUMMARY
Universal health coverage (UHC) is defined as ensuring that all people can use the promotive, preventive, curative, 
rehabilitative and palliative health services they need, of sufficient quality to be effective, while also ensuring that the 
use of these services does not expose the user to financial hardship. UHC is prominent in the SDG declaration and has a 
specific target under the health goal. It is the only target that underpins, and is key to the achievement of, all the others.
During the MDG era, much progress was made in the coverage of key interventions for maternal and child health and 
against infectious diseases. Coverage gaps between the rich and the poor for these interventions were reduced in many 
countries. Per capita government expenditure on health went up by about 40% in real terms between 2000 and 2013, 
and out-of-pocket spending decreased slightly from 35% to 31% of total health spending.
Country actions supported by global agencies and partnerships and the scaling-up of innovative interventions for diagnosis 
(e.g. rapid tests for malaria and HIV), prevention (e.g. vaccines) and treatment (e.g. ART and ACTs) have contributed to 
improved service provision and performance. 
Major health system weaknesses remain. Many countries lack sound health financing, leading to high out-of-pocket 
payments and financial catastrophe or impoverishment for families, and have major inadequacies in health workforce and 
infrastructure (especially in the rural areas), medical products (poor access, inappropriate use and reports on substandard, 
spurious, falsified, falsely labelled and counterfeit (SSFFC) medicines entering the supply chain), service quality and 
information and accountability. Weak health systems also leave major gaps in the national, regional and global defences 
against outbreaks of infectious diseases, such as Ebola virus disease and influenza epidemics.
While the MDG focus on specific diseases and health issues encouraged a tendency to reinforce programme silos set up 
to deliver selected interventions, all countries now face a much broader spectrum of health challenges, including the rapid 
rise of NCDs, the challenges of injuries and health security. Strong health systems are required to sustain and expand the 
unfinished MDG agenda, make major progress toward UHC and ensure resilience against epidemic diseases and disasters.
The SDG targets include a comprehensive set of health targets that address the unfinished and expanded MDG agenda, 
as well as major challenges related to NCDs, injuries and environmental issues. The target on UHC underpins all other 
targets and provides an opportunity to refocus efforts on a more sustainable approach through system-wide reform, based 
on the principles of efficiency and health service integration and people-centred care. The SDGs also fundamentally call 
for intersectoral action, acknowledging that attainment of health goals is dependent not only on actions within the health 
sector, but also on economic, social, cultural and environmental factors. Making progress towards UHC depends to a 
considerable extent on the broader policy context within which health systems operate and on levels and differentials in 
socioeconomic development.
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UHC is coverage that provides people with the health 
services they need while protecting them from exposure 
to financial hardship incurred in obtaining care.1 In this 
definition, health services are broadly defined to include 
health promotion initiatives (such as anti-tobacco policies 
or emergency preparedness), disease prevention activities 
(such as vaccination) and the provision of treatment, 
rehabilitation and palliative care (such as end-of-life care) 
of sufficient quality to be effective. The MDGs made no 
reference to UHC, which has gained renewed momentum as 
an idea and an aspiration following the 2005 World Health 
Assembly call for countries to plan for the transition to 
UHC.2 This was followed by the 2008 World Health Report 
on primary health care,3 the pivotal 2010 World Health 
Report on health financing for UHC,1 a 2011 World Health 
Assembly resolution4 and a 2012 UN General Assembly 
resolution on UHC.5 In contrast to the MDGs, the SDGs 
refer to UHC both directly and indirectly, thus reflecting an 
emerging consensus regarding the importance of UHC. The 
preamble (point 26) of the final text of the 2030 agenda for 
sustainable development states: “To promote physical and 
mental health and well-being, and to extend life expectancy 
for all, we must achieve universal health coverage and 
access to quality health care. No one must be left behind”.6 
SDG Target 3.8 calls upon countries to: “Achieve UHC, 
including financial risk protection, access to quality essential 
health-care services and access to safe, effective, quality 
and affordable essential medicines and vaccines for all.” 
Two additional SDG targets directly relate to health systems 
strengthening in developing countries; building upon MDG 
Target 8, SDG Target 3.b is formulated as: 
Support the research and development of 
vaccines and medicines for the communicable and 
noncommunicable diseases that primarily affect 
developing countries, provide access to affordable 
essential medicines and vaccines, in accordance with 
the Doha Declaration on the TRIPS Agreement and 
Public Health, which affirms the right of developing 
countries to use to the full the provisions in the 
Agreement on Trade-Related Aspects of Intellectual 
Property Rights regarding flexibilities to protect 
public health, and, in particular, provide access to 
medicines for all. 
SDG Target 3.c focuses on health financing and the 
workforce in developing countries: 
Substantially increase health financing and the 
recruitment, development, training and retention 
of the health workforce in developing countries, 
especially in least-developed countries and small 
island developing States.
There are also a number of SDG targets that address non-
health sector issues that nevertheless have important 
implications for health and thus relevance for UHC. For 
example, coverage targets for safe water and sanitation 
have a significant bearing on universal coverage of disease 
prevention, and the same is true of targets relating to 
road traffic deaths and urban development. Similarly, the 
labour markets in health (and other social sectors) can 
stimulate economic growth, productive employment, 
youth employment and decent work (Goal 8). Specific 
linkages between health services and a number of other 
SDGs are also clear, including the health service-poverty 
linkage (Goal 1); gender equity in service delivery (Goal 5); 
water and sanitation in health facilities (Goal 6); service 
delivery in slums (Goal 11); and the use of institutional 
health partnerships for capacity building (Goal 17). Indeed, 
the SDGs provide a basis for forging strategic partnerships 
for action at the country level on health service delivery.
Because UHC is cross-cutting and linked to the achievement 
of all health SDG targets, it offers a platform for the 
integration of health and related targets and, taken together 
with a Health-in-All-Policies approach, may serve as a 
powerful focus for reflection and policy development.
UHC comprises two components – health service coverage 
on the one hand and financial protection coverage on the 
other – both of which need to be assessed at the level of the 
whole population. Thus, three dimensions – health services, 
finance and population – are typically represented in what 
has come to be known as the “coverage box” (Figure 3.1). 
Through their health system reforms, all countries struggle 
to fill the box (i.e. to extend coverage of quality services 
with financial protection), including high-income countries 
with long established institutional arrangements for health 
systems that may, for example, be fighting to maintain their 
levels of coverage in the face of rising costs. Demographic 
(e.g. population ageing) and epidemiological (e.g. rising 
chronic diseases) changes play an important role with 
technological advances and changes in people’s patterns 
of service utilization. It is for this reason that the UHC 
endeavour is generally referred to as a journey rather than 
a destination, a progressive or dynamic process rather than 
a once-and-for-all solution that can be “achieved”. 
Direct costs:
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Population: who is covered?
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Figure 3.1 
Three dimensions of UHC1
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Lessons learned from the Ebola virus disease outbreak in 
West Africa are a reminder of the importance of strong 
health systems with robust primary care services and 
capable public health surveillance and management 
functions.7,8,9 Within this framework, focused efforts in 
public health information systems, supply chain, workforce, 
safe services (including infection prevention and control), 
financing and governance will also be core to sustainable 
efforts to prevent, detect and respond to emerging 
health security threats.  Resilience is a key attribute and 
indicator of strong well-performing health systems. It 
implies that countries and communities are capable of 
effectively minimizing the consequences of emergencies 
by reducing the likelihood of the disaster happening (where 
possible), reducing their vulnerability to the event itself and 
strengthening their capacity to respond and recover.   
TRENDS
Although the MDGs included no explicit goal for UHC, 
they did address services that are generally identified as 
priorities in countries with a UHC-oriented reform agenda, 
including reproductive, maternal, newborn and child health 
(RMNCH), and the high-burden infectious diseases HIV/
AIDS, malaria and tuberculosis (Figure 3.2). In contrast, 
NCDs – a priority concern in countries with commitments 
to UHC – were passed over in the MDGs, and have seen 
much more limited improvement in the past 15 years (NCDs 
are discussed in detail in Chapter 6). 
There is evidence that socioeconomic disparities in 
coverage of UHC health services have declined slightly in 
many countries as a result of faster improvements among 
disadvantaged subgroups. For instance, based on data from 
28 low- and middle-income countries during 1995–2013, 
the median composite coverage index of eight RMNCH 
indicators in four intervention areas – family planning, 
maternal and newborn care, immunization, and treatment 
of sick children – had an increase of 11 and 4 percentage 
points in the poorest and the richest wealth quintiles, 
respectively, resulting in the reduction of wealth-related 
inequality. The same index increased 10 and 5 percentage 
points in rural and urban areas, respectively, narrowing 
down place-of-residence inequality (Figure 3.3). Broadly 
speaking, however, inequity in access to quality health 
care both within and between countries continues to be a 
major concern.
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RMNCH composite coverage index, change over time in national average and in 
population subgroups in low- and middle-income countries,a 1995–201311
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UHC-related efforts must address not only health service 
coverage, but also health service quality and financial 
protection. Key to delivering quality, people-centred 
integrated health services is the establishment of efficient, 
decentralized, integrated health systems staffed by well-
trained, motivated professionals, offering and ensuring 
appropriate use of the full range of quality-guaranteed 
essential medical products (including medicines, blood 
and medical devices), financed in ways that guarantee 
predictable adequate funding for the system while at the 
same time offering financial protection to the users.1 
In some of these areas a few encouraging trends have 
emerged in the past 15 years such as the development of 
hospital accreditation12,13 and the move away from inpatient-
centric health services towards outpatient, decentralized, 
integrated health systems that deliver health care across 
the full spectrum of available services that is seamless 
and easy to navigate.14 Key to delivering such services 
is an emphasis on primary health care centres that take 
greater responsibility for health-care coordination.15,16 In 
terms of specific medical interventions, there is evidence 
of progress in reducing the number of unsafe injections in 
low- and middle-income countries, achieved largely through 
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a reduction in the reuse of injection devices. The average 
number of injections per person per year has declined 
from 3.4 to 3.0 during 2000–2010, while the proportion 
of reuse of injection devices dropped from 40% to 6%.17 
In other areas, however, there is little large-scale evidence 
of improvements of the quality of care and reductions in 
medical care-associated complications, even from high-
income countries. 
Health service financing has also improved, not just in 
terms of the amount of money going into health, but also 
the way it is raised and spent. Per capita government 
health expenditure globally increased by about 40% in 
real terms between 2000 and 2013 (Figure 3.4) with major 
increases in all regions. This reflects economic growth and, 
in several countries, the increased priority for health that 
governments are making in their budget allocations (Figure 
3.6). On average across countries, global out-of-pocket 
health spending is down slightly (from 35% of total health 
spending in 2000–2004 to 31% in 2010–2013) (Figure 3.5), 
which suggests an improvement in financial protection, but 
average levels, particularly in low-income countries (42%) 
remain high.
On the workforce front there has also been some 
improvement, but it has been piecemeal. For example, some 
countries affected by major health worker shortages have 
reported improvements in the availability of skilled health 
professionals.19 This includes improved rural retention of 
health workers through changes in national policies. The 
world market for medicines and technologies continues to 
grow (estimated at almost US$ 11 trillion) but reliable data 
on the availability and quality of medicines and technologies 
are generally limited. A survey in 26 low-income and lower-
middle-income countries, using the standardized WHO/
Health Action International (HAI) methodology,20 showed 
that generic medicines were available in 58% and 67% 
of public and private sector health facilities, respectively, 
with large variation between countries.21 The availability 
of donated blood has improved somewhat with donations 
increasing 25% since 2004,22. On the other hand, promising 
eHealth initiatives, such as eLearning for health workers or 
electronic health records, have not yet achieved their full 
demonstrable and documented impact.23,24 
There has been a marked improvement in our ability to 
monitor progress on key health indicators, especially 
through household health surveys allowing for the collection 
of data on mortality, fertility and MDG-related intervention 
indicators. International household survey programmes 
such as the USAID Demographic and Health Survey (DHS) 
and the UNICEF Multiple Indicator Cluster Sample Survey 
(MICS) have been instrumental, reaching well over 100 
countries with multiple surveys. In recent years, more 
countries are conducting surveys that also collect data 
on NCD-related risk factors.25 Many surveys now also 
collect biological and clinical data such as anthropometry, 
blood pressure or HIV testing. In addition, there were 
improvements in other types of data such as tracking of 
health spending through national health accounts.26
POSITIVE DEVELOPMENTS
UHC is a multifaceted and complex endeavour and many 
factors contribute to its successful development. Key 
lessons learnt include: (i) the centrality of country leadership 
and political commitment to the concept of UHC; (ii) the 
important role played by partnerships, including cross-
sectoral action and community and civil society mobilization; 
and (iii) the need for support from development partners in 
low- and lower-middle income countries. The substantial 
increases in both domestic and external funding, even if 
mainly targeted at disease-specific interventions, have 
stimulated progress. However, sustaining and enhancing 
progress will be difficult without taking a more holistic 
approach to health system strengthening.
Country actions: These include high-level political 
commitment, coordinated national strategies and plans, 
implementation of innovative approaches and scaling-up 
of proven interventions.
• Many countries have developed unified national health 
policies, strategies and plans. For example, national 
health workforce strategies and plans increasingly 
address overall quality and performance orientation and 
are designed to tackle issues related to health workforce 
recruitment, training, retention and migration. In many 
cases, strategies to reinforce health worker motivation 
to promote the delivery of priority health services 
have been supported by specific incentives introduced 
through health financing reforms.27 Several countries 
have established comprehensive health sector results 
frameworks that focus on UHC and ensure regular 
monitoring and inclusive review of progress.28
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• Over 70 countries have established hospital accreditation 
schemes to improve quality of care. Some 140 countries 
have defined national essential medicines lists to 
guide purchasing decisions. The incorporation of good 
manufacturing practices into national medicines laws in 
more than 100 countries is another example of country 
efforts to strengthen health services.
• The greatest progress towards UHC has been made in 
countries that have made special efforts to make health 
services accessible and affordable to the poor.11
Global partnerships and actions: Multiple global declarations 
and partnerships have put health systems strengthening 
and UHC on the agenda of countries, development partners, 
civil society and others with variable success. Through the 
World Health Assembly, countries have adopted several 
resolutions related to health systems strengthening and 
UHC.29,30 Furthermore, the UN General Assembly adopted 
a resolution on UHC in 2012.5 Some of these declarations 
and partnerships have been short-lived and have lacked 
resources, others have given rise to overlapping agendas, 
yet some have made a significant impact. Examples include:
• Efforts related to improve aid effectiveness such as 
the Paris Declaration on Aid Effectiveness, the Accra 
Agenda for Action31 and, in 2011, the Busan Partnership 
for Effective Development Co-operation.32 The IHP+ 
was established in 2007 and currently brings together 
in a collaborative endeavour 65 developing countries, 
bilateral donors, international agencies and foundations.33 
It achieves results by encouraging national governments, 
development agencies, civil society and others to align 
their efforts with a single, country-led national health 
strategy and plan. 
• Some partnership strategies have been directed to 
strengthening specific aspects of health systems. 
Examples include the Global Health Workforce Alliance, 
created in 2006 as a common platform to address the 
health workforce crisis,34 the Commission on Information 
and Accountability for Women’s and Children’s Health,35 
the Countdown for Maternal, Newborn and Child Survival 
that tracks progress in key indicators of RMNCH,36 the 
Health Metrics Network that focused on building country 
health information systems;37 and the patient safety 
initiative focused on ensuring quality of care.38
• Other strategies and partnerships have taken a broad-
based, systemic approach to health systems. These 
include: Providing for Health (P4H),39 a global network 
of development partners active in supporting country 
reforms related to UHC and social health protection; 
the regional initiative on Harmonization for Health in 
Africa,40,41 focusing on health system strengthening; and 
Health Systems Global, a society led by researchers, 
policy-makers and implementers to develop the field 
of health systems research.42 These partnerships have 
generated momentum for UHC and progress towards 
consensus around specific issues such as the need to 
reduce dependence on out-of-pocket spending.
• In addition, there are examples of multicountry efforts 
that have contributed to an accumulating body of policy 
and technical guidance to support country efforts to 
make progress towards UHC.43,44 For instance, the 
World Health Report 2010 on health financing for UHC 
was instrumental in raising the profile of UHC and 
related technical and policy support to countries have 
enabled the lessons of experience to be disseminated 
widely. Another example is the WHO prequalification 
programme which helps to make quality priority 
medicines available to all countries. 
Innovative approaches: The impact of new technologies 
including information and communication technologies 
(ICT) on improved service provision and system 
performance has been dramatic in many settings. New 
therapies, including ART, and ACTs and hepatitis C 
treatment, have greatly enhanced access to treatment 
across all socioeconomic groups. New diagnostic techniques 
and testing methods now permit early detection and the 
application of simplified therapeutic decision-making, not 
only in relation to infectious diseases, such as HIV and 
malaria, but also with regard to cancers (notably cancer 
of the cervix), and chronic conditions such as anaemia, 
diabetes and hepatitis. The use of ICT in health, often 
referred to as eHealth and mHealth, has tremendous 
potential to enhance communications between health-
care workers and individuals and communities and there 
are numerous examples of success in improving adherence 
to treatment regimens as well as facilitating access to 
emergency care. Moreover, eHealth/mHealth is helping to 
increase the emphasis on performance measurement and 
accountability by facilitating data collection, management, 
sharing and dissemination. 
CHALLENGES
Health system weaknesses: Despite increases in domestic 
(government and private) and external expenditures on 
health, in many countries health systems remain underfunded 
and struggle to provide even basic health service coverage 
to their populations. Access to services is still low for rural 
and the poorest populations and many facilities deliver 
substandard care due to inefficient management and 
inadequate technical and managerial capacities. Many 
countries lack critical resources in multiple areas.
Health financing: Every year, some 100 million people 
fall below the poverty line as a result of out-of-pocket 
expenditures on health, and a further 1.2 billion, already 
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living in poverty, are pushed further into penury for the same 
reason.1 Other challenges include system-wide inefficiencies 
arising from vertical, disease-specific structures set up 
in low- and middle-income countries that are a legacy 
of the response to the health MDGs and supported by 
global financing mechanisms. Finally, the understandable 
focus on raising more money to enable greater progress 
towards UHC risks making it solely a funding issue. At 
least equal attention should be given to addressing system 
inefficiencies and improving quality coverage of services for 
all population groups.45 
Inadequate human resources: Despite the modest 
improvements cited, many countries still face major 
shortages, especially in rural areas.19 Implementation of 
the WHO Global Code of Practice on the International 
Recruitment of Health Personnel has been inconsistent 
across countries and the number of skilled health 
professionals who choose to migrate continues to increase 
year-on-year.46 Major inequalities in the distribution of 
health workers within countries persist, health workforce 
education may be poor and outdated, and often not 
competency-based, and despite health worker salaries 
representing a significant share of total health expenditure 
there is an unacceptably low level of transparency and 
quality on health workforce data47 in many countries. 
Inadequate medical products: There has been uneven progress 
in providing access to affordable essential medicines,48 
while in many countries SSFFC drugs are found in the 
supply chain, risking people’s health and undermining 
the credibility of health services.49 The complexity of new 
medicines and medical products and the internationalization 
of production and distribution of medical products pose 
increasing challenges to regulatory systems. In the case 
of antimicrobials, inappropriate prescription and use of 
medicines also leads to growing problems with resistance. 
On the blood products front, the global imbalance 
between donations and need is an ongoing concern, with 
approximately half of the donations collected in the high-
income countries, which are home to less than one fifth of 
the world’s population.22 
Service quality: Regarding health service quality, while a 
number of countries are embracing accreditation as a way 
to raise standards in hospitals,50 and working on system 
integration as a way to deliver people-centred care,51 many 
are still delivering substandard care characterized by high 
levels of medical error52,53 through health systems skewed 
towards hospitals that have little connection with the 
health-care system around them or the communities they 
are supposed to serve.54 Accreditation of primary health-
care clinics is virtually non-existent.12,55 Systems to monitor 
and improve performance are weak in most countries.
Weak governance: In general, governance of the health 
sector in many countries remains weak, while the rapidly 
increasing share of private health service provision is often 
poorly regulated, leading to potential distortions in the type, 
quantity, distribution, quality and price of health services.56 
Other aspects of health governance such as enhanced 
participation, transparency and accountability, although 
improving, are often still limited. Furthermore, systems to 
monitor and improve performance are inadequate in many 
countries.
Inadequate information and accountability: There are 
major data gaps in almost every area affecting planning, 
targeted implementation, performance improvement and 
accountability to civil society, parliament, development 
partners, etc. For instance, most low- and lower-middle-
income countries lack civil registration and vital statistics 
(CRVS) systems, well-functioning health facilities and 
community information systems, disease surveillance 
systems, health workforces and health financing accounts. 
Fragmentation: One of the unintended consequences of the 
MDGs focus on specific diseases and health issues was a 
tendency to reinforce programme silos set up to deliver 
selected interventions. This often resulted in duplicate, 
parallel structures that added to overall system costs and 
posed obstacles to the coherent governance of the health 
system. All countries now face a much broader spectrum 
of health challenges, including the rapid rise of NCDs, 
and there is broad acknowledgement that the SDG health 
targets – including the target for UHC – are an opportunity 
to refocus efforts on a more efficient approach via system-
wide reform, based on the principles of health service 
integration and people-centred care, 57,58,59 and unification of 
underlying support systems (e.g. information, procurement, 
supply chain). The global drive for results linked to disease-
specific funding, however, continues to present a major 
challenge that requires creative solutions at the national 
level.
Lack of health systems resilience: Weak health systems are 
associated with diverse health security risks, including 
spreading epidemics, and are incapable of responding when 
health emergencies occur. This was glaringly apparent in 
West Africa where Guinea, Liberia and Sierra Leone all 
struggled in the face of the Ebola crisis because of the 
poor health system infrastructure and resources in addition 
to lack of preparedness.7 In other settings, preparation 
and management of emergencies resulting from disasters 
(natural and man-made) as well as conflicts have often 
proved inadequate. Health systems resilience comprises the 
capacity to prepare for and effectively respond to crises, and 
to maintain or adapt core health system functions when a 
crisis hits.9 Resilience is built on sound legal, regulatory and 
policy foundations (at both the country and global levels). 
The International Health Regulations (IHR) provide a global 
framework for enhancement of collective health action, and 
IHR core capacities mirror health system components such 
as quality surveillance and laboratory capacity, response 
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capacity with good linkages to the community and a 
well-trained health workforce.60 The IHR implementation, 
however, has been far from satisfactory (see Chapter 5). 
Inadequate investments in research and development (R&D): 
Structural imbalances persist in terms of investments in 
and access to innovative diagnostics, vaccines, treatments 
and medical products. There is much more to be done to 
expand technology transfer for expanded access to medical 
products in low- and middle-income countries. With regard 
to medical devices, increased use of systematic health 
technology assessment61 is helping some (mostly high-
income) countries buy the right products for their needs, 
while frugal innovation offers the prospect of devices that 
are not only cheaper, but also better adapted to local 
conditions.62 Indeed, the opportunity for reverse innovation 
– south to north transfer – is being increasingly explored.63 
Similarly, there are major gaps in health systems, policy and 
implementation research that need to be addressed to make 
health systems more efficient and effective. 
R&D for new medicines, vaccines and other medical 
products for neglected diseases remains insufficient. Only 
4% of new products registered during 2000–2011 were for 
neglected diseases64 and only about 1% of R&D investments 
in 2010 were made for neglected diseases.65 The private 
sector invests little due to lack of profit prospects, and 
public funding and special initiatives – although increasing 
and starting to give results – are not yet covering the full 
spectrum. Numerous new initiatives and approaches to 
tackle this gap have been debated and also led to the 
adoption of a WHA resolution.66
STRATEGIC PRIORITIES
Even though health system strengthening for UHC was not 
an explicit focus during the MDG era, multiple investments 
were made by countries and global partners in specific 
components of health systems that led to improvements 
in key areas. Several countries also developed robust 
pro-poor policies that supported progress towards UHC 
targets. Such efforts provide an important foundation 
for UHC going forward. Similarly, the strategic agenda 
in support of the SDG target for UHC can build upon 
the multiple resolutions focused on health systems and 
UHC that have been adopted by countries in the World 
Health Assembly and UN General Assembly since 2005, 
including health workforce (seven resolutions), medicines 
and technologies (18 resolutions), health financing and UHC 
(three resolutions), health information (one resolution), 
policy dialogue (one resolution) and many others in regional 
fora. These resolutions are not just a reflection of country 
debates and policies, but can also be used to influence 
country policies, strategies and plans. In some cases, 
resolutions also serve to enhance monitoring of progress 
through focused data collection, reporting and progress 
reviews. At the same time, the large number of specific 
resolutions on aspects of health systems appears to have 
stimulated a greater interest at the global and regional levels 
in integrated people-centred health services.
Goal 3 has nine substantive targets and four additional 
points which are also targets but are listed as means of 
implementation. The section on the new agenda in the SDG 
declaration states: 
To promote physical and mental health and well-
being and to extend life expectancy for all, we must 
achieve universal health coverage and access to 
quality health care. No one must be left behind. We 
commit to… 
This places UHC as the target that underpins and is key 
to the achievement of all the others. Without UHC as the 
underpinning approach, there is a risk that pursuing the 
individual targets separately will lead to more fragmentation 
and confusion in countries. UHC, rather than being one 
target among many therefore needs to be seen as having an 
integrating role, underpinning a more sustainable approach 
to the achievement of the other health targets and creating 
a balance among them. 
Because of the cross-cutting nature of the health system 
development actions needed for progress towards UHC, 
it can be viewed as the most efficient platform for the 
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integration of all SDG health targets, while also having 
strong links to the health-related targets in other SDGs 
(including education, employment, gender, nutrition, 
poverty and others). Moreover, the UHC agenda has 
relevance for all countries, since all countries have room 
for improvement on the goals embedded in the definition 
of UHC. Specific SDG targets relate to medicines and 
vaccines, and health financing and health workforce in the 
least-developed countries, but system-wide strengthening 
is a sine qua non for sustaining progress towards UHC, 
supported by increased reliance on compulsory pooled 
financial resources (i.e. from taxes and other contribution 
mechanisms mandated by law) as described in the World 
Health Report 2010,1 and monitored using the kind of 
framework proposed by the WHO/World Bank in their 
recent, jointly constructed monitoring framework for UHC.67
UHC-oriented reforms should address a wide range of 
issues. The prioritization of these issues depends on the 
country situation.
People-centred and integrated health services: While each 
country is different, it is essential that UHC agendas 
prioritize quality of health service delivery. To support that 
agenda, and to address core health system challenges, 
WHO is preparing to launch a global strategy on integrated 
people-centred health services,68,69 which is based on five 
strategic directions, including reorienting the model of care 
away from care delivery silos and towards integrated health 
services that are coordinated across the care continuum. 
This applies to all stages of the life course, including older 
ages, where health systems need to deal with people 
with multiple pathologies and to define success in terms 
of continued functioning and autonomy rather than the 
absence of particular diseases. 70 The strategy also focuses 
on empowering and engaging people and strengthening 
governance and accountability. 
An adequate health workforce: The WHO Global Strategy 
on Human Resources for Health: Workforce 2030 will be 
submitted to the World Health Assembly in May 2016. 
It considers the health workforce a key lever for change 
and progress towards the SDGs, as the health sector 
is a major employer (public, private and other) and a 
driver of economic growth. The four objectives of the new 
strategy are to: (i) optimize the impact of the current health 
workforce towards UHC, SDGs and global health security; 
(ii) align human resources for health (HRH) investment 
frameworks to the future needs of health systems and 
demands of the health labour market, maximizing 
opportunities for employment creation and economic 
growth; (iii) build the capacity of national and international 
institutions for an effective leadership and governance 
of HRH; and (iv) ensure that reliable, harmonized and 
up-to-date HRH data, evidence and knowledge underpin 
monitoring and accountability of HRH efforts at national 
and global levels.47,71 It is also important to refocus attention 
on the WHO Global Code of Practice on the International 
Recruitment of Health Personnel to address the issue of 
worker migration, while acknowledging the importance of 
employment on economic growth.72 For the latter, WHO will 
coordinate, under the auspices of the UN Secretary-General, 
a Commission on Future Health Employment and Economic 
Growth, to report in 2016.
Medical products: Multiple resolutions and international 
agreements allow the identification of a few key areas of 
strategic interest, including the strengthening of national 
policy and regulatory authorities,73 R&D for diseases that 
disproportionally affect developing countries (see also 
SDG 3.b) and expanding access to essential medicines, 
vaccines and diagnostics in the context of UHC.74 The 
latter means: (i) continuing to support improving access 
to interventions for priority diseases, using effective 
prequalification; (ii) appropriate selection of essential 
medicines and other medical products including the use 
of health technology assessments and policies to achieve 
affordable pricing (iii) improving medical product coverage 
for NCDs; (iv) ensuring appropriate use of medicines; 
(v) addressing antimicrobial resistance and responsible use 
of medicines; and (vi) addressing underserved clinical areas, 
for example, by promoting technology transfer. 
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Health information and accountability: A roadmap and call 
to action for measurement and accountability for health 
results outline the main priorities during 2015–2030.75 
The focus of this roadmap is on low- and middle-income 
countries. The main drivers are the new challenges related 
to monitoring the health SDGs, which are much broader 
than the MDGs, and the new opportunities presented 
by the data revolution. The goal is that all countries have 
well-functioning health information and accountability 
systems that meet country demands and allow SDG 
progress monitoring through greater and more efficient 
investments, focus on institutional capacity strengthening, 
addressing population health data gaps (especially 
strengthening of CRVSs), effective transparent health 
facility and community information systems, and inclusive 
accountability mechanisms. 
Health research: The World Health Report 2013 has set 
out priorities for research for UHC that require national 
and international backing. Systems are needed to develop 
national research agendas to raise funds, strengthen 
research capacity and make appropriate and effective use 
of research findings.76 Going forward, the context-specific 
nature of UHC challenges and opportunities – especially 
those related to services delivery and financing – will require 
research approaches that fully reflect conditions on the 
ground, such as implementation research.77 It is for this 
reason that global networks and partnerships have made 
implementation research a priority field.78 R&D of new 
products that meet people’s health needs in all countries is 
required. Investments in health research and development 
should be aligned with public health demands.65
Health financing: The World Health Report 2010 and 
subsequent reports and resolutions regarding health finance 
provide a sound conceptual basis for the main financing 
reforms needed. Reducing out-of-pocket health spending 
is a strategic priority everywhere and moving towards 
predominant reliance on compulsory/public funding sources 
for the health system is required. Thus, efforts to increase 
public spending on health are needed in those countries in 
which government health spending is still quite low. More 
specifically, this means greater attention must be given 
to increasing the level of government budget revenues 
for health by strengthening domestic tax systems and/or 
increasing the share of public spending devoted to health. 
However, simply raising more money for the health system 
will not be enough. Reforms to enhance the redistributive 
capacity of these funds (by reducing fragmentation in 
pooling) and to promote greater efficiency in the use of 
health system resources (by increasing use of strategic 
purchasing mechanisms) are also required. 
Intersectoral collaboration: The attainment of health goals 
is dependent not only on actions within the health sector, 
but also on economic, social, cultural and environmental 
factors. Achieving UHC depends to a considerable extent 
on the broader policy context within which health systems 
operate and on levels and differentials in socioeconomic 
development. Intersectoral action contributes to enhanced 
health outcomes and minimizes the adverse effects of crises 
and emergencies. Public policy is an essential instrument 
for the removal of socioeconomic disparities that adversely 
affect health. Public policies must be shaped in such a 
way to have the potential to influence exposure to risks, 
increase access to care and mitigate the consequences 
of ill-health. Cross-sectoral action is thus essential for the 
implementation of strategies to promote and protect health, 
including anti-tobacco policies, environmental protection, 
food security and safety, safe water and sanitation. Access 
to education, safe employment and poverty reduction 
measures enable people to achieve and maintain good 
health and benefit from UHC. The SDGs provide an 
opportunity to tackle health and development in a holistic 
manner, providing a critical starting point for tracing the links 
between the goals.
Improved governance: Managing the complexity of each 
of the above elements of health systems strengthening 
is challenging, and demands strong governance capacity 
to lead a unified national health system, guided by strong 
information and financial management systems that can 
ensure transparency, accountability and adaptability to new 
challenges. Good governance also depends on adequate 
regulatory and legal frameworks to ensure sustainability, 
effective intersectoral collaboration, dealing with the donor 
community, and the monitoring of performance.
Resilient health systems: The Ebola virus disease outbreak in 
West Africa and other recent outbreaks such as the MERS 
outbreak in the Republic of Korea have underscored the 
importance of strong health systems with capable public 
health surveillance and management functions in order to 
prevent, detect and respond to emerging health threats. This 
requires reinforcing systems of infection prevention and 
control, developing real-time surveillance integrated with 
broader health management information systems, ensuring 
access to high quality essential services, addressing 
immediate public health workforce issues and enhancing 
community mobilization.79 It also needs strengthening of 
governance, management and accountability systems as 
well as cross-border and subregional/regional actions in 
support of the countries’ and their neighbours efforts.
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GOVERNANCE
Governance in the health sector concerns actions and means adopted by a society to organize itself in the 
promotion and protection of the health of its population of which the performance can be assessed in a 
systematic manner.80,81,82 Governance involves ensuring that a strategic policy framework (that covers both 
public and private sectors) exists and is combined with effective oversight, coalition building, regulation, 
attention to system design and accountability. Robust and realistic national health policies, strategies and 
plans are key for the strengthening of health systems and advancing towards UHC. The effectiveness of 
health policies and plans is greatly enhanced if developed in collaboration with other sectors, taking into 
account the broader socioeconomic, environmental and cultural contexts within which the health sector 
functions. This brief overview focuses primarily on developing countries (low- and lower-middle-income 
countries).
TRENDS 
Many countries have invested in rationalizing and bringing coherence to 
fragmented health systems characterized by diversity of key stakeholders 
(e.g. public providers, private-not-for-profit, and private-for-profit 
firms and corporations) and complexity of demand by individuals and 
communities. As a consequence, there has been a renewed interest in 
developing regulatory capacity83 and strengthening policy instruments to 
develop, negotiate and implement more robust and responsive national 
health policies, strategies and plans.30 In 2014, 134 countries could 
be identified with a national health policy, strategy or plan to guide 
their work in achieving better health outcomes for the population.84 
A recent review of national health planning in 24 low- and lower-middle-
income countries reported that: (i) the predictability of national public 
funding had improved with nearly 70% of countries executing at least 
85% of the budgeted amount for health; (ii) 19 out of 24 ministries 
of health reporting having a medium-term expenditure framework or 
rolling three-year budget in place; and (iii) an increasing number of 
countries have a jointly assessed national health sector strategy that 
includes targets and budgets.85
Beyond the health system, governance means collaborating with other 
sectors as well as the private sector and civil society, to promote and 
maintain population health in a participatory and inclusive manner. 
Civil society organizations have a particularly important role to play, 
and it is encouraging that 16 of the 17 low- and lower-middle-income 
countries with data involved such organizations in coordination meetings 
and technical working groups, while all involved civil society in joint 
annual health sector reviews.85 
Increasingly, countries also have a comprehensive health sector 
results framework in place, and development partners are aligning 
their support with those frameworks, although alignment varies 
from 21% to 98% of total funding. Mutual accountability processes 
(through which concerned stakeholders such as the government, the 
private sector, the civil society and development partners hold each 
other to account on progress made against commitments to support 
the national health strategy), are also being introduced with 71% of 
countries reporting a mutual assessment review.85
POSITIVE DEVELOPMENTS
National policy dialogue: The importance of strategic plans and mutual 
accountability has received more attention, as exemplified in resolution 
WHA64.8 on strengthening national policy dialogue to build more robust 
health policies, strategies and plans, endorsed in 2011.30 In several 
countries, national policy dialogues involved more stakeholders and 
included more cross-sectoral contributions to health policies. There 
were also increased commitments from the international community 
in funding the development, monitoring implementation of national 
strategies.86,87
Regulation: Many high-income countries that have made significant 
progress towards UHC have also succeeded in strengthening regulation 
mechanisms. Resolution WHA63.27 identified the significance of private 
providers in the delivery of health care and the need to strengthen 
regulatory mechanisms, which is gradually receiving more attention 
in countries.88 
Global partnership: International development agencies and countries 
have committed to improving the efficiency and impact of development 
cooperation through a series of agreements – the Paris Declaration 
on Aid Effectiveness and the Accra Agenda for Action31 and, in 2011, 
the Busan Partnership for Effective Development Co-operation.32 
IHP+ was established in 2007 and currently involves 65 developing 
countries, bilateral donors, international agencies and foundations.33 
IHP+ achieves results by mobilizing national governments, development 
agencies, civil society and others to support a single, country-led 
national health strategy. 
Accountability: Defined as a cyclical process of monitoring, review 
and remedial action for the implementation of national plans received 
greater emphasis. The framework of the Commission on Information 
and Accountability for Women’s and Children’s Health was implemented 
in 63 countries.89 Mutual accountability between government and 
donors was promoted through the IHP+; partners which sign up to 
IHP+ commit to holding each other to account.
Link with investments: The launch of multiple global health initiatives and 
the growing influence of private foundations had important implications 
for governance at local and national levels. For example, investments 
by GAVI and the Global Fund in immunization, HIV, tuberculosis and 
malaria programmes have been accompanied by requirements linked 
to strengthening and establishing specific governance structures at 
the country level. 
Increased participation: The global health governance conversation 
is no longer confined to a select group of governments and actors, 
but rather includes a wide range of stakeholders, including public-
private partnerships, philanthropic organizations, private industry, 
nongovernmental entities, professional associations, academic 
institutions and other civil society organizations. While this expanding 
field has served to enhance inclusive, participatory processes, it has 
also brought increased complexity to the global governance stage.
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CHALLENGES
Increased complexity: Countries are faced with increasingly complex 
health sector governance “space”, in which central government, local 
government, non-governmental agencies and private sector are all 
playing a role. This poses significantly more challenges for a national 
government trying to exercise overall stewardship over the health 
sector and requires governments to adapt its policies and strategies. 
Financial management concerns: In low- and lower-middle-income 
countries, there is stagnation or decline in use by development partners 
of national financial management systems and in the predictability of 
funding.85 Additionally, there is no clear improvement in the amount 
and quality of public financial management in the health sector, as 
assessed by the World Bank country policy and institutional assessment 
process.90
Regulation: despite more attention for regulation as a key tool for 
governments to support the implementation of national health strategies, 
many countries face challenges with their capacity and capability to 
develop and implement effective regulation. These challenges include 
a lack of human resources with relevant legal expertise, a dearth of 
evidence base on effective regulations and regulatory challenges 
posed by entrepreneurial behaviour in the health system (from both 
private and public providers).
STRATEGIC PRIORITIES
The SDG declaration pays considerable attention to the importance of 
governance for sustainable development and effective implementation. 
For instance, under the means of implementation targets under policy 
and institutional coherence Target 17.15 refers to “Respect each 
country’s policy space and leadership to establish and implement 
policies for poverty eradication and sustainable development”6. 
Priorities for improving governance in health include:
• Strengthen budget process and financial management to enable 
predictable funding for health services, a core requirement for 
effective service delivery.
• Build up capacity for data collection and analysis through developing 
strong monitoring, information and accountability plans and capacity, 
with coordinated support from international partners.
• Continue promoting and enabling participation by multiple stakeholders 
in sector processes, for accountability and to ensure effective 
planning and implementation – civil society, private sector health 
care providers, parliamentarians as well as international partners.
• Strengthen governance institutions and mechanisms aiming at 
improving quality integrated health services including inspection 
and supervision.
• Provide evidence-based guidance documents and tools on governance 
to enable countries make progress towards UHC.
In many countries, health system reforms to progress towards UHC will 
need to be implemented through national laws dealing with matters 
including access, equity, cost and quality. In order to achieve this, 
several actions will be taken, including to:
• Provide direct legal and policy support for countries states wishing 
to develop laws and legal frameworks to enable UHC. 
• Develop an up-to-date evidence base of legislation, case studies, 
and other research to inform future work on legal frameworks for 
UHC.
• Build strategic partnerships and alliances with individuals and 
organisations to advocate for and support the implementation of 
effective legal frameworks for UHC.
Faster progress to achieve results requires governments, civil society 
organizations, private sector and especially international development 
partners to take action. IHP+ has developed the most critical areas 
for action for development partners (Box 3.1). Recent meetings of 
global health leaders have strongly supported renewed action on these 
seven behaviours, which, if implemented, would bring visible results. 
Box 3.1 
IHP+ seven behaviours91
• Agreement on priorities that are reflected in a single national health strategy and 
underpinning subsector strategies, through a process of inclusive development 
and joint assessment, and a reduction in separate exercises.
• Resource inputs recorded on budget and in line with national priorities.
• Financial management systems harmonized and aligned; requisite capacity-
building done or under way, and country systems strengthened and used.
• Procurement/supply systems harmonized and aligned, parallel systems phased 
out, country systems strengthened and used with a focus on best value for money. 
National ownership can include benefiting from global procurement.
• Joint monitoring of process and results is based on one information and 
accountability platform, including joint annual reviews that define actions that 
are implemented and reinforce mutual accountability.
• Opportunities for systematic learning between countries developed and supported 
by agencies (south–south/triangular cooperation).
• Provision of strategically planned and well-coordinated technical support.
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HEALTH FINANCING
A country’s health financing arrangement is an important determinant of the overall performance of the 
health system, including a country’s progress towards UHC.1 Over the past 20 years, many countries have 
taken steps to improve their health financing systems in line with their available resources, but important 
challenges remain. Several important lessons have been learnt about both promising directions for reform 
as well as pitfalls to avoid.
TRENDS 
Between 1995 and 2013, there has been a steady decline in the share 
of total health expenditure in the form of out-of-pocket spending at 
the time of use, particularly in low-income countries (Figure 3.5). 
This is important because out-of-pocket spending is both a barrier 
to needed service use for those unable to pay and pose a threat to 
financial risk protection.92 
In general, the greater the level of health spending from public/
compulsory sources, the lower the dependence of systems on out-
of-pocket spending. And indeed it appears that, as part of improved 
health financing policies more generally, an important reason why 
out-of-pocket spending has declined has been a growth in public 
spending on health (Figure 3.6).
Globally, and especially in low-income countries, the data reveal 
that behind this growth in public spending has been an increased 
commitment to the health sector by governments (Figure 3.7), although 
in many cases this has been strongly supported by external funds that 
flow through government systems.
Despite this progress, out-of-pocket spending remains high, and 
millions of people globally are at risk of financial harm (including 
impoverishment) as a consequence of paying for health services.
Figure 3.6 
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Figure 3.5 
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Figure 3.7 
General government expenditure on health as a percentage of total general 
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POSITIVE DEVELOPMENTS
Convergence on core principles: While there is no single “best model” 
of health financing, common core principles are reflected in the reforms 
of countries that have made progress, and there has been a similar 
convergence in the approaches supported by international agencies 
such as WHO1,93 and the World Bank.94,95 These can be viewed as 
desirable attributes for any country’s health financing arrangements 
in order to promote progress towards UHC, and specifically include 
efforts to move towards predominant reliance on compulsory (i.e. 
public) funding sources96 for the health system, reduce fragmentation 
in pooling arrangements,97,98,99,100 and increasingly link the payment 
of providers101,102,103 to information on their performance and the 
health needs of the populations they serve. These are reflected in 
the following points.
Country actions focusing on the poor: Many countries have made 
comprehensive changes in the way they finance health, including 
changing the mix of revenue sources, restructuring pooling to enhance 
the redistributive capacity of these funds and aligning policies on 
benefits with purchasing mechanisms to transform the promise of 
declared entitlements into a reality. In several countries, this approach 
has involved making explicit use of general budget revenues to expand 
coverage for the poor, people in the informal sector or for the entire 
population.104,105,106,107,108,109,110
Performance focus: Another important development is the shift of 
focus from simply raising the level of funding to reforming provider 
payment methods to create an incentive environment that drives 
efficiency gains and encourages providers to increase the quantity 
and quality of services delivered. The so-called “performance-based 
financing movement” in Africa27 is of particular interest in this regard, 
as is the growing evidence of countries adapting strategic purchasing 
techniques to their own context.102,111 The transition from paper to 
electronic systems has been a critical enabling factor in the diffusion 
of provider payment reforms.
CHALLENGES
Increasing government budget revenues: Fiscal pressures on public 
revenues combined with ongoing technological advances that drive 
up both demand and cost will likely increase political and technical 
challenges for health systems. 
Verticalization: Another important challenge is a legacy of the response 
of the international community to the health MDGs, addressing the 
system-wide inefficiencies that to some extent arise from vertical, 
disease-specific structures set up in low- and middle-income countries. 
Narrow approach to sustainability: Increased attention being given by 
funding agencies to a “transition to domestic financing” risks framing 
sustainability as solely a revenue issue; at least equal attention should 
be given to addressing system inefficiencies.45 Sustaining current and 
improved levels of coverage will require a focus on addressing these 
inefficiencies and not merely a focus on generating new revenues. In 
the World Health Report 2010,1 it was estimated that between 20% 
and 40% of all health spending is currently wasted through inefficiency. 
The potential health gains from redirecting the resources to improve 
population health would be enormous in all countries as health is one 
of the world’s biggest economic drivers, with US$ 7.1 trillion spent 
annually (2012 figure) and an annual expenditure growth rate of 6.7% 
over the past decade.
STRATEGIC PRIORITIES
The SDG include two targets related to health financing. Target 3.8 on 
UHC refers to financial protection and Target 3.C includes “Substantially 
increasing health financing … in developing countries, especially in 
least developed countries and small island developing States”. Multiple 
resolutions in the UN General Assembly and World Health Assembly 
have addressed UHC, but much still needs to be done to ensure that 
UHC becomes the integrative platform underpinning all health targets. 
Looking to the immediate future, several priorities emerge from what 
has been learnt about health financing for UHC, particularly in the 
context of low- and middle-income countries. 
Given the context of high informality, its fiscal implications and the 
recognized weaknesses of voluntary prepayment,112,113,114,115 it is 
evident that greater attention must be given to increasing the level 
of government budget revenues for health, by both strengthening 
domestic tax systems and increasing the share of public spending 
devoted to health. Without this, systems will be more dependent 
on private funding sources, with both out-of-pocket spending and 
voluntary health insurance associated with inequity and poor financial 
protection. Furthermore, governments will not have the purchasing 
power to manage cost growth in the private provision sector. Thus, 
failure to increase the share of total health spending coming from 
public sources will have harmful efficiency consequences as well. 
While increasing public spending on health is necessary for progress 
in most countries, simply throwing more money at the system will not 
be adequate. Funds must be utilized efficiently if progress towards UHC 
is to be sustained. Reform experience suggests that a key direction 
for change is to enable strategic purchasing techniques to be applied 
to general budget revenues.116 
Greater attention must be given to enhancing productive dialogue 
between a country’s health and finance ministries (or their equivalent) 
on both the level of funding for health as well as aligning financing 
reform strategies with public finance management rules to enable 
systems to take real steps towards results-oriented accountability 
rather than merely a focus on input control and budget implementation. 
Finally, there remains an important gap to fill: better understanding 
the demand-side barriers to use of needed services beyond the need 
to pay for health services including transport to health facilities or the 
potential of lost income associated with care seeking. Policy responses 
to these challenges do not necessarily involve financing, but instead 
may be more in the realm of innovative service delivery. Thus, going 
forward, it is essential to ensure a balanced, nuanced approach involving 
both service delivery and financing in the diagnosis of problems and 
development of reform solutions.  
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HEALTH WORKFORCE
Health systems and services depend critically on the size, distribution, competencies and performance of 
the health workforce. Typically, the health workforce is discussed in terms of four dimensions: availability, 
accessibility, acceptability and quality.19 Availability is a measure of the supply of health professionals 
coming through the training pipeline, plus the pool of trained health professionals already providing health 
care. Accessibility is a measure of how easily people in need of care can get to see a health professional. 
Both dimensions have a bearing on the extent to which a health-care system covers the needs of the 
general population. Acceptability and quality, meanwhile, relate to the nature of the health care provided.
TRENDS 
The 2006 World Health Report identified an estimated global deficit 
of 2.3 million skilled health professionals (e.g. midwives, nurses and 
physicians) and over 4 million health workers overall.117 Countries 
with the greatest burden of disease have the smallest skilled health 
professional workforce, often concentrated in urban populations. The 
situation has changed very little since then (Figure 3.8). 
The assessment of the trend in densities of health workers in urban 
and rural areas within countries is hampered, for instance, by a lack 
of reliable and comparable data over time. In general, however, there 
appears to be evidence for a modest improvement in national densities 
of skilled health professionals in just over half of the countries affected 
by severe shortage.19
POSITIVE DEVELOPMENTS
Global advocacy and mobilization: The World Health Report 2006 
drew attention to the global health workforce crisis that threatened 
the attainment of the health-related MDGs and prompted national, 
regional and global responses.119,120,121 The Global Health Workforce 
Alliance was created in 2006 as a common platform to address the 
workforce crisis.34 Three global forums on human resources for health 
were convened in 2008, 2011 and 2013 to mobilize all relevant 
actors, share experiences and galvanize action. Seven resolutions, 
specific to the workforce agenda were adopted by the World Health 
Assembly.119,120 ,122,123,124,125,126
WHO Global Code of Practice on the International Recruitment of Health 
Personnel:127 In 2010, the Code was adopted by the World Health 
Assembly and encourages information exchange on issues related to 
health personnel and health systems in the context of migration and 
stipulates regular reporting every three years on measures taken to 
implement the Code. Implementation of the Code was assessed in 
2015 after its first five years of implementation. The review stipulated 
the continuing relevance of the Code, but called for extra measures 
among stakeholders to bolster its effectiveness. A second round of 
national reporting is due in 2016.128
Country actions: A number of countries have produced new or revised 
national HRH strategies aligned with their MDGs and national health 
objectives. As a result, many have focused on ensuring equitable 
access to care, and in some countries effective coverage has improved; 
in particular, there has been an increased focus on the availability, 
accessibility, acceptability and quality of all types of health workers, 
including community-based, mid-level and advanced practitioners, 
as well as the services they provide.19 
New approaches: Strategies that put health professionals closer to the 
communities they serve and backed by new normative guidance from 
WHO (e.g. on education,129 retention130 and nursing and midwifery131) are 
making services and health workers more accessible and acceptable. 
Other policy tools that have been effective in improving health worker 
distribution include: financial incentives; continuing professional and 
career development opportunities; prolonging the residency period; 
introducing periods of training in rural areas; and other non-financial 
incentives such as free housing, security and free access to health 
care.19 New analyses on the potential impact and cost-effectiveness 
of community-based practitioners warrants further exploration and 
the development of an improved evidence base to guide national 
decision-making.132,133
Improving the quality of health professional education has been a 
specific focus for some countries, including Brazil, Cambodia, Mexico 
and Norway.19
Figure 3.8 
Distribution of skilled health professional by level of health expenditure and 
burden of disease,a by WHO region (2004–2005 versus 2013–2014)118
a The size of bubble indicates level of health expenditure as % of global health expenditure.
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CHALLENGES
Underinvestment: In many low- and middle-income countries, 
underinvestment in the education, deployment and retention of health 
professionals has been the most significant barrier to meeting the 
health-related MDGs. 47,134,135
Continuing and projected shortages: The shortages are large in 
many countries and involve existing and emerging categories of the 
health workforce. The increasing workforce feminization globally, 
particularly among physicians, may have an impact on, for instance, 
the availability of primary health care services, although this is likely to 
be small.136,137 The drivers of observed differences between male and 
female primary care physicians are complex and nuanced. Additional 
research examining gender differences in practice patterns, scope of 
work and the impact for national health workforces and health systems 
is warranted. Further challenges are anticipated from an ageing health 
workforce and too few new recruits to replace retirees – for example, 
the retirement bulge in the coming years may drastically shrink the 
health workforce in high-income countries.138 
Inequalities: Pronounced inequalities of distribution and access within 
countries attributed to differentials of environments, motivation levels, 
productivity and performance. Skill-mix imbalances, such as too many 
physicians and too few nurses in some countries, persist alongside 
underutilization of skilled personnel.
Poor education: Health workforce education limited by outdated 
academic, content-oriented curricula as opposed to, for example, 
competency-based education.139
Poor data: Despite good progress in HRH information and improvements 
of data availability, the challenge of fragmented, underresourced and 
underutilized data remains. The majority of countries are lagging 
behind in their capacity to estimate future needs and formulate the 
relevant policies to meet them.
Resistance to new models of care: Professional associations and 
institutions may resist new models of service delivery such as task 
shifting, home care and the use of ICT.140
STRATEGIC PRIORITIES
The WHO Global Strategy on Human Resources for Health: Workforce 
2030,71 which is to be submitted to the World Health Assembly in May 
2016, puts forward a vision of how countries can respond to today’s needs, 
while anticipating tomorrow’s expectations and future opportunities. 
At the core of the new strategy is the emerging consensus that the 
creation of employment opportunities (public, private and other) in 
the health and social sectors is a driver of economic growth and a 
major contributor to female participation in the labour force. Taken 
together with the likely beneficial effects on health outcomes, and 
the improved capacity to detect and respond to disease outbreaks, 
these benefits make the health workforce a key lever for change 
and progress towards the SDGs (e.g. addressing poverty, education, 
employment, gender and health).141
Elements that inform the new strategy include:47
• planning guided by a thorough understanding of health labour 
markets; 
• investment in data and evidence for sound planning and decision-
making;
• leadership and governance for effective stewardship of HRH 
development;
• education and training in line with integrated people-centred service 
delivery;
• mobilizing financial resources and securing their strategic use;
• transforming education, deploying health workers where they are 
needed, and maximizing quality, performance of existing health 
workers;
• promoting self-reliance in communities; 
• harnessing the private sector capacity for public sector goals. 
An emerging consensus informing the new strategy is that the 
creation of employment opportunities (public, private and other) in 
the health and social sectors is a driver of economic growth and 
a major contributor to female participation in the labour force. The 
establishment of a Commission on Future Health Employment and 
Economic Growth, under the auspices of the UN Secretary-General, 
will be tasked to consolidate evidence and policy recommendations, 
from a multi-sectoral and multi-constituency perspective, on how 
investment in human resources for health will contribute to the 
attainment of health and broader economic development objectives 
within the SDGs. Taken together with the likely beneficial effects on 
health outcomes and the improved capacity to detect and respond to 
disease outbreaks, these benefits make the health workforce a key 
lever for change and progress towards the SDGs (e.g. addressing 
poverty, education, employment, gender and health).141
The global strategy includes a specific focus on reducing data gaps 
through the adoption of national health workforce accounts142 as a 
harmonized, integrated approach for annual and timely collection of 
health workforce information. Its purpose is to standardize the health 
workforce information architecture and interoperability, tracking of HRH 
policy performance towards UHC and monitoring the implementation of 
global health policy instruments such the WHO Global Code of Practice 
on the International Recruitment of Health Personnel and the IHR (2005). 
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MEDICAL PRODUCTS 
Access to quality essential medical products – including medicines, vaccines, blood and blood products, 
and medical devices – is critical to achieving UHC. In all four areas, it is possible to point to some 
positive trends in the past 15 years, in terms of access and use in health service delivery. However, major 
challenges remain.
TRENDS 
Improving access to essential medicines is part of MDG 8 and progress 
was monitored by the MDG gap task force. Medicines expenditures 
account for 10% of health spending in high-income countries, and for 
up to 50% of health spending in low- and middle-income countries; 
between 50% and 80% of medicines spending in LMIC is out-of-
pocket payments. Based on data from 26 surveys in low-income 
and lower-middle-income countries, using the standardized WHO/HAI 
methodology,20 generic medicines were available in 58% and 67% of 
public and private sector health facilities,48 respectively, with large 
variation between countries.21 Access to vaccines and rapid diagnostics 
such as malaria and HIV tests also greatly improved.
In 2012, 108 million blood donations were collected globally, an 
increase of almost 25% from 80 million donations collected in 
2004.22 Seventy-three countries reportedly collect over 90% of their 
blood supply from voluntary unpaid blood donors. An increase of 8.6 
million blood donations from voluntary unpaid donors was reported 
from 2004 to 2012.22
POSITIVE DEVELOPMENTS
Better policies and regulation: National medical product quality begins 
with a national policy designed to ensure the continuous provision of 
appropriate, quality products in adequate quantities and at affordable 
prices.143 Currently, more than 140 countries have defined national 
essential medicines lists to guide their purchasing decisions. Increasingly 
countries are developing and implementing comprehensive national 
medicines policies and strengthening their governance frameworks 
in the pharmaceutical sector.143 Also, 70% countries had a national 
blood policy in 2012, compared with 60% of countries in 2004.22
Innovation: Pharmaceutical innovation continues to drive improvements 
in health outcomes. Meanwhile the frugal innovation movement is 
discovering ways to adapt technologies developed for high-income 
countries for use in low- and middle-income countries.144
Increased access to medical products: The rise of the global market in 
generic drugs has brought down costs and increased access to essential 
medicines.145 Procurement agencies use the WHO prequalification 
programme, which was first established in 1989 for vaccines, and 
since then has been expanded to cover around 250 medicines for 
priority diseases. 
Access: Accessibility of vaccines, diagnostics and treatments has 
greatly benefited from global efforts such as GAVI, Global Fund and 
HIV, TB and malaria partnerships and initiatives. 
Quality improvement: Since its inception, more than 100 countries have 
incorporated the good manufacturing practice provisions into their 
national medicines laws, and many more have adopted its provisions 
and approach in defining their own national good manufacturing 
practice requirements.146
Rational and effective use: National programmes have been implemented 
to improve the use of medicines (including antibiotics), to enhance 
good surgical and anaesthetic techniques, and, in case of blood, to 
reduce blood loss and use alternatives to whole blood for volume 
replacement.22
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CHALLENGES
Weak policies: National policy development and implementation needs 
to be supported by sound health technology assessment to guide 
research, innovation and procurement and use.147 
Regulatory deficiencies: The complexity of new medicines and medical 
products and the internationalization of the production and distribution 
of medical products pose increasing challenges to country and regional 
regulatory systems. 
Medicines and technologies access: Many people still lack regular 
access to essential medicines and technologies.20 For instance, 
access to NCD drugs is still very poor in many low- and lower-middle-
income countries (Figure 3.9).148,149 Similarly, in a survey, 25 countries 
reported being unable to screen all donated blood for one or more of 
HIV, hepatitis B, hepatitis C and syphilis, with the lack of test kits as 
the most commonly cited reason.22 Inappropriate use of medicines 
remains widespread, compromising treatment success, promoting 
antimicrobial resistance and leading to waste of resources.
Quality problems with medical products: The number of reports on 
SSFFC medicines is growing, especially from low- and middle-income 
countries, and have led to serious problems including deaths. Their 
occurrence is a threat to patient safety and undermines the credibility 
of health systems.
Neglected diseases: The profit motive for innovation has provided 
inadequate incentives for research and development (R&D) into 
the medical products needed to prevent and treat the diseases that 
especially afflict the poor.64 Tensions remain between the system of 
intellectual property protection for pharmaceutical products on the 
one hand and international human rights obligations and public health 
requirements on the other.
Drug prices: In a survey in 26 countries, patient prices for lowest-priced 
generics were, on average, 2.9 times higher than international reference 
prices in public sector facilities and 4.6 times higher in private sector 
facilities.150 Patients buying medicines in the public sector of the low-
income countries paid on average 2.4 times international reference 
prices, whereas patients paid 3.4 times international reference prices 
in lower-middle-income countries. A similar picture was seen in the 
private sector.48 The price of new vaccines is a source of concern in 
many countries. Many new medicines, such as cancer and hepatitis 
C medicines, are largely unaffordable while under patent, even for 
many high-income countries.
STRATEGIC PRIORITIES
The SDG Target 3.b states: 
Support the research and development of vaccines and 
medicines for the communicable and noncommunicable diseases 
that primarily affect developing countries, provide access to 
affordable essential medicines and vaccines, in accordance 
with the Doha Declaration on the TRIPS Agreement and Public 
Health, which affirms the right of developing countries to use 
to the full the provisions in the Agreement on Trade-Related 
Aspects of Intellectual Property Rights regarding flexibilities 
to protect public health, and, in particular, provide access to 
medicines for all. 
The World Health Assembly has adopted multiple resolutions that have 
laid out the key areas of strategic interest and are closely related to 
SDG Target 3.b:
• strengthening national policy and regulatory authorities;73
• expanding access to essential medicines, vaccines and diagnostics 
in the context of UHC:74
– continuing to support improving access to interventions for 
priority diseases, maintain an effective prequalification; 
– selection of essential medicines and other medical products, 
including using health technology assessments and pricing 
policies aimed at affordability; 
– improving medical product coverage for NCDs;
– ensuring appropriate use of medicines and other medical 
products;
– addressing antimicrobial resistance (discussed in Chapter 5) 
and responsible use of medicines;
– national policies on production of medical products that put 
access first, addressing underserved clinical areas, e.g. by 
promoting technology transfer; 
• developing new models for innovation for underserved clinical areas 
and technology transfer for expanded access in low- and middle-
income countries, following up on the report of the Consultative 
Expert Working Group on Research and Development.151
Figure 3.9 
Availability of antibiotics and NCD essential medicines in selected countries,a 
2013–2015149
a Unweighted mean availability of 12 antibiotics and 17 NCD essential medicines on 
the day of the survey, among health facilities that offered NCD services. Data are 
from most recent survey in each country.
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HEALTH INFORMATION
Health information systems are the foundation of health systems, providing critical information for 
planning, targeting and monitoring. Many countries are gradually improving their information systems, but 
major gaps in data availability, quality and use remain. Focus on performance measurement and value for 
money, as well as greater accountability, defined as a cyclical process of monitoring, review and remedial 
action, of all stakeholders are considered increasingly important in all countries.
TRENDS 
The availability of health data has improved considerably, mainly due 
to international health survey programmes. More than 500 national 
surveys in low- and middle-income countries have been supported 
through the DHS programme,152 primarily funded by the United States 
Government, and the UNICEF MICS programme.153 The survey programmes 
have provided critical data for monitoring the MDG health indicators154 
and on the coverage of interventions for maternal, newborn and child 
health.155 Disease surveillance for HIV, TB, malaria and other diseases 
also improved during the past two decades. Many countries have 
taken steps to improve the availability and reliability of data derived 
from health facilities that are often the main source of information to 
guide decision-making and resource allocation at local and district 
levels. More countries are conducting regular national health accounts 
exercises, and increasingly with subaccounts on specific programmes. 
In addition, 91% of countries took part in the 2010 round of censuses, 
up from 84% in the 2000 round.156
 
Other areas of progress and greater investment include work on global 
health estimates through UN agencies and academic institutions,157 
the availability of disaggregated data to assess inequalities within 
populations158 and more emphasis on accountability for health, including 
data sharing, transparency and use of data to track resources and 
document results.159
POSITIVE DEVELOPMENTS
More investment: The continuous investments of global agencies in 
international survey programmes, both financially and technically, 
have greatly improved the standardization of data collection and 
quality of health surveys. DHS is already in its fourth decade. MICS 
has completed its second decade of support. 
Better measurement: Methods of data collection have improved 
in several areas, including the standardization of measurement 
of economic status. There are ongoing efforts to harmonize data 
collection instruments such as DHS and MICS and to identify the 
most effective and efficient ways of soliciting valid information from 
survey respondents, in particular, with regard to service use.160 The 
addition of biological and clinical data collection to household surveys 
is greatly enhancing public health information.161 Examples include 
anthropometry, measuring blood pressure and testing blood for HIV 
or malaria parasites.
 
Political mobilization: The 2010 round of censuses was a success 
because all countries through the UN Statistical Commission and 
regional bodies threw their weight behind it.162
Global collaborations: The report of the Commission on Information 
and Accountability for Women’s and Children’s Health,163 the work by 
IHP+,164 the Countdown for Maternal, Newborn and Child Survival,155 
global and local civil society action in, for instance, the field of HIV/
AIDS and other initiatives were all supportive of greater emphasis on 
information and accountability within countries and globally. Examples 
of concrete products of collaborations include alignment of health 
surveys between DHS and MICS and the global reference list of 100 
core health indicators.165 Multiple interagency, reference groups and 
academic institutions have advanced the field of measurement and 
estimation for key mortality and health indicators.166
Digital revolution: While many innovative approaches are still in the 
early stages, several have gone to scale, such as the use of web-based 
reporting systems for health facility data (e.g. DHIS 2167), open source 
data systems for electronic health records (e.g. Open MRS168) and 
active disease surveillance through portable devices. The number of 
mobile-cellular telephone subscriptions (Figure 3.10) and households 
with Internet access at home have increased dramatically in the last 
decade.169
Spread of national policy: A WHO assessment indicated that over 100 
countries have developed eHealth policies and strategies.170 According 
to a recent OECD survey, 22 of 25 reporting high-income countries 
have a national plan or policy to implement electronic health records, 
while 20 reported starting implementation.171 
Figure 3.10 
Number of mobile-cellular telephone subscriptions per 100 inhabitants, 
2005–2015172
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CHALLENGES
Data gaps: Most low- and lower-middle-income countries (Figure 
3.11) do not have reliable data on mortality by sex, age and cause of 
death. Only 50% of countries reported cause-of-death data to WHO in 
2014 (45% in 1990). Major gaps exist because the key data sources 
are not functioning well, including CRVS systems, health facility and 
community information systems, disease surveillance systems, health 
workforce and health financing accounts.
Limited data use: Analytical capacity is limited in many developing 
countries, there are no well-established public health institutions and 
data are not translated into action. Improving accountability is still in its 
early stages, needs considerable work in the coming decade and will 
require greater involvement of civil society, politicians and the media.
Insufficient investment: Global investments in health information will 
continue to be critical in low- and lower-middle-income countries. 
Fragmentation along programme-specific lines results in reduced 
efficiency of such investments when it comes to country health 
information system strengthening. The same applies to ICT innovations 
which often results in uncoordinated, piecemeal efforts.173,174
Lack of data standards: Even where countries collect data, problems 
arise. Fewer than half of countries participating in a recent OECD 
survey reported having succeeded in implementing a system where all 
electronic health records have key data elements that are structured 
and follow a clinical terminology standard.171
Data privacy: Increased data collection and connection has implications 
for privacy. Resolving this issue will require the development of patient 
health data privacy and security standards, and the development and 
adoption of national regulations governing the collection, storage and 
use of patient health data.171,176
STRATEGIC PRIORITIES
The importance of disaggregated data, monitoring and accountability 
is highlighted in the SDG under the means of implementation targets. 
For instance, Target 17.18 states: 
By 2020, enhance capacity-building support to developing 
countries, including for least developed countries and small 
island developing states, to increase significantly the availability 
of high-quality, timely and reliable data disaggregated by income, 
gender, age, race, ethnicity, migratory status, disability, geographic 
location and other characteristics relevant in national contexts. 
The global strategy for low- and middle-income countries is captured in 
a recent roadmap and call to action for measurement and accountability 
for health results during 2015–2030.75 The focus of this roadmap is 
on the five points of the call to action:
 
1. Increase the level and efficiency of investments by governments and 
development partners to strengthen the country health information 
system in line with international standards and commitments.
2. Strengthen country institutional capacity to collect, compile, share, 
disaggregate, analyse, disseminate and use data at all levels of 
the health system.
3. Ensure that countries have well-functioning sources for generating 
population health data, including CRVS, census and health survey 
programmes tailored to country needs, in line with international 
standards.
4. Maximize effective use of the data revolution, based on open 
standards, to improve health facility and community information 
systems, including disease and risk surveillance, financial and 
health workforce accounts, and empowering decision-makers at 
all levels with real-time access to information.
5. Promote country and global governance with citizen participation for 
accountability through monitoring and regular inclusive transparent 
reviews of progress and performance at facility, subnational, national, 
regional and global levels, linked to the health-related SDGs.
The digital revolution provides many opportunities for health information 
systems (Box 3.2), and should greatly contribute to a data revolution. A 
data revolution for sustainable development entails integration of these 
new data with traditional data to produce high-quality information, the 
increase in the usefulness of data through much greater openness 
and transparency and, ultimately, more empowered people, better 
policies and decisions and greater participation and accountability.177
Box 3.2 
From digital to data revolution
• Active diseases surveillance and response systems through portable devices;
• Digital information systems from health facility to the national level; 
• Digital tracking systems for expenditure and resource flows;
• Digital health workforce registries with individual level data;
• Digital registers and databases with individual level patient data;
• Digital health records for individuals with patient data-based aggregate systems;
• Comprehensive health examination surveys using mobile devices and biological 
and clinical data collection;
• Longitudinal individual-based tracking systems;
• Interoperable databases for medical care, including logistics, lab and patient care;
• Big data analytics;
• Geospatial analysis for many health indicators;
• Electronic dashboards for managers.
Figure 3.11 
Cause-of-death information by country, 2014175
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SERVICE DELIVERY
In order to achieve UHC, health services should be based on a primary health care approach that is 
people-centred, integrated and responsive. To achieve this goal, the availability, quality and safety of 
health services must be improved. In many countries, health services are poorly organized and managed, 
understaffed and crowded with long waiting times, and unresponsive to people’s cultural, ethnic or gender 
preferences. Even when services are accessible, they can be of poor quality, endangering the safety of 
patients and compromising health outcomes.
TRENDS 
There have been significant gains in terms of access to services for 
infectious diseases, HIV/AIDS, malaria and tuberculosis, as well as 
marked improvement in MDG-target areas such as RMNCH, including 
immunization.178 These gains have occurred in all population groups 
and are often largest in the poorest populations.11 
Despite the growth of quality improvement initiatives, it is difficult to 
ascertain on a global or even national scale whether and how much 
the quality and safety of services have improved as comparable data 
are limited, even for high-income countries. Progress has been made 
in the implementation of a number of interventions to improve the 
quality of services such as accreditation of facilities, improvements in 
the numbers, distribution and performance of the health workforce,19 
specific interventions such as surgical safety179 and combating 
health-care associated infections,180 and the greater decentralization 
of services to primary care providers. 
POSITIVE DEVELOPMENTS
Increased accreditation: Hospital accreditation has greatly increased 
since 1995 and is now an integral part of health systems in over 70 
countries, with documented impact in some countries.12 Most recently, 
accreditation has been adopted in a number of low- and middle-income 
countries, often as a strategy to improve basic health service quality.50
Global campaigns to promote quality and safety: There have been a 
number of global and regional initiatives, including the WHO “Clean 
care is safer care” and the “Safe surgery saves lives” campaigns.179 
To support widespread recognition of the importance of patient 
safety, WHO established the World Alliance for Patient Safety in 2004, 
renaming it the Patient Safety Programme in 2009. The linkage of 
a global movement and local action on patient safety was pivotal 
to improvement efforts. In particular, the role of institutional health 
partnerships in service delivery improvement has been highlighted.181
Primary health care emphasis: Many countries have continued or 
strengthened their efforts to develop better integrated health systems, 
with primary health care clinics taking a greater role in health-care 
coordination,15 acting as gatekeepers to the specialized health-care 
space.16 In many high-income countries, hospitals are being reassigned 
a narrower, specialist role, and being called on to support the systems 
around them.182 Several countries also aim to increase community 
involvement in planning and goal setting, as well as the provision of 
community-based services.183,184,185 
Digital revolution: Over the past 15 years, the rapid expansion of ICT has 
begun to change the way health services are delivered with potentially 
positive effects on outcomes of care or population health.23 A number 
of countries are working on ICT-based applications to monitor health 
services quality.186,187
CHALLENGES
Fragmented health services: In all countries, there is room for improvement 
in how health-care services are organized in order to improve access to 
primary care and manage patients in the community so as to minimize 
hospital-based treatments. While a number of countries are embracing 
health services integration as a way to deliver people-centred care,51 
many are still relying on hospitals and specialist medicine that have 
little connection with the health-care system around them or the 
communities they are supposed to serve.12 
Lack of  access and infrastructure: In several cases, national intervention 
coverage already surpasses 80%. However, there is still a long way 
to go on the road to UHC. It is estimated, for example, that at least 
400 million people do not have access to at least one of six essential 
services such as family planning or child immunization and major 
inequalities still persist across subgroups within countries (Figure 
3.12).11,178 Also, access to emergency and essential health services is 
extremely limited in low- and middle-income countries, where surgical 
care is concentrated in urban centres.188 
NCD epidemic with an ageing population: An overwhelming challenge 
facing health services in all countries is the explosion of chronic 
diseases as the primary driver of health-care utilization and costs. 
There is a need for continuity of integrated care over time and for both 
preventive and long-term treatment interventions. Serving a patient 
population that is increasingly older with multi-morbidities creates 
challenges in terms of care, home- or facility-based; requiring new 
models of care provision.
Persistent disease-oriented approach: The drive to produce results 
for programme-oriented MDGs led many stakeholders to focus on 
a single priority. There is broad acknowledgement,57 however, that 
this approach has limitations and that even these disease-oriented 
objectives cannot be sustainably achieved without concrete health 
system strengthening and a more integrated approach.58,59
Lack of data: In many countries, data on service delivery are neither 
captured nor used effectively, either to inform patient care or to 
underpin service management and resource allocation. There is need 
for investment in service delivery metrics to complement disease-
oriented indicators with clearly defined service delivery targets so that 
countries can shift their resources towards sustainable improvements 
in health systems. Measurement of service delivery processes provides 
a method to monitor progress so that policy-makers, managers and 
providers may make informed decisions to improve service delivery. 
Lack of scaling-up for improvement initiatives: Initiatives for quality 
improvement have been developed in many countries, but few have 
achieved their objectives at scale, remaining limited to small-scale 
and context-specific projects that are usually not embedded in broader 
health system transformation strategies. 
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STRATEGIC PRIORITIES
The SDG target most relevant to service delivery is Target 3.8 on UHC. 
Effective delivery of promotive, preventive, curative, rehabilitative and 
palliative services is also critical for the health goal overall and most 
of the specific health targets. It is essential to ensure that national 
health system reforms for UHC position quality of care as integral to 
expanding population coverage. Aligning global and national efforts 
to support robust, evidence-based approaches to providing safe, 
quality health-care services to populations within the context of UHC 
will thus be critical, including improved measurement of quality and 
safety of care. 
WHO has launched the global strategy on people-centred integrated 
health services.68 The strategy is designed to help countries progress 
towards “a future in which all people have access to health services 
that are provided in a way that responds to their life course needs 
and preferences, are coordinated across the continuum of care and 
are safe, effective, timely, efficient and of acceptable quality” and 
focuses on five strategic directions that each offer evidence-based 
interventions that countries can consider when seeking to redesign 
the service delivery model:
• empowering and engaging people;
• strengthening governance and accountability; 
• reorienting the model of care; 
• coordinating services across the continuum of care;
• creating an enabling environment that supports health services 
transformation.
To improve the major gap in access and quality of surgical services 
a resolution was adopted by the World Health Assembly to promote 
the integration of safe, quality and cost-effective surgical care 
into the health system as a whole.190 The resolution highlights the 
importance of both expanding access and improving the quality and 
safety of services; strengthening the surgical workforce; improving 
data collection, monitoring and evaluation; ensuring access to safe 
anaesthetics such as ketamine; and fostering global collaboration 
and partnerships.
Poor quality of care: This remains a key challenge in all countries. Moving 
forward with UHC reforms without placing quality as a precondition 
will jeopardize outcomes as well as the reputation and utilization of 
health services. High levels of medical error are reported across the 
full range of health services.53,189 Investments in information and 
performance improvement systems to assess and improve the quality 
and effectiveness of care have been limited in developed countries 
and non-existent in developing countries.
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61UNIVERSAL HEALTH COVERAGE
Figure 3.12 
Median coverage of selected interventions by wealth quintile, in low- and middle-income countries, 2005–2013178
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RESEARCH FOR UHC
Research evidence is vital in developing the technology, systems and services needed to achieve UHC. Of 
paramount importance in both understanding and overcoming barriers to the delivery of health services 
in the face of often stringent resource constraints, research informs strategies aimed at improving quality 
health care and promoting equity. Finally, research and the evidence it generates is also needed to 
ascertain how to optimize the coverage of existing interventions and how to select and introduce new ones 
to further the UHC endeavour.76
TRENDS
New products: The past 15 years has seen a range of new products 
for prevention and treatment of public health priorities, such as the 
new vaccines, rapid diagnostics and treatments. This also includes 
simplifications of treatment regimens and the use of combination 
therapies.
Improved research activity/production: Globally, there has been a marked 
increase in research activity and capacity in the wake of the 1990 report 
of the Commission on Health Research for Development.191 Notable 
developments include: augmented research capacity to address key 
questions about health, and greater guidance for, and adherence to, 
good practices in the design, conduct, ethics and reporting of results; 
and improved setting of research priorities, evaluation of disease 
burden, conducting of primary studies and systematic reviews of 
evidence (Figure 3.13). 
Improved dissemination and use of results: Important progress has 
also been made in research dissemination (including increased open 
access publishing), knowledge management and support for evidence-
informed policy- and decision-making processes. 
More systematic research assessment and use: More systematic 
approaches are now used to facilitate the assessment and use of research, 
a notable example being the GRADE (Grading of Recommendations 
Assessment, Development and Evaluation) system to assess the 
quality of evidence and strength of recommendations on the basis of 
existing knowledge.192 
Greater accountability/transparency: Improvements have also been 
made in the accountability and transparency of research, key initiatives, 
including WHO establishing the International Clinical Trials Registry 
Platform (ICTRP) that now contains records of nearly 300 000 trials.193 
Several countries have also established national registries (e.g. Brazil, 
China, India, Pan African registry), in addition to strengthening the ethical 
conduct of research, with guidance from institutional review boards.
Greater access to knowledge: The global volume and access of 
research publications has grown dramatically. For instance, the WHO 
evidence-based guidelines present a major global use of research 
outputs for policy and programme guidance. Enhanced dissemination 
of research and related publications through the HINARI programme, 
has resulted in much greater access to scientific journals, databases 
and eBooks to more than 100 low and middle-income countries until 
2020, and possibly beyond.194
POSITIVE DEVELOPMENTS
Increased awareness of need: The 1990 report of the independent 
Commission on Health Research for Development exposed the 
mismatch between investment in health research in low- and middle-
income countries and the disease burden they carry, a mismatch later 
characterized as the 10/90 gap (i.e. less than 10% of global spending 
on research is devoted to diseases and conditions that account for 
90% of the burden of ill-health).195 
Increased funding: More funding has been allocated to health research. 
Total investment in health research reached US$ 240 billion by 2009.65 
Increased health policy and systems research: Support for health policy 
and systems research has grown significantly,196 and many countries 
now have a national health research policy and give higher priority to 
research for health system development, strengthening links between 
scientific evidence and the development of health policy.197 
Increased global collaboration: Multiple global collaborations and 
partnerships exist, including Health Systems Global,42 the Alliance 
for Health Policy and Systems Research,198 and the Council on Health 
Research for Development (COHRED),199 among others, which advocate 
for greater research investments and facilitate capacity strengthening 
in low- and middle-income countries.
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Conducting systematic reviews by selected WHO region, 1996–2002 and 
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CHALLENGES
Persistent 10/90 gap: Progress in generating research evidence to 
support UHC has been uneven, and low-income countries have yet to 
see a significant increase in research production (Figure 3.14). Even 
today, a mere 10% of health policy and systems research globally is 
conducted on low- and middle-income countries.200 
Fragmented research: Despite increased global collaboration, poor 
coordination and fragmentation of health research are still major 
issues, in addition to lack of prioritization, low quality in conducting 
and reporting research, and duplication and waste of research effort.201
Lack of funding: In spite of a positive trend, health policy and systems 
research still accounts for only a small fraction of health research 
funding in both low- and middle-income countries and high-income 
countries. Furthermore, health research is still largely focused on 
biomedical and clinical interventions, while health policy and systems 
research remains underfunded.202 
Inadequate use of evidence: Even though the importance of linking 
knowledge generation and decision-making is widely recognized, 
these remain largely separate processes. Because of the importance 
of context in the development of UHC systems, there is a need to go 
beyond models that call for the linear use of evidence in decision-
making, recognizing that knowledge is broader, contextualized and 
informed by a number of factors other than empirical evidence.
Inadequate ethics: Application of the highest ethical standards in 
research remains a critical issue everywhere.
STRATEGIC PRIORITIES
The World Health Report 2013 has set priorities for research for 
UHC that require national and international backing. Systems are 
needed to develop national research agendas, raise funds, strengthen 
research capacity and make appropriate and effective use of research 
findings.76 Going forward, the context-specific nature of UHC challenges 
and opportunities – especially those related to services delivery 
and financing – will require research approaches that fully reflect 
conditions on the ground. Health policy and system research offers 
great potential in this regard, allowing for multiple methods to address 
challenges of implementation and, crucially, scale-up (Figure 3.15).77 
It is for this reason that global networks and partnerships have made 
implementation research a priority field.203 
In addition, there is a need for greater integration of research into 
decision-making processes and for the production of demand-driven 
research as an integral part of programme planning and implementation.204 
Integrated or embedded research should be prioritized as a means 
to foster evidence-informed policy- and decision-making processes.
Greater efforts also need to go into ensuring that the research undertaken 
is aligned with need. The R&D inequalities and challenges are described 
in the overview section and the section on medical products in this 
chapter. The development of the Global Health R&D Observatory, 
mandated by resolution WHA66.22,206 is notable in this regard as its 
main focus is the monitoring and analysis of relevant information on 
health R&D, building on national and regional observatories (or equivalent 
functions) and existing global data collection mechanisms to identify 
gaps and opportunities for health R&D. It will be launched in 2016.
Finally, the development of research capacity in support of UHC will 
depend on teaching health policy and systems research in both schools 
of public health and schools of public policy. Collaborative networks 
of research centres and learning-by-doing opportunities are also 
important in this regard. 
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Figure 3.14 
Research publication by income group, 2000–201076
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SUMMARY
Deaths among pregnant women, children and adolescents account for more than one third of the global burden of 
premature mortality, despite the fact that the vast majority of these deaths are preventable. Rates of maternal mortality 
are 19 times higher in developing countries than in developed, and children in developing countries are eight times more 
likely to die die before they reach five years. 
Despite substantial progress on maternal and child mortality, neither MDG 4 nor MDG 5 targets will be met. The global 
under-five mortality rate (U5MR) fell by 53% between 1990 and 2015, short of the targeted two thirds reduction, and the 
global maternal mortality ratio (MMR) declined by 44%, well short of the targeted 75% fall. 
It is estimated that 5.9 million children under five will die in 2015, and there will be 303 000 maternal deaths. The African 
Region and South-East Asia Region account for a disproportionate share of maternal, newborn and child deaths.  
Major efforts to eradicate polio have led to dramatic decreases in the number of countries with endemic transmission to 
just two, and a fall in wild poliovirus cases from about 2000 in 2005 to 359 cases in 2014. The prevalence of underweight 
among children under five years declined from 25% to 14% between 1990 and 2015, nearly reaching the MDG 1.C target 
of a 50% reduction.
 
Global, regional and national political commitment, global partnerships and funding – some of which have come only 
recently – contributed to the achievements, as did improvements in socioeconomic conditions, education, gender equality 
and the environment. Many countries achieved major increases in the coverage of family planning, antenatal care, skilled 
attendance at birth and child immunization and successfully scaled up new interventions such as insecticide-treated 
mosquito net (ITN), treatment with antimalarials and prevention of mother-to-child HIV transmission since 2000. 
A comprehensive set of targets for addressing the health and well-being of women, children and adolescents has been 
adopted under the SDGs, including the targets under the health goal and other relevant goals, such as on hunger (SDG 2). 
Ambitious targets are set to end preventable maternal and child deaths and achieve universal access to reproductive 
health-care services. Newborns are explicitly included.
The UN Secretary-General’s new Global Strategy for Women’s, Children’s and Adolescents’ Health 2016–2030, released at 
the same time as the adoption of the SDG declaration, provides a broad multistakeholder framework for the implementation, 
follow-up and review of progress towards the relevant health and related targets.
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While not all MDG targets will be met, important progress 
has been made in recent years in reducing maternal and child 
mortality, as well as child undernutrition, with substantial 
improvements across key indicators since 1990. The least-
developed countries continue to face the greatest challenges 
in improving maternal and child health, struggling with a 
combination of poor coverage and quality of health care 
services and public health interventions, inadequate water 
and sanitation, poor infrastructure, low food security, and 
limited education and economic opportunity. These same 
countries also often face obstacles in ensuring universal 
access to sexual and reproductive health services, as well 
as safe-guarding the health of adolescents – challenges that 
are shared by most world regions.
Globally, in 2012, 37% of YLLs was due to deaths from 
maternal causes or deaths among those younger than 
15 years (Figure 4.1). The difference in the fraction of 
YLLs accounted for by reproductive, maternal, newborn, 
child and adolescent health (RMNCAH) between the 
African Region and high-income OECD countries is a stark 
reminder that many of these deaths are avoidable. In high-
income OECD countries, only 4% of total YLLs occurs 
among pregnant women and children under 15 years of 
age, compared to 63% in the African Region, 51% in the 
Eastern Mediterranean Region and 36% in the South-East 
Asia Region. Some of this divergence can be explained by 
differences in age structure, but it is clear that MDGs 4 and 
5 constitute two parts of a far-from-finished agenda. 
Fortunately, the SDGs will keep the spotlight on the 
unfinished agenda of ending preventable maternal, newborn 
and child mortality. SDG 3.1 aims to reduce the global MMR 
to less than 70 per 100 000 live births by 2030, and to have 
no country with an MMR above 140 – significantly below the 
current global MMR of 216 per 100 000. About 303 000 
women are expected to die in 2015 due to maternal causes,2 
which makes maternal mortality the second leading cause 
of death among women age 15–49, after HIV. Globally, 
women face a 1 in 180 lifetime risk of dying due to maternal 
causes, which are dominated by haemorrhage, hypertensive 
disorders, sepsis and abortion (Figure 4.2).3 In the African 
Region, however, the MMR is still running at 540 per 
100 000 live births, which, combined with the high levels of 
fertility, translates into a lifetime risk of dying from maternal 
causes of 1 in 37.
The SDGs also contain ambitious targets for child mortality, 
with SDG 3.2 seeking to end preventable deaths of newborns 
and children under five. These include national targets of 
a U5MR of no more than 25 deaths per 1000 live births, 
and a neonatal mortality rate (NMR) of no more than 12 
per 1000 live births. This compares with a global U5MR of 
43 per 1000 live births in 2015 (5.9 million children under-
five deaths), and a NMR of 19 per 1000 live births (2.7 
million deaths the first 28 days of life). The major causes 
of newborn mortality in 2015 are prematurity, birth-related 
complications (birth asphyxia) and neonatal sepsis, while 
leading causes of child death in the post-neonatal period 
are pneumonia, diarrhoea, injuries and malaria (Figure 4.2). 
Target 4.2, which calls for efforts to ensure that all girls and 
boys have access to quality early childhood development, 
care, and pre-primary education (as part of the broader 
education goal) is also likely to have an impact on child 
mortality, while also improving children’s chances of living 
long and rewarding lives.
Figure 4.2 
Global major causes of maternal and under-five child mortality, 20153,4
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Figure 4.3 
MDG and SDG targets related to reproductive, maternal, newborn, child and adolescent health and malnutrition
SDG
SDG Target 2.2
By 2030, end all forms of malnutrition, including achieving, by 
2025, the internationally agreed targets on stunting and wasting 
in children under five years of age, and address the nutritional 
needs of adolescent girls, pregnant and lactating women and 
older persons
SDG Target 3.1
By 2030, reduce the global maternal mortality ratio to less than 
70 per 100 000 live births
SDG Target 3.2
By 2030, end preventable deaths of newborns and children under 
five years of age, with all countries aiming to reduce neonatal 
mortality to at least as low as 12 per 1000 live births and under-
five mortality to at least as low as 25 per 1000 live births
SDG Target 3.7
By 2030, ensure universal access to sexual and reproductive 
health-care services, including for family planning, information 
and education, and the integration of reproductive health into 
national strategies and programmes
MDG
MDG Target 1.C
Halve, between 1990 and 2015, the proportion of people who 
suffer from hunger
MDG Target 4
Reduce by two thirds, between 1990 and 2015, the under-five 
mortality rate
MDG Target 5.A
Reduce by three quarters, between 1990 and 2015, the maternal 
mortality ratio
MDG Target 5.B
Achieve, by 2015, universal access to reproductive health
Reducing malnutrition is key to improving health, including 
the health of children and pregnant women. As part of Goal 
2 on ending hunger, SDG 2.2 is, therefore, as critical as it is 
expansive, aiming to end all forms of malnutrition by 2030, 
including achieving by 2025 the internationally agreed 
targets on stunting and wasting in children under five, 
and addressing the nutritional needs of adolescent girls, 
pregnant and lactating women, and older people. In 2015, 
one in four children (156 million) is estimated to be affected 
by stunting, and one in seven (93 million) is underweight.5 
Stunted children can face a lifetime of disadvantages, such as 
poor cognitive abilities and educational performance, which 
have a knock-on effect for adult wages and productivity. 
It is estimated that undernutrition is an underlying factor 
in 45% of child deaths,6 and 80% of newborn mortality 
occurs in babies who are of low birth weight.7 Malnutrition 
is important in older ages too, with anaemia contributing 
to 20% of maternal deaths.5
New in the SDGs is the emphasis on youth as a vulnerable 
population. In some cases the topic is addressed explicitly, 
as with SDG 2.2, which includes targets for the nutritional 
needs of adolescent girls (Figure 4.3). Though generally a 
healthy group, adolescents8 are exposed to a range of risks 
and diseases, and as many health behaviours established 
during adolescence have profound effects over the rest 
of the life course, they are a population deserving more 
concerted attention from the global health community in 
the SDG era. Globally, road injuries, HIV/AIDS and self-harm 
are the leading causes of adolescent death.9 
While mortality and burden of disease statistics are 
important, they sometimes fail to capture significant 
aspects of health and well-being. This is particularly true 
of sexual and reproductive health, where certain aspects 
of human experience are beyond the purview of morbidity 
and mortality data. It is estimated that between 100 and 
140 million women alive today have been subjected to 
female genital mutilation (FGM),10 while an estimated 15 
million girls marry before age 18 each year,11 and nearly one 
in three women has experienced physical or sexual intimate 
partner violence.12 The SDGs confront several of these 
issues head on. For example, under Goal 5 for achieving 
gender equality, SDG 5.2 calls for the elimination of all 
forms of violence against all women and girls, and SDG 5.3 
aims to eliminate all harmful practices, such as child, early 
and forced marriage and FGM. In the health goal, SDG 3.7 
targets universal access to sexual and reproductive health-
care services, following on from MDG 5.B. Much work is still 
needed to meet these targets.
Similarly, current metrics poorly capture developmental 
indices that tell whether children who survive are also able 
to thrive. Conservative estimates show that 1 in 3 children 
globally are at risk of sub-optimal development because of 
poverty and undernutrition.13 If other risk factors such as low 
maternal education and exposure to violence are added, the 
proportion of children at risk increases. The SDG framework 
includes targets to protect, promote and support early child 
development and increasingly indicators and assessment 
tools are becoming available that can generate comparable 
data across settings and time.14    
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ACHIEVEMENTS
The MDG era was marked by significant progress in 
reducing maternal and child mortality, even though the 
global community fell short of achieving the ambitious 
mortality targets set by MDGs 4 and 5 (Figure 4.4). The 
global U5MR declined by 53% between 1990 and 2015, 
falling short of the MDG 4 target of a two thirds reduction, 
with 62 countries meeting the MDG 4 target on child 
mortality.15 
The world’s MMR fell by 44% between 1990 and 2015, 
missing the target of a 75% reduction.2 Country-level 
estimates of the trends in the MMR are much more 
uncertain than for children because of data gaps. It is 
estimated that of the 95 countries with an MMR of at least 
100 per 100 000 live births in 1990, 9 countries are meeting 
the MDG 5 target and another 42 countries have at least 
halved the MMR. 
The Western Pacific Region had the largest decline in U5MR 
between 1990 and 2015 at 74%, while the South-East Asia 
Region had the most dramatic decline in the MMR, with a 
69% reduction. The Eastern Mediterranean Region (48%) 
and the African Region (54%) had the smallest declines in 
U5MR, and the African Region (44%) and the Region of 
the Americas (49%) made the least progress in reducing 
the MMR. In 2015, the African Region accounts for 47% of 
child deaths and 64% of maternal deaths.
Importantly, global rates of progress have accelerated 
since 2000, with the average annual rate of decline in 
U5MR increasing from 1.8% during 1990–2000 to 3.9% 
during 2000–2015, and for MMR increasing from 1.2% in 
1990–2000 to 3.0% in 2000–2015.
Running parallel to the declines in maternal mortality, 
global coverage of skilled birth attendance (an indicator 
for MDG 5) has increased, rising from 58% in 1990 to 
73% in 2013.16 This means that the fraction of births 
not attended by a skilled birth attendant17 has fallen by 
more than one third since 1990. MDG 4 named only 
one indicator for interventions to reduce child mortality – 
measles vaccination – and here too the news is positive, 
with coverage of measles immunization increasing from 
73% to 85% between 1990 and 2014 in infants younger 
than 12 months. Since 2000, measles deaths in children 
under 5 are estimated to have decreased by over 75%.4 For 
child mortality globally, more than half of the decline since 
2000 has been achieved through reductions in deaths due 
to pneumonia, diarrhoea, measles and malaria, all of which 
tend to affect children older than one month.18  
Polio eradication is one of the earliest globally agreed 
health goals, even though it was not an explicit target 
in the MDGs. On 27 March 2014, the South-East Asia 
Region was certified polio-free, joining the Region of the 
Americas, Western Pacific Region and European Region; 
and brought the percentage of the world’s population now 
living in certified polio-free regions to 80%, a significant 
leap towards global eradication.
There has also been substantial progress in reducing child 
undernutrition globally (Figure 4.5). The proportion of 
children under five who were underweight is estimated to 
Figure 4.4 
Global trends in maternal mortality, neonatal and under-five child mortality, 1990–20152,15
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Global prevalence of stunting and underweight for children under five, 1990–20155
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have declined from 25% to 14% between 1990 and 2015, 
a 44% reduction that falls just short of the MDG Target 1.C 
of a 50% reduction. The prevalence of underweight in the 
Western Pacific Region declined by 82%, falling from 23 
million in 1990 to 3 million in 2015, while the South-East 
Asia Region had 43 million underweight children in 2015, 
compared to 83 million in 1990. As with underweight, all 
WHO regions reduced the absolute numbers of children 
affected by stunting between 1990 and 2015, except the 
African Region, where population growth outpaced a 27% 
reduction in stunting prevalence. Globally, stunting fell by 
41% between 1990 and 2015.5 
The target of achieving universal access to reproductive 
health (MDG 5.B) was only added to MDG 5 in 2007, but 
some progress has been made, nonetheless (Figure 4.6). 
MDG 5.B included four specific indicators: adolescent 
birth rate; antenatal care visits; contraceptive prevalence 
rate; and unmet need for family planning. Improvements 
in these areas are expected to reduce maternal mortality 
– since high fertility rates are correlated with an increased 
lifetime risk of dying from maternal causes – as well as 
improve the health of adolescent girls. Based on current 
projections to 2015,19 the adolescent birth rate fell from 59 
births per 1000 women age 15–19 in 1990 to 51 per 1000 in 
2015. Declines in the adolescent birth rate were greater in 
developed (50% decline) than in developing regions (13% 
decline). However, southern Asia saw an impressive 47% 
decline. With regard to the recommended four or more 
antenatal care visits, coverage in developing regions nearly 
doubled, increasing from 31% in 1990 to 60% in 2013. 
While this is encouraging, 4 out of 10 women still do not 
have four routine antenatal clinic visits, and many of those 
that do experience poor quality of care.16 As noted above, 
skilled birth attendance coverage also increased. In east 
Asia and the Pacific as well as in Latin America and the 
Caribbean, about 9 in 10 births now occur in health facilities. 
In contrast, in south Asia and sub-Saharan Africa, where 
the burden of maternal and newborn deaths is highest, 
only about half of births (45% and 46%, respectively) are 
delivered in a health facility.20
With regard to family planning services, contraceptive 
prevalence with a modern method rose from 48% to 58% 
between 1990 and 2015 among married or in-union women 
age 15–49, driven by a 10 percentage point increase in 
developing countries.21 Meanwhile, family planning demand 
satisfied with a modern method increased from 68% 
in 1990 to 76% in 2015. All WHO regions reduced the 
unmet demand for family planning with a modern method 
by at least 25%, with the European Region and the South-
East Asia Region achieving over a 30% reduction since 
1990. These changes corresponded with a slight decline 
in unintended pregnancies, which fell from 43% to 40% 
between 1995 and 2012.22 Among adolescents, in particular, 
Figure 4.6 
Changes in four MDG 5.B indicators, developing and developed countries, 1990–201521
 Developing region    Developed region
Bi
rth
s 
pe
r 1
00
0 
gi
rls
 a
ge
 1
5–
19
60
50
40
30
20
10
70
Adolescent birth rate
1990 2000 2015
0
Co
ve
ra
ge
 (%
)
60
50
40
30
20
10
100
90
80
70
Contraceptive prevalence 
(modern method)
1990 2000 2015
Met demand for family 
planning (modern method)
1990 2000 2015
Antenatal care (4+ visits)
1990 2000 2013
0
75REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, ADOLESCENT HEALTH AND UNDERNUTRITION
access to contraception is only one part of the picture 
determining pregnancy rates. In some settings, important 
cultural factors are in play, including traditions of child 
marriage. Globally, one in four young women in 2014 was 
married in childhood versus one in three in the early 1980s 
and the proportion of young women married before age 15 
declined from 12% to 8% over the same period.11 
The SDG era will include an increased focus on equity. 
As we enter this new era, it is important to recognize 
that there have actually been substantial improvements 
in equity in a number of RMNCAH areas, although these 
gains are certainly not universal.23 For example, within 
many developing countries, absolute increases in coverage 
of diphtheria, tetanus and pertussis (DTP) (three doses/
DTP3) immunization coverage have tended to be greater 
for the poor than for the rich. A similar pattern is observable 
in under-five mortality, with gains for the poorest quintile 
outpacing those in the richest quintile by at least 26 deaths 
per 100 000 live births over a 10-year period. There has 
also been a decrease in inequality regarding unmet demand 
for family planning across educational groups within 
many countries. Despite these relative reductions, large 
inequalities still remain in these and many other areas. 
SUCCESS FACTORS
Increased coverage of proven high impact child health 
interventions: Country plans and programmes increasingly 
focused on achieving high coverage of key interventions 
for maternal and child health. The global consensus on 
essential interventions, commodities and guidelines for 
reproductive, maternal, newborn and child health has 
contributed to convergence in investments.24 Countries with 
higher levels of coverage tend to have lower child mortality 
than countries with low coverage.25 It is thus reasonable 
to suppose that the scaling up of priority interventions, 
alongside poverty reduction and improvements in basic 
living conditions, has been beneficial for health outcomes 
and has contributed to the impressive falls in child mortality 
since 1990. For instance, in high mortality countries, four 
out of five children are receiving two doses of Vitamin 
A supplementation,26 an estimated 2–3 million deaths 
are prevented every year by vaccination against DTP and 
measles,27 and in 2014, 84% of children globally received 
three doses of the polio vaccine. The proportion of children 
in countries with high malaria risk that were sleeping under 
an ITN increased from essentially 0 in 2000 to 43% in 
2013, and similar gains were made in ART provision (see 
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Chapter 5). As noted above, there has been an increase in 
coverage of antenatal care, skilled attendance at birth and 
institutional deliveries. 
Global and country-level consensus and commitments: 
The MDGs themselves constituted a significant global 
commitment to address maternal and child mortality. 
Also of note was the Lancet child survival series in 2003, 
followed by the Countdown to 2015 for maternal and child 
survival, and the support provided to countries by UN 
agencies led by the UNICEF, WHO, UNFPA and the World 
Bank, bilateral agencies and civil society organizations. A 
global partnership on maternal, newborn and child health 
was established in 2005.28 However, in recognition of 
the relatively lacklustre investment in this area, in 2010, 
UN Secretary-General Ban Ki-moon launched the Global 
Strategy for Women’s and Children’s Health 2010–2015, 
which galvanized efforts to accelerate progress towards 
MDGs 4 and 5 in a number of countries.29 In support of 
the implementation of the Global Strategy, the Commission 
on Information and Accountability for Women’s and 
Children’s Health30 and the Commission on Life-saving 
Commodities for Women’s and Children’s Health made 
a number of recommendations that have supported work 
on health system strengthening. The H4+ partnership,31 
country commitment and leadership, and coordination 
and advocacy by the UN Secretary-General Every Woman 
Every Child initiative have also contributed to improvements 
in RMNCH outcomes,32 as has increased and predictable 
financing (US$ 45 billion committed as of 2012–2013, with 
US$ 27 billion already disbursed). 
Another notable effort is the the Global Polio Eradication 
Initiative, launched in 1988 as a result of the World Health 
Assembly resolution for the worldwide eradication of polio 
by 2000, which has become one of the largest global 
public health programmes, and has succeeded in mobilizing 
significant funding, through coordinated advocacy over a 
prolonged period of time. Additionally, the International 
Conference on Population and Development Programme 
of Action, focusing on sexual and reproductive health 
and rights, was adopted by 179 countries in 1994, and 
reviewed in 2014.33,34 Meanwhile, early child development 
and adolescent health are increasingly recognized as 
critical areas of public health, not only for improving health 
outcomes in the short term, but also for building human 
capital along the life course.9,35,36 As a consequence, the new 
Global Strategy for Women’s, Children’s and Adolescents 
Health has been expanded to address these challenges.
Socioeconomic changes: Prosperity brings many benefits (and 
challenges) for health. For example, increases in household 
income have improved the ability of families to obtain 
increased quantities and greater variety of foods for infants 
and young children.37 It also contributes to improvements 
in basic infrastructure that are vital for improving health, 
including improved water and sanitation, roads and 
transport, and communication technology. Progress in 
education – especially of women and girls – also has a major 
impact on maternal and child mortality, early marriage 
and early pregnancy.38,39 More than half of countries have 
achieved or nearly achieved universal primary education.40 
Rates of enrolment in secondary school have increased 
globally since 1990. For example, in 2000, the out-of-school 
population of children of lower secondary school age was 
97 million, compared to 63 million by 2012,41 despite an 
absolute increase in the population in this age range. 
Improvements in legislation: Marked improvements have 
been seen in national policies and regulation for increasing 
access and coverage to reproductive, maternal, newborn 
and child health services. For example, among 68 countries 
monitored by the Countdown initiative between 2008 and 
2015, 15 countries adopted policies enabling midwives to 
deliver life-saving interventions for emergency obstetric 
maternal and newborn care, representing a 57% increase, 
and 23 countries began allowing community health 
workers to identify and treat children with uncomplicated 
pneumonia in the community.26 Progress was also made 
in legislation for sexual and reproductive health and rights, 
FGM and violence (see relevant sections). For instance, at 
least 24 of the 29 countries in which FGM is practised have 
passed anti-FGM laws or decrees.42
Financing: Global annual growth in development assistance 
for health doubled after the adoption of the MDGs in 
2000. Funding for child health increased by 8.3% annually 
from 2000 to 2014, while maternal funding only grew 
at an average rate of 3.0% in the same time period. In 
comparison, funding for HIV, tuberculosis and malaria all 
increased by an average of more than 15% per year since 
2000. Despite growth in overall assistance stagnating 
since 2010, funding for maternal and child health increased 
by 11% per year between 2006 and 2013. With funding 
falling slightly in 2014, maternal, newborn and child health 
received 27% of development assistance for health, with 
US$ 3.0 billion dispersed for maternal health and US$ 6.6 
billion dispersed for child health. It is also worth noting that 
government health expenditure has increased substantially 
in the MDG era, growing at an average rate of 8.1% annually 
between 1995 and 2012 among low- and middle-income 
countries. This means that, while important, development 
assistance for health only accounts for roughly 5% of total 
health expenditure in these countries.43 Also of note, is 
the fact that a number of countries have embraced health 
financing systems based on prepayment and pooling of 
resources and/or have introduced exemption schemes 
for MDG-target areas such as RMNCH to make services 
accessible to the poor16 (see Chapter 2).
Improved measurement and monitoring: The investments 
of global agencies in international survey programmes 
to measure RMNCH indicators, notably through the 
DHS, mainly funded by the United States Agency for 
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International Development, and Multiple Indicator Cluster 
Surveys (MICS), led by UNICEF, have been critical. 
The surveys have also formed the basis for the global 
production of regular estimates of maternal and child 
mortality through interagency and expert mechanisms44 
and for regular monitoring of intervention coverage.45 
These data, widely used in global planning, monitoring 
and review mechanisms, have helped sharpen the focus 
on RMNCH. The monitoring process implemented for 
tacking polio eradication shows what is possible, with the 
establishment of real-time surveillance and data analysis, a 
laboratory network that spans 145 countries, accountability 
mechanisms in countries with weak health systems, and 
specific strategies for accessing children in conflict areas.46
CHALLENGES
Improving care during time around birth: Declines since 1990 
in neonatal mortality have been slower than for under-
five mortality, and neonatal deaths now account for 45% 
of child deaths. The reduction in maternal mortality was 
also slower than that for children age 1–59 months over 
the same period. More rapid improvements in maternal 
and neonatal mortality will require increased focus on 
health-care services during labour, childbirth and in the 
first week of a newborn’s life. High-impact, cost-effective 
interventions that benefit both mother and baby exist, 
and must be a focus of health system strengthening and 
improvements in quality of care. Improving maternal and 
newborn health should no longer be pursued with separate 
strategies, as outcomes are correlated (Figure 4.7).
Providing on-demand treatment: Essential interventions to 
improve newborn and child survival are well known and 
can be implemented at scale even in resource-constrained 
settings. However, increases in coverage have been variable. 
Interventions that can be scheduled such as immunization 
and vitamin A supplementation have much higher coverage 
than those that require around-the-clock medical services 
that can be accessed on demand, such as treatment of 
pneumonia, diarrhoea and malaria. Less than half of children 
with signs of pneumonia, diarrhoea or malaria access 
appropriate treatment in countries with a high burden of 
morbidity and mortality due to these conditions.26
Enhancing quality of health care services: As access and 
utilization of health services improves, the quality of 
those services comes under greater scrutiny. Poor 
quality maternal, newborn, child and adolescent health 
care remains a pervasive problem, preventing progress 
in mortality reduction even in those settings where 
coverage rates of health service utilization are increasing. 
Fundamental challenges remain with regard to attracting, 
training, deploying, motivating, managing and retaining 
skilled, committed and caring health workers.47 Shortages 
in medicines and supplies, poorly defined referral pathways, 
and the lack of regular and supportive supervision are other 
key factors affecting quality of care in particular in resource-
constraint settings. 
Reducing inequity in access to care: Across a spectrum of 
RMNCH coverage indicators, including access to family 
planning, antenatal care and skilled birth attendance, and 
measles vaccination, access to care varies importantly 
by household economic status within low- and middle-
income countries (Figure 4.8). The largest gaps in coverage 
– between the richest and poorest, the most and least 
educated, and urban and rural areas – are reported for 
skilled birth attendance, which varies by as much as much 
as 80%.23
Conflict situations and fragile states: Access to and quality 
of regular primary health care services may collapse 
and severely disrupt the provision of essential RMNCH 
services. Eradication efforts are also affected. Polio remains 
endemic in Afghanistan and Pakistan and until poliovirus 
transmission is interrupted in these countries, all countries 
remain at risk of re-infection, especially in the “poliovirus 
importation belt” of countries from West Africa to the 
Horn of Africa. Several countries in the Middle East are 
at elevated risk because of deterioration of immunization 
systems due to the security situation in those countries.48
Reducing malnutrition in all forms: Stunting and wasting 
remain major causes for concern. An estimated one in 
four children (23%), or 156 million children, in 2015, are 
affected by stunting globally, and are exposed to risks that 
include diminished cognitive and physical development.5 
Globally, less than 40% of infants younger than six months 
are exclusively breastfed, often owing to inadequate 
care that starts in the first week of a baby’s life and in 
spite of the fact that suboptimal breastfeeding practices 
contribute to 800 000 deaths among children under five 
each year.6 Reductions in maternal anaemia have also 
been disappointing, ranging from 43% to 38% in pregnant 
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women between 1995 and 2011.49 Even as malnutrition due 
to undernutrition has improved in some areas, the growing 
rates of child and adolescent overweight and obesity in 
many counties pose serious risks to their health now and 
in the future.
Increasing contraceptive prevalence: While there was an 8.4 
million increase in the number of girls and women using 
modern contraceptive methods between 2012 and 2013, it 
is still below the benchmark of 9.4 million new users, and 
more needs to be done to provide access to all.50 
Protecting the rights of young girls and adolescents: Despite 
some progress in certain countries, and the fact that FGM 
has gained recognition as a human rights violation, annually, 
more than 3 million girls are at risk in Africa, living in areas 
where FGM is practised.51 Globally, one in four young 
women in 2014 was married in childhood. The highest 
rates of child marriage are found in south Asia and sub-
Saharan Africa.11 Overall, there were an estimated 1.3 million 
adolescent deaths in 2012, most from causes that could 
have been prevented. Mortality is higher in boys than in 
girls. While there are many causes of mortality common 
to both sexes, violence is a particular problem for boys and 
maternal causes for girls. 
Improving monitoring: Relatively sparse data on maternal 
mortality, morbidity and causes of death make monitoring 
progress challenging. For example, many countries with 
high rates of maternal mortality have only a few nationally 
representative surveys between 1990 and 2015, which 
provide imprecise estimates of the MMR. Limited country-
level data preclude accurate monitoring of trends in child 
causes of death, and data on adolescents are also very 
incomplete. Better birth registration is also critical. Only 
59% of infants younger than 12 months is registered 
globally, with around 33% registered in south Asia and 
sub-Saharan Africa.52
STRATEGIC PRIORITIES
Women and children’s health remains a central concern 
in the SDGs, as evidenced by the strong commitment to 
ending preventable newborn, child and maternal deaths by 
2030, to ensure universal access to sexual and reproductive 
health-care services, including for family planning, 
information and education, and to protect, promote and 
support early child development and adolescents’ health. 
The first Global Strategy for Women’s and Children’s Health, 
launched by the UN Secretary-General in 2010, resulted 
in increases in financing, policy strengthening and dozens 
of global, regional and national initiatives.53 The updated 
Global Strategy for Women’s, Children’s and Adolescents’ 
Health 2016–2030 (Global Strategy 2.0),54 launched in 
September 2015, acknowledges the unfinished MDG 
agenda regarding preventable mortality, takes into account 
new evidence regarding areas in which progress can be 
accelerated and emphasizes the importance of ensuring 
health and well-being for all at all ages on the SDG agenda.29 
An important focus is the scaling up of priority intervention 
areas and/or specific high-impact interventions to address 
major gaps in the continuum of care (Figure 4.9). There 
are also multiple initiatives and resolutions that provide 
impetus to specific interventions, such as Family Planning 
2020,55 A Promise Renewed,52 Every Newborn Action 
Plan,56 improving pneumonia prevention and treatment57 
and GAVI.58 While each specific strategy has a legitimate 
rationale to address a major public health problem, the need 
to provide an integrated approach is paramount. 
Figure 4.8 
Wealth-related inequality in RMNCH intervention coverage indicators in low- and 
middle-income countries, 2005–201323
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Under the new Global Strategy there is a clear desire to 
respond to governments’ request for less fragmentation 
and better alignment of efforts. Three interconnected 
action areas underpin the delivery of the Global Strategy: 
country planning and implementation; financing of country 
plans and implementation; and engagement and alignment 
of global stakeholders. Global and regional partners are 
therefore working towards a simplified architecture in which 
many former initiatives will converge around a common 
coordination mechanism to enable harmonized support to 
countries with predictable financing.
The Global Strategy 2.0 pays particular attention to 
equity, rights and gender issues, while also highlighting 
the importance of innovation, including research and 
development of new technologies and operational 
innovations such as a more integrated approach to women’s 
and children’s health. The importance of accountability is also 
stressed, particularly with regard to meeting commitments 
for results and resources both at the country and global 
level. A Global Financing Facility in collaboration with Every 
Woman Every Child59 has been established in support 
of the Global Strategy 2.0, using an innovative approach 
that combines external support, domestic financing and 
innovative sources for resource mobilization and delivery 
(including the private sector) in a synergistic way.
Priority strategies to improve RMNCAH include:
• ensuring universal access to high quality RMNCAH 
information and services that are free at the point of use, 
including for management of complications; 
• strengthening care around the time of childbirth, with 
a focus on improving quality and experience of care, 
while ensuring full integration of services for mothers 
and babies;
• ensuring a continuum of health care across the life 
course of women, children and adolescents and between 
levels of service delivery – including community, primary 
care and referral levels; 
• strengthening prevention and case management of 
childhood illness including pneumonia, diarrhoea, 
malaria, HIV and malnutrition, including through 
community-based health workers;
• implementing policies that are health promoting and 
mandate interventions to prevent exposure from harm 
– for example to decrease road traffic accidents or use 
of harmful substances such as tobacco;
• addressing inequities in access to and quality of sexual, 
reproductive, maternal, newborn and adolescent health 
care;
• ensuring accountability and transparency to improve 
access to quality of care and equity;
• harnessing the power of parents, families and 
communities and engagement with society at large; 
• reaching out beyond the health sector to engage with 
other sectors that have an important impact on health, 
such as water and sanitation, education, economic and 
social protection, environment and gender .
The SDG targets on malnutrition and hunger resonate with 
several resolutions endorsed by the World Health Assembly, 
including resolution WHA65.6 on the comprehensive 
implementation plan on maternal, infant and young child 
nutrition60 and resolution WHA63.23 on infant and young 
child nutrition in which Member States were urged to 
end inappropriate promotion of food for infants and 
Co
ve
ra
ge
 (%
)
80
Figure 4.9 
Intervention coveragea along the continuum of care26
a Median national coverage of 75 countries, based on most recent survey 2009 or later.
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young children.61 Specific indicators have been proposed 
to monitor progress in these areas. A global movement 
founded on the principle that all people have a right to food 
and good nutrition has been established.62 Examples of 
areas requiring specific attention concerning young children 
include scaling up coverage of programmes that promote 
healthy, diversified diets, including high-quality, nutrient-
rich foods in the complementary feeding period (6–23 
months), scaling up the management of acute malnutrition 
and enacting labour policies in support of exclusive and 
continued breastfeeding.
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MATERNAL HEALTH
Ending preventable maternal mortality remains one of the world’s most critical challenges despite 
significant progress over the past decade. There will be roughly 303 000 maternal deaths in 2015, largely 
from preventable causes before, during and after the time of giving birth.2 Globally among women of 
reproductive age, maternal mortality is the second leading cause of death, and women currently face a 1 in 
180 chance of dying from maternal causes.
ACHIEVEMENTS 
Since 1990, the number of maternal deaths per 100 000 live births 
(the MMR) dropped by 44%. While this is a significant improvement, 
showing what can be achieved given sustained commitment, the 
world failed to meet the 75% reduction target set by MDG 5. The MMR 
dropped from 385 in 1990 to 341 in 2000 to 216 per 100 000 live 
births in 2015, indicating major acceleration of the decline after 2000.
The global declines in the MMR since 1990 have been driven largely by 
declines in the South-East Asia Region (69% decline) and the Western 
Pacific Region (64% decline). The African Region has shown the least 
progress, with a 44% decline between 1990 and 2015 (Figure 4.10) 
and now accounts for more than 6 out 10 maternal deaths globally.
SUCCESS FACTORS 
Country improvements in service coverage: Coverage of antenatal care, 
skilled attendance at birth and institutional deliveries has increased, 
along with the increased integration in the delivery of health services 
(Figure 4.11). Almost 90% of women have at least one antenatal care 
visit, and over 60% at least four.16 Coverage of skilled attendance 
at birth increased from 58% to 73% between 1990 and 2013.16 
There has also been an increase in contraceptive prevalence, which 
gives women the ability to reduce their number of pregnancies and, 
therefore, mortality risk.
Global Strategy for Women’s and Children’s Health 2010–2015 and 
related initiatives: The slow initial progress towards the MDG target 
for maternal mortality led to a series of global initiatives in support 
of country action and mobilization of funds from 2005. The impetus 
provided by the WHO-led Making Pregnancy Safer initiative, the 
Global Strategy,29 the Commission on Information and Accountability 
for Women’s and Children’s Health,30 the H4+ partnership31, country 
commitment and leadership, along with increased and predictable 
financing (US$ 45 billion committed as of 2012–2013, with US$ 27 
billion already disbursed), have all contributed to improvements in 
maternal health outcomes, as did the earlier Partnership for Maternal 
Child and Newborn Health (2005).32
Socioeconomic development: Higher levels of education, especially 
for women and girls, are associated with lower levels of maternal 
mortality.64 For women age 25 and above, average educational 
attainment has increased from 4.7 years in 1990 to 7.0 years in 
2015.65 In the African Region, it rose from 2.0 to 4.1 years, and in the 
South-East Asia Region it went from 2.0 to 4.3 years. Especially in 
Asia, the large maternal mortality declines are likely to have benefited 
from economic developments, leading to better access of services.
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Figure 4.10 
Trendsa in the maternal mortality ratio (MMR) by WHO region, 1990–20152
Figure 4.11 
Global trends in coverage of maternal health interventions, 1990–201363
90
70
60
50
80
Co
ve
ra
ge
 (%
)
 Antenatal care, 1+ visit    Skilled attendant at birth    Antenatal care, 4+ visits
100
1990 1995 2000 2005 2010
30
2015
40
20
10
0
82 HEALTH IN 2015: FROM MDGs TO SDGs
CHALLENGES
Access to skilled care at birth: Despite steady improvement globally 
and within regions, more than 40% of women in the African Region 
and South-East Asia Region did not have access to a skilled health 
provider at birth in 2013.
Quality of care: As more women give birth in health facilities, the 
quality of care will become increasingly important.66 Fundamental 
health systems challenges remain with regard to attracting, training, 
deploying, motivating, managing and retaining skilled, committed and 
caring health workers.47 
Indirect maternal deaths: The increasing importance of the infectious 
and chronic noncommunicable diseases that contribute directly and 
indirectly to maternal mortality is a matter for concern. As countries 
reduce the MMR, there is a need to strengthen the recognition and 
management of indirect causes of maternal death, and coordinate 
with other relevant sectors and health providers to address care for 
noncommunicable diseases, develop innovative education, screening and 
management approaches for these conditions, as well as appropriate 
clinical guidelines and protocols.67
Inequity in access: In many countries, the delivery care women receive 
is strongly associated with their income, whether they live in an urban 
or rural area, and their level of education. Disparities across economic, 
education and urban/rural gradients are particularly pronounced in 
low-income countries (Figure 4.12). 
Health workforce: Fundamental health systems challenges remain 
with regard to attracting, training, deploying, motivating, managing 
and retaining skilled, committed and caring health workers.
Funding: In addition to an overall funding gap for maternal health, 
there are large disparities in the targeting of donor funding and 
country needs, with some very poor countries with a high MMR getting 
relatively little funding.68
Monitoring: Sparse data on maternal mortality and morbidity and 
on causes of death in children in many countries make monitoring 
progress challenging. Vital statistics based on death registration is 
lacking. Even in high-income countries, vital registration systems 
typically miss about one third of maternal deaths.2
STRATEGIC PRIORITIES
There is a specific SDG target on maternal mortality under the health 
goal, based on the WHO Ending Preventable Maternal Mortality (EPMM) 
initiative.67 The goal of the post-2015 maternal health strategy is to 
end all preventable maternal mortality using a holistic, human rights-
based approach to sexual, reproductive, maternal and newborn health 
that rest on a foundation of implementation effectiveness. Specifically, 
the global target is that the global MMR is reduced to less than 70 
per 100 000 live births by 2030. The EPMM target also specifies that 
no country has an MMR greater than 140 per 100 000. This implies 
countries achieving at least a two thirds reduction in their MMR 
between 2010 and 2030. 
The key EPMM strategic objectives are to:
• address inequities in access to and quality of sexual, reproductive, 
maternal and newborn health information and services;
• ensure UHC for comprehensive sexual, reproductive, maternal and 
newborn health care;
• address all causes of maternal mortality, reproductive and maternal 
morbidities, and related disabilities;
• strengthen health systems to respond to the needs and priorities 
of women and girls;
• ensure accountability to improve quality of care and equity.
Other strategic objectives include improving metrics, measurement 
systems and data quality and allocating adequate resources and 
effective health-care financing. In this regard, it is vital to continue 
momentum to sustain and increase funding for RMNCH within the 
Global Strategy 2.0 through, for instance, the Global Financing Facility.59
Figure 4.12 
Births attended by skilled health personnel in low-income countriesa by multiple 
dimensions of inequality, 2005–201323
a  Median value of 30 selected countries.
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NEWBORN HEALTH
Global efforts to reduce child mortality have had most impact on children who have already survived their 
first month of life. In 2015, there were 2.7 million neonatal deaths (deaths within the first 28 days of life) 
globally, which represents 45% of all deaths among children under five.15 The vast majority of newborn 
deaths is preventable, with 73% occurring within seven days of birth,69 and require many of the same 
investments in health systems that are needed to improve maternal health outcomes. 
ACHIEVEMENTS 
NMRs have declined across all WHO regions since 1990, with the global 
rate falling from 36.2 to 19.2 deaths per 1000 live births between 
1990 and 2015, a 47% decline.15 Yet, the percentage of deaths in 
children under five that occurred in the neonatal period increased 
from 40% to 45% because mortality at age 1–59 months declined 
faster. The Western Pacific Region experienced the greatest decline 
in the NMR at 75%, while the Eastern Mediterranean Region and the 
African Region the smallest (both 38%).
Since 2000, neonatal mortality has fallen largely due to decreases in 
deaths from its two main causes, birth asphyxia (34% of total reduction) 
and prematurity (21%). Deaths due to neonatal tetanus have fallen by 
almost 80% (Figure 4.13).4
MAIN SUCCESS FACTORS
Country improvements in service coverage: Coverage of interventions 
for family planning, antenatal care, skilled attendance at birth and 
postnatal care for mother and baby in the first week of life are expected 
to lower NMRs.70 There is, for example, a correlation between NMRs 
and coverage of skilled attendance at birth (Figure 4.14). The fraction 
of babies protected against tetanus at birth rose from 60% in 1990 to 
83% in 2014.71 By 2014, 60 out of 75 countries with a high burden of 
maternal and newborn mortality reported having a policy on home-
based newborn care for mother and baby.72 
Global commitments/partnerships: Much of the decline in neonatal 
mortality occurred before the global community started to prioritize 
newborn health, largely driven by the increasing relative importance 
of deaths in the first month of life. Many governments and partners 
responded to the UN Secretary-General Global Strategy for Women’s 
and Children’s Health in 201073 and its accompanying Every Woman 
Every Child initiative74 as well as to recommendations made by the 
Commission on Information and Accountability30 and the UN Commission 
on Life-Saving Commodities for Women and Children.75 The global 
movement Committing to Child Survival: A Promise Renewed was 
initiated in 201252 and the global Every Newborn Action Plan (ENAP) 
was published in 2014.76
Non-health sector determinants: Other factors that have contributed to 
improved newborn survival include better water and sanitation, maternal 
education, poverty reduction, social protection (including conditional 
and unconditional cash transfers), policies and legislation to create a 
conducive environment and mitigate risks (e.g. maternity protection, 
restrictions on marketing of breast-milk substitutes) and urbanisation 
in so far as this leads to better access to quality health services.77
 Figure 4.13 
Global cause-specific risks of neonatal deaths, 2000–20154
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Figure 4.14 
Current neonatal mortality rate (NMR) and skilled birth attendance coverage in 
selected countriesa, 15,63
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CHALLENGES
Scaling up effective interventions: Low coverage and poor quality 
maternal and neonatal health care account for high rates of newborn 
mortality (Figure 4.15) as well as maternal mortality and intrapartum 
stillbirths.52,76 Interventions with the greatest bottlenecks to scaling 
up are those related to the prevention and management of preterm 
births, inpatient supportive care of ill and small newborn babies, the 
management of severe infections, and kangaroo mother care.78 It has 
been estimated that almost 3 million maternal and newborn deaths 
and preventable stillbirths could be averted by 2025 for US$ 1.15 
per person in the 75 worst affected countries if coverage levels of 
essential interventions around the time of childbirth and for small and 
sick babies would improve.70
Strengthening weak health systems: System constraints to scaling up 
effective intervention packages are found in all high-burden countries, 
particularly for health workforce, finance and service delivery for 
newborn health.78 Many high-burden countries face serious shortages 
in midwifery personnel, depriving women and newborns of essential 
care when they need it most.79 
Overcoming inadequate postnatal care: Less than half of women 
and their newborn babies receive postnatal care within the first two 
days after birth.80 Postnatal care is particularly important for reducing 
newborn mortality that occurs on the first day of life, but care during 
the first weeks postpartum also has an impact on maternal and 
newborn health.81 
Reducing inequity: Inequitable access to quality health care continues to 
be prominent, due to geographical barriers, financial barriers or cultural 
barriers. Inequalities in access to essential newborn interventions 
remains pervasive even in countries where use of antenatal, child 
birth and postnatal care services is increasing. 
Making every child count: Progress cannot be monitored without basic 
data collection. Only 59% of infants younger than 12 months have 
their births registered, with around 33% registered in south Asia and 
sub-Saharan Africa.52
STRATEGIC PRIORITIES
The SDGs include a specific target for newborns: by 2030, achieve 
national NMRs of less than 12 deaths per 1000 live births. ENAP also 
includes a target on stillbirth: a reduction of the stillbirth rate to 12 
deaths per 1000 total births. ENAP provides strategic directions on how 
to address the burden of preventable newborn mortality, highlighting 
that such investment will generate a triple return on investment, 
and also prevent maternal mortality and stillbirths. The main ENAP 
strategic objectives are: 
• Strengthen and invest in care during labour, childbirth and the first 
day and week of life. 
• Improve the quality of maternal and newborn care by introducing 
high-quality care with high-impact, cost-effective interventions for 
mother and baby together – in most cases, by the same health 
providers at the same time. 
• Reach every woman and every newborn to reduce inequities, notably 
through the introduction of financing based on prepayment and 
pooling as the basis for UHC.
• Harness the power of parents, families and communities. Evidence 
has shown the power of engaged community leaders, women’s 
groups and community workers in turning the tide for better health 
outcomes for newborns. 
• Count every newborn. There is an urgent need to improve health 
metrics globally and nationally, especially for birth outcomes and 
quality of care. Every newborn needs to be registered and newborn 
deaths need to be counted. Counting every maternal death and 
stillbirth is of equal importance.
Figure 4.15 
Neonatal mortality rate (NMR), 201515
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CHILD HEALTH
An estimated 5.9 million children under five will die in 2015.15 While still unacceptably high, this represents 
more than a halving of the global child mortality rate in 1990. The vast majority of deaths occurs in less 
developed countries and are caused by infectious diseases, aggravated by poor nutrition, and manageable 
conditions around birth. Cost-effective, life-saving interventions exist and need to scale up further.
ACHIEVEMENTS 
Globally, the U5MR has declined only from 91 to 43 per 1000 live 
births, that is, by 53% since 1990, and will thus fall short of the MDG 
target of a two thirds reduction. However, many countries have made 
tremendous progress, and 62 have achieved MDG 4, including several 
low-income countries (Figure 4.16). Progress was two times faster 
since 2000 than during the 1990s.15
From 2000 to 2015, the decline in child mortality has been driven 
by reductions in deaths due to pneumonia (47%), diarrhoea (57%), 
malaria (58%) and intrapartum-related complications (38%), and a 
dramatic decline in measles deaths of over 75%.4 
Figure 4.16 
Country progress towards MDG 4, relative decline in under-five mortality rate, 1990–201515 
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MAIN SUCCESS FACTORS 
Immunizations: Since 2000, global coverage of several immunizations 
has increased, some rapidly (Figure 4.17). In the same period, coverage 
of the Hib3 vaccine, which protects against meningitis and pneumonia, 
has leapt to over 50%, and in the past five years vaccines against 
pneumococcal disease (PCV3) and diarrhoea (rotavirus) have been 
introduced.71 Efforts to eradicate polio have also resulted in an increase 
in immunization coverage (see subsequent section).
Coverage of other high impact interventions: Among the 75 countries 
with the highest burden of child mortality, there have been significant 
increases since the 1990s in the proportion of children sleeping under 
ITN, receiving treatment with recommended antimalarials and, to a 
lesser extent, treatment of children with diarrhoea and suspected 
pneumonia.25 Apart from south Asia and sub-Saharan Africa, deaths 
attributable to vitamin A deficiency have almost been eliminated.82
Reductions in undernutrition: Prevalence of underweight children 
is projected to decline by 44% between 1990 and 2015,5 a critical 
achievement as 45% of under-five deaths are linked to malnutrition.
Global Strategy 2.0 and related initiatives: Child survival has been a 
priority in the support given by UN agencies, especially UNICEF, bilateral 
donors, civil society organizations and WHO. Since 2010, following the 
launch of the UN Global Strategy for Women’s and Children’s Health 
2010–2015, many more initiatives have emerged and many countries 
have accelerated action since. Examples of global initiatives for 
children include the Child Survival Call to Action, the UN Commission 
on Life-Saving Commodities for Women and Children and the Global 
Action Plan for Pneumonia and Diarrhoea. 
Non-health sector determinants: Major progress was made in key 
determinants of child survival including reductions in extreme poverty,19 
increased primary school net enrolment for both girls and boys19 and 
improved access to improved water and sanitation.83 
Data and monitoring: U5MR is arguably the most consistently well-
measured health outcome in developing countries, especially through 
household surveys, which has allowed for monitoring progress 
towards MDG 4.
MAIN SUCCESS FACTORS cont.
86 HEALTH IN 2015: FROM MDGs TO SDGs
CHALLENGES
Leaving no country behind: Deaths of children under five are increasingly 
concentrated in the African Region, where nearly half of all under-five 
deaths occurred in 2015, despite only having one quarter of global live 
births. Fragile states are a particularly great challenge. 
Strengthening weak health systems: Major obstacles to UHC for child 
health interventions include: limited access and poor quality of health 
services; suboptimal programme management; poor procurement 
and supply chain management systems; inadequately prepared and 
supported health workforce with service provider shortages; and 
failure to convert national policies into actions.84
Renewing momentum for preventive and treatment interventions: 
There has been only modest progress in increasing rates of exclusive 
breastfeeding, appropriate care-seeking for signs of pneumonia and oral 
rehydration therapy for diarrhoea.25 Coverage rates of new vaccines are 
below 50% and rates of increase in the coverage of well-established 
vaccines have waned since 2010 (Figure 4.17). 
Addressing NCDs and injuries: Globally, more than one in four deaths 
in children age 1–59 months are now caused by non-infectious 
conditions.4 Childhood obesity is increasing, particularly in urban 
settings. In 2015, over 41 million children under five were overweight, 
with five out of six of them living in developing countries (Figure 4.18).5 
Overweight and obese children are likely to stay overweight and obese 
into adulthood and are more likely to develop NCDs such as diabetes 
and cardiovascular diseases at younger ages. Addressing common 
causes of fatal injuries in children, especially those age five to nine, 
requires action to reduce road traffic injuries, drowning and burns.
Addressing child development: An estimated 200 million children 
are at risk of not reaching their full development potential because 
of undernutrition and poverty. Investing in early child development as 
part of interventions that promote survival is essential.
Reducing inequality: Children are at greater risk of dying before age five 
if they are born in rural areas, poor households or to mothers denied 
basic education. While there has been a reduction in the difference 
in U5MR between the rich and the poor in most regions since 1990, 
disparities still remain, with regions having around a 1.5–2.5 times 
higher U5MR among the poor as compared to the rich.52 
Figure 4.17 
Global coverage of key immunizations to protect children, 1990–201471
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Figure 4.18 
Number of overweight children under five by WHO region,a 1990 and 20155
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STRATEGIC PRIORITIES
There is a specific SDG target for child mortality reduction, which 
includes the target that every country should reduce its U5MR to 25 
per 1000 live births or fewer by 2030, set a few years earlier as part 
of the movement Committing to Child Survival: A Promise Renewed.52 
Specific plans such as the Global Action Plan for Pneumonia and 
Diarrhoea propose concrete operational targets in immunization, 
nutrition and water and sanitation with the aim of averting 2 million 
child deaths every year.85 
Strategic directions for the post-2015 child health agenda include:
• Strengthen and invest in health system service delivery to ensure 
access to integrated packages of child health interventions through 
an optimal mixture of community and facility-based care. 
• Promote coordinated and integrated actions to improve infant and 
young child feeding and nutrition, access to safe drinking-water 
and sanitation, handwashing with soap, reduction in indoor air 
pollution, immunization, malaria and HIV prevention, and treatment 
of malaria, pneumonia and diarrhoea.
• Improve quality of care at all levels of service provision, supported 
by appropriate managerial responses at subnational and national 
levels. 
• Promote equity and reduce inequities through multidimensional 
approaches such as conditional cash transfers, voucher schemes, 
microcredit, outreach services and/or targeted community health 
services to ensure UHC.
• Identify and address emerging priorities of congenital anomalies, 
injuries and NCDs, including for children age five to nine years.
• Foster intersectoral collaboration of health, education, local 
government and other sectors.
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POLIO
Poliomyelitis (polio) is a highly infectious viral disease, which mainly affects young children. One in 200 
infections leads to irreversible paralysis (usually in the legs), and 5–10% of those paralysed die. There 
is no cure for polio. It can only be prevented. Polio vaccine, given multiple times, can protect a child for 
life. If enough people in a community are immunized, then the virus will be deprived of susceptible hosts 
and will die out. High levels of vaccination coverage must be maintained to stop transmission and prevent 
outbreaks occurring.
TRENDS 
Since 1988, the number of polio cases has decreased by over 99% 
from an estimated 350 000 cases in more than 125 endemic countries 
to fewer than 2000 cases in 2005, and 359 in 2014 (Figure 4.19). In 
the first nine months of 2015 there have been 44 cases in Afghanistan 
and Pakistan. However, the risk of international spread from endemic 
areas into polio-free areas remains high, as was demonstrated in 2014 
with 19 cases in non-endemic countries. The extinction of infection 
with type 2 wild-type poliovirus, one of the three wild viruses, was 
proclaimed globally in 2000 and proved that eradication was possible. 
Nigeria was declared polio-free in September 2015.
In 1994, the Region of the Americas was the first to be certified polio-
free (all types), followed by the Western Pacific Region in 2000 and the 
European Region in June 2002. On 27 March 2014, the South-East 
Asia Region was certified polio-free, meaning that transmission of wild 
poliovirus has been interrupted in this bloc of 11 countries stretching 
from India to Indonesia. This achievement marks a significant leap 
forward in global eradication, with 80% of the world’s population now 
living in certified polio-free regions. This is testament to the success 
of vaccination efforts. Vaccination coverage with three doses of polio 
vaccine has increased during the same period in all regions of the 
world (Figure 4.20).
Figure 4.19 
Number of wild poliovirus cases, 2000–201486
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Figure 4.20 
Coverage of third dose of polio vaccine, in selected WHO regions and globally, 
1990–201487
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POSITIVE DEVELOPMENTS
Technology: The development of effective vaccines to prevent 
paralytic polio was one of the major medical breakthroughs of the 
20th century. Research and development efforts have continued and, 
with the development and evaluation of bivalent oral polio vaccine in 
2009, there now is an armoury of five different vaccines to stop polio 
transmission, including four oral and one inactivated polio vaccine 
given by injection.
Partnership: Inspired by the success of global smallpox eradication, 
in 1988, the Forty-first World Health Assembly adopted a resolution 
for the worldwide eradication of polio by 2000. It marked the launch 
of the Global Polio Eradication Initiative, spearheaded by national 
governments, WHO, Rotary International, the United States Centers 
for Disease Control and Prevention (CDC), UNICEF, and supported by 
key partners including the Bill & Melinda Gates Foundation.
 
Funding: The Global Polio Eradication Initiative has become one of 
the largest global public health programmes, and has succeeded in 
mobilizing significant funding for polio eradication, through coordinated 
advocacy over a prolonged period of time. As a result, the programme 
benefits from a mix of funding that includes domestic resources, donor 
government funding, business and philanthropy. External funding for 
104 countries in 2005–2012 hovered between US$ 1.5–2.0 billion 
per year. The economic benefits of polio, however, greatly outweigh 
these investments.88
Effective immunization strategy: The key components of the strategy 
are a standardized, real-time surveillance and response capacity, 
routine immunization of infants with polio vaccine, supplemental 
national or regional immunization campaigns based on detailed 
mapping of communities and rapid response to disease outbreaks. 
The partnership has mobilized and trained millions of volunteers, social 
mobilizers and health workers to implement this strategy, and used 
this same infrastructure to bring other health interventions such as 
vitamin A to underserved communities. 
CHALLENGES
Endemic countries: Polio remains endemic in two countries: Afghanistan 
and Pakistan. In 2014, all cases of paralytic polio due to wild poliovirus 
were caused by wild poliovirus type 1 and most (85%) of them occurred 
in Pakistan. In Afghanistan, the reported cases were primarily a result 
of cross-border importation, although transmission of an indigenous 
wild poliovirus continued in the southern region.
Imported polio cases: Until poliovirus transmission is interrupted in 
the all countries, all remain at risk of importation of polio, especially 
in countries affected by conflict where immunization services falter. In 
2014, seven countries reported polio cases associated with imported 
wild poliovirus, including Iraq, Somalia and the Syrian Arab Republic. 
Countries, and regions such as the Middle East, in close proximity to 
endemic countries and with deteriorating immunization systems, are 
at particularly high risk.48
Disasters, emergencies and conflict: Most of the remaining pockets of 
polio are in conflict-affected countries. Persisting reservoirs of naturally 
occurring (wild-type) polio have proven stubbornly resistant to control 
in Afghanistan and Pakistan in large measure due to continuing conflict.
Local resistance: Suspicion and mistrust in some communities have 
hindered progress towards universal immunization. This has occurred 
in Afghanistan and Pakistan as well as in Nigeria, where a poor 
public health infrastructure and, until recently, a lack of political will 
has resulted in very low routine immunization rates and ineffective 
supplemental immunization activities.89 
Vaccine-derived polio: A further challenge has been the emergence of 
vaccine-derived polioviruses, genetically unstable viruses that revert 
towards the profile of the virulent parent strain as they circulate for 
extended periods in a population with low immunity levels. As wild 
poliovirus is eventually stopped, the risks of oral polio vaccine will 
start to outweigh its benefits, due to the threat of vaccine-derived 
poliovirus. A coordinated switch in type of vaccine will be necessary.90,91
STRATEGIC PRIORITIES
Polio eradication is one of the earliest globally agreed health goals, and 
was subsumed under the general child health and immunization goal in 
the MDGs. Even though polio eradication is not explicitly mentioned in 
the health SDG, there are implicit linkages to the health SDG, including 
Target 3.b on access to vaccines, Target 3.d on implementation of 
the IHR and Target 3.8 on universal access to health services and 
vaccines. SDG 16 on promoting peaceful and inclusive societies is 
highly relevant for polio eradication.
Recognizing both the epidemiological opportunity and the significant 
risks of potential failure, a new Polio Eradication and Endgame 
Strategic Plan 2013–2018 has been developed, in consultation with 
polio-affected countries, stakeholders, donors, partners and national 
and international advisory bodies.92 It is the first plan to eradicate all 
types of polio disease simultaneously – both due to wild poliovirus 
and due to vaccine-derived polioviruses.
Successful polio eradication is potentially an early milestone for the 
SDGs, if political and financial commitment is maintained. Lessons 
learnt from the polio eradication programme can also play an important 
role in the implementation the SDGs. Some of the lessons include 
the establishment of real-time surveillance and data analysis, with 
a laboratory network that spans 145 countries, the importance of 
establishing accountability mechanisms in countries with weak health 
systems, and specific strategies for accessing children in conflict areas.46
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UNDERNUTRITION
Of the three key undernutrition measures – underweight (defined as inadequate weight for age), stunting 
(defined as inadequate length/height for age) and wasting (low weight for height)93 – stunting best reflects 
the cumulative effects of child undernutrition and infection during the critical 1000-day period covering 
pregnancy and the first two years of a child’s life. An estimated one in four children (23.2%), or 156 million 
children, is affected by stunting globally in 2015, and is exposed to risks that include diminished cognitive 
and physical development.5 An estimated 93 million children under five (one in seven children globally) 
suffer from the negative effects of underweight,5 and 45% of child deaths is linked to undernutrition.
ACHIEVEMENTS 
Between 1990 and 2015, the prevalence of underweight declined 
from 25% to 14% (Figure 4.21), a 44% reduction that falls slightly 
short of the MDG 1 target of halving the prevalence of underweight. 
All regions have experienced a decline in the prevalence of stunting 
among children, however, due to population growth, in the African 
Region the number of children affected by stunting increased by 28% 
between 1990 and 2015.5
Modest progress has been made in reducing maternal anaemia, which 
has dropped from 33% to 29% in non-pregnant women, and from 43% 
to 38% in pregnant women between 1995 and 2011.49 
In 1990, 28% of infants younger than six months was exclusively 
breastfed compared to an estimated 34% in 2010. During this time 
period, 25 countries recorded gains of 20% or more in exclusive 
breastfeeding rates.94
SUCCESS FACTORS
Economic development: Increases in household income have improved 
the ability of families to obtain increased quantities and greater variety 
of foods for infants and young children.37
Ancillary health programmes: Child illness has an important effect on 
the growth of children. Nutritional status has benefited from progress in 
the widespread delivery of related public health programmes, including 
malaria control, treatment of diarrhoea and pneumonia, immunization 
of children, deworming, water and sanitation, female education, and 
delayed umbilical cord clamping.
Enabling environment: Policies guided by the WHO UNICEF Global Strategy 
for Infant and Young Child Feeding, including national legislation on the 
International Code of Marketing of Breast-milk Substitutes, maternity 
protection for working women, and standards for maternity facilities 
have been implemented to remove barriers to breastfeeding.95
Service delivery: Community-based programmes to address acute 
malnutrition and vitamin and mineral supplementation have directly 
improved nutritional status. Increased capacity of health providers and 
community workers in providing counselling has given caregivers the 
skills they need to improve infant and young child feeding practices.6
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Figure 4.21 
Proportion of underweight children under five by WHO region,a 1990 and 20155
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Figure 4.23 
Stunting prevalence in children under five in low- and middle-income countries,a 
by multiple dimensions of inequality, 2005–201323 
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CHALLENGES
Stunting in Africa and India: Post-2015, efforts will need to focus on 
reducing the number of stunted children, with particular emphasis 
on India and the African Region (Figure 4.22).
Underweight: While the MDG for underweight was nearly met, there is 
still work to be done. The South-East Asia Region and African Region 
combined account for an estimated 84% of the global burden of 
underweight children under five. The percentage of babies with low 
birth weight varies widely from an average of 28% in south Asia to 
only 6% east Asia and the Pacific.97
Maternal anaemia: Progress has been made in reducing maternal 
anaemia, but most countries still have anaemia as a moderate or 
severe public health problem.98 New and innovative strategies will be 
needed to effectively reduce anaemia to acceptable levels.
Wasting: Wasting is a strong predictor of mortality among children 
under five,99 and is usually the result of acute significant food shortage 
and/or disease. Rates of severe wasting remain unacceptably high in 
the South-East Asia Region (4.3%), the Eastern Mediterranean Region 
(3.8%) and the African Region (3.3%).5
Inequity in child undernutrition: Prevalence of undernutrition is higher 
in disadvantaged children (Figure 4.23). In half of 77 low- and middle-
income countries the absolute difference in stunting prevalence between 
richest and poorest quintiles was 18 percentage points or more.23
Inadequate implementation: Only a small minority of countries have 
fully implemented the International Code of Marketing of Breast-milk 
Substitutes or fully comply with the ILO Convention 183 on maternity 
protection.100
Inadequate resources: While new resources have been mobilized to 
address stunting in high-burden countries, other forms of malnutrition, 
including obesity, micronutrient deficiencies, breastfeeding and 
appropriate complementary feeding have not received the attention 
they deserve.
STRATEGY FOR THE SDGs
SDG Target 2.2 aims to end all forms of malnutrition by 2030, as part of 
the goal to “end hunger, achieve food security and improved nutrition 
and promote sustainable agriculture”. This approach recognizes the 
global dimension of the nutrition issue, as practically no country is 
exempt from malnutrition. The 2012 World Health Assembly endorsed 
six global nutrition targets for 2025:60
• achieve a 40% reduction in the number of children under five who 
are stunted;
• achieve a 50% reduction of anaemia in women of reproductive 
age;
• achieve a 30% reduction in low birth weight;
• ensure that there is no increase in childhood overweight; 
• increase the rate of exclusive breastfeeding in the first six months 
up to at least 50%;
• reduce and maintain childhood wasting to less than 5%.
Key strategies to achieve these targets have been identified in the World 
Health Assembly Comprehensive implementation plan on Maternal, 
Infant and Young Child Nutrition and the Framework for Action.101 
They include a range of interventions such as scale-up coverage of 
programmes that promote healthy, diversified diets, including high-
quality, nutrient-rich foods in the complementary feeding period (6–23 
months), improvement of micronutrient intake through food fortification, 
including of complementary foods, and use of supplements and use 
of multiple channels for messaging and counselling on optimal infant 
and young child nutrition. 
Figure 4.22 
Prevalence of stunting in children under five96 
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ADOLESCENT HEALTH
A focus on the adolescent phase of the life course is crucial for building a solid foundation for the SDGs. 
Today’s adolescents will be 2030 policy and decision-makers. Adolescents8 are exposed to a range of risks 
and suffer from a variety of illnesses, the most significant being unipolar depressive disorder, road injury, 
iron deficiency anaemia, HIV/AIDS and self-harm.9 While mortality rates are low compared to other age 
groups, most causes of death among adolescents are preventable. Importantly, many health behaviours 
that are adopted during adolescence can have lasting impacts on health through the life course.
TRENDS 
Adolescent mortality rates declined between 2000 and 2012, with the 
number of global deaths falling from 1.5 million to 1.3 million.9 The 
adolescent birth rate (births to those age 15–19) declined by about 
30% between 1990–1995 and 2010–2015 (Figure 4.24). The declines 
were greatest in lower-middle-income countries (44%).102 
In 2014 over 1.6 million adolescents in the African Region were living 
with HIV/AIDS, which has become a leading cause of death among 
adolescents globally.9,103
POSITIVE DEVELOPMENTS 
Increased policy focus in countries: Among the national health policy 
documents from 109 countries retrieved in 2013 from the WHO 
Country Planning Cycle Database, 84% of the policies included some 
attention to adolescents.
Global advocacy: The new UN Every Woman Every Child Global 
Strategy 2015–2020 includes adolescent health and, in 2012, the UN 
Secretary-General called for the development of a UN system-wide 
Action Plan on Youth (Youth-SWAP) to enhance the coherence and 
synergy of UN system-wide activities in key areas related to youth 
development, including health. 
Improved coverage of interventions: Across countries with available 
data, there has been a steady increase in young women’s use of modern 
contraceptive methods over the past two decades.104 In eastern and 
southern Africa, where the HIV burden is high, the percentage of girls 
and boys who was sexually active before age 15 declined, and rates 
of condom use among girls increased from 22% to 33%.103 
Benefits from childhood interventions: The increase in the immunization 
coverage with measles vaccine in childhood translated into health 
gains for adolescents, which reiterates the importance of the life 
course approach to policies and interventions.
Education: Rates of enrolment in secondary school have increased 
globally since 1990. For example, in 2000, the out-of-school population 
of children of lower secondary school age was 97 million, compared 
to 63 million by 2012,20 despite an absolute increase in the population 
in this age range. 
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Adolescent birth rates by country income group, 1990–2015102
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Global top 10 causes of death among adolescents by sex, 20121
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CHALLENGES
Spurring action in countries: Major causes of deaths and ill-health 
in adolescents, such as mental health, substance use and nutrition 
related disorders, do not get sufficient attention in national health 
policies. Among the national health policy documents from 109 
countries, only approximately one third address tobacco and alcohol 
use among adolescents, and only one quarter address mental health.
Reducing road traffic injuries: The leading cause of death among 
adolescents is road traffic injuries (Figure 4.25), which will become 
an even greater problem as rates of vehicle ownership increase in 
the future, particularly in developing countries.
Treating mental illness: Suicide is estimated to be the number one 
cause of death among women age 15–19, and depression is the 
leading cause of illness and disability in adolescence. In any given 
year, 10–20% of adolescents will experience a mental health problem, 
most commonly depression or anxiety.105
Improving nutrition and physical activity: Many boys and girls in 
developing countries enter adolescence undernourished. The number 
of adolescents who are overweight or obese is increasing in both low- 
and high-income countries. Available survey data indicate that fewer 
than one in every four adolescents meets the recommended guidelines 
for physical activity. Anaemia resulting from a lack of iron affects girls 
and boys, and is the third cause of years lost to death and disability.9 
Ensuring sexual and reproductive health services and rights: There are 
considerable barriers to access to health services due to mandatory third 
party authorization, and barriers to implementation of comprehensive 
sexuality education.106 Early marriage of an estimated 39 000 adolescent 
girls every day often deprives them of their education, health and 
long-term prospects.107 An estimated 33 million women age 15–24 
have an unmet need for family planning in 61 countries.104 Globally, 
some 30% of girls age 15–19 who are cohabiting have experienced 
violence by a partner.9 Although the overall number of HIV-related 
deaths is down 30% since the peak eight years ago, estimates 
suggest that adolescents are the only population group in which HIV 
deaths are rising.105
Confronting adolescent male mortality: In the Region of the Americas, 
the adolescent mortality rate for males has been stagnant since 
STRATEGIC PRIORITIES
The 2030 SDG declaration mentions adolescents or youth in several 
instances as a vulnerable population. The targets include a few specific 
targets for youth, mostly on employment, but several targets that, if 
met, will substantially improve adolescent health. In addition to disease-
specific interventions, such as increasing access to male circumcision 
and HPV vaccination, structural, environmental and social changes 
are required. These include infrastructure changes to improve road 
safety, greater alcohol and tobacco taxation, and increased access to 
education. In addition, actions to create adolescent-responsive health 
systems are necessary, such as  facilitation of the adoption of health 
promoting and protecting policies that prevent exposure to harms and 
enable adolescents to adopt healthy lifestyles and  strengthening of the 
capacity of primary and referral-level facilities to deliver adolescent 
responsive services.
2000, where one out of every three deaths among boys age 15–19 
is due to interpersonal violence. The rate among those age 15–19 in 
the Eastern Mediterranean Region has increased since 2000 due to 
war-related deaths.9
Increasing monitoring: Although one in six people in the world is an 
adolescent, adolescent health is monitored poorly compared to many 
other age groups.
Improving equity: Adolescents have decreased rates of access to family 
planning services compared to older age groups. For example, based 
on survey data from 49 low- and middle-income countries, median 
coverage of demand for family planning satisfied with modern and 
traditional contraceptives is 1.5 times higher in women age 20–49 
(66%) than in adolescents age 15–19 (42%).16
Removing barriers to care: Adolescents often find health services 
unacceptable because of perceived lack of respect, confidentiality 
and fear of stigma or discrimination. For adolescents responding to 
a WHO global consultation, cost and poor access were the top two 
reasons preventing them from using health services.9
CHALLENGES cont.
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ACHIEVEMENTS 
Globally, contraceptive prevalence with any method rose from 55% 
in 1990 to 63% in 2010, with 58% of married women of reproductive 
age projected to be using a modern method by 2015 (Figure 4.26). 
The increase was primarily due to a 10 percentage point increase 
in developing countries. The unmet need for contraception with a 
modern method fell from 32% in 1990 to 24% in 2010, driven by 
decreases in developing countries. For women in the African Region, 
the met demand for family planning with a modern method jumped 
by 85% between 1990 and 2010 and is projected to have more than 
doubled by 2015.21
As a result, between 1995 and 2012, rates of unintended pregnancy 
fell from 69 per 1000 women to 53 per 1000 women.22
Primary infertility (non-voluntary childlessness) significantly has 
declined since 1990 in sub-Saharan Africa, where it is most common 
and in south Asia, although there was little change in other regions 
between 1990 and 2010.108 
 
Globally, one in four young women in 2014 was married in childhood 
versus one in three in the early 1980s.11 The proportion of young 
women who entered into marriage before age 15 declined from 12% 
to 8% between the early 1980s and 2014.11 
SEXUAL AND REPRODUCTIVE HEALTH 
AND RIGHTS
The MDG 5.B target for sexual and reproductive health and rights that sought to “achieve universal 
access to reproductive health” was added in 2007. This target covers a wide range of health issues, from 
contraception to FGM, which makes it difficult to agree on a manageable set of appropriate indicators for 
the target. In the SDG, the sexual and reproductive rights are included in the gender goal.
POSITIVE DEVELOPMENTS
Policies and legislation: In the past five years, 77% of country 
governments implemented concrete measures to increase women’s 
access to comprehensive sexual and reproductive health services, 
regardless of marital status and age.109 FGM gained recognition as a 
human rights violation and in the 29 countries that practise FGM, at 
least 24 have enacted anti-FGM laws or decrees.42 Between 1975 and 
2010, 119 countries enacted 260 changes in legislation to address 
intimate partner violence, 95% of these changes enacted since 1995.110
Global and country-level commitments: Notable commitments include 
the International Conference on Population and Development Programme 
of Action, which was adopted by 179 countries in 1994 and focuses 
on sexual and reproductive health and rights.34 Over 30 country 
governments have committed to achieving Family Planning 2020 
(FP2020), with 120 million new users of contraceptives by 2020, and 
donors provided US$ 1.3 billion dollars for family planning in 2013.111
Investments in education: Several high-quality interventions have 
demonstrated a link between investing in education and decreases 
in early marriage and early pregnancy.38 More than half of countries 
and areas worldwide have achieved or nearly achieved universal 
primary education.40 
Figure 4.26 
Trends in contraceptive prevalence and met need for family planning by WHO region, 1990–201521 
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CHALLENGES
Ending child marriage: Despite progress, of the world’s 1.1 billion 
girls, 22 million are already married and hundreds of millions more 
are at risk, and the number will only grow as populations increase.11 
Eradicating FGM: Annually, more than 3 million girls are potentially at 
risk of FGM in Africa.51 The available evidence suggests only a modest 
decline in prevalence of FGM from the mid-1990s to the present.112
Stopping intimate partner violence: 30% of “ever partnered” women 
experience physical or sexual intimate partner violence in their lifetimes. 
The highest rates are in the South-East Asia Region (38%) and the 
African Region (37%), but reports by women from all regions indicate 
that it is a common behaviour.12 
Halting sexually transmitted infections: The incidence of sexually 
transmitted infections remains high for many pathogens and coverage 
is still inadequate for several interventions (see Chapter 5). 
Making abortion safe: In 2008, roughly half of the estimated 43.8 
million induced abortions that occurred globally were unsafe, with the 
majority of them occurring in developing countries.113 Induced abortion 
rates were between 20 and 40 per 1000 women of reproductive age 
in regions with legal restrictions on induced abortion. Around 8% of 
maternal deaths are due to abortion.3
STRATEGIC PRIORITIES
The SDGs include a specific target on ensuring universal access to 
sexual and reproductive health-care services as part of the health goal, 
and several targets on sexual and reproductive rights are included 
under the gender goal. All components of sexual and reproductive 
health such as family planning, prevention of unsafe abortion, 
eliminating harmful practices such as female genital mutilation, 
addressing violence against women, and ensuring access to sexual 
and reproductive health services by all who need them, including 
adolescents, are being addressed within the new Global Strategy 
for Women’s, Children’s and Adolescents’ Health launched by the 
Secretary-General in September 2015. 
Several World Health Assembly resolutions have addressed some of 
these issues including the Global Reproductive Health Strategy.114 
Global campaigns and action plans have been developed and are 
in place to address variety of sexual and reproductive health issues 
supporting the implementation of the Global Reproductive Health 
Strategy, such as Family Planning 2020, a global initiative aiming to 
accelerate meeting unmet needs in contraception,115 a Global Health 
Sector Strategy for Sexually Transmitted Infections,116 and a global 
plan of action to strengthen health system response to interpersonal 
violence, in particular against women and girls, are being prepared. 
Other efforts to address violence against women and girls, including 
female genital mutilation and child marriage, include the UN Secretary-
General UNiTE Campaign to Eliminate Violence against Women117 and 
the UNICEF #ENDviolence against Children campaign.118
95REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, ADOLESCENT HEALTH AND UNDERNUTRITION
1 Global Health Estimates: Deaths, disability-adjusted life year (DALYs), years of life lost (YLL) 
and years lost due to disability (YLD) by cause, age and sex, 2000–2012. Geneva: World 
Health Organization (http://www.who.int/healthinfo/global_burden_disease/estimatesen/, 
accessed 21 September 2015).
2 Trends in Maternal Mortality: 1990 to 2015. Geneva, New York (NY) and Washington (DC): 
World Health Organization, United Nations Children’s Fund, United Nations Population Fund, 
World Bank, United Nations Population Division; 2015 (http://www.who.int/reproductivehealth/
publications/monitoring/maternal-mortality-2015/en/, accessed 12 November 2015).
3 Say, L, Chou D, Gemmill A, Tunçalp O, Moller A-B, Daniels J et al. Global causes of maternal 
death: a WHO systematic analysis. Lancet Global Health. 2014;2(6):e323–33 (http://www.
thelancet.com/journals/langlo/article/PIIS2214-109X(14)70227-X/fulltext, accessed 21 
September 2015).
4 Estimates of child causes of death 2000–2015. Geneva and Baltimore (MD): World Health 
Organization and Maternal and Child Epidemiology Estimation (MCEE); 2015. In press.
5 Joint child malnutrition estimates – Levels and trends (2015 edition). New York (NY), 
Geneva and Washington (DC): United Nations Children’s Fund, World Health Organization 
and World Bank; 2015 (http://www.who.int/nutgrowthdb/estimates2014/en/, accessed 
19 October 2015).
6 Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M et al. Maternal and 
child undernutrition and overweight in low-income and middle-income countries. Lancet. 
2013;382(9890):427–51 (http://www.thelancet.com/journals/lancet/article/PIIS0140-
6736%2813%2960937-X/fulltext, accessed 19 October 2015).
7 Lawn JE, Blencowe H, Oza S, You D, Lee ACC, Waiswa P et al. Every Newborn: progress, 
priorities, and potential beyond survival. Lancet. 2014;384(9938):189–205 (http://www.
thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960496-7/fulltext, accessed 
19 October 2015).
8 WHO defines adolescents as people between 10 and 19 years old. 
9 Health for the world’s adolescents: a second chance in the second decade. Geneva: World 
Health Organization; 2014 (http://apps.who.int/adolescent/second-decade/, accessed 18 
September 2015).
10 Sexual and reproductive health: female genital mutilation and other harmful practices. 
Geneva: World Health Organization (http://www.who.int/reproductivehealth/topics/fgm/
prevalence/en/, accessed 18 September 2015).
11 Ending child marriage: progress and prospects. New York (NY): United Nations Children’s 
Fund; 2014 (http://www.unicef.org/media/files/Child_Marriage_Report_7_17_LR..pdf, 
accessed 18 September 2015).
12 Global and regional estimates of violence against women: prevalence and health effects 
of intimate partner violence and non-partner sexual violence. Geneva, London and 
Tygerberg: World Health Organization, London School of Hygiene & Tropical Medicine and 
South African Medical Research Council; 2013 (http://www.who.int/reproductivehealth/
publications/violence/9789241564625/en/, accessed 17 September 2015).
13 Grantham-McGregor S, Cheung YB, Cueto S, Glewwe P, Richter L, Strupp B et al. 
Developmental potential in the first 5 years for children in developing countries. Lancet. 
2007;369(9555):60–70 (http://www.thelancet.com/journals/lancet/article/PIIS0140-
6736%2807%2960032-4/fulltext, accessed 19 October 2015).
14 Daelmans B, Black MM, Lombardi J, Lucas J, Richter L, Silver K et al. Effective interventions 
and strategies for improving early child development. BMJ. 2015;351:h4029 (http://www.
bmj.com/content/351/bmj.h4029, accessed 19 October 2015).
15 Levels and trends in child mortality report 2015. Estimates developed by the UN Inter-
agency Group for Child Mortality Estimates. New York (NY), Geneva and Washington (DC): 
United Nations Children’s Fund, World Health Organization, World Bank and United Nations 
(http://www.childmortality.org/, accessed 18 September 2015).
16 Tracking universal health coverage: first global monitoring report. Geneva and Washington 
(DC): World Health Organization and World Bank; 2015 (http://www.who.int/entity/healthinfo/
universal_health_coverage/report/2015/en/index.html, accessed 18 September 2015).
17 WHO defines a skilled birth attendant as someone “trained to proficiency in the skills 
needed to manage normal (uncomplicated) pregnancies, childbirth and the immediate 
postnatal period, and in the identification, management and referral of complications in 
women and newborns”. 
18 Estimates of child causes of death 2000–2015. Geneva and Baltimore (MD): World Health 
Organization and Maternal and Child Epidemiology Estimation (MCEE); 2015. In press.
19 Millennium Development Goals report 2015. New York (NY): United Nations; 2015 (http://
unstats.un.org/unsd/mdg/Resources/Static/Products/Progress2015/English2015.pdf, 
accessed 16 September 2015).
20 UNICEF data: monitoring the situation of children and women: delivery care. New York 
(NY): United Nations Children’s Fund (http://data.unicef.org/maternal-health/delivery-care.
html, accessed 22 September 2015).
21 Alkema L, Kantorova V, Menozsi C, Biddlecom A. National, regional, and global rates and 
trends in contraceptive prevalence and unmet need for family planning between 1990 
and 2015: a systematic and comprehensive analysis. Lancet. 2013;381(9878):1642–52 
(http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2962204-1/
fulltext, accessed 18 September 2015).
NOTES AND REFERENCES
22 Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 
and recent trends. Stud. Fam. Plan. 2014;45(3):301–14 (https://www.guttmacher.org/
pubs/journals/j.1728-4465.2014.00393.x.pdf, accessed 18 September 2015).
23 State of inequality: reproductive, maternal, newborn and child health. Geneva: World Health 
Organization; 2015 (http://www.who.int/gho/health_equity/report_2015/en/, accessed 18 
September 2015).
24 Essential interventions, commodities and guidelines for reproductive, maternal, newborn 
and child health. A global review of the key interventions related to reproductive, maternal, 
newborn and child Health. Geneva: The Partnership for Maternal, Newborn & Child Health; 
2011 (http://www.who.int/pmnch/knowledge/publications/201112_essential_interventions/
en/, accessed 19 October 2015).
25 Countdown to 2015. Fulfilling the health agenda for women and children: the 2014 report. 
New York (NY) and Geneva: United Nations Children’s Fund and World Health Organization; 
2014 (http://www.countdown2015mnch.org/reports-and-articles/previous-reports/2014-
report, accessed 20 October 2015).
26 Countdown to 2015. A decade of tracking progress for maternal, newborn and child 
survival: the 2015 report. New York (NY) and Geneva: United Nations Children’s Fund and 
World Health Organization; 2015 (http://www.countdown2015mnch.org/reports-and-
articles/2015-final-report, accessed 20 October 2015).
27 Immunization coverage. Fact sheet No378, updated September 2015. Geneva: World 
Health Organization (http://www.who.int/mediacentre/factsheets/fs378/en/, accessed 
18 September 2015).
28 The Partnership for Maternal, Newborn and Child Health. Geneva: World Health Organization 
(http://www.who.int/pmnch/en/, accessed 18 September 2015).
29 Saving Lives, protecting futures. Progress report on the global strategy for women’s 
and children’s health. New York (NY): United Nations, Every Woman Every Child (http://
everywomaneverychild.org/images/EWEC_Progress_Report_FINAL_3.pdf, accessed 18 
September 2015).
30 Commission on information and accountability for women’s and children’s health. Geneva: 
World Health Organization (http://www.who.int/woman_child_accountability/about/coia/
en/, accessed 18 September 2015). 
31 The H4+ partnership: joint support to improve women’s and children’s health. Progress 
report – 2013. Geneva: World Health Organization; 2014 (http://apps.who.int/iris/
bitstream/10665/134746/1/WHO_RHR_14.27_eng.pdf?ua=1&ua=1, accessed 18 
September 2015).
32 News release, 12 September 2005. New global partnership will take immediate action to 
help women and children survive. Geneva: World Health Organization; 2005 (http://www.
who.int/mediacentre/news/releases/2005/pr41/en/, accessed 18 September 2015). 
33 Framework of actions for the follow-up to the Programme of Action of the International 
Conference on Population and Development. New York (NY): United Nations Population 
Fund; 2014 (http://www.unfpa.org/publications/framework-actions-follow-programme-
action-international-conference-population-and, accessed 18 September 2015).
34 Programme of Action, 20th anniversary edition. Adopted at the International Conference 
on Population and Development, Cairo, 5–13 September 1994. New York (NY): United 
Nations Population Fund; 2014 (http://www.unfpa.org/sites/default/files/pub-pdf/
programme_of_action_Web%20ENGLISH.pdf, accessed 18 September 2015).
35 Meeting report. Nurturing human capital along the life course: investing in early 
child development, World Health Organization, Geneva, Switzerland, 10–11 
January 2013. Geneva: World Health Organization; 2013 (http://apps.who.int/iris/
bitstream/10665/87084/1/9789241505901_eng.pdf?ua=1, accessed 19 October 2015).
36 Chan M. Linking child survival and child development for health, equity, and sustainable 
development. Lancet. 2013;381(9877):1514–15 (http://www.thelancet.com/journals/
lancet/article/PIIS0140-6736%2813%2960944-7/fulltext, accessed 19 October 2015).
37 Marmot M, Friel S, Bell R, Houweling TAJ, Taylor S on behalf of the Commission on Social 
Determinants of Health. Closing the gap in a generation: health equity through action on 
the social determinants of health. Lancet. 2008;372(9650):1661–69 (http://www.thelancet.
com/journals/lancet/article/PIIS0140-6736%2808%2961690-6/fulltext, accessed 19 
October 2015).
38 Hindin MJ, Fatusi A. Exploration of young people’s sexual and reproductive health and 
assessment practices. Final report. Johns Hopkins Bloomberg School of Public Health 
and Bill & Melinda Gates Institute for Population and Reproductive Health; 2014 (http://
gatesinstitute.org/sites/default/files/Exploration%20of%20Young%20People%C2%B9s%20
Sexual%20and%20Reproductive%20Health%20Assessment%20Practices_Final.pdf, 
accessed 18 September 2015).
39 Commission on Social Determinants of Health – final report: Closing the gap in a generation: 
Health equity through action on the social determinants of health. Geneva: World Health 
Organization; 2008 (http://www.who.int/social_determinants/thecommission/finalreport/
en/, accessed 18 September 2015).
40 UNICEF data: monitoring the situation of children and women: primary education. New 
York (NY): United Nations Children’s Fund (http://data.unicef.org/education/primary.html, 
accessed 22 September 2015).
41 UNICEF data: monitoring the situation of children and women: secondary education. New 
York (NY): United Nations Children’s Fund (http://data.unicef.org/education/secondary.
html, accessed 18 September 2015). 
42 Female genital mutilation/cutting: a statistical overview and exploration of the dynamics 
of change. New York (NY): United Nations Children’s Fund; 2013 (http://www.unicef.org/
cbsc/files/UNICEF_FGM_report_July_2013_Hi_res.pdf, accessed 22 September 2015).
96 HEALTH IN 2015: FROM MDGs TO SDGs
43 Financing global health 2014: shifts in funding as the MDG era closes. Seattle (WA): 
Institute for Health Metrics and Evaluation; 2014 (http://www.healthdata.org/sites/default/
files/files/policy_report/2015/FGH2014/IHME_PolicyReport_FGH_2014_1.pdf, accessed 
18 September 2015).
44 A number of major monitoring initiatives including the UN Inter-agency Group for Child 
Mortality Estimation (IGME), and the Maternal Mortality Estimation Inter-Agency Group 
(MMEIG).
45 World Health Statistics 2015. Geneva: World Health Organization; 2015 (http://apps.who.
int/iris/bitstream/10665/170250/1/9789240694439_eng.pdf?ua=1&ua=1, accessed 22 
September 2015).
46 Cochi S, Freeman A, Guirguis S, Jafari H, Aylward B. Global polio eradication initiative: 
lessons learned and legacy. J Infect Dis. 2014;210(Suppl 1):S540–46  (Abstract: (http://
jid.oxfordjournals.org/content/210/suppl_1/S540.abstract, accessed 28 August 2015). 
47 Every Woman Every Child. Consultations on updating the global strategy for women’s, 
children’s and adolescents’ health: round 1 – priorities for the global strategy. Geneva: 
The Partnership for Maternal, Newborn & Child Health; 2015 (http://www.who.int/pmnch/
activities/advocacy/globalstrategy/2016_2030/gs_round1_report.pdf?ua=1, accessed 17 
September 2015). 
48 WHA68.3. Poliomyelitis. In: Sixty-eight World Health Assembly, Geneva, 18–26 May 2015. 
Agenda item 15.2. Geneva: World Health Organization; 2015 (WHA68.3; http://apps.who.
int/gb/ebwha/pdf_files/WHA68/A68_R3-en.pdf, accessed 7 October 2015). 
49 Global nutrition targets 2025: anaemia policy brief. Geneva: World Health Organization; 
2014 (WHO/NMH/NHD/14.4; http://apps.who.int/iris/bitstream/10665/148556/1/
WHO_NMH_NHD_14.4_eng.pdf?ua=1, accessed 21 September 2015).
50 FP2020 core indicators: key findings for 2013. Washington (DC): Family Planning 2020 
(http://progress.familyplanning2020.org/fp2020-core-indicators-key-findings-for-2013, 
accessed 21 September 2015).
51 Female genital mutilation and other harmful practices: prevalence of FGM. Geneva: World 
Health Organization (http://www.who.int/reproductivehealth/topics/fgm/prevalence/en/, 
accessed 19 October 2015).
52 Committing to child survival: a promise renewed. Progress report 2014. New York (NY): 
United Nations Children’s Fund; 2014 (http://www.apromiserenewed.org/APR_2014_
web_15Sept14.pdf, accessed 21 September 2015).
53 Global strategy for women’s and children’s health. New York (NY): United Nations; 
2010 (http://www.everywomaneverychild.org/images/content/files/global_strategy/
full/20100914_gswch_en.pdf, accessed 21 September 2015).
54 The global strategy for women’s, children’s and adolescents’ health (2016–2030): 
survive, thrive, transform. New York (NY): United Nations, Every Woman Every Child (http://
globalstrategy.everywomaneverychild.org/index.html, accessed 19 October 2015).
55 FP2020: progress report 2013–2014. Washington (DC): Family Planning 2020 (http://
progress.familyplanning2020.org/, accessed 21 September 2015).
56 Every newborn: an action plan to end preventable deaths. Geneva: The Partnership for 
Maternal, Newborn & Child Health (http://www.everynewborn.org/, accessed 19 October 
2015).
57 Resolution WHA63.24. Accelerated progress towards achievement of Millennium Development 
Goal 4 to reduce child mortality: prevention and treatment of pneumonia. In: Sixty-third 
World Health Assembly, Geneva, 17–21 May 2010. Resolutions and decisions, annexes. 
Geneva: World Health Organization; 2010:51–3 (WHA63/2010/REC/1; http://apps.who.
int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf, accessed 28 August 2015).
58 Gavi: the Vaccine Alliance. Geneva: Gavi Alliance Secretariat (http://www.gavi.org/, accessed 
21 September 2015).
59 Global financing facility in support of Every Woman Every Child. Washington (DC): World 
Bank (http://www.worldbank.org/en/topic/health/brief/global-financing-facility-in-support-
of-every-woman-every-child, accessed 21 September 2015).
60 Resolution WHA65.6. Comprehensive implementation plan on maternal, infant and young 
child nutrition. In: Sixty-fifth World Health Assembly, Geneva, 21–26 May 2012. Resolutions 
and decisions, annexes. Geneva: World Health Organization; 2012:12–13 (WHA65/2012/
REC/1; http://apps.who.int/gb/ebwha/pdf_files/WHA65-REC1/A65_REC1-en.pdf, accessed 
16 September 2015).
61 Resolution WHA63.23. Infant and young child nutrition. In: Sixty-third World Health Assembly, 
Geneva, 17–21 May 2010. Resolutions and decisions, annexes. Geneva: World Health 
Organization; 2010:47–50 (WHA63/2010/REC/1; http://apps.who.int/gb/ebwha/pdf_files/
WHA63-REC1/WHA63_REC1-en.pdf, accessed 28 August 2015).
62 About Scaling Up Nutrition (http://scalingupnutrition.org/about, accessed 21 September 
2015).
63 WHO estimates. [From analysis prepared for Tracking universal health coverage: first 
global monitoring report. Geneva and Washington (DC): World Health Organization and 
World Bank; 2015 (http://www.who.int/entity/healthinfo/universal_health_coverage/
report/2015/en/index.html, accessed 18 September 2015)].
64 Bhalotra S, Clarke D. Educational attainment and maternal mortality. Background paper 
prepared for the Education for All Global Monitoring Report 2013/4. Teaching and 
learning: achieving quality for all. (2014/ED/EFA/MRT/PI/14; http://unesdoc.unesco.org/
images/0022/002259/225945E.pdf, accessed 21 September 2015).
65 WHO analysis of Barro-Lee educational attainment dataset (http://www.barrolee.com/, 
accessed 20 October 2015).
66 Tuncalp O, Were WM, MacLennan C, Oladapo OT, Gülmezoglu AM, Bahl R et al. Quality of 
care for pregnant women and newborns: the WHO vision. BJOG. 2015;122(8):1045–49 
(http://onlinelibrary.wiley.com/doi/10.1111/1471-0528.13451/full, accessed 21 September 
2015). 
67 Strategies toward ending preventable maternal mortality. Geneva: World Health Organization; 
2015 (http://who.int/reproductivehealth/topics/maternal_perinatal/epmm/en/, accessed 
21 September 2015).
68 Tracking financial commitments to the global strategy for women’s and children’s health. 
Geneva: The Partnership for Maternal, Newborn & Child Health; 2014 (http://www.who.
int/pmnch/knowledge/publications/2014_pmnch_report/en/, accessed 16 September 
2015).
69 Oza S, Cousens S, Law JE. Estimation of daily risk of neonatal death, including the day 
of birth, in 186 countries in 2013: a vital-registration and modelling-based study. Lancet 
Glob Health. 2014;2(11)e635–e644 (http://www.thelancet.com/journals/langlo/article/
PIIS2214-109X%2814%2970309-2/fulltext, accessed 18 September 2015).
70 Bhutta ZA, Das JK, Bahl R, Lawn JE, Salam RA, Paul VK et al. Can available interventions 
end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? 
Lancet. 2014;384(9940):347–70 (http://www.thelancet.com/journals/lancet/article/
PIIS0140-6736%2814%2960792-3/fulltext, accessed 21 September 2015).
71 WHO vaccine-preventable disease monitoring system, 2015 global summary. Geneva: World 
Health Organization; 2015 (http://www.who.int/immunization/monitoring_surveillance/
data/gs_gloprofile.pdf, accessed 21 September 2015). 
72 Maternal, newborn, child and adolescent health policy indicator dashboards and notes. 
Geneva: World Health Organization (http://www.who.int/maternal_child_adolescent/
documents/countries/indicators/dashboards/en/, accessed 21 September 2015). 
73 Global Strategy for Women’s and Children’s Health. Geneva: The Partnership for Maternal, 
Newborn & Child Health; 2010 (http://www.who.int/pmnch/knowledge/publications/
fulldocument_globalstrategy/en/, accessed 21 September 2015). 
74 Every Woman Every Child initiative. New York (NY): United Nations, Every Woman Every 
Child (http://www.everywomaneverychild.org/, accessed 21 September 2015). 
75 UN Commission on Life-Saving Commodities for Women and Children. Commissioners’ 
Report, September 2012. New York (NY): United Nations, Every Woman Every Child 
(http://www.unfpa.org/sites/default/files/pub-pdf/Final%20UN%20Commission%20
Report_14sept2012.pdf, accessed 21 September 2015). 
76 Every newborn: an action plan to end preventable deaths. Geneva and New York (NY): 
World Health Organization and United Nations Children’s Fund; 2014 (http://apps.who.int/
iris/bitstream/10665/127938/1/9789241507448_eng.pdf?ua=1, accessed 21 September 
2015). 
77 Success factors for improving maternal and child health: multisector pathways to progress. 
Country reports. Geneva: The Partnership for Maternal, Newborn & Child Health; 2014 
(http://www.who.int/pmnch/successfactors/en/index2.html, accessed 21 September 
2015).
78 Dickson KE, Simen-Kapeu A, Kinney MV, Huicho L, Vesel L, Lackritz E et al. Health system 
bottlenecks and strategies to scale-up in countries. Lancet. 2014;384(9941)438–54 
(http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2814%2960582-1/
fulltext, accessed 21 September 2015).
79 The State of the world’s midwifery 2014: a universal pathway. A woman’s right to Health. 
New York (NY): United Nations Population Fund; 2014 (http://www.unfpa.org/sites/default/
files/pub-pdf/EN_SoWMy2014_complete.pdf, accessed 21 September 2015).
80 Countdown to 2015. Accountability for maternal, newborn and child survival: the 2013 
update. Geneva and New York (NY): World Health Organization and United Nations Children’s 
Fund; 2013 (http://countdown2015mnch.org/documents/2013Report/Countdown_2013-
Update_withprofiles.pdf, accessed 21 September 2015).
81 WHO recommendations on postnatal care for the mother and the newborn 2013. Geneva: World 
Health Organization; 2013 (http://apps.who.int/iris/bitstream/10665/97603/1/9789241506649_
eng.pdf?ua=1, accessed 21 September 2015).
82 Stevens GA, Bennett JE, Hennocq Q, De-regil LM, Rogers L, Danaei G et al. Trends and 
mortality effects of vitamin A deficiency in children in 138 low-income and middle-income 
countries between 1991 and 2013: a pooled analysis of population-based surveys. Lancet 
Glob Health. 2015;3(9):e528–36 (http://www.thelancet.com/journals/langlo/article/
PIIS2214-109X%2815%2900039-X/fulltext, accessed 21 September 2015). 
83 Progress on sanitation and drinking water: 2015 update and MDG assessment. Geneva 
and New York (NY): World Health Organization and United Nations Children’s Fund; 2015 
(http://apps.who.int/iris/bitstream/10665/177752/1/9789241509145_eng.pdf?ua=1, 
accessed 28 August 2015).
84 Gill CJ, Young M, Schroder K, Carvajal-Velez L, McNabb M et al. Bottlenecks, barriers, 
and solutions: results from multicountry consultation focused on reduction of childhood 
pneumonia and diarrhoea deaths. Lancet. 2013;381(9876):1487–98 (http://www.thelancet.
com/journals/lancet/article/PIIS0140-6736%2813%2960314-1/fulltext, accessed 21 
September 2015). 
85 Ending preventable child deaths from pneumonia and diarrhoea by 2025: The integrated 
Global Action Plan for Pneumonia and Diarrhoea (GAPPD). Geneva and New York (NY): 
World Health Organization and United Nations Children’s Fund; 2013 (http://www.who.
int/maternal_child_adolescent/documents/global_action_plan_pneumonia_diarrhoea/
en/, accessed 21 September 2015).
86 Poliomyelitis and acute flaccid paralysis data. Geneva: World Health Organization (https://
extranet.who.int/polis/public/CaseCount.aspx, accessed 7 October 2015).
97REPRODUCTIVE, MATERNAL, NEWBORN, CHILD, ADOLESCENT HEALTH AND UNDERNUTRITION
87 Data, statistics and graphics. Immunization, vaccines and biologicals. Geneva: World 
Health Organization (http://www.who.int/immunization/monitoring_surveillance/data/
en/, accessed 28 August 2015).
88 Duintjer Tebbens R, Pallansch M, Cochi S, Wassilak S, Linkins J, Sutter R et al. Economic 
analysis of the global polio eradication initiative. Vaccine. 2010;29(2):334–43 (http://www.
sciencedirect.com/science/article/pii/S0264410X10014957, accessed 28 August 2015).
89 Modlin J. The bumpy road to polio eradication. N Engl J Med. 2010;3622346–49  (http://
www.nejm.org/doi/full/10.1056/NEJMp1005405, accessed 28 August 2015).
90 Thompson K, Tebbens R. National choices related to inactivated poliovirus vaccine, innovation 
and the endgame of global polio eradication. Expert Rev Vaccines. 2014;13(2):221–34. 
91 Thompson K. Polio endgame management: focusing on performance with or without 
inactivated poliovirus vaccine. Lancet. 2014;384(9953):1480–2 (http://www.thelancet.
com/journals/lancet/article/PIIS0140-6736%2814%2960983-1/fulltext?rss=yes, accessed 
28 August 2015).
92 Polio Eradication and Endgame Strategic Plan 2013–2018. Geneva: Global Polio Eradication 
Initiative (http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx, accessed 
28 August 2015).
93 Progress for children: a world fit for children statistical review. New York (NY): United 
Nations Children’s Fund (http://www.unicef.org/progressforchildren/2007n6/index_41505.
htm, accessed 21 September 2015).
94 Roberts TJ, Carnahan E, Gakidou E. Can breastfeeding promote child health equity? A 
comprehensive analysis of breastfeeding patterns across the developing world and what 
we can learn from them. BMC Med. 2013;11:254 (http://www.biomedcentral.com/1741-
7015/11/254, accessed 21 September 2015). 
95 Breastfeeding on the worldwide agenda: findings from a landscape analysis on political 
commitment for programmes to protect, promote and support breastfeeding. New York 
(NY):  United Nations Children’s Fund; 2013 (http://www.unicef.org/eapro/breastfeeding_
on_worldwide_agenda.pdf, accessed 19 October 2015).
96 Global targets tracking tool. Nutrition. Geneva: World Health Organization; (http://www.
who.int/nutrition/trackingtool/en/, accessed 21 September 2015).
97 Global nutrition targets 2025: low birth weight policy brief. Geneva: World Health Organization; 
2014 (WHO/NMH/NHD/14.5; http://apps.who.int/iris/bitstream/10665/149020/2/
WHO_NMH_NHD_14.5_eng.pdf?ua=1, accessed 19 October 2015).
98 The global prevalence of anaemia in 2011. Geneva: World Health Organization; 2015 (http://
www.who.int/nutrition/publications/micronutrients/global_prevalence_anaemia_2011/
en/, accessed 21 September 2015). 
99 McDonald CM, Olofin I, Flaxman S, Fawzi WW, Spiegelman D, Caulfield LE et al. The effect 
of multiple anthropometric deficits on child mortality: meta-analysis of individual data in 
10 prospective studies from developing countries. Am J Clin Nutr. 2013;97(4):896–901 
(http://ajcn.nutrition.org/content/97/4/896.long, accessed 21 September 2015).
100 Maternity and paternity at work: law and practice across the world. Geneva: International 
Labour Organization (http://www.ilo.org/global/topics/equality-and-discrimination/
maternity-protection/publications/maternity-paternity-at-work-2014/lang--en/index.htm, 
accessed 19 October 2015).
101 Comprehensive implementation plan on maternal, infant and young child nutrition. 
Geneva: World Health Organization; 2014 (WHO/NMH/NHD/14.1; http://apps.who.int/
iris/bitstream/10665/113048/1/WHO_NMH_NHD_14.1_eng.pdf?ua=1, accessed 21 
September 2015).
102 World population prospects, 2015 revision. New York (NY): United Nations, Department of 
Economic and Social Affairs, Population Division (http://esa.un.org/unpd/wpp/, accessed 
18 September 2015).
103 How AIDS changed everything: MDG 6: 15 years, 15 lessons of hope from the AIDS 
response. Geneva: UNAIDS; 2015 (http://www.unaids.org/sites/default/files/media_asset/
MDG6Report_en.pdf, accessed 21 September 2015).
104 MacQuarrie KLD. Unmet need for family planning among young women: levels and trends. 
DHS comparative Reports No. 34. Rockville (MD): ICF International; 2014 (http://www.
dhsprogram.com/pubs/pdf/CR34/CR34.pdf, accessed 19 October 2015).
105 Adolescents: health risks and solutions. Fact sheet N°345, updated May 2014. Geneva: 
World Health Organization; 2014 (http://www.who.int/mediacentre/factsheets/fs345/en/, 
accessed 21 September 2015).
106 Young people today: time to act now. Eastern and Southern Africa commitment: one 
year in review, 2013–2014. Paris: United Nations Educational, Scientific and Cultural 
Organization (http://youngpeopletoday.net/wp-content/uploads/2014/12/ESACommitment-
Progress_AnnualReport-DIGITAL.pdf, accessed 21 September 2015).
107 News release, 7 March 2013. Child marriages: 39 000 every day. Geneva, World 
Health Organization; 2013 (http://www.who.int/mediacentre/news/releases/2013/
child_marriage_20130307/en/, accessed 21 September 2015). 
108 Mascarenhas MN, Flaxman SR, Boerma T, Vanderpoel S, Stevens GA. National, regional and 
global trends in infertility prevalence since1990: a systematic analysis of 27 health surveys. 
Plos Med[electronic resource]. 18 December 2012;doi:    10.1371/journal.pmed.1001356 
(http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001356, accessed 
21 September 2015). 
109 Reproductive health policies 2014. New York (NY): United Nations Population Division, 
Department of Social and Economic Affairs; 2014 (http://www.un.org/en/development/
desa/population/publications/policy/reproductive-health-policies-2014.shtml, accessed 
21 September 2015).
110 Pierotti RS. Increasing rejection of intimate partner violence: evidence of global cultural 
diffusion. Am. Sociol. Rev. 2013;78(2)240–65 (http://asr.sagepub.com/content/78/2/240.
full.pdf, accessed 21 September 2015).
111 FP2020: partnership in progress, 2013–2014. Washington (DC): Family Planning 2020; 
2014 (http://progress.familyplanning2020.org/uploads/ckfinder/files/FP2020_Progress_
Report_Digital_View_2013-2014.pdf, accessed 21 September 2015).
112 Female genital mutilation/cutting: data and trends update 2014. Washington (DC): 
Population Reference Bureau; 2014 (http://www.prb.org/Publications/Datasheets/2014/
fgm-wallchart-2014.aspx, accessed 21 September 2015).
113 Safe and unsafe inducted abortion: Global and regional level in 2008, and trends during 
1995–2008. Geneva: World Health Organization; 2012 (WHO/RHR/12.02; http://apps.who.
int/iris/bitstream/10665/75174/1/WHO_RHR_12.02_eng.pdf, accessed 18 September 
2015).
114 Reproductive health strategy to accelerate progress towards the attainment of international 
development goals and targets. Geneva: World Health Organization; 2004 (WHO/RHR/04.8; 
http://apps.who.int/iris/bitstream/10665/68754/1/WHO_RHR_04.8.pdf, accessed 20 
October 2015).
115 Family Planning 2020 (http://www.familyplanning2020.org/, accessed 20 October 2015).
116 Global health sector strategy on sexually transmitted infections 2016–2021. Draft for 
consultation. Geneva: World Health Organization (http://www.who.int/reproductivehealth/
STIConsultationDraft.pdf, accessed 20 October 2015).
117 UNiTE to end violence against women. New-York (NY): United Nations (http://www.un.org/
en/women/endviolence/, accessed 20 October 2015).
118 #ENDviolence against children. New York (NY): United Nations Children’s Fund (http://
www.unicef.org/endviolence/, accessed 20 October 2015).
98 HEALTH IN 2015: FROM MDGs TO SDGs
  
INFECTIOUS 
DISEASES
5

SUMMARY
SDG Target 3.3 is focused on the major infectious diseases and includes HIV/AIDS (1.2 million deaths), TB (1.1 million 
deaths) and malaria (438 000 deaths). Encouraged by the major achievements of the MDG era, ambitious new global 
targets have been set for HIV, TB and malaria in the World Health Assembly and by the Joint United Nations Programme 
on HIV/AIDS (UNAIDS) Programme Coordination Board. The SDG target also goes beyond the MDGs in broadening the 
scope of attention to specifically include ending neglected tropical diseases (NTDs), and combating waterborne diseases, 
viral hepatitis and other communicable diseases. 
Globally, the number of deaths due to infectious diseases, including parasitic diseases and respiratory infections, fell from 
12.1 million in 2000 to 9.5 million in 2012. The percentage of all deaths due to infectious diseases decreased from 23% 
to 17%. In the African Region, and to a lesser extent the South-East Asia Region and the Eastern Mediterranean Region, 
infectious diseases are still a leading cause of death. The three regions account for 81% of all deaths and 89% of all YLL 
due to infectious and parasitic diseases in the world.
MDG Target 6 has been met for the major infectious diseases. Incidence (new HIV infections and new cases of malaria 
and TB) has declined: compared to 2000, the number of people newly infected with HIV was 35% lower; the malaria 
incidence rate among the population at risk was 37% lower and the TB incidence rate was 18% lower. 
Major increases in the coverage of key interventions have been recorded for all three diseases. In 2014, 14.9 million people 
living with HIV were receiving ART, up from 690 000 in 2000. Coverage of (new) malaria interventions also increased 
rapidly. For instance, in sub-Saharan Africa an estimated 68% of children under five were sleeping under an ITN in 2015, 
compared to less than 2% in 2000. TB case detection rates increased from 38% to 63%, while maintaining high levels 
of treatment success (85% or higher) since 2007.
MDG progress has been made because of increased political commitment, strong global partnerships, drastic increases 
in funding, scaling up of new and existing interventions and better monitoring and use of data.
Infectious disease outbreaks remain a concern to all countries, imposing a significant burden on economies and public 
health. Several respiratory infectious disease outbreaks have occurred since 2000, including the 2003 severe acute 
respiratory syndrome (SARS) epidemic and the 2009 A(H1N1) influenza virus epidemic. Cholera is endemic in many 
countries and the Haiti outbreak of 2010–2011 provided a vivid reminder of its potential to spread. Most recently, the 
outbreak of Ebola virus disease in West Africa resulted in over 28 000 cases and more than 11 295 deaths (as of 23 
September 2015), causing considerable concern across the globe.
The spread of infectious diseases is affected by multiple socioeconomic, environmental and ecological factors as well 
as rapidly increasing antimicrobial resistance. The SDGs provide a new platform for an integrated approach across the 
economic, social and environmental pillars of development, which should be used to address all infectious diseases.
101INFECTIOUS DISEASES
Infectious and parasitic diseases are on the decline. Globally, 
the number of deaths due to infectious diseases, including 
parasitic diseases and respiratory infections, fell from 12.1 
million in 2000 to 9.5 million in 2012.1 The percentage of all 
deaths that was due to infectious diseases decreased from 
23% to 17%. Yet, infectious diseases are still a major global 
public health problem for several reasons.
First, deaths due to infectious diseases occur at younger 
ages than deaths due to other causes, and thus account 
for a higher proportion – an estimated 26% worldwide – of 
YLL. Second, infectious diseases continue to weigh heavily 
in certain regions (Figure 5.1). For example, in the African 
Region, 50% of YLL are due to infectious and parasitic 
diseases, while in the South-East Asia Region and the 
Eastern Mediterranean Region, they account for 24% 
and 27% of all YLL, respectively. Globally, the three most 
affected regions account for 81% of all deaths and 89% of 
all YLL due to infectious and parasitic diseases.
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Third, emerging infectious diseases – 60% of which are 
zoonotic, mostly originating in wildlife and livestock3,4 
– impose a significant burden on global economies and 
public health. The spread of emerging infections is highly 
correlated with socioeconomic, environmental and 
ecological factors such as population growth, density and 
movement, urbanization, environmental and land-use 
changes, climate change and changing human behaviours, 
and thus presents particular challenges for prevention and 
control. Finally, the threat of infectious diseases is further 
intensified by increased antimicrobial resistance. The 
pathogens that cause infectious diseases and the vectors 
that carry them are increasingly resistant to the drugs and 
insecticides used to control them, threatening the effective 
prevention and treatment of an ever-increasing range of 
infections caused by bacteria, parasites, viruses and fungi.5 
Infectious diseases are a key focus of the SDG health goal, 
with Target 3.3 calling specifically to, “By 2030, end the 
epidemics of AIDS, TB, malaria and neglected tropical 
diseases and combat hepatitis, waterborne diseases 
and other communicable diseases”.6 This represents a 
significant widening of focus relative to MDG 6 in two ways: 
a shift from control to elimination and specific reference to 
TB, NTDs, hepatitis and waterborne diseases in addition 
to HIV/AIDS, malaria and “other diseases” (Figure 5.2).7
SDG Target 3.3 includes HIV/AIDS (1.2 million deaths)8, 
TB (1.1 million deaths)9 and malaria (438 000 deaths).10 
Encouraged by the major achievements of the MDG era, 
ambitious new global targets have been set for HIV, TB 
and malaria in the World Health Assembly and by the 
UNAIDS Programme Coordination Board (see Table 5.1 in 
the strategy section). 
As noted, the SDGs also go beyond the MDGs in broadening 
the scope of attention to include NTDs, waterborne diseases 
(including 1.5 million deaths due to diarrhoeal diseases) 
and viral hepatitis (1.4 million deaths). Tackling the 17 
NTDs would reduce an important source of disability and 
chronic illness, NTDs being endemic in 149 countries and 
putting more than 1 billion people at risk of infection. NTDs 
represent a disease burden of at least 26 million disability-
adjusted life years (DALYs), that is roughly half the burden 
of TB or malaria.1,11 
There is also a strong case for tackling hepatitis, which was 
relatively neglected during the MDG era, despite having a 
disease burden comparable to infections such as HIV, TB or 
malaria. Viral hepatitis infection is a major cause of death 
mostly through liver cirrhosis or cancer due to chronic 
hepatitis B and C,12 but major reductions can be achieved 
through prevention and treatment. 
With regard to waterborne diseases, diarrhoeal diseases 
being the most prominent subgroup, the case for a target 
is also strong. Diarrhoea is a symptom of infections caused 
by a host of bacterial, viral and parasitic organisms, such 
as Rotavirus and Escherichia coli, and diarrhoeal diseases are 
responsible for 1.5 million deaths every year – more than half 
of that burden, or 842 000 deaths per year, attributable to 
unsafe water supply, and lack of sanitation and hygiene.13 
Addressing the problem requires a multisectoral response, 
a fact reflected in the SDGs. Goal 6 (Ensure availability and 
sustainable management of water and sanitation for all) 
includes targets to achieve universal and equitable access 
to safe and affordable drinking-water (6.1) and adequate 
and equitable sanitation and hygiene for all (6.2). This is 
an expansion of MDG target 7.c on water and sanitation.
Several important diseases (referred to as “other 
communicable diseases”) are not specifically mentioned 
in the SDG target, including meningitis, which was 
associated with an estimated 395 000 deaths in 2012, 
and sexually transmitted infections (STIs), which account 
for an estimated half a billion new infections every year.14 
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As an example, STIs are included  in this chapter. Lower 
respiratory infections (especially pneumonia) and vaccine-
preventable diseases such as measles are also not specified 
in the SDG. In this report, they are discussed in Chapter 4 
in the context of SDG Target 3.2 for child health.
Infectious disease outbreaks, such as epidemics of influenza, 
Ebola or cholera, are a global concern with potentially 
large economic and public health consequences. The most 
relevant SDG target is Target 3.d “Strengthen the capacity 
of all countries, in particular developing countries, for early 
warning, risk reduction and management of national and 
global health risks”. 
While there is no explicit SDG target on antimicrobial 
resistance, the issue is mentioned in paragraph 26 of the 
SDG declaration: “We will equally accelerate the pace of 
progress made in fighting malaria, HIV/AIDS, tuberculosis, 
hepatitis, Ebola and other communicable diseases and 
epidemics, including by addressing growing anti-microbial 
resistance and the problem of unattended diseases affecting 
developing countries.” 
ACHIEVEMENTS 
The MDG target has been met for the major infectious 
diseases. Incidence rates have declined since 2000 (or 
possibly earlier) (Figure 5.3). HIV incidence increased 
dramatically during the 1990s but, by 2014, the number 
of people newly infected with HIV was 35% lower than 
in 2000. New HIV infections among children declined 
from 520 000 in 2002 to 220 000 in 2014, mainly due 
to increased access to ARVs for HIV-infected pregnant 
women.8 The malaria incidence rate among population at 
risk decreased by 37% globally between 2000 and 2015. 
Of 106 countries with ongoing transmission of malaria in 
2000, 102 are estimated to have met the MDG target for 
incidence reversal, while increasing numbers of countries 
are moving towards malaria elimination.10 Between 2000 
and 2014, the TB incidence rate fell at an average rate of 
1.5% per year.9 The TB incidence rate is also falling in all 
WHO regions and most of the high-burden countries. 
In spite of the growing world population, the declines in 
incidence rates have meant that absolute numbers of new 
infections and cases of disease have also been falling: to 
214 million cases of malaria in 2015, and 9.6 million cases 
of TB disease and 2.0 million new HIV infections in 2014.
Mortality also fell for the three diseases (Figure 5.4). By 
2014, AIDS-related deaths had declined by 42% since 
mortality peaked in 2004. Malaria deaths are estimated 
to have declined by 53% between 2000 and 2015 and TB 
deaths fell by 29% between 2000 and 2014. By contrast, 
deaths due to hepatitis have increased since 2000.
Figure 5.2 
MDG to SDG targets related to infectious diseases
SDG
SDG Target 3.3
By 2030, end the epidemics of AIDS, tuberculosis, malaria and 
neglected tropical diseases
and
combat hepatitis, waterborne diseases and other communicable 
diseases
SDG Target 6.1
By 2030, achieve universal and equitable access to safe and 
affordable drinking-water
SDG Target 6.2
By 2030, achieve access to adequate and equitable sanitation 
and hygiene for all and end open defecation, paying special 
attention to the needs of women and girls in those vulnerable 
situations
MDG
MDG Target 6.A
Have halted by 2015 and begun to reverse the spread of HIV/AIDS
MDG Target 6.B
Achieve, by 2010, universal access to treatment for HIV/AIDS for 
all those who need it
MDG Target 6.C
Have already halted by 2015 and begun to reverse the incidence 
of malaria and other major diseases
MDG Target 7.C
Halve, by 2015, the proportion of people without sustainable 
access to safe drinking-water and basic sanitation
Figure 5.3 
Global trends in HIV, malaria and TB incidence rates, 2000–20159,10,15
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Progress towards the MDG 6 targets is also measured by 
several intervention coverage indicators. 
Increases in the coverage of key interventions have been 
recorded for all three diseases. In 2014, 14.9 million people 
living with HIV were receiving ART, up from 690 000 
in 2000.8 This represents 40% of the estimated 36.9 
million people living with HIV compared with 2% in 2000 
(Figure 5.5).17 Coverage of (new) malaria interventions 
also increased rapidly. For instance, in sub-Saharan Africa 
an estimated 68% of children under five were sleeping 
under an ITN in 2015, compared to less than 2% in 2002.10 
Regarding TB, the case detection rate for new and relapse 
cases (defined as the number of reported cases divided by 
estimated incidence in the same year) increased from 38% 
in 2000 to 63% in 2014. The global TB treatment success 
rate was 86% in 2013, and has been sustained at 85% or 
higher since 2007.9 This corresponds to about 51% effective 
coverage, defined as successful treatment outcome among 
all cases.
While inclusion in the MDG infectious disease targets 
seems to have had a positive impact on the disease 
programmes concerned, there has also been progress in 
areas not specifically mentioned in the MDGs. For example, 
concerted efforts to combat NTDs, both at the global level 
and in endemic countries, have resulted in the passing 
of some important milestones, including unprecedented 
reductions in the numbers of new cases of human African 
trypanosomiasis (sleeping sickness), dracunculiasis 
(guinea-worm disease) and visceral leishmaniasis (Kala-
Azar).19
The headline achievement with regard to hepatitis is the 
reduction in hepatitis B infections as a result of expanded 
hepatitis B vaccination programmes. Global coverage with 
three doses of hepatitis B vaccine in 2014 is estimated 
to be 82% and is as high as 88% and 92% in the WHO 
Region of the Americas and the Western Pacific Region, 
respectively.20 The latter region is on track to reach its goal 
of reducing the prevalence of chronic hepatitis B (HBV) 
infection to less than 1% by 2017.21 The development of 
new safe oral medicines that can cure over 90% of cases 
of chronic hepatitis C (HCV) infection has the potential 
to be a “game-changer” for the hepatitis response in the 
post-2015 era.
On the waterborne diseases front, there has been a sharp 
decline in diarrhoeal disease-related mortality (see Chapter 
4) largely due to improvements in access to safe water 
and sanitation. Access to an improved drinking-water 
source grew from 76% coverage in 1990 to 91% in 2015, 
an increase of 2.6 billion people.22 Today 58% of the global 
population now enjoys the highest level of access: a piped 
drinking-water connection on their premises. Progress has 
been less impressive with regard to sanitation. The MDG 
sanitation target called for a reduction of the proportion of 
the global population without access to improved sanitation 
to 23% in 2015, but one third is still without access.
Trends in mortality due to infectious disease outbreaks are 
difficult to ascertain, but annual numbers of deaths are 
considerably smaller than those caused by, for instance, 
HIV, TB and malaria. The SARS epidemic in 2003, for 
example, was associated  with just 8098 cases and 774 
deaths, but caused considerable disruptions in trade and 
travel. The MERS-CoV epidemic first occurred in 2012 in the 
Kingdom of Saudi Arabia and has resulted in 1112 confirmed 
cases and 422 deaths (as of 11 May 2015).23 The most 
severe recent epidemic occurred in 2009, and was caused 
by the A(H1N1) influenza virus, a recombination of swine, 
bird and human influenza viruses. The epidemic is estimated 
to have resulted in more than 200 000 deaths.24,25 Other 
outbreaks, such as the H5N1 avian influenza virus in 2003 
and H7N9 in 2013, caused concern but were not associated 
with high case numbers or deaths.
The global trend in cholera cases is difficult to ascertain as 
official reporting is grossly inadequate. During 2000–2014, 
an annual average of 208 000 cases and 4157 deaths 
were reported to the WHO, with a low of 101 383 cases 
in 2004.26 Africa remains the continent most affected by 
cholera, but the incidence spikes in 2010–2011 were caused 
by a severe outbreak in Haiti following the catastrophic 
Figure 5.4 
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Figure 5.5 
Global coverage of interventions: ART among people living with HIV, ITN use among 
children under five and successful treatment for TB cases, 2000–20158,10,18
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earthquake and subsequent UN emergency response. 
Over 7000 deaths occurred due to cholera in Haiti and the 
neighbouring Dominican Republic in 2010–2011. 
Most recently, the outbreak of Ebola virus disease in West 
Africa resulted in 28 295 cases and more than 11 295 
deaths (as of 23 September 2015) and caused considerable 
concern across the globe.27 Since its discovery in 1976, 
there have been Ebola virus disease outbreaks in multiple 
countries in the African Region, the outbreaks generally 
occurring in remote communities and lasting for a short 
time.28 The most recent outbreak in three countries in 
West Africa is quite different, however, involving major 
urban as well as rural areas, crossing international borders 
in a number of cases,29 and affecting far more people. 
The outbreak is also projected to lead to major declines 
in economic activity in the three most severely affected 
economies of Guinea, Liberia and Sierra Leone.30
SUCCESS FACTORS 
Although there are several important differences between 
the diseases and the programmes devoted to tackling them, 
there are common elements that have contributed to the 
impressive achievements made in recent years. 
Political commitment: The establishment of a specific MDG 
for infectious diseases in the Millennium Declaration in 
2000, and the subsequent investments in monitoring 
progress towards achieving the MDGs,7 have positively 
influenced the battle against HIV, TB and malaria. HIV was 
also the topic of UN General Assembly special sessions in 
2001 and 2011. Multiple resolutions on the three diseases 
were endorsed by the World Health Assembly (see below 
for detail). This translated into significantly strengthened 
global and country action. Also water and sanitation 
received greater attention through the International Decade 
“Water for Life”.31
Global advocacy and partnership efforts: The establishment 
of broad partnerships committed to addressing the 
diseases and their consequences has made a major 
difference. UNAIDS was established in 1996, the Roll 
Back Malaria Partnership was founded in 1998 and the 
Stop TB Partnership in 2001. These partnerships have 
played important roles in, for example, advocacy, resource 
mobilization, price negotiations with industry, setting a 
research agenda, coordination of activities and civil society 
engagement.
There are striking examples of the power of partnerships 
for all three diseases. For HIV, alongside the establishment 
of UNAIDS, the UN General Assembly calls for action as 
well as the creation of special funds such as the Global 
Fund, the United States President’s Emergency Plan for 
AIDS Relief (PEPFAR) and UNITAID are key aspects of the 
worldwide response. In addition, there has been a plethora 
of global, regional, country and local civil society initiatives. 
Especially in HIV/AIDS, a strong civil society response 
played a critical role at all levels, raising the bar for the role 
of civil society in all other health and disease areas. The 3 by 
5 Initiative launched in 2003 by WHO and UNAIDS led to 
a rapid uptake of ART and showed that complex treatment 
programmes could be rolled out in resource-poor countries. 
Strengthened partnerships and advocacy, notably through 
the Stop TB Partnership, have been crucial in mobilizing 
enhanced and collaborative action to address the challenge 
of TB, framed around three global five-year plans to stop 
TB. The Global Fund and UNITAID contributed significantly 
to the increase in resources. Improved control of malaria 
has been achieved thanks to the alignment of ministries 
of health and international agencies around WHO policy 
recommendations and a unified Global Malaria Action 
Plan, with increased support from, for instance, the Global 
Fund, the President’s Malaria Initiative (PMI) and the Bill & 
Melinda Gates Foundation. Progress on hepatitis has been 
achieved in large part due to GAVI support, which enabled 
significant reductions in the price of hepatitis B vaccine and 
its introduction into the routine vaccination schedule as a 
component of the pentavalent vaccine.
Increased funding: International funding for control of 
infectious diseases in low- and middle-income countries 
has increased considerably over the past decade, especially 
for HIV, TB and malaria. Domestic funding also increased 
significantly in many middle-income countries. ODA 
disbursements for HIV more than doubled between 2005 
and 2013 to US$ 7.9 billion per year, a figure that dwarfs the 
ODA funding directed to other infectious diseases (Figure 
5.6).32 As much as US$ 113 billion was invested in sub-
Saharan Africa for HIV between 2000 and 2014, including 
domestic funding. Total funding for HIV in low- and middle-
income countries in 2015 is estimated to reach US$ 21.7 
billion. The United States is the largest donor for HIV, 
accounting for 47% of all bilateral assistance since 2000.8
Figure 5.6 
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International TB funding increased gradually to nearly 
US$ 1 billion in 2013 and malaria to about US$ 2 billion, with 
the Global Fund and the United States Government as lead 
donors. Other funding sources, such as foundations, have 
also increased support for control of infectious diseases, 
notably HIV. Domestic funding increases for TB were 
considerable: overall, about 87% (US$ 5.8 billion) of the 
US$ 6.6 billion available in 2015 is from domestic sources. 
In lower middle-income countries, TB domestic funding 
has risen from US$ 0.2 billion in 2006 to almost US$ 0.5 
billion in 2015.9
New interventions and approaches: The development and 
global scale-up of access to ART has been one of the most 
successful public health interventions of the MDG era. 
The spectacular drop in the prices of ARVs, from around 
US$ 10 000 per person per year in 2000 to around US$ 100 
by 2011,8 due to global advocacy, greater predictability of 
demand, economies of scale, increased competition among 
manufacturers, engagement of generic manufacturers33 and 
voluntary licensing, has made treatment more affordable 
and sustainable. Innovative health system approaches, such 
as task shifting among health workers and decentralization, 
were used to deliver the ARVs.34 Treatment regimens were 
standardized and simplified where possible. For instance, 
ARV therapy was based on eight pills a day in 2000, and only 
one in 2015.8 Malaria control efforts received a major boost 
through scaling up of multiple new interventions, including 
LLINs, ACT and rapid diagnostic tests. The development of 
a range of highly effective, safe, oral direct-acting antivirals 
that result in cure rates exceeding 90% for people with 
chronic HCV infection provide new opportunities to push 
back against HCV epidemics.
Scaling up effective approaches: Global strategies and related 
policy/normative guidance have provided a foundation 
for success. Progress in several areas was driven by more 
successful implementation of existing interventions. Clearly 
it is not just a question of spending more, but spending 
smart – that is to say spending money on approaches that 
work. Successful prevention and treatment programmes 
have resulted in declines in new infections, cases and 
mortality for several diseases. For example, reductions 
in diarrhoeal diseases have been achieved through 
significant improvements in access to safe drinking-water 
sources. Reductions in HBV infection are due to expanded 
vaccination. Reductions in HIV infections in newborns have 
resulted from programmes for the prevention of mother-
to-child transmission of HIV.8 TB progress is largely due 
to the widespread adoption of a standardized approach 
to diagnosis and treatment based on global strategies 
developed by WHO (the DOTS strategy from the mid-
1990s until 2005, and the Stop TB Strategy during 2006–
2015).
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Global response to infectious disease outbreaks: Another critical 
development has been the revision of the IHR, spurred by 
the outbreak of SARS in 2003. The revised IHR, endorsed 
in 2005, came into force in 2007. Its scope is limited to 
five hazards: infectious, zoonoses, food safety, chemical, 
and radio nuclear.35,36 Several global collaborations have 
also helped strengthen health security mechanisms. For 
example, the Global Outbreak Alert and Response Network 
(GOARN), a multidisciplinary technical collaboration of 
over 200 technical institutions and networks that works 
with over 600 partners worldwide, was established in 
2000 by WHO and partners and contributes to global 
health security by ensuring that countries have rapid access 
to the most appropriate resources and experts for the 
identification, assessment and response to public health 
emergencies of international importance.37,38 The WHO 
Global Influenza Surveillance and Response System (GISRS) 
monitors the evolution of influenza viruses and provides 
recommendations in areas including laboratory diagnostics, 
vaccines, antiviral susceptibility and risk assessment. It also 
serves as a global alert mechanism for the emergence of 
influenza viruses with pandemic potential.39 Also notable 
in this context is the framework for pandemic influenza 
preparedness, adopted by the World Health Assembly in 
2011, which has been developed in part out of the need 
to ensure novel influenza virus sharing for collective risk 
assessment and to increase access to vaccines and other 
products.40,41
Better data and monitoring: Increased investments in 
population-based surveys and disease surveillance, 
combined with better population-based measurement 
methods, including testing for HIV antibodies, TB presence 
and malaria parasites have resulted in better data for 
country policy-makers and implementers in many countries, 
and improved global reporting. Some progress was also 
made in monitoring risk- and treatment-seeking behaviours.
CHALLENGES 
Increasing funding: Despite significant increases in resources, 
there are still major funding shortfalls in key programme 
areas in many developing countries. For example, in 2015 
there is an estimated funding gap of US$ 1.4 billion for a 
full response to the global TB epidemic in low- and middle-
income countries.9 Inadequate investment in TB R&D is 
also an issue, with an estimated funding shortfall of US$ 1.3 
billion per year for R&D related to new TB diagnostics, 
drugs and vaccines in 2013.42 The funding gap for malaria 
programmes was estimated to be US$ 2.4 billion (53% 
of the total need) in 2013.43 It is also estimated that an 
additional US$ 8–12 billion needs to be available annually 
by 2020 for HIV.8 NTD programmes in many low-income 
countries have been highly dependent on community 
volunteers and external funding, with only two major 
bilateral donors.19 To date, there has been no significant 
external funding for public health programmes addressing 
viral hepatitis, apart from HBV vaccination. Domestic 
levels of investment in infectious disease control have been 
growing, especially among middle-income countries, but 
are still inadequate.
Reducing rates of new infection and disease: Given the 
absence of effective vaccines for prevention of HIV, TB 
and malaria, it is essential to step up primary prevention 
and improve early recognition and treatment-seeking 
behaviour. With regard to HIV, for example, universal 
access to, and uptake of, condoms is still lacking. In 2014, 
two out of three women with multiple sexual partners still 
reported not using a condom the last time they had sex.8 
Young women are especially vulnerable due to gender 
inequalities and gender violence. Interrupting HIV and 
hepatitis virus transmission among sex workers, men who 
have sex with men, people who inject drugs and other most-
at-risk populations, remains challenging in many countries. 
Service access problems are often compounded by stigma 
and discrimination. In many instances, infection rates are 
as much a function of awareness and individual behaviours 
as they are of service availability. Some behavioural risks 
are surprisingly persistent. For example, it is estimated that 
only 19% of people globally wash their hands with soap 
and clean water after defecation or contact with excreta.44 
Inadequate drinking-water, sanitation and hygiene are 
estimated to cause 842 000 preventable deaths each year.13
Improving intervention coverage: Ensuring that people in 
need of health services get them is a challenge for all of the 
infectious diseases for which SDG targets have been set. 
New treatment guidelines indicate ART should be initiated 
in everyone living with HIV,45 yet only 40% are on treatment 
currently, notwithstanding the significant increases in 
coverage over the past decade. In spite of steady progress 
for more than a decade, only 54% of new TB cases are 
currently detected, treated and cured. In 2013, 278 million 
of the 840 million people at risk of malaria in sub-Saharan 
Africa lived in households without even a single ITN, 15 
million of the 35 million at risk pregnant women did not 
receive preventive treatment and between 56 and 69 
million children with malaria did not receive ACTs.43 Very 
often, it is the rural poor who suffer most from lack of 
access. For example, of the 150 million people still relying on 
untreated surface water, over 92% live in rural areas. Rural 
residents also account for 70% of the 2.4 billion people who 
do not have access to an improved sanitation facility.22 The 
majority of people requiring preventive chemotherapy for at 
least one NTD are not getting it (61%).19 An estimated 62% 
of newborns are not receiving hepatitis B immunization.20 
Despite the effectiveness of curative treatments for chronic 
HCV infection, and suppressive treatment for chronic HBV 
infection, few public health programmes exist, with most 
treatment provided through individual clinical care for those 
who can pay for treatment.
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Improving quality of care: The quality of care is a challenge 
for infectious diseases as in other areas of public health. An 
issue of significant concern is unsafe injection and blood 
transfusion practices. Reuse of syringes and needles without 
sterilization is thought to have declined from very high 
levels, but is still common and contributes to transmission 
of hepatitis B and C and HIV.46,47 Patient behaviour is 
another area of concern. For example, it is estimated that 
50% of patients self-administering medical treatments fail 
to follow the full course prescribed.48 Suboptimal adherence 
to treatment schedules can also contribute to increasing 
resistance to medicines.
Increasing drug resistance: Antimicrobial resistance is a 
huge global concern across a wide range of infections. 
Box 5.1 describes some of the major issues in antibacterial 
resistance. HIV, TB and malaria face specific drug 
resistance challenges. There were an estimated 480 000 
new cases of multidrug-resistant TB (MDR TB) in 2014. 
Reducing the burden of MDR TB will require preventing 
the development of drug resistance through high-quality 
treatment of drug-susceptible TB, and development of 
more effective treatment regimens for those with MDR TB 
(successful treatment rates average around 50% globally). 
With regard to malaria, Plasmodium falciparum is already 
resistant to artemisinin in five countries. Strains of drug 
resistant HIV are also emerging and, while the use of 
combination therapies has been successful in keeping 
levels of resistance manageable, they impose a much higher 
treatment cost.
Insecticide resistance: Major achievements in reducing 
the global burden of malaria in the last 10–15 years 
have been driven by scaling up access to LLINs. With 
insecticide resistance of vectors becoming widespread in 
disease-endemic areas, the effectiveness of this tool that 
currently uses a single class of insecticides (pyrethroids) 
is threatened. Effective and sustained use of insecticide-
based vector control tools will require enhanced investment 
in product development, monitoring and management of 
insecticide resistance, and capacity strengthening in public 
health entomology and low-risk use of pesticides.
Climate change: Rising temperatures, changes in 
precipitation patterns, increases in extreme weather events 
and biodiversity loss may affect the spread of infectious 
diseases in complex ways.49 Climate change may alter the 
distribution of disease vectors such as mosquitoes carrying 
dengue50 or malaria, enhance the spread of diseases through 
contaminated water including cholera and create conditions 
favourable to the transmission for pathogens such as West 
Nile or Hantavirus.51
 
Addressing the social determinants: The incidence and 
consequences of infectious diseases are not randomly 
distributed in the population,52 the poor, the less educated 
and rural populations generally bearing the greater disease 
burden. Gender issues play a critical role, especially with 
regard to HIV.53 The SDGs will have to reinvigorate efforts 
to address the determinants in an integrated and more 
effective manner than the MDG did.
Enhancing the response to outbreaks: The continued and 
increasing risks of emerging and re-emerging infectious 
disease outbreaks due to virulent, drug-resistant and 
lethal microbial organisms are an major concern, as is 
the risk of bioterrorism, for example in the form of a 
deliberately dispersed pathogenic biological agent. Even 
though there has been progress in the implementation 
of the IHR core capacities in recent years, the situation 
in 2014 is far from satisfactory, especially in the African 
Region (Figure 5.7). In fact, 84 of the 196 IHR States 
Parties (43%) have requested and obtained extensions 
to 2016 to meet IHR core capacity requirements.54 There 
are still major deficiencies in preparedness, surveillance, 
response capacity and other critical capacities.55 The 
Ebola epidemic in West Africa has stimulated in-depth 
reflection on the state of global health security, not least 
in terms of inadequate global capacity for quick response. 
WHO was first alerted to the outbreak on 23 March 2014, 
but it was not until 8 August 2014, after a meeting of the 
International Health Regulations Emergency Committee, 
that it declared a public health emergency of international 
concern.56 The epidemic has also revealed weaknesses 
in the funding mechanisms used to finance outbreak 
responses. Of the US$ 2.89 billion that the international 
community pledged to support the Ebola response, little 
more than 40% had reached the affected regions by the 
beginning of 2015.57 
Box 5.1
Antimicrobial resistance: a global threat
Antimicrobial resistance threatens the effective prevention and treatment of an 
ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. 
For instance, increasing rates of antibacterial resistance are reported for multiple 
respiratory, gastrointestinal, wound and other infections caused by E. coli and Klebsiella 
pneumonia, which are resistant to third generation cephalosporins. For example, 
Streptococcus pneumoniae, is showing reduced susceptibility to penicillin, leading 
to invasive pneumococcal disease (e.g. pneumonia and meningitis), especially in 
children and elderly people. S. aureus is showing high rates of methicillin-resistance, 
with implications for common skin and wound infections. Neisseria gonorrhoeae is 
increasingly resistant to third generation cephalosporins, the treatment of last resort 
for gonorrhoea.
The consequences of antibacterial resistance are multiple. Patients with infections 
caused by bacteria resistant to a specific antibacterial drug generally have an increased 
risk of worse clinical outcomes and death and consume more health-care resources 
than patients infected with the same bacteria not demonstrating the resistance pattern 
in question. Available data are insufficient to estimate the wider societal impact and 
economic implications when effective treatment for an infection is completely lost as 
a result of resistance to all available drugs. Nevertheless, it is clear that antimicrobial 
resistance is a global health security threat that requires concerted cross-sectoral 
action by governments and society as a whole. Surveillance that generates reliable 
data is the essential basis of sound global strategies, and public health actions to 
contain antimicrobial resistance are urgently needed around the world.5
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Figure 5.7 
IHR implementation status: average of 13 capacity scores, 2010 and 201458
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Developing new products: The importance of new drugs and 
vaccines in combating infectious diseases has already been 
stated, but it is clear that continuous drug and vaccine R&D 
is vital if momentum is to be maintained. R&D investments 
in diseases that are major public health problems in low- 
and middle-income countries is only small fraction of global 
R&D investment.59 The task is daunting. For example, work 
on an effective malaria vaccine has been going on for at 
least 20 years, and has thus far resulted in one semi-viable 
vaccine, RTS,S/AS01.60 It is a similar story with HIV, where 
dozens of clinical trials of vaccines are ongoing (Phase I and 
II), testing a variety of candidates and vaccine concepts. It 
remains to be seen whether any winner will emerge. The 
only TB vaccine that is currently in use was developed in 
the 1920s, and while it provides protection against severe 
forms of TB in children, its efficacy in preventing TB in adults 
(who account for about 90% of the world’s cases) is highly 
variable. There are currently 15 TB vaccine candidates in 
clinical trials. With regard to NTDs, there is an urgent need 
for more R&D to combat the emergence of resistance 
to medicines as well as to pesticides for vector control. 
There are multiple new medicines in the pipeline to cure 
chronic HCV infection, however, their high prices and the 
lack of simple and affordable diagnostics pose barriers to 
implementing scalable public health programmes. There 
is also the need for more effective, curative treatment and 
simpler diagnostics for chronic HBV infection.
STRATEGIC PRIORITIES 
The SDG targets for infectious diseases are very ambitious, 
but are in line with what a number of disease-specific 
strategies and WHA resolutions have already been 
exploring. For all infectious diseases, the targeted reductions 
aimed at progressing towards elimination goals in the 
coming 15 years far outstrip what has been achieved since 
2000. 
New strategies include:
• UNAIDS global strategy Fast Track: Ending the AIDS 
Epidemic by 2030 and the draft WHO Global Health 
Sector Strategy on HIV 2016–2021;61,62
• The End TB Strategy;63,64 
• Global Technical Strategy for Malaria 2016–2030;65 
• NTD Roadmap;66 and Water Sanitation and Hygiene for 
Accelerating and Sustaining Progress on NTDs: A Global 
Strategy 2015–2020;67 
• Draft Global Health Sector Strategy on Viral Hepatitis 
2016–2021.68
The strategies and related documents have proposed 
a number of more specific targets and indicators for 
monitoring progress towards the goals, linked to the overall 
SDG target (Table 5.1).
The battle against infectious diseases needs to focus on the 
geographic areas and populations that are at the highest 
risk. The African Region has by far the highest burden of 
infectious diseases, followed by the South-East Asia Region 
and the Eastern Mediterranean Region. Major reductions in 
new infection rates are needed, implying an emphasis on 
prevention efforts complemented by effective treatment. A 
number of common strategic priorities can be identified for 
all infectious diseases.
Prevention: Preventive efforts include: (i) environmental 
measures, such as improved water, sanitation and hygiene 
to reduce transmission of waterborne diseases, hepatitis 
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and NTDs; (ii) behavioural changes such as safe sex and 
condom use to reduce HIV, STI and hepatitis B transmission; 
(iii) harm reduction for people who inject drugs to prevent 
HIV, HBV and HCV acquisition; (iv) use of ITNs for malaria 
prevention; and (v) improved health-care safety to reduce 
nosocomial transmission of HIV, hepatitis and other 
pathogens. Preventive chemotherapy based on large-scale 
delivery of free, safe, single-dose, quality-assured medicines 
at regular intervals is a cornerstone of tackling NTDs. Child 
vaccination is a priority intervention to combat hepatitis B, 
including the administration of a birth dose, and Rotavirus 
vaccination to reduce the incidence of diarrhoea (see 
Chapter 3). For other diseases, continued investments in 
the development of vaccines are needed which may pay 
off in the coming 15 years.
Detection, diagnosis and treatment: Expansion of effective 
case detection, rapid diagnosis and high-quality treatment 
are essential components of the post-2015 strategies for all 
infectious diseases. The encouragement of health-seeking 
behaviour and provision of good diagnostic and treatment 
facilities are essential to increasing treatment coverage. 
Lack of awareness of HIV status is often the main reason 
for low coverage with ARVs, which requires easy access 
and high utilization of HIV testing for all relevant population 
groups.8 Effective and simple screening, diagnosis and 
disease staging are critical to identify people with chronic 
HBV and HCV infection and to determine their eligibility 
for treatment.
High-level coverage with quality interventions is a core 
strategy for all programmes. This requires the availability 
of low-cost, quality medicines for all, evidence-based 
health service delivery and high adherence to prescribed 
treatments by individuals. Maintaining high-quality 
treatment programmes has been a cornerstone of TB 
programmes for two decades. For HIV too, coverage 
expansion is a core strategic objective, as countries work to 
meet the requirements of the new WHO treatment initiation 
guidelines. For NTDs, treatment coverage expansion is vital, 
and if high-quality coverage is sustained for long enough – 
as few as three years for some NTDs requiring preventive 
chemotherapy – it may be sufficient for transmission to 
be completely interrupted. However chemotherapy must 
be complemented with interventions to improve water, 
sanitation and hygiene, to be most effective. High treatment 
coverage is not only an important preventive measure for 
diseases such as TB and malaria, where a cure can be 
achieved, but also for HIV, for which it has been shown that 
effective viral suppression can lead to reduced incidence in 
the general population.70 Advances in treatment of chronic 
HBV and HCV infection need to be translated into public 
health programmes.
Antimicrobial resistance: In response to the antimicrobial 
resistance challenge, the WHO draft global action plan 
on antimicrobial resistance was presented to the World 
Health Assembly in May 2015.71,72 The goal of the global 
action plan is to ensure, for as long as possible, continuity of 
successful treatment and prevention of infectious diseases 
with effective and safe medicines that are quality assured, 
used in a responsible way and accessible to all who need 
them. To achieve this goal, the action plan sets out five 
strategic objectives: 
• improve awareness and understanding of antimicrobial 
resistance; 
SDG target Specific plan – main targets 2030
Ending the epidemic of AIDS Reduce the annual number newly infected with HIV by 90% and the annual number of people dying from AIDS-related causes by 80% (compared 
with 2010)
Ending the epidemic of TB 90% reduction in TB deaths 
80% reduction in TB incidence rate (to less than 20 per 100 000 population)
Zero TB-affected families facing catastrophic costs due to TB
Ending the epidemic of malaria 90% reduction in global malaria mortality rate
90% reduction in global malaria case incidence
Malaria eliminated from at least 35 countries 
Re-establishment of malaria prevented in all countries identified as malaria-free
Ending the epidemic of NTDs 90% reduction in the number of people requiring interventions against NTDs
Combat hepatitis 95% decline in new cases of chronic HBV infection between 2010 and 2030; 80% reduction in new cases of chronic HCV infection over the same 
period; 65% reduction in HBV- and HCV-related deaths
Combat waterborne diseases69 No one practises open defecation (by 2025)
Everyone uses a basic drinking-water supply and handwashing facilities at home
Everyone uses adequate sanitation when at home (by 2040)
All drinking-water supply, sanitation and hygiene services are delivered in progressively affordable, accountable and financially and environmentally 
sustainable manner
Table 5.1
Summary of specific targets in global plans and other international agreements for SDG Target 3.3 on infectious diseases
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• strengthen knowledge through surveillance and research; 
• reduce the incidence of infection; 
• optimize the use of antimicrobial agents; 
• ensure sustainable investment in countering 
antimicrobial resistance.
Integrated approach and universal health coverage (UHC): 
Priority strategies for the infectious disease SDGs will 
necessarily reflect the principal challenges identified. 
Expanded population coverage with quality prevention and 
management services supported by adequate funding must 
be at the centre of efforts in the post-2015 era. The proximity 
of this objective to that of UHC suggests that there will be 
many opportunities for alignment, integrating disease-
specific initiatives with broader, system-wide reforms. The 
specific strategies outline such a focus. For instance, HIV 
focuses on inclusiveness: a focus on populations that have 
been left behind by the HIV response, such as adolescent 
women, key populations such as sex workers, migrants, 
children and older people. TB focuses on integrated, patient-
centred care and prevention, including early diagnosis of 
TB; treatment of all people with TB, including those with 
drug-resistant TB; collaborative TB/HIV activities and 
management of co-morbidities; preventive treatment of 
people at high risk; and vaccination against TB. HIV also 
aims for an integrated HIV response that expands the 
contribution towards UHC, including health workforce, 
procurement systems, injection and blood safety, and 
treatment of coinfections.73 All require universal access 
affordable quality services.
IHR implementation: A report submitted to the World 
Health Assembly in 201574 identified several strategic 
priorities for improving IHR implementation. Many of 
these are based on lessons learnt from Ebola outbreaks 
and focus on the need to be able to draw upon existing 
public health capacities and networks during emergencies. 
Key actions needed in the coming decade include: (i) in-
country leadership, integration of laboratory services and 
surveillance systems to improve integrated surveillance; 
(ii) building multisectoral surveillance capabilities at 
local and community levels, with trained staff working 
with clinicians, integrating surveillance systems for both 
communicable diseases and other hazards, and establishing 
early warning alert and response systems; (iii) building up 
core capacities at points of entry, particularly in terms of 
surveillance, preparedness and response capacities; and 
(iv) identifying new mechanisms to address continuing 
gaps in core capacities in countries and the inadequacy of 
current methods to accurately monitor their development 
and status, including independent status assessment of IHR 
core capacities complementing self-assessment. Preventing 
and reducing the likelihood of outbreaks, detecting threats 
early, and rapid, effective response requires multi-sectoral, 
international coordination and communication.75 
Intersectoral action: This is also critical, especially for 
preventive purposes. An obvious example is waterborne 
diseases where better water supply, safer sanitation, 
strengthened action in the crucial area of hygiene promotion 
and expanded efforts in neglected rural areas all require 
the involvement of multiple sectors.76 But multisectoral 
action is also critical for many other diseases such as 
HIV, malaria and NTDs, including addressing the social 
determinants of health, such as gender, education etc. 
Tackling the causes and consequences of climate change 
also requires a multisectoral approach, investing in public 
health and collaboration across multiple disciplines and 
countries to protect the health of people and animals.49 
Similarly, addressing antimicrobial resistance requires the 
engagement of multiple sectors.
Monitoring and research: Monitoring and surveillance is 
needed to detect infectious disease patterns and trends, 
not only to respond to major disease outbreaks, and to 
identify successful (and unsuccessful) interventions 
and approaches. Research is essential to optimize 
implementation, document impact and develop and 
promote innovations. Strengthening country capacity for 
both monitoring and research with regular quality data is 
thus critical. In addition, greater investment is needed in 
research and development of effective interventions for 
NTDs in developing countries. 
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HIV/AIDS
More than 30 years since the disease was first described in 1981, HIV remains a leading cause of ill-health 
and mortality. While investments in the HIV response have achieved unprecedented results, globally, in 
2014, there were 36.9 million people living with HIV, 2.0 million new infections and 1.2 million deaths.8 
Seven out of ten people living with HIV are in sub-Saharan Africa, where HIV is a leading cause of death 
among adults, women of child-bearing age and children.
ACHIEVEMENTS 
MDG Target 6A (halting and beginning to reverse the spread of HIV 
by 2015) has been achieved. By 2014, the number of people newly 
infected with HIV was about 40% lower than peak incidence in the 
second half of the 1990s (Figure 5.8). AIDS-related deaths have 
declined by 42% since the peak in 2004. New HIV infections among 
children declined from 520 000 in 2000 to 220 000 in 2014, mainly 
due to increased access to ARVs for HIV-infected pregnant women.8
There has also been good progress towards MDG Target 6.B (universal 
access to treatment) with 14.9 million people living with HIV receiving 
ART globally by the end of 2014, up from 690 000 in 2000 (Figure 5.9). 
However, this still only represents 40% of the estimated 36.9 million 
people living with HIV.17 In sub-Saharan Africa, the ART coverage rate 
stands at 10.7 million of a total of 25.8 million people living with HIV.8
SUCCESS FACTORS
The worldwide response and partnership: The strong combination 
of domestic, donor and public-private financing, based on the UN 
General Assembly declarations on HIV/AIDS and the establishment 
of new and innovative funding mechanisms for HIV such as PEPFAR, 
the Global Fund and UNITAID, along with global and local civil society 
mobilization, have provided leadership, advocacy, coordination and 
resources for a worldwide response. 
Preventive interventions: Combinations of effective interventions have 
contributed to reduced HIV transmission, including behaviour change 
communication to encourage changes in sexual behaviour; programmes 
targeting key populations such as harm-reduction programmes for 
people who inject drugs; maximizing the prevention benefits of ARVs, 
including for the prevention of mother-to-child transmission of HIV;71 and 
voluntary medical male circumcision in high HIV-prevalence settings.
ART: The development and global scale-up of access to ART has been 
one of the most successful public health interventions of the MDG 
era. The drop in the prices of ARVs, owing to global advocacy, greater 
predictability of demand, economies of scale, increased competition 
among manufacturers, involvement of generic manufacturers33 and 
voluntary licensing have made treatment more affordable.
Increased funding: In 2015, US$ 21.7 billion, four times that in 2000, was 
invested in the AIDS response in low- and middle-income countries; in 
2014, 57% of these investments came from domestic sources. Since 
2000, international funding has increased approximately tenfold, rising 
from nearly US$ 900 million to US$ 8.6 billion in 2014.8 
Innovative approaches to services delivery: The use of task shifting, 
decentralization and community involvement helped stretch health-care 
delivery systems to expand services without comprising quality. This 
has extended the public health approach into communities.
Figure 5.8 
Global trends in HIV incidence and mortality, 1990–20148
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Scale-up of ART in the WHO African Region and other WHO regions, 2000–201415
 WHO African Region    Other WHO regions
Pe
op
le
 re
ce
iv
in
g 
AR
T 
(m
ill
io
ns
)
l
2000
l
2002
l
2004
l
2006
l
2008
l
2010
l
2014
l
2012
6 —
4 —
3 —
2 —
5 —
9 —
11 —
1 —
7 —
8 —
10 —
12 —
14 —
15 —
13 —
0 —
112 HEALTH IN 2015: FROM MDGs TO SDGs
CHALLENGES78
Africa: 70% of people living with HIV are in the African Region, where 
nearly one in every 20 adults is infected (Figure 5.10). An integrated 
multisectoral, multifaceted approach will require continued substantial 
external funding together with increased domestic contributions.
Treatment coverage: The 2015 revision of the WHO guidelines for 
ART45 removes the threshold for treatment initiation, recommending 
treatment for all, which expands the population eligible for treatment 
and presents an obvious coverage challenge. The main obstacle to 
higher treatment coverage is not access to treatment, but unawareness 
of HIV status; it is estimated that about half of all people living with 
HIV are not aware that they are infected.8,79,80
 
Vaccines: More than 30 clinical trials of HIV vaccines, testing a variety 
of candidates and vaccine concepts, are currently under way (Phases I 
and II), but no effective vaccine is likely to be available in the near future. 
Bringing down incidence: Universal access to, and uptake of, male and 
female condoms is still lacking, especially for young people. Young 
women are especially vulnerable, due to various factors, including 
gender inequalities and gender violence. Interrupting HIV transmission 
among key populations, including sex workers, men who have sex 
with men, people who inject drugs, transgender people and prisoners, 
remains a challenge in many countries.
Stigma and discrimination: Legal environments in many countries 
increase HIV vulnerability, contribute to risk behaviours and inhibit access 
to HIV services. Many countries retain laws that either criminalize, or 
sanction the persecution of, people (or their behaviours) who are at 
higher risk of HIV infection. 
Eliminating health-care associated transmission: In spite of major 
reductions in HIV transmission through unsafe injections and blood 
transfusion, 24% of blood donations in low-income countries are not 
screened for one or more viruses (HIV, HBV, HCV) using basic quality 
procedures. 
Coinfections and other comorbidities: TB, hepatitis (B and C), and other 
communicable diseases occur in conjunction with HIV infection. As 
people living with HIV live longer on ART they experience a broader 
range of NCDs related to their chronic HIV infection, side-effects of 
their treatment and ageing, including cardiovascular disease, diabetes, 
respiratory disorders and cancers, all requiring chronic care. 
STRATEGIC PRIORITIES
The SDG target is to end the AIDS epidemic by 2030. UNAIDS has 
led the development of a global strategy, Fast Track: Ending the AIDS 
Epidemic by 2030, while more detailed, sectoral strategies such 
as the WHO Global Health Sector Strategy on HIV 2016–2021 are 
under development.61,62 The global strategy targets a reduction in 
the annual number of people newly infected with HIV by 90% and 
the annual number of people dying from AIDS-related causes by 80% 
(compared with 2010).
The main areas of focus post-2015 include:
• a focus on populations that have been left behind by the HIV response, 
such as adolescent girls, key populations (sex workers, men who 
have sex with men, people who inject drugs and transgender 
people), migrants, children and older people;
• a focus on locations where the greatest HIV transmission is occurring 
and with the greatest HIV burden, and the use of data to support 
the impact of programmes; 
• an integrated HIV response that expands the contribution towards 
UHC, including health workforce, procurement systems, injection 
and blood safety and treatment of coinfections;
• sustainable programmes with transitioning to domestic funding of 
essential HIV services.
Figure 5.10 
HIV prevalence among adults 15–49 years by WHO region, 201415
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TUBERCULOSIS 
TB is a treatable and curable disease, but remains a major global health problem. In 2014, there were 
9.6 million new TB cases and 1.5 million deaths, including 0.4 million deaths among HIV-positive people.9 
For the past two decades, national and international efforts in TB prevention, diagnosis and treatment 
have been guided by the DOTS strategy (mid-1990s until 2005) and subsequently the Stop TB Strategy 
(2006−2015).81 The Stop TB Strategy was designed to achieve global TB targets set for 2015 within the 
context of the MDGs.82
ACHIEVEMENTS
MDG 6C targeted a decline in the TB disease incidence rate by 2015.83 
Targets to halve prevalence and mortality rates by 2015 compared 
with 1990 levels were established during the development of the 
Global Plan to Stop TB 2001−2005.84 Global progress on all these 
fronts has been remarkable (Figure 5.11). The TB incidence rate has 
been falling since 2000 at an average rate of 1.5% per year during 
2000−2014, while TB mortality and prevalence rates have fallen by 
47% and 42%, respectively, during 1990−2015. 
Case detection and treatment success rates have been monitored at 
national and global levels since 1995, following the establishment of 
global targets (70% and 85%, respectively) for these indicators.85 The 
case detection rate for new and relapse cases increased to 63% by 
2014, up from 38% in 2000. The global TB treatment success rate was 
86% in 2013, and has been sustained at around 85% since 2007. In 
combination, this means that 51% of TB cases were reported to have 
received diagnosis and successful treatment in 2013 (Figure 5.12).86
Figure 5.11 
Global trends in TB incidence, prevalence and mortality rates, 1990–20159
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Global trends in TB case detection and treatment success rates, with estimated 
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MAIN SUCCESS FACTORS
Adoption of effective interventions: The widespread adoption of DOTS 
and the Stop TB Strategy since the mid-1990s has been critical to 
progress. By 2007, virtually all countries had adopted DOTS.87
Increased funding: An estimated US$ 6.6 billion was available for TB 
prevention, diagnosis and treatment in 2015, more than double the 
level of 2006 (US$ 3.2 billion).9
Strengthened partnerships and advocacy: The Stop TB partnership 
was founded in 2001 and by 2014 included 1300 international and 
technical organizations, government programmes, research and funding 
agencies, foundations, nongovernmental organizations, civil society 
and community groups and the private sector. In 2001, it established 
a Global Drug Facility, which by 2014, had delivered more than 24 
million high-quality affordable treatment courses to 133 countries.
CHALLENGES9,42,88
Reaching missed cases: Each year more than 3 million people who 
develop TB disease are either detected but not reported or not diagnosed 
at all, resulting in high TB mortality, especially in the African Region 
and the South-East Asia Region (Figure 5.13).
MDR TB epidemic: Although there is no evidence that the epidemic is 
worsening at the global level, there were an estimated 480 000 new 
cases of MDR TB in 2014. Reducing the burden of MDR TB will require 
preventing the development of drug resistance through high-quality 
treatment of drug-susceptible TB and better treatment regimens for 
MDR-TB. Globally, the cure rate is only 50%.
TB/HIV epidemic: Coverage of ART among HIV-positive TB cases is 
still low and needs to be increased.
Inadequate funding: Despite increases in funding, there is an estimated 
funding gap of US$ 1.4 billion for a full response to the global TB 
epidemic in low- and middle-income countries in 2015. In several 
countries, more than 90% of available funding in 2015 is from 
international donor sources.
Inadequate investment in TB R&D: The Global Plan to Stop TB 2011−2015 
estimates that an additional US$ 2 billion per year is required for R&D 
related to new TB diagnostics, drugs and vaccines. In 2013, there was 
a shortfall of US$ 1.3 billion.
STRATEGIC PRIORITIES
SDG Target 3.3 aims to end the epidemic of TB by 2030. The End TB 
Strategy, endorsed by the World Health Assembly in 2014,63,64 has the 
overall goal of ending the global TB epidemic by 2035. The targets for 
2030 are a 90% reduction in TB deaths and an 80% reduction in the 
TB incidence rate (to less than 20 per 100 000 population) compared 
with 2015. An earlier target, linked to progress towards UHC, is that zero 
TB-affected families should face catastrophic costs due to TB by 2020.
The three main pillars of the End TB Strategy are: 
Integrated, patient-centred TB care and prevention: including early 
diagnosis of TB; treatment of all people with TB, including those with 
drug-resistant TB; collaborative TB/HIV activities and management 
of co-morbidities; preventive treatment of people at high risk; and 
vaccination against TB. 
Bold policies and supportive systems: including political commitment 
with adequate resources for TB care and prevention; engagement of 
communities, civil society organizations and public and private care 
providers; UHC policy and regulatory frameworks for case notification, 
vital registration, including ascertainment of causes of deaths in 
hospitals and communities, quality and rational use of medicines, 
and infection control; and social protection, poverty alleviation and 
actions on the other determinants of TB. 
Intensified research and innovation: including discovery, development 
and uptake of new tools, interventions and strategies; and research 
to optimize implementation, impact and promotion of innovations. 
Figure 5.13 
TB mortality rates excluding TB deaths among HIV-positive people, 20149
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MALARIA 
Almost half the world’s population, living in nearly 100 countries and territories, are at risk of malaria. 
There are an estimated 214 million cases and approximately 438 000 deaths in 2015 – most of these in 
children under five living in Africa. Sub-Saharan Africa bears the highest burden of the disease, accounting 
for 89% of cases and 91% of deaths. More than two thirds of malaria deaths occur in children under five.
ACHIEVEMENTS 
The incidence rate of malaria is estimated to have decreased by 37% 
globally between 2000 and 2015 and malaria mortality rates have 
fallen by 60% (Figure 5.14). Hence the MDG Target 6.C (to have halted 
by 2015 and begun to reverse the incidence of malaria) has been met. 
Of 106 countries with ongoing transmission of malaria in 2000, 102 
are estimated to have met the MDG target of reversing the incidence 
of malaria. An increasing number of countries have moved towards 
eliminating malaria from within their borders. In 2014, 13 countries 
with malaria in 2000 reported zero indigenous cases. Another six 
countries reported fewer than 10 cases.10
The coverage of key interventions has increased dramatically during 
the MDG era. In sub-Saharan Africa, an estimated 68% of children 
under five were sleeping under an ITN in 2015, compared to less 
than 2% in 2000. (Figure 5.15).10 Coverage of at least one dose of 
intermittent preventive treatment in pregnancy (IPTp) increased from 
less than 5% in 2000 to 57% by 2013. The proportion of suspected 
malaria cases that was tested for parasites rose from 47% in 2010 
(when the WHO recommendation to test all suspected malaria cases 
was introduced) to 62% in 2013, mainly due to an increase in the 
use of rapid diagnostic tests. By 2013, ACT had been adopted as the 
national policy for first-line treatment in 79 of 87 countries in which 
P. falciparum is endemic.43 However, treatment with appropriate 
antimalarial drugs continues to be inadequate with an estimated 13% 
of febrile children receiving ACTs in 2015.
SUCCESS FACTORS
Increased funding: Annual funding for malaria control and elimination 
totalled US$ 2.7 billion in 2013. International financing for malaria 
control has increased 20 fold since 2000, reaching US$ 2.2 billion 
in 2013. Domestic investments have also increased year on year.10
Innovation: Programmes have benefited from technologies that were 
not available in 2000, including LLIN, rapid diagnostic tests and ACTs. 
Partnership and advocacy: The Roll Back Malaria Partnership, comprising 
more than 500 partners, was established in 2001 as a global framework 
to mobilize resources, forge consensus among partners and implement 
coordinated action against malaria. 
Planning and programming: Malaria control is now high on the agenda 
of ministries of health and international agencies, which have aligned 
their malaria control policies with WHO recommendations. They also 
united their efforts around a Global Malaria Action Plan developed in 
response to a call for universal access to malaria interventions by the 
UN Secretary-General in 2008. Malaria-endemic countries have defined 
national strategies aiming to ensure that cost-effective interventions 
are accessible to all in need. Effective partnerships have been formed 
at the country level to help implement national strategic plans. 
Economic development and rising incomes have also contributed to 
reductions in malaria incidence and mortality. Among the many benefits 
of increased prosperity is the strengthening of health systems that 
have reduced both the risk of acquiring malaria and the consequences 
of infection.
Figure 5.14 
Global trends in malaria incidence and mortality rates, 2000–201510
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Proportion of children under five sleeping under insecticide-treated mosquito 
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CHALLENGES10,43
Sub-Saharan Africa: Children under 5 living in sub-Saharan Africa suffer 
the largest burden of malaria disease and mortality, where malaria 
accounts for 10% of all deaths in this age group in 2015 (Figure 5.16).
Inadequate funding: The funding gap for malaria programmes was 
estimated to be US$ 2.4 billion (53%) in 2013. 
Resistance: The effectiveness of vector control is threatened as malaria 
mosquitoes develop resistance to the insecticides used in ITNs and 
indoor residual spraying. Resistance of P. falciparum to artemisinin 
in five countries and multiple drug resistance in western Cambodia 
highlights the importance of eliminating P. falciparum in the Greater 
Mekong subregion.
Gaps in intervention coverage: In 2013, 278 million of the 840 million 
people at risk of malaria in sub-Saharan Africa lived in households 
without even a single ITN; 15 million of the 35 million pregnant 
women did not receive preventive treatment; and between 56 and 69 
million children with malaria did not receive ACTs. This is because a 
substantial proportion of these patients do not seek care, and not all 
those who do seek care receive appropriate antimalarial treatment.
STRATEGIC PRIORITIES
The SDG Target 3.3 is to end the malaria epidemic by 2030. New 
malaria goals and targets were endorsed by the World Health Assembly 
in 2015.65 The targets for 2030, with 2015 as the baseline year, are:
• 90% reduction in global malaria mortality rate;
• 90% reduction in global malaria case incidence;
• malaria eliminated from at least 35 countries; 
• re-establishment of malaria prevented in all countries identified 
as malaria-free 
The global technical strategy for 2016–2030 aims to maximize the 
impact of current interventions, focusing on three pillars:
• ensuring universal access to malaria prevention, diagnosis and 
treatment; 
• accelerating efforts towards elimination and attainment of malaria-
free status; 
• transforming malaria surveillance into a core intervention. 
This strategy is to be supported by optimizing the use of innovation, 
expanding research and strengthening the enabling environment, 
including political and financial commitments, multisectoral approaches 
and capacity strengthening.
Figure 5.16 
Percentage of deaths caused by malaria in children under five in sub-Saharan Africa, 2000 and 201510
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NEGLECTED TROPICAL DISEASES 
NTDs89 are endemic in 149 countries. More than 1 billion people are at risk of infection and 17 NTDs 
currently account for a disease burden that is around half the burden of TB or malaria.1 There are five key 
interventions to tackle NTDs: preventive chemotherapy based on large-scale delivery of free, safe, single-
dose, quality-assured medicines at regular intervals; innovative and intensified disease management; 
vector ecology and management based on sound ecological principles and the judicious use of pesticides 
to reduce the transmission of diseases carried by insects; improvements in water, sanitation and hygiene 
in NTD-endemic areas to sustain reductions in prevalence; and veterinary interventions among animals to 
protect and improve human health.
ACHIEVEMENTS19,90,91,92,93 
• In 2014, there were just 126 cases reported of dracunculiasis 
(guinea-worm disease), compared to almost 1800 in 2010 and 
3.5 million in the mid-1980s. 
• In 2014, the number of new cases of human African trypanosomiasis 
dropped to fewer than 4000 annually for the first time in 50 years. 
• In 2013, Colombia became the first country where WHO verified 
the elimination of onchocerciasis, followed by Ecuador in 2014 
and Mexico in 2015. 
• In 2014, the elimination of visceral leishmaniasis (Kala-Azar) as 
a public health problem has been achieved in 87% of endemic 
districts and subdistricts in the South-East Asia Region.
Since 2006, more than 5 billion NTD treatments have been delivered to 
people in need. In 2012 alone, 800 million people received preventive 
chemotherapy for at least one disease, the number dropping to a little 
more than 785 million in 2013, as a result of the successful interruption 
in transmission in a number of areas. Indeed, by the end of 2014, 
18 countries with endemic lymphatic filariasis (elephantiasis) had 
achieved a reduction in infection such that preventive chemotherapy 
was no longer required.94 Globally, 43% of people requiring preventive 
chemotherapy for at least one NTD received it in 2013 (Figure 5.17). 
SUCCESS FACTORS
NTD concept and approach: The concept of NTDs and the integrated 
approach to their prevention and control began to take shape in the 
early years of the MDGs. The focus on poor, rural and marginalized 
populations and co-implementation of key interventions across 
the diseases most common to those populations have boosted the 
investment case for NTDs.
Global leadership and country ownership: WHO established global 
strategies in the Global Plan to Combat Neglected Tropical Diseases, 
2008–2015. The NTD Roadmap for implementation, launched in 
2012, set clear targets for universal access to interventions and the 
eradication or elimination of 11 NTDs by 2020. Countries have taken 
ownership of implementation, building on existing health systems at 
the community level. 
Partnership: The NTD Roadmap was followed by the London Declaration 
on NTDs,97 with a broad set of partners, including the pharmaceutical 
industry, pledging to provide the resources necessary for implementation. 
In 2012–2013 alone, 2.5 billion treatments were donated. External 
assistance is estimated at US$ 200–300 million per year, excluding 
the drug donations of the pharmaceutical industry.98 The Roadmap has 
given renewed impetus for collaboration between WASH and NTD actors, 
and in 2015 a joint strategy was developed to ensure more effective 
delivery of WASH alongside other NTD interventions.67 Partnerships 
with civil society have been critical in many countries globally.
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Global status of preventive chemotherapy coverage: proportion of people 
receiving preventive chemotherapy out of those requiring it for five NTDs,95 
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CHALLENGES
Inequality within countries: Today 1 billion (about three quarters) of the 
world’s poor live in middle-income countries. Similarly, most (about 
two thirds) of the people requiring, but not yet receiving interventions 
against NTDs, live in middle-income countries (Figure 5.18).
Funding gap: NTD programmes have been disproportionately 
dependent on community volunteers and development assistance, 
with most funding provided by just two bilateral donors. Domestic 
levels of investment are still inadequate, especially in middle-income 
countries. Additional investment of US$ 450 million per year is targeted 
in the period 2015–2020 for treatment and care, including preventive 
chemotherapy (excluding vector control).
Inadequate coverage: Coverage with early diagnosis and treatment as 
well as appropriate and timely implementation of vector management, 
water, sanitation and hygiene, and veterinary public health interventions 
remain patchy. The “last mile” of preventive chemotherapy coverage 
is the most difficult and costly; when preventive chemotherapy stops, 
another challenge begins – verifying the interruption of transmission 
and maintaining surveillance to prevent recrudescence.
Climate change: The distribution and incidence of at least some 
NTDs are expected to increase with climate variability and long-term 
environmental changes, as well as unplanned urbanization and increased 
international movement of people and goods. This is especially true of 
the rapidly expanding burden of dengue and chikungunya. Capacity-
building and mitigation measures need to be developed in the most 
vulnerable areas.
R&D: There is a need for more R&D across the five key interventions, 
and containment of the emergence of resistance to medicines as well 
as to pesticides. Improved diagnostics would be a priority through 
broad-based efforts such as the Special Programme for Research 
and Training in Tropical Diseases (TDR).100 Discovery of insecticides 
with new modes of action, development of new vector control tools – 
particularly to curb the spread of vectors that spread disease such as 
dengue and chikungunya – and insecticide resistance management 
are the priorities for effective vector management. 
STRATEGIC PRIORITIES
SDG Target 3.3 is to “end the epidemic” of NTDs. NTDs are also closely 
linked to the UHC target, as a measure of success in reaching the 
poorest. The UHC target of 80% coverage of essential health services 
by 2030 is consistent with coverage targets for the prevention of NTDs 
by 2020 (Figure 5.16).101 If high-quality coverage is sustained for long 
enough – as few as three years for some NTDs requiring preventive 
chemotherapy – transmission may be completely interrupted. The total 
number of people requiring interventions against NTDs may begin to 
decrease as soon as 2017, as diseases are eradicated, eliminated and 
controlled (Figure 5.19). Scale-down for some diseases should free 
up resources for the management of epidemic-prone NTDs, including 
dengue, chikungunya and leishmaniasis.
For global advocacy purposes, the existing coverage and eradication or 
elimination targets for individual NTDs could be brought together under 
a single indicator and target for 2030: for instance, a 90% reduction 
in the number of people requiring interventions against NTDs. This 
means a 90% reduction in the number of people in need of preventive 
chemotherapy and in the number of new cases requiring innovative 
and intensified disease management. It includes, but is not limited 
to: eradication of dracunculiasis (2015102) and yaws (2020); global 
elimination103 of leprosy (2020), lymphatic filariasis (2020), trachoma 
(2020), onchocerciasis (2025) and human African trypanosomiasis 
(2020, with zero incidence in 2030); and regional elimination103 of 
schistosomiasis (2015–2020), rabies (2015) and visceral leishmaniasis 
(2020). These remain critical milestones on the path towards the end 
of the NTD epidemic by 2030.
Figure 5.18 
Number of people requiring and receiving interventions against NTDs, by country 
income group, 2000–2015a,99
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a The period 2013–2015 is based on an assumption of linear scale-up from actual 
coverage reported in 2012 towards 2020 targets.
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Figure 5.19 
Targeted number of people requiring interventionsa against NTDs if coverage 
targets are met, by country income group, 2015–203099
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a Preventive chemotherapy and innovative and intensified disease management.
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HEPATITIS
Viral hepatitis is caused by five different viruses, and transmission occurs through contaminated food 
or water (hepatitis A and E) or through exposure to blood or body fluids (hepatitis B, C, D). Viral hepatitis 
infection kills an estimated 1.45 million per year, with approximately 90% of deaths due to chronic HBV 
and HCV infection, which cause cirrhosis and liver cancer.12 The majority (85%) of viral hepatitis deaths 
occur in Asia, North Africa, East Africa and West Africa. A comprehensive set of hepatitis prevention 
interventions exists (Table 5.2) and effective treatment can cure more than 90% of patients with chronic 
HCV infection and suppress viral replication of hepatitis B. Despite the high disease burden and available 
prevention and treatment interventions, hepatitis has not received the same attention as other diseases 
with a comparable burden of disease, such as HIV, TB or malaria.
ACHIEVEMENTS 
Vaccination: The reduction in HBV infections as a result of hepatitis 
B vaccination programmes is the greatest achievement in hepatitis 
control. By the end of 2014, 194 countries had introduced the vaccine 
into their immunization schedules.104,105 Global coverage with three 
doses of hepatitis B vaccine is estimated to be 82% (Figure 5.20) 
and is as high as 92% in the WHO Region of the Americas and the 
Western Pacific Region. The Western Pacific Region is on track to 
reach its goal of reducing the prevalence of chronic HBV infection to 
<1% by 2017.21 In China, the prevalence of chronic HBV infection has 
been reduced to 1% among children age 1–4 years (Figure 5.21).106 
Eighteen countries104 have introduced universal childhood hepatitis 
A vaccination by the end of 2014 and reductions in incidence have 
been documented.107
Injection safety: Surveys data from developing countries suggest that, 
between 2000 and 2010, reuse of injection equipment decreased 
from 39.6% to 5.5% – an 86% reduction.109 Over the same period, 
unnecessary injections also fell, the average number of injections 
per person in developing countries declining from 3.4 to 2.9. In 2000, 
unsafe injections were responsible for 19.7 million new hepatitis B 
cases, 1.9 million new hepatitis C cases and 267 000 HIV infections. 
In 2010, those numbers had dropped to an estimated maximum 
34 000 for HIV, 1.7 million for hepatitis B and 315 000 for hepatitis C.
Virus Prevention intervention
A E Safe water and food
A Hepatitis A vaccination according to the country's epidemiological 
situation
B Hepatitis B vaccination for all children and administration of birth dose
B C Access to safe blood (universal screening of all blood donations in 
a quality-assured manner)
B C Access to sterile injections and other invasive medical equipment 
in formal and informal health settings
B C Access to sterile injection equipment and other harm-reduction 
measures for people who inject drugs
A B C Promotion of safe sex practices
Table 5.2. 
Elements of a comprehensive hepatitis prevention programme
Figure 5.20 
Global coverage of third dose of hepatitis B vaccine in infants, 1990–2014108
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Figure 5.21 
Prevalence of hepatitis B surface antigen (HBsAg) by age group, China, 1992 and 
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SUCCESS FACTORS
Hepatitis B vaccination: Support by GAVI led to reductions in the price 
of hepatitis B vaccine and its introduction in the routine vaccination 
schedule as a component of the pentavalent vaccine. This led to a 
dramatic increase in immunization coverage.
Injection safety: The Safe Injection Global Network (SIGN) was created 
with the support of partners, including PEPFAR. Its three core strategies 
are: to promote behaviour change among patients and health-care 
workers in order to reduce unnecessary injections and ensure safe 
practices; to increase the availability of essential and good quality 
injection devices and supplies; and to properly manage sharps disposal.
Harm-reduction programmes: Expansion of sterile needle and syringe 
programmes, opioid substitution treatment for opioid users and peer 
outreach programmes have resulted in significant reductions in risk 
behaviours, although the high infectivity of HCV requires enhanced 
harm-reduction programmes.
New treatments: Dramatic progress in drug development has yielded 
a number of safe, oral treatment regimens that can cure almost all 
chronic HCV infections and suppress hepatitis B viral replication.
CHALLENGES
Lack of political engagement: Viral hepatitis was not included in the 
MDGs, reflecting a general lack of political engagement and funding. 
As a result, hepatitis control did not feature prominently in international 
health strategies such as those promoted by WHO and much will need 
to be done to address this gap.
Strategic information: There is a lack of reliable data on infection 
incidence and prevalence as well as for health outcomes and impact. This 
lack of data undermines national planning efforts as well as advocacy. 
Comprehensive programmes: Addressing viral hepatitis requires a 
holistic approach that involves many components of the health sector. 
However, only a few countries have comprehensive public health 
programmes for viral hepatitis. 
Mother-to-child transmission of hepatitis B: This remains a major source 
of infection. To minimize this risk, WHO recommends that all children 
receive a dose of hepatitis B vaccine within 24 hours of birth. Global 
coverage of the birth dose is currently estimated to stand at just 38%.
Hepatitis diagnosis and screening: The majority of people with chronic 
HBV and HCV infection are unaware of their status until they become 
sick. Improved and affordable diagnostics and testing approaches are 
required to identify people with chronic viral hepatitis early.
Scaling up care and treatment services: This will be a major challenge 
that will depend on major reductions in the prices of medicines, 
particularly for the treatment of chronic HCV infection.
STRATEGIC PRIORITIES
Combating hepatitis is now an explicit SDG target (part of Target 
3.3). In 2014, the World Health Assembly requested that WHO initiate 
a process to examine the feasibility of eliminating hepatitis B and 
hepatitis C. Accordingly, a Global Health Sector Strategy on Viral 
Hepatitis is under development that will set global targets towards 
the elimination of HBV and HCV as public health threats by 2030.110
Vaccination will remain a priority preventive intervention, along with 
expanding blood and injection safety within and beyond health-care 
settings, and taking harm-reduction programmes to scale for people 
who use drugs. Expansion of treatment will require innovations in 
diagnostics, including point-of-care technologies, reductions in prices 
of medicines and a public health approach to treatment and care.
Implementation of the global strategy will aim to achieve a 90% 
reduction in new cases of chronic HBV and HCV infection and hepatitis 
deaths from 1.4 million to fewer than 500 000 by 2030. To achieve 
this impact, services will need to be expanded to achieve universal 
access to HBV vaccination (including birth dose), safe injections and 
harm reduction, and 80% of people with chronic hepatitis receiving 
treatment. 
Table 5.2 shows the priority interventions of a comprehensive programme, 
including prevention of transmission through safe water, safe sex, and 
safe medical practices as well as vaccination.
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WATERBORNE DISEASES
Waterborne diseases, by definition, are those that are transmitted by ingestion of contaminated water. 
Important waterborne diseases include diarrhoeal diseases, cholera, shigella, typhoid, hepatitis A and E, 
and poliomyelitis. Diarrhoeal diseases alone account for an estimated 3.6% of the global burden of disease 
(DALYs), and are responsible for of 1.5 million deaths (2012). It is estimated that 58% of that burden in 
low- and middle-income countries – 842 000 deaths per year, including 361 000 in children under five – is 
attributable to unsafe water supply, inadequate sanitation and lack of hygiene.13 
ACHIEVEMENTS 
Between 1990 and 2012, the number of diarrhoeal diseases attributable 
to inadequate water, sanitation and hygiene fell from 1.8 million to 
842 000, with all regions experiencing major declines (Figure 5.22).
Substantial progress has been made in improving access to safe 
drinking-water and sanitation in both urban and rural populations 
(MDG 7).22 Access to an improved drinking-water source jumped 
from 76% coverage in 1990 to 91% in 2015, an increase of 2.6 billion 
people. Of the global population, 58% (4.2 billion people), now enjoy 
the highest level of access: a piped drinking-water connection on the 
premises. On the sanitation front, progress has been less impressive. 
Open defecation decreased from 24% to 13% between 1990 and 
2015, and 2.1 billion people gained access to improved sanitation, but 
almost one third of the global population remains without access, well 
short of the MDG coverage target of 23% lacking improved sanitation. 
Despite improvements during the MDG era, people living in rural 
areas remain at a considerable disadvantage in terms of access to 
both safe water and sanitation compared with those in urban areas 
(Figure 5.23). In 2015, only an estimated one person in three living 
in rural areas had piped water on the premises, compared with 79% 
in urban areas. Although half of those living in rural areas were using 
improved sanitation facilities, this compares poorly with over 80% of 
those in urban areas. 
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Figure 5.22 
Decline in diarrhoea deaths attributable to inadequate water and sanitation in 
low- and middle-income countries, by WHO region, 1990 and 201213
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Figure 5.23 
Trends in proportion of the global population with access to improved drinking-water source and improved sanitation, urban and rural, 1990 and 201522
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SUCCESS FACTORS
Global advocacy and action: Increased attention on the issue of water 
and sanitation, typified by the International Decade for Action “Water 
for Life” 2005–201531 and the sector-wide technical consultation on 
drinking-water, sanitation and hygiene (WASH),76 has helped drive 
change, as has improved collaboration between global agencies and 
organizations. The WHO/UNICEF Joint Monitoring Programme has 
sharpened focus on the issue and enhanced collaboration.111
Country action: The push to improve access to safe water and sanitation 
has been broadly supported at the country level. Two thirds of surveyed 
countries recognize access to both safe drinking-water and sanitation 
as human rights in national legislation,112 while national policies on 
drinking-water and sanitation have been approved in over 80% of 
surveyed countries. Many governments are investing in infrastructure 
development, especially in transitional economies.
Funding: Development assistance commitments for water and sanitation 
increased by 30% since 2000 to over US$ 10.9 billion in 2012, with 
support increasingly directed towards low-income countries.112 
Improved case management and treatment: Increased recourse to 
oral rehydration therapy, better nutrition and other evidence-based 
interventions have probably contributed to reductions in diarrhoeal 
disease related mortality, especially among children.
CHALLENGES
Marginalized rural populations: Of the 159 million people still relying on 
untreated surface water, 93% live in rural areas. Rural residents also 
account for 70% of the 2.4 billion people who do not have access to 
an improved sanitation facility, while open defecation (that is, without 
even basic sanitation such as a pit latrine) is predominantly a rural 
issue, with 90% of open defecators living in rural areas.22 
Lack of focus on health facilities and schools: Inadequate water and 
sanitation policies and practices are fuelling the spread of disease, not 
only in households and communities, but in schools and health facilities. 
Poor hand hygiene: It is estimated that only 19% of the world’s population 
wash hands with soap after defecation or contact with excreta.44 
Poor maintenance: Even improved water supplies are frequently 
contaminated (though not as frequently or as seriously as unimproved 
supplies) and improved sanitation facilities are often associated with 
environmental discharges of untreated faecal waste.
Weak country capacity to implement plans: Despite strong political 
support for universal access to water and sanitation, few countries 
surveyed have the capacity to fully implement their national WASH 
plans and conduct meaningful monitoring and review.
Inadequate funding: Current funding levels are insufficient to meet 
targets for drinking-water and sanitation in many countries. Out-of-
pocket payments to obtain or connect to existing water and sanitation 
services exclude the poorest; affordability schemes to subsidize water 
supply to the poorest are only operational in a minority of countries.112 
STRATEGIC PRIORITIES FOR THE SDG
The overall SDG health goal (Goal 3) includes a specific target (3.3) for 
waterborne diseases, while Goal 6 (Ensure availability and sustainable 
management of water and sanitation for all) includes targets to achieve 
universal and equitable access to safe and affordable drinking-water 
(6.1) and adequate and equitable sanitation and hygiene for all (6.2), 
as well as reducing the proportion of untreated wastewater (6.3). 
Meeting these challenges will require a multisectoral response and 
monitoring. To a large degree, strategies to increase access to safe 
and sufficient drinking-water and adequate sanitation, along with 
improved hygiene, are also implied in multiple SDGs, including the 
eradication of poverty and hunger, achieving health and well-being 
for all and ensuring environmental sustainability.112 
There is a broad consensus on what needs to be done regarding 
drinking-water, sanitation and hygiene, as indicated by the proposed 
policy goals that emerged from the broad, sector-wide technical 
consultation on WASH.76 However, effectively implementing WASH 
policies at the national level is going to require efforts on several fronts, 
starting with securing, absorbing and targeting sustained international 
and national financing. The priority areas for action are: 
• renewed focus on health facilities; 
• strengthened action in the crucial area of hygiene promotion; 
• support for the operation and maintenance of existing infrastructure 
and services; 
• expanded efforts in neglected rural areas where the need for 
improved services is greatest;
• developing effective monitoring and evaluation to track progress 
and identify gaps.
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Figure 5.24 
Reported cholera cases by continent, 1989–201426
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CHOLERA
Cholera is an acute diarrhoea caused by infection due to ingestion of food or water contaminated with 
the bacterium Vibrio cholerae. It is endemic in more than 50 countries, mostly in Africa and Asia, and 
may also cause epidemics.113 More than 1 billion people are at risk of cholera in endemic countries, with 
an estimated 2.9 million cholera cases and 95 000 deaths per year.114 The most recent major cholera 
epidemic occurred in Haiti in 2010–2011, following an earthquake, causing over 7000 deaths in Haiti and 
neighbouring Dominican Republic.115,116 Environmental factors are critical in the epidemiology of cholera. 
Climate change, war, natural disasters, population movement and urbanization are complicating efforts to 
control the disease.117
TRENDS 
From the reported data on cholera cases it is difficult to ascertain 
whether progress has been made in reducing global incidence rates, 
as official reporting is far from complete. Figure 5.24 shows the 
global and regional numbers of reported cases to WHO during the 
last two decades. In general, Africa is the most affected continent. 
Peaks in the numbers of cases occurred in 1991–1992 and 2011, 
associated with severe outbreaks in the Americas. In 2015, a cholera 
outbreak was reported in the Kigoma region of the United Republic of 
Tanzania. Cholera is endemic in the region, but due to a recent influx of 
thousands of Burundian refugees, overcrowding and poor sanitation, 
the situation has deteriorated. 
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POSITIVE DEVELOPMENTS
Water and sanitation: Cholera is a waterborne disease and can be 
largely prevented when people have access to safe drinking-water 
and sanitation facilities. A major achievement during the MDG era 
has been the progress in improving access to safe drinking-water 
and sanitation in urban and rural populations (MDG 7).22 Access to an 
improved drinking-water source jumped from 76% coverage in 1990 to 
91% in 2015, an increase of 2.6 billion people. On the sanitation front, 
progress has been less impressive. Open defecation decreased from 
24% to 13% between 1990 and 2015, and 2.1 billion people gained 
access to improved sanitation, but one third of the global population 
is still without access in 2015.
Case management: Alongside progress in cholera prevention, there 
have also been advances in the ability to effectively manage cholera. 
In particular, the use of oral rehydration therapy has become a more 
widely applied standard of care. Very severely dehydrated patients 
require administration of intravenous fluids. Such patients also require 
appropriate antibiotics to diminish the duration of diarrhoea, reduce 
the volume of rehydration fluids needed and shorten the duration 
of V. cholerae excretion. Recommended control methods, including 
standardized case management, have proven effective in reducing 
the case-fatality rate and reduce the mortality of severe cholera to 
less than 1%, even in resource-limited settings.118
CHALLENGES
New strains: The majority of cholera outbreaks are caused by one 
strain – V. cholera, but recently new variant strains have been detected 
in several parts of Africa and Asia. Observations suggest that these 
strains cause more severe cholera with higher case fatality rates. 
The main reservoirs of V. cholerae are people and aquatic sources 
such as brackish water and estuaries. Recent studies indicate that 
global warming creates a favourable environment for the bacteria.119 
Prevention: Cholera transmission is closely linked to inadequate 
environmental management. Typical at-risk areas include peri-urban 
slums, where basic infrastructure is not available, as well as camps for 
internally displaced people or refugees, where minimum requirements 
of clean water and sanitation are not met. The consequences of a 
disaster – such as disruption of water and sanitation systems, or the 
displacement of populations to inadequate and overcrowded camps 
– can increase the risk of cholera transmission should the bacteria 
be present or introduced. 
Vaccination: A review of recent studies shows levels of protective 
effectiveness ranging from 23–58% (overall 37%)120 and there is 
also evidence of some beneficial indirect effects on the unvaccinated 
population.121 However, the use of the parenteral cholera vaccine has 
never been recommended by WHO due to its low protective efficacy and 
the high occurrence of severe adverse reactions. Very few countries 
have vaccination programmes. 
Preparedness: Early in cholera epidemics mortality rates can still 
exceed 10% before appropriate response mechanisms, such as 
local treatment centres become available to improve rapid access to 
therapy and minimize the time to initial rehydration, as the incubation 
time and the time between onset of symptoms and dehydration and 
death is short.122,123
STRATEGIC PRIORITIES
In 2011, the WHO Member States unanimously agreed that cholera 
needs to be recognized as an increasing public health threat for many 
countries and regions, as it is on the rise due to climate change.124 This 
requires prevention, epidemic preparedness and response. Proper, timely 
and solid surveillance systems, improved environmental management 
– in particular, access to clean water and proper sanitation – and 
the adequate use of cholera vaccines as a complementary measure 
are essential. Cholera prevention requires access to safe water, 
adequate sanitation, adequate food safety, appropriate hygiene and 
a community-based approach.
An internationally licensed oral cholera vaccine is currently available 
on the market in limited stocks and is suitable for travellers. WHO 
recommends that it should always be used as an additional public health 
tool, but should not replace usually recommended control measures 
such as improved water supplies, adequate sanitation and health 
education. Countries neighbouring an area affected by cholera should 
improve preparedness to rapidly respond to an outbreak and improve 
surveillance for risk assessment and early detection of outbreaks.
Cholera is recognized as a clear marker of environmental management, 
as well as an indicator of how the global public health community 
should engage with the IHR and conduct surveillance.
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SEXUALLY TRANSMITTED INFECTIONS
STIs are caused by more than 30 different bacteria, viruses and parasites and are spread predominantly 
by sexual contact. Of the eight pathogens known to be transmitted through sexual contact linked 
to the greatest incidence of illness, four are currently curable (syphilis, gonorrhoea, chlamydia and 
trichomoniasis) and four incurable (the viral pathogens hepatitis B, herpes, HIV and human papillomavirus 
[HPV]), but susceptible to mitigation through treatment. 
ACHIEVEMENTS 
STIs are an important cause of morbidity and mortality; gonorrhoea 
and chlamydia, for example, being major causes of pelvic inflammatory 
disease, adverse pregnancy outcomes and infertility, while HPV 
infection causes 264 000 cervical cancer deaths each year.1 Syphilis 
in pregnancy leads to 305 000 fetal and neonatal deaths every year 
and leaves 215 000 infants at increased risk of dying from prematurity, 
low birth weight or congenital disease. Some STIs can increase the 
risk of HIV acquisition three-fold or more. Despite steady progress 
in reducing the prevalence and incidence of STIs, there are still 
an estimated 357 million new infections of curable STIs per year 
(Table 5.3) as well as 84 000 deaths. Trichomoniasis and chlamydia 
represent the bulk of curable STI cases, but gonorrhoea infection is 
also significant, at an estimated 78 million new cases per year. The 
burden of viral STIs is also high with an estimated 417 million cases of 
herpes infection and 291 million women infected with HPV.125,126,127 The 
epidemiology of STIs is changing, with an increase in viral infections, 
while other previously common infections, such as chancroid, have 
nearly disappeared.128,129
Reduced syphilis infection: Syphilis data show a decreasing trend 
since 1995, while there has also been substantial progress towards 
global elimination of congenital syphilis. Maternal and congenital 
syphilis decreased by 33% between 2008 and 2012.126 Cuba achieved 
elimination of mother-to-child transmission of syphilis and HIV in 2015 
and 13 more countries are promising candidates for elimination of 
vertical syphilis transmission.
SUCCESS FACTORS
Evidence-based, affordable and cost-effective interventions: The 
Global Strategy for the Prevention and Control of Sexually Transmitted 
Infections: 2006–2015 has been adapted for use in all WHO regions 
and is being used by the majority of countries. Most countries report 
using syndromic case management for STI treatment and 88% of 
reporting countries has updated national STI guidelines since 2006. In 
addition, 60% of reporting countries has a national strategy in place for 
elimination of mother-to-child transmission of syphilis. Nearly 90% of 
countries reported offering symptomatic STI treatment for sex workers 
in 2013 and 80% reported that STI services were available for men 
who have sex with men.126 
Linkage to HIV prevention: Interventions for prevention of STIs and HIV 
overlap to a large degree and programmes targeting key populations 
for HIV are reaching those most at risk for STIs.
Advances in diagnosis and treatment: Rapid tests to diagnose syphilis 
infection have become widely available, contributing to increased 
coverage of syphilis screening and treatment, especially among 
pregnant women. Antenatal screening for STIs increased globally 
from 78% in 2008 to 84% in 2013 and syphilis seropositivity among 
pregnant women decreased by nearly half over the same period, from 
1.4% to 0.6%.5 Treatment regimens for common STI syndromes have 
been standardized and simplified with use of single-dose treatments 
wherever possible. 
STI Estimated new cases (millions)
Chlamydia trachomatis 130.9
Neisseria gonorrhoeae 78.3
Syphilis 5.6
Trichomonas vaginalis 142.6
Total 357.4
Table 5.3
Global estimates of new cases of curable STIs, 2012125
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CHALLENGES
Inadequate funding: National STI programmes are experiencing funding 
gaps and staffing crises due to shortage of funds. Globally, there are 
no special funds for STI control other than HIV.
Coverage of STI prevention and treatment services: Most of the 
implemented interventions are not of a scale or scope sufficient 
to achieve universal access. Barriers to access include persistent 
stigma and discrimination, criminalization of behaviours of highest 
risk populations, weak political commitment to STI control and lack 
of funding.
Lack of quality data: Few etiological and prevalence studies have been 
conducted in the past decade as STI programmes were merged into 
HIV programmes. STI surveillance systems lack the capacity to provide 
robust and consistent information and data to support decision-making.
Global threat of gonococcal antimicrobial resistance: The Global 
Antimicrobial Resistance Surveillance Programme (GASP) has been 
reintroduced as a response to the emergence of gonococcal antimicrobial 
resistance, but with insufficient funding and staff. Monitoring for 
antimicrobial resistance is still patchy in the majority of WHO regions.
Changing epidemiology: STI epidemiology is changing with viral 
STIs becoming more prevalent than bacterial pathogens, requiring 
updated information for locally appropriate prevention and treatment 
strategies. More research is needed for development of prevention 
interventions for viral infections, such as vaccines, microbicides and 
other new technologies.
Lack of diagnostic test capability: The majority of STIs are asymptomatic 
(especially among females), and require development and widespread 
availability of reliable and simple diagnostic tests to augment syndromic 
management of symptomatic cases.
STRATEGIC PRIORITIES
There is no explicit STI target but STIs relate to multiple targets in the 
health goal. STI prevention and control activities will support the SDG 
targets to reduce child and neonatal mortality (3.2), end the epidemics 
of AIDS and other communicable diseases (3.3), reduce NCDs and 
improve mental health (3.4), sexual and reproductive health (3.7) and 
universal health coverage (3.8). The current STI prevention and control 
strategy ends in 2015 and development of the next phase will focus on 
building on successes to achieve universal coverage, developing new 
technologies for diagnosis and prevention and improving behaviour 
change interventions. The next phase of the global STI strategy will 
address the following areas:
• Strengthening financing mechanisms for services for STIs and 
increasing human resource capacity.
• Increasing coverage of services through the integration of STI 
prevention and management into the broader agendas on HIV 
infection and reproductive health. Strategies for increasing access 
to services for key populations and other vulnerable populations, 
such as adolescents, are needed.
• Strengthening surveillance and data quality to improve knowledge 
and increase the number of countries reporting on prevalence, 
etiologies of STI syndromes and antimicrobial resistance. 
• Developing strategies for addressing gonococcal antimicrobial 
resistance, which threatens to reverse successes achieved to 
date. An aggressive response is needed to prevent gonorrhoea 
from becoming a non-curable disease.
• Accelerating research on and access to innovations, including 
point-of-care diagnostic tests, more efficacious therapeutics, STI 
vaccines, microbicides and health promotion methods. There is 
a growing need for rapid diagnostic tests to augment syndromic 
management and detect asymptomatic infections, particularly in 
women.
• Eliminating the consequences of STI, particularly congenital syphilis 
and cervical cancer.
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SUMMARY
NCDs are included as a specific SDG target (reducing premature mortality from NCDs by one third) and are part of several 
other health targets.
In 2012, an estimated 52% of all deaths under age 70 was due to NCDs, and two thirds of those deaths were caused by 
cardiovascular diseases (CVD), cancer, diabetes and chronic respiratory disease (CRD).
Premature mortality rates due to NCDs declined globally by 15% between 2000 and 2012. A major factor is the decrease 
in CVD mortality, driven by population-level blood pressure improvements, declines in tobacco use and advances in 
medical treatment. Declines have been greater in high-income countries than in the low- and middle-income countries.
Achieving the SDG target for NCDs will require major interventions to deal with a context characterized by ageing 
populations, rapid unplanned urbanization and globalization of markets that promote inactivity and unhealthy diets, and 
will focus on the development and implementation of strong national plans that emphasize prevention and treatment 
access for all (half of all countries had neither a national plan nor budget in 2013).
The UN Political Declaration on NCDs adopted at the UN General Assembly in 2011 and the UN Outcome Document 
on NCDs adopted at the UN General Assembly in 2014 include a roadmap of commitments made by governments. The 
WHO Global Action Plan for the Prevention and Control of NCDs 2013–2020 endorsed by the World Health Assembly in 
May 2013 sets priorities and provides strategic guidance on how countries can implement the roadmap of commitments. 
The Global Action Plan includes voluntary targets that focus on risk factors such as tobacco use, high blood pressure, high 
salt intake, obesity and physical inactivity, as well as targets on access to essential NCD medicines and technologies, and 
drug therapy and counselling.
The WHO Framework Convention on Tobacco Control (WHO FCTC), ratified by 180 Parties – representing 90% of 
the global population – is the first public health treaty negotiated under the auspices of WHO. SDG target 3.a commits 
governments to strengthen the implementation of the WHO FCTC in all countries. The prevalence of tobacco smoking 
among people age 15 years and older has declined globally from 27% in 2000 to 21% in 2013, though not in all regions. 
Effective country implementation of multisectoral control measures such as raising taxes on tobacco and banning smoking 
in public places are major success factors.
SDG Target 3.9 aims to reduce deaths and illnesses related to hazardous chemicals, as well as air, water and soil pollution 
and contamination. About 7 million NCD deaths are attributed to indoor and outdoor air pollution. Global awareness of the 
need for multisectoral action is exemplified by the inclusion of air quality in three other goals and a recent World Health 
Assembly resolution on addressing the health impacts of air pollution.
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NCDs are estimated to kill around 38 million people per 
year, accounting for 68% of all deaths worldwide,1 and the 
main NCDs (CVD, cancers, CRD and diabetes), taken singly, 
are among the top 10 leading killers. Nearly 80% of NCD 
deaths – 30 million – occurs in low-, middle- and non-OECD 
high-income countries, where NCDs are fast replacing 
infectious diseases and malnutrition as the leading causes 
of disability and premature death. Despite their obvious 
and growing significance, NCDs have long been hidden, 
misunderstood and underrecorded. They were passed over 
in the MDGs, which, by focusing attention on other issues, 
may have actually contributed to the sidelining of this core 
public health concern in global health.2
Unlike the MDGs, the SDGs include a specific target 
for NCDs and several NCD-related targets. Target 3.4 
calls for a one third reduction in premature mortality 
from NCDs by 2030, and is an extension of the global 
voluntary NCD mortality target, which defines premature 
NCD mortality as the probability of dying from any of the 
four main NCDs between the ages of 30 and 70.3 Other 
relevant SDG targets include: Target 3.a on improvements 
in tobacco control; Target 3.5 on substance abuse, including 
harmful use of alcohol (discussed in Chapter 7 along with 
mental health); Target 3.b on supporting research and 
development of vaccines and medicines for NCDs that 
primarily affect developing countries, as well as providing 
access to affordable essential medicines and vaccines for 
NCDs; and Target 3.9 on deaths and illnesses related to 
hazardous chemicals, as well as air, water and soil pollution 
and contamination (addressed in chapters 2, 5 and this 
chapter). Finally, Target 3.8 addresses UHC, which has 
implications for a wide range of NCD-related promotion, 
prevention and treatment interventions (UHC within the 
SDGs is discussed fully in Chapter 3).
The SDG NCD Target 3.4 lacks specificity in terms of 
diseases. Where the SDG do identify a particular issue, it is 
generally in terms of risk factors (for example, tobacco use 
or harmful use of alcohol) rather than a particular disease. 
However, there can be little doubt about the specific NCDs 
that should be addressed, the burden of disease being very 
much concentrated in the four major diseases already cited, 
and targeted by WHO,3 the UN General Assembly4,5 and 
the UN system.6 In terms of mortality, the leading NCD is 
CVD, which claimed 17.5 million lives in 2012 (46% of all 
NCD deaths), 6 million of which were people under age 
70 (Figure 6.1).1 Of those 17.5 million deaths, 7.4 million 
were due to coronary heart disease (heart attacks) and 
6.7 million to stroke. Cancers kill around half as many 
(8.2 million, with 4.3 million under age 70), while CRD and 
diabetes accounted for 4.0 million and 1.5 million deaths, 
respectively.1 Diabetes is also a risk factor for CVD, with 
about 11% of cardiovascular deaths attributed to high blood 
glucose.7
TRENDS 
Overall, there has been a steady decline in NCD mortality 
rates in the past decade or so, with age-standardized 
rates falling 12% between 2000 and 2012 (from 613 per 
100 000 to 538 per 100 000).1 Much of the current public 
health focus is on premature mortality from NCDs, and 
this is reflected in the SDG target. Globally, the probability 
of premature death from the four main NCDs has fallen 
by 15% between 2000 and 2012 (Figure 6.2). In the high-
income OECD countries, the probability of premature death 
from the four main NCDs is particularly low, indicating 
that many more of the deaths in other countries can be 
prevented by effective public health interventions, including 
risk reduction (public health interventions) and improved 
disease management interventions.
The major factor contributing to reduced NCD mortality is 
declining CVD deaths, which have decreased in every region 
(Figure 6.3). Age-standardized CVD death rates fell 16% 
globally between 2000 and 2012. Particularly significant 
declines have occurred in low-, middle- and non-OECD 
high-income countries in the European Region – the region 
with the highest levels of NCD mortality – and in high-
income OECD countries.1 These declines have been the 
main reason for overall improvements in life expectancy in 
high-income countries.9 
Figure 6.1 
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The leading risk factor for CVD is high blood pressure.7 
Although population-level blood pressure improvements 
are a likely major contributor to declining CVD mortality 
rates in many countries, along with declines in tobacco use 
and advances in medical treatment, several countries have 
recorded increases in population-level blood pressure.10 
So not all regions are making progress at the same rate. 
Reasons for this include inadequate reduction (or even 
increase) in tobacco use, high levels of salt consumption 
and lack of access to appropriate health care, including 
effective medication such as anti-hypertensive medicines 
and statins.11
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Figure 6.3 
NCD death rates, by cause and region, 2000 and 20121,8
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By contrast, global declines in cancer mortality have been 
less striking, with only a 6% reduction in age-standardized 
rates during 2000–2012. That said, cancer covers many 
different conditions that present diverse mortality trends. 
For example, stomach cancer, a leading cause of cancer 
death for both men and women, has declined around 
20% globally since 2000. On the other hand, lung cancer 
mortality has fallen only 4% in men and has actually 
increased in women. Regional variability further complicates 
the picture, with an estimated 19% decrease in lung cancer 
mortality for men in the high-income OECD countries, 
compared to increases of greater than 15% for men in 
the South-East Asia Region, and both men and women 
in the Western Pacific Region, excluding high-income 
OECD countries. Lung cancer mortality rates are mainly 
determined by the prevalence of tobacco smoking. The 
largest overall improvement in cancer mortality during 
2000–2012 was in the high-income OECD countries, due to 
falls in lung cancer mortality in men, stomach and colorectal 
cancer in both sexes, and breast cancer mortality in women 
(even though breast cancer incidence did not decline). 
Globally, the prevalence of diabetes continues to increase.12 
The leading risk factors for type 2 diabetes are excess 
body weight and physical inactivity. Diabetes is highly 
correlated with the global prevalence of obesity, which has 
nearly doubled since 1980. In 2014, 11% of men and 15% of 
women age 18 and older were obese, while more than 42 
million children under five years were overweight in 2013.13 
It is encouraging to note, however, that a few high-income 
countries have managed to slow or halt the increase in 
obesity prevalence in children,14,15 which may eventually help 
to stabilize diabetes prevalence. In 2012, diabetes was the 
direct cause of 1.5 million deaths (4% of all NCD deaths), 
46% of which occurred under age 70.1 Apart from being a 
disease in its own right, diabetes is also a significant risk 
factor for CVD. The interlinked nature of the two diseases 
has important implications for health policy responses, as 
discussed below.  
Progress on CRD has been impressive, with a 26% decline 
in estimated age-standardized CRD mortality rates between 
2000 and 2012 and a near halving of CRD rates in the 
Western Pacific Region, excluding high-income OECD 
countries. Overall, it is estimated that CRD still accounted 
for 4 million deaths (10.7% of NCD deaths in 2012),1 with 
1.3 million of those deaths occurring under age 70. The 
reasons for these declines are not clear and some trends are 
puzzling. For example, the main known causes of the leading 
CRD, chronic obstructive pulmonary disease (COPD) are 
tobacco smoking and air pollution, but COPD mortality 
has declined even when tobacco smoking and air pollution 
have not improved.1
POSITIVE DEVELOPMENTS
NCDs are characterized by multiple, often interlinked 
chains of causation, which means that identifying the 
specific factors that have led to their decline is challenging. 
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Figure 6.2 
Probability of death from the four main NCDs (CVD, cancer, CRD and diabetes) 
between ages 30 and 70, by region and globally, 2000 and 20121,8
25
AFR
20
00
20
12
AMR
20
00
20
12
SEAR
20
00
20
12
EUR
20
00
20
12
EMR
20
00
20
12
WPR
20
00
20
12
High- 
income 
OECD
20
00
20
12
Pr
ob
ab
ili
ty
 o
f d
ea
th
 (%
)
30
35
 Target 2030 (SDG)    Target 2025
Global
20
00
20
12
0
135NONCOMMUNICABLE DISEASES
Nevertheless, important lessons have been learnt regarding 
where efforts should be focused. 
A focus on prevention: It would be difficult to overstate the 
importance of health promotion and disease prevention 
in regard to NCDs, which are associated with a number 
of risk factors that present excellent opportunities for 
interventions at the population level. Reductions in tobacco 
use and elevated blood pressure levels have undoubtedly 
been key reasons for past declines in NCD mortality in many 
countries (figures 6.4 and 6.11).10,11 
Global action: The WHO FCTC, ratified in 2005 by 180 
Parties, representing 90% of the global population, is the 
first public health treaty negotiated under the auspices of 
WHO and is designed to counter the tobacco use epidemic. 
The WHO FCTC requires its parties to implement policies 
designed to reduce both demand and supply of tobacco 
products, thus addressing social determinants of health. 
The WHO FCTC offers a model for addressing the negative 
effects of globalization on health, including the focus on 
a small number of evidence-based interventions, regular 
review of progress and country support.
Multisectoral responses: Many risk factors for NCDs relate 
to the air (and tobacco smoke) we breathe, the food and 
beverages we eat and drink, and the extent to which we 
move our bodies. NCD health gains have been achieved by 
influencing public policy in sectors such as trade, taxation, 
agriculture, urban development and food production. 
These types of policy responses are based on multisectoral 
consultation and collaboration. The Health-in-All-Policies 
approach advocated by WHO provides the foundation for 
the development of multisectoral responses to NCDs18 and 
has already been highly effective in tobacco control.19 Its 
importance is recognized by the WHO FCTC, which lists 
comprehensive multisectoral measures and responses 
among its guiding principles.
Early detection, diagnosis and treatment: Lack of awareness 
and late detection is an issue across all the leading NCDs and 
it is essential to support and develop primary health-care 
services required for their early detection and management. 
Effective, low-cost interventions are available; for example, 
cervical cancer screening using visual inspection with 
acetic acid and cryotherapy or cold coagulation treatment 
of precancerous lesions. This type of “screen-and-treat” 
programme has been successfully implemented in, for 
instance, India.20 New rapid and inexpensive tests for human 
papillomavirus detection are also becoming available.21 
Integrated approaches to NCD care: Just as multisectoral 
collaboration is fundamental to a coherent and 
comprehensive NCD response, so is integrated health care. 
For example, the monitoring of blood pressure status should 
be integrated with the monitoring of blood cholesterol and 
blood sugar. The prevention of heart attacks and strokes 
through a “total cardiovascular risk approach” is more 
cost-effective than treatment based on individual risk factor 
thresholds only and should be part of the basic package 
for UHC.13 A total risk approach has been implemented in 
several high-income countries,22 and an increasing number 
of low- and middle-income countries are also adopting it, 
training primary care workers, including family practitioners, 
to assess and manage cardiovascular risk, using tools of 
the WHO Package of Essential Noncommunicable (PEN) 
disease interventions for primary health care in low-
resource settings.23 Innovative service delivery models such 
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Trends in mean systolic blood pressure among females age 25 and older,a 1980–200816,17
a Age-standardized estimates. 
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as task sharing using community health workers for CVD 
risk assessment would free up trained health professionals 
in low-resource settings to do tasks that need high levels 
of professional training.24
CHALLENGES
Despite declines in NCD mortality, business-as-usual will 
be insufficient to meet the WHO 25-by-25 NCD mortality 
target (a 25% relative reduction in premature mortality from 
the four main NCDs by 2025),25 which can be considered 
a critical milestone for the SDG target of a one third 
reduction in premature NCD mortality by 2030. Many of 
the key challenges listed here are, effectively, inversions 
of the positive developments listed above. They include 
the following.
Lack of preventive action: While policy attention to NCDs has 
increased, too many countries continue to pay insufficient 
attention to the problem. For example, according to the 
WHO 2015 Country Capacity Survey, only 54% of countries 
reported having an operational national NCD policy with a 
budget for implementation (up from 32% of countries in 
2010).5,26 Of these, only 37% have an NCD policy or plan 
which covers all four main NCDs and four main behavioural 
risk factors.27 Where policies or plans exist, too often they 
are far from being fully funded. The effects of inadequate or 
inappropriate promotion and prevention are at least partly 
reflected in recent worldwide increases in body mass index, 
overweight (Figure 6.5) and obesity.  
Limitations in primary health care, access to medicines and 
technology: In many countries, especially those with limited 
resources, health systems lack the financing, governance, 
workforce, health information, medical products and service 
delivery capacity required to meet the demands of the NCD 
epidemic. Primary health care services for NCDs have to be 
strengthened and chronic care models adopted.29 Lessons 
learnt from management of chronic infections such as HIV 
may be useful.30
Profit-driven disease: Many of the products associated with 
the development of NCDs make companies money. The 
multi-decade tobacco control struggle is just one example 
of how difficult it is to get companies to change their ways. 
Even though tobacco smoking prevalence is declining 
worldwide and in many settings, it is likely increasing in 
some regions, specifically among men in the African Region 
and the Eastern Mediterranean Region.31 The tobacco 
industry is also fiercely challenging the implementation 
of pictorial health warnings and plain packaging in 
multiple countries, arguing that the packaging regulations 
impinge upon trademark and intellectual property rights. 
Globalization of marketing and trade offers unprecedented 
opportunities for companies to promote products leading 
to tobacco use, harmful use of alcohol, consumption of 
food that is high in fat, especially saturated and trans fats, 
sugars, and salt/sodium, and sedentary lifestyles, often 
taking advantage of the weaker regulatory frameworks in 
many low- and middle-income countries 32.
Rapid, unplanned urbanization: Unplanned or poorly managed 
urbanization brings with it many risks that have implications 
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Figure 6.5 
Trends in prevalence of overweight (BMI ≥ 25 kg/m2) among adults age 25 and older,a 1980–200828
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for NCD incidence and mortality, notably increased urban 
air pollution and sedentary lifestyles. To focus on one 
aspect: there has been little or no improvement in ambient 
air quality over the last decade, with roughly 75% of the 
global population being exposed to particulate matter in 
concentrations exceeding WHO Air Quality Guidelines in 
2012, compared to 76% between 1998 and 2000. There 
are, however, important regional variations. For example, 
in many high-income countries, including in Europe and 
North America, air pollution has decreased markedly over 
the past decades because of efforts to reduce smog-forming 
emissions and particulate matter. These gains are balanced 
by significant declines in air quality in south and east Asia, 
largely as a result of population growth, rising population 
density in the regions’ highly polluted cities, and increased 
industrialization.33 It should be noted that urbanization also 
brings economic benefits and easier access to health care 
and public health messaging, and that sound urban planning 
can mitigate the negative effects of urbanization.
Ageing populations: NCD incidence and mortality increase 
sharply with age, and both the absolute number of older 
adults and percentage of the population that is older are 
increasing in all regions (Figure 6.6). In 2012, 58% of 
NCD deaths occurred in people over 70. The strain on 
health systems will increase in the coming years as ageing 
populations drive the increases in NCD disease and mortality. 
Patients with chronic conditions commonly suffer from 
several diseases simultaneously, making their treatment 
more complex, and increasing the need for quality care.34,35
Figure 6.6 
Percentage of population over age 70 by region, 1970–2030;36 number of NCD deaths 
by region, 2000–203025 
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Inequalities: Overall declines in NCD mortality can mask 
increasing inequalities within countries.37 Where data 
are of sufficient quality to measure NCD mortality by 
socioeconomic status, those with lower status generally 
have higher mortality than those with higher status.38 In 
many countries, NCD inequalities are the most important 
source of inequalities in total mortality and life expectancy.38 
Achieving global targets for NCD will increasingly depend 
on governments’ ability to implement policies and services 
that work effectively across all social groups to achieve UHC. 
NCDs are now recognized by governments as one of the 
major challenges for development in low- and middle-
income countries in the 21st century.39 Poverty exposes 
people to risk factors for NCDs and, in turn, the resulting 
NCDs may keep people trapped in chronic poverty.
STRATEGIC PRIORITIES
The SDG target for NCDs is based on previous UN and 
WHO declarations that provide strategic direction. The UN 
Political Declaration on NCDs,39 adopted at the UN General 
Assembly in 2011 by heads of state and governments, 
included a roadmap of concrete commitments, among 
which was a commitment to establish multisectoral 
national policies and plans for the prevention and control 
of NCDs. This declaration was followed by the World Health 
Assembly in May 2013, with the endorsement of the WHO 
Global Action Plan for the Prevention and Control of NCDs 
2013–2020.3 The plan includes six key strategic objectives:
• To raise the priority accorded to the prevention and 
control of NCDs in global, regional and national agendas 
and internationally agreed development goals, through 
strengthened international cooperation and advocacy.
• To strengthen national capacity, leadership, governance, 
multisectoral action and partnerships to accelerate 
country response for the prevention and control of NCDs. 
• To reduce modifiable risk factors for NCDs and 
underlying social determinants through creation of 
health-promoting environments. 
• To strengthen and orient health systems to address 
the prevention and control of NCDs and the underlying 
social determinants through people-centred primary 
health care and UHC. 
• To promote and support national capacity for high-
quality research and development for the prevention 
and control of NCDs. 
• To monitor the trends and determinants of NCDs and 
evaluate progress in their prevention and control.
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The stated aim of the strategy is progress on nine global 
NCD targets to be attained in 2025 (Box 6.1), including the 
target of a 25% relative reduction in premature mortality 
from NCDs by 2025, that is to say an approximate doubling 
of what has been achieved since 2000. The mortality target 
is extended to a one third reduction in premature NCD 
mortality by 2030 for SDG Target 3.4. Meeting six of the 
global NCD targets (for hypertension, overweight/obesity, 
diabetes, high sodium, tobacco and alcohol use) (Box 
6.1) would go most of the way towards meeting the NCD 
mortality target.25 Action on tobacco use and raised blood 
pressure, including reducing salt intake would make the 
largest contribution to reducing NCD mortality. The SDG 
targets specify only two of the risk factors: tobacco use and 
harmful use of alcohol (see Chapter 7).
Box 6.1 
Global voluntary targets41
In May 2013, the Sixty-sixth World Health Assembly adopted the comprehensive 
global monitoring framework for the prevention and control of NCDs. This framework 
includes 25 indicators to monitor trends and assess progress made in the prevention 
and control of NCDs; nine areas were selected from the 25 indicators to be targets. All 
targets were set for 2025, with a baseline of 2010. The global voluntary targets are:
1. A 25% relative reduction in the risk of premature mortality from CVD, cancer, 
diabetes or CRD.
2. At least 10% relative reduction in the harmful use of alcohol.
3. A 10% relative reduction in prevalence of insufficient physical activity.
4. A 30% relative reduction in mean population intake of salt/sodium.
5. A 30% relative reduction in prevalence of current tobacco use.
6. A 25% relative reduction in the prevalence of raised blood pressure.
7. Halt the rise in diabetes and obesity.
8. At least 50% of eligible people receive drug therapy and counselling (including 
glycaemic control) to prevent heart attacks and strokes.
9. An 80% availability of the affordable basic technologies and essential medicines, 
including generics, required to treat major NCDs in both public and private facilities.
The first global voluntary target is closely linked to SDG Target 3.4, to reduced premature 
NCD mortality by one third by 2030.
Also central to this endeavour is the transition to UHC, 
including person-centred primary care integrating the 
WHO PEN23 interventions. This includes achieving the 
two NCD health coverage targets: (i) at least 50% of 
eligible people receive drug therapy and counselling to 
prevent heart attacks and strokes; and (ii) at least 80% 
availability of essential medicines required to treat major 
NCDs. The WHO Global Action Plan for the Prevention 
and Control of NCDs 2013–2020 also highlights the 
importance of implementing cost-effective interventions 
to combat NCDs.40 UHC provides an overall framework for 
the integration of NCD prevention and treatment services 
with other health services. 
Finally, the plan calls for promotion and support for national 
research and development capacity for the prevention and 
control of NCDs, and support for improved measurement 
and monitoring of the disease burden imposed by NCDs 
and their risk factors. At a more macro level, the plan 
underlines the importance of managing real, perceived or 
potential conflicts of interest, and the need for multisectoral 
action. It is perhaps in these last areas that we face our 
biggest challenge.
In 2014, the UN General Assembly adopted the 2014 
Outcome Document on NCDs in which ministers committed 
themselves to setting (by 2015) national targets for 2025 
and process indicators based on national situations, 
taking into account the nine global targets for NCDs.5. In 
September 2015, WHO published the WHO NCD Progress 
Monitor 201542 which provides information for each country 
related to their progress regarding these indicators based 
on data collected during the first half of 2015. The Director-
General of WHO will use the indicators to report towards 
the end of 2017 to the UN General Assembly, in preparation 
for the third UN High-level Meeting on NCDs in 2018 
to take stock of national progress in implementing the 
roadmap of commitments included in the 2011 UN Political 
Declaration and 2014 Outcome Document on NCDs.
Tobacco control is a critical measure to achieve SDG Target 
3.4 on reducing premature mortality due to NCDs, being 
one of the leading risk factors. In addition, one of the health 
targets is specifically about tobacco control: “Strengthen 
the implementation of the World Health Organization 
Framework Convention on Tobacco Control in all countries, 
as appropriate”.
The SDG means of implementation (Target 3.a) implies 
strengthening of the implementation of the WHO FCTC in 
all countries. These interventions include, among others: 
raising taxes on tobacco; banning smoking in public places; 
pictorial health warnings; bans on tobacco advertising; 
controlling illicit trade of tobacco products; identifying 
alternative crops to tobacco farming and preventing sales to 
and by minors; and collecting and sharing data on tobacco 
use and prevention efforts.
Unlike tobacco control, environmental determinants 
such as air, water and soil pollution and contamination 
and hazardous chemicals are not central to most NCD 
policies and strategies. These environmental risk factors 
are, however, receiving increasing attention, especially 
air quality, as exemplified by a recent WHA resolution 
to strengthen international cooperation to address air 
pollution. The SDGs, with air quality dimensions in at least 
three other goals, can provide a good platform for integrated 
efforts to address air pollution and other environmental 
determinants of NCDs.
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Total CVD mortality is estimated to have declined in every region, with 
the largest declines in the low-, middle- and non-OECD high-income 
countries in the European Region, and in the high-income OECD countries, 
where age-standardized mortality rates declined a staggering 35% 
in 12 years (Figure 6.7).1 Declines in CVD mortality rates ranged from 
1% to 20% in other regions, with a global average of 16%. 
POSITIVE DEVELOPMENTS
The leading risk factor for CVD is high blood pressure, which is in 
turn associated with unhealthy diets, particularly diets high in salt, 
and physical inactivity.7 Some 58% of cardiovascular deaths is 
attributable to high blood pressure.7 Common in all countries across 
the income range, and affecting both men and women, blood pressure 
is nevertheless susceptible to amelioration with well-established health 
interventions, including regular physical activity, healthy eating and 
treatment with anti-hypertensive medicines. Tobacco use is another 
major risk factor for CVD, with 30% of cardiovascular deaths caused 
by direct tobacco smoking or second-hand smoke.7
Declines in tobacco smoking, improvements in medical care and 
drug therapies, and population-level improvements in mean systolic 
blood pressure are thought to be the leading causes of declining CVD 
mortality rates in many countries.10,11 CVD mortality rates declined in 
spite of the ongoing obesity epidemic.10,43,44 The driving factors in the 
declines in CVD mortality include:
• Improvements in coronary care during and after acute events 
(myocardial infarctions) have been strongly linked to declining 
case-fatality and cardiovascular mortality.45 
• Targeted preventive treatment for high-risk patients with no history 
of coronary heart disease with anti-hypertensives and statins has 
protected the people who were most likely to die from CVD.46 
• Mean systolic blood pressure and cholesterol have declined in 
some countries, protecting the larger number of people who are 
at lower risk of dying from CVD.16,47 
• Global and country measures have resulted in declines in tobacco 
use (see specific section below) and contributed to improvements 
in cardiovascular mortality.10,11 
• Other factors such as reduced infections, nutritional and health-care 
changes, including fetal and childhood health, may have contributed 
to these declines, but further evidence is needed to substantiate 
these hypotheses.10
CARDIOVASCULAR DISEASES
More people die annually from CVD than from any other cause, with an estimated 17.5 million deaths in 
2012 (46% of all NCD deaths).13 Of these deaths, an estimated 7.4 million were due to coronary heart 
disease and 6.7 million were due to stroke. Around one third of these CVD deaths occur in adults age 
30–70, which are the focus of the global NCD and SDG targets.
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Figure 6.7 
CVD death rates, by region and globally, 2000 and 20121,8
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Despite declines in mortality, CVD remain a problem everywhere, 
including mortality due to CVD before age 70. Low- and middle-
income countries face the heaviest disease burden. The principal 
challenges faced are:
• Undetected hypertension, diabetes, and other risk factors: Prevalence 
of hypertension, blood cholesterol, and diabetes remain high in 
some regions (figures 6.8 and 6.10). People are often unaware of 
their blood pressure, blood cholesterol and blood sugar levels.48 
Undetected, these can increase the risk of premature mortality 
from CVD. 
• Lack of access to integrated health care services: People who suffer 
from CVD and other NCDs need access to effective, equitable and 
responsive health-care services, including diagnosis, medication 
and treatment, with an emphasis on continuity of care.29 
• Unhealthy diet and the food industry: Processed foods and beverages 
high in trans fats, saturated fats, sugar and salt are associated 
with increased risk of hypertension, diabetes, raised cholesterol 
and CVD. 
• Tobacco use and exposure to air pollution: (see specific sections 
in this chapter).
• Sedentary lifestyles: Increased urbanization and mechanization, 
including use of motorized transport, may be causing less physically 
active lifestyles, which have implications for cardiovascular 
health. Data on trends in overall physical activity are sparse and 
inconsistent.49
• Equity: Cardiovascular mortality rates are higher in poorer countries. 
Scaling up interventions will be challenging in settings with weak 
health systems that still have a large burden of communicable 
diseases. Within countries, people living in poorer communities 
generally have higher cardiovascular mortality than those living 
in wealthier communities.38  
STRATEGIC PRIORITIES
The 2011 UN Political Declaration on NCDs39 and the 2014 UN 
Outcome Document on NCDs5 include a roadmap of commitments 
which governments have made to reduce premature mortality from 
NCDs, which will attain the NCD-related targets included in the SDGs. 
The WHO Global Action Plan for the Prevention and Control of NCDs 
2013–20203 outlines strategic priorities and policy options on how 
governments can fulfil these commitments.
Promotion of healthy diets will be an important step towards meeting 
these targets. This implies limiting the marketing of unhealthy foods/
non-alcoholic beverages to children (per WHO recommendations), 
reducing the amount of salt consumed, increasing the consumption 
of fruit and vegetables, replacing saturated fatty acids/trans fats 
with unsaturated fatty acids, reducing free/added sugars in food and 
non-alcoholic beverages, and reducing calorie intake through smaller 
portion sizes and less energy-dense foods. The promotion of physical 
activity will be another key area of focus, including “active transport” 
(cycling and walking, supported by urban planning/transport policies 
to improve infrastructure for walking and cycling), recreation, leisure 
and sport. Quality physical education is also vital, not just in schools 
and for children, but also for people of all ages. Reducing the harmful 
use of alcohol and tobacco will also play important roles (discussed 
elsewhere). Finally, mass media campaigns can play an important 
part in changing attitudes to healthy living.
On the health systems front, a total-risk approach, which is more 
cost-effective than treatment decisions based on individual risk factor 
thresholds only,46 needs to be adopted for early detection and cost-
effective management of cardiovascular health in order to prevent 
heart attacks, strokes and other complications.23 The WHO Global 
Action Plan for the Prevention and Control of NCDs 2013–2020 sets 
the global target that at least 50% of eligible people should receive 
drug therapy and counselling (including glycaemic control) to prevent 
heart attacks and strokes. It has been estimated that scaling up a 
multidrug regimen targeted at individuals with existing CVD or who are 
at high absolute risk of CVD could avert almost 18 million deaths over 
the next 10 years in 23 low-income and middle-income countries.50
Figure 6.8 
Mean systolic blood pressure among males age 18 and older,a 201413
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Worldwide age-standardized cancer mortality improved modestly 
between 2000 and 2012, with a 6% decline overall (Figure 6.9). But 
that number masks significant regional, gender and disease type 
variations. The largest regional improvement in cancer mortality 
during 2000–2012 was in the high-income OECD region, mainly due 
to improvements in men’s lung cancer mortality, stomach cancer 
and colorectal cancer mortality in both sexes, and women’s breast 
cancer mortality. Age-standardized cancer death rates increased in 
the South-East Asia Region and the Western Pacific Region, excluding 
high-income OECD countries.
Among the leading cancers, the largest decline in mortality rates was 
observed in stomach cancer, which has declined around 20% globally 
since 2000 (Table 6.1). Cervical cancer was the only other major cancer 
with a mortality decline since 2000 exceeding 10%.
Lung cancer mortality has fallen 4% for men, but increased for 
women. There is evidence of considerable regional variability, with 
an estimated 19% decrease in lung cancer mortality for men in the 
high-income OECD countries, compared to increases of greater than 
10% for men in the South-East Asia Region and both men and women 
in the Western Pacific Region, excluding high-income OECD countries. 
Unlike CVD, total cancer mortality rates are not lowest in the high-
income OECD countries. Cancer totals mask diverse patterns in specific 
cancer types, some of which have higher incidence in wealthier 
countries (e.g. colorectal and breast cancer), while others have a 
lower incidence in such settings (e.g. stomach cancer and cervical 
cancer). Still others vary according to their main cause (e.g. lung 
cancer is mainly determined by tobacco use, which does not have a 
linear relationship with wealth). Nearly one third of cancer deaths are 
caused by five leading behavioural and dietary risks: high body mass 
index; low fruit and vegetable intake; lack of physical activity; tobacco 
use; and alcohol use.53 Chronic infections, mainly Helicobacter pylori, 
human papillomavirus, and HBV/HCV are estimated to be associated 
with around 16% of cancers worldwide (with a larger role in sub-
Saharan Africa).54
POSITIVE DEVELOPMENTS
Improved prevention: Reductions in tobacco use, as the single most 
important risk factor for cancer causing about 20% of global cancer 
deaths, have contributed to declines in cancer mortality, especially 
lung cancer.7 Several other changes in exposures and lifestyles have 
likely contributed to declines in incidence and mortality from stomach 
cancer, including reductions in salt intake coupled with increases in 
fresh fruits and vegetable consumption and improvements in hygiene 
leading to reduced infection with Helicobacter pylori.55 
Early detection, diagnosis and treatment: In high-income countries, 
declines in mortality in the face of increasing cancer incidence are 
likely a result of advanced quality health care.56,57 However, low-tech 
approaches to early detection of cancer have proven their efficacy in 
developing countries too. A prime example is cervical cancer screening 
using visual inspection with acetic acid and cryotherapy or cold 
coagulation treatment of precancerous lesions. This type of “screen-
and-treat” programme has been successfully implemented in India.58
Legislation to reduce exposure and risk behaviours: Lessons from 
cancer control measures in high-income countries show that prevention 
works, but that health promotion needs to be supported by appropriate 
legislation. For instance, the first international treaty sponsored by WHO, 
the FCTC, has been critical in reducing tobacco consumption through 
legislative actions, including those that increase tobacco taxes, which 
is one of the most effective tobacco control interventions to reduce 
consumption. Similar approaches need to be evaluated with regard to 
the consumption of alcohol, and in limiting exposure to occupational 
and environmental carcinogenic risks, including air pollution.
CANCER
In 2012, the worldwide incidence of cancer rose to an estimated 14 million new cases per year, with an 
estimated 8.2 million cancer deaths. Globally, in 2012 the most common cancers diagnosed were those of 
the lung (1.8 million cases, 13% of the total), breast (1.7 million, 11.9%) and colon (1.4 million, 9.7%). The 
most common causes of cancer death were cancers of the lung (1.6 million, 19.4% of total cancer deaths), 
liver (0.7 million, 9.1%) and stomach (0.7 million, 8.8%).51 For some cancer types such as lung cancer, 
incidence rates are similar to death rates, indicating that most diagnosed cases end in death, while other 
cancer types, such as breast or cervical cancer, are less likely to be fatal and can be diagnosed early and 
effectively treated.
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Figure 6.9 
Cancer death rates, by region and globally, 2000 and 20121,8 
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Lack of access to effective, timely diagnosis and treatment: In the 
absence of effective early detection programmes such as cancer 
awareness or screening, patients are diagnosed at very late stages 
when curative treatment is no longer an option. Population-based 
screening methods have been implemented for cancer of the cervix, 
breast and colon-rectum in some high-income countries. Screening, 
however, is not widely implemented as the necessary resources 
are not available in most regions. Furthermore, diagnostic services 
including histopathology and treatment access are poor in many 
low- and lower-middle-income countries, resulting in high cancer-
related mortality. Immediate investment in human resources, health 
services and sustainable supply chains are needed to provide timely 
diagnosis and treatment.
Profit-driven disease: Many of the product consumption risks associated 
with the development of cancers are found in high-sodium processed 
foods and alcoholic beverages, both of which make companies 
money.59 The sale of tobacco is also extremely profitable. Challenging 
the production and distribution of profit-generating carcinogens is a 
major challenge for all countries.
Sedentary lifestyles: Physical inactivity increases the risk of several 
cancers, both directly60 and as a result of increased body mass index 
(BMI).61
Spiralling costs: The financial cost of dealing with the growing cancer 
burden is damaging the economies of even the richest countries. In 
2010, the total annual economic cost of cancer was estimated to reach 
approximately US$ 1.16 trillion.56 The costs of treatment for individuals 
can be prohibitive, resulting in forgoing treatment or catastrophic 
medical expenses. At the country level, failing to invest in basic cancer 
management can result in billions of dollars of economic loss.62 
Lack of palliative care: Moderate to severe cancer pain is suffered by 
over 80% of cancer patients in the terminal phase.63 Effective public 
health strategies, comprising community- and home-based care, 
and including improved access to oral morphine are thus essential.
STRATEGIC PRIORITIES
Cancer prevention and control efforts programmes are a critical 
component for the achievement of the SDG target reduction in premature 
mortality due to NCDs. The SDG also includes several other targets 
that aim to reduce the exposure of people to carcinogens by creating 
a healthier environment with less pollution and contamination of air, 
water and soil (for example, Target 3.9).
As this brief outline indicates, any cancer response will need to be 
carried forward on multiple fronts. WHO and the International Agency 
for Research on Cancer (IARC) are collaborating with other UN agencies 
on the UN Noncommunicable Diseases Interagency Taskforce (2014) 
to increase political commitment for cancer prevention and control. 
Efforts are focusing on coordinating and conducting research on the 
causes of human cancer and the mechanisms of carcinogenesis, as 
well as on the monitoring of the cancer burden (as part of the work 
of the Global Initiative on Cancer Registries). 
Going forward, it will be imperative to develop proven strategies for 
cancer prevention and control, and to generate new knowledge, and 
disseminate existing knowledge to facilitate the delivery of evidence-
based approaches. It will also be essential to develop standards 
and tools to guide the planning and implementation of interventions 
for prevention, early detection, treatment and care, and to provide 
technical assistance for rapid, effective transfer of best practice 
interventions to developing countries. Implementation of WHO toolkits, 
such as the WHO Package of Essential Noncommunicable Diseases 
Interventions, will improve service delivery throughout the health 
sector by promoting early detection and effective management.23 
Finally, countries themselves need to increase efforts to strengthen 
health systems at national and local levels to ensure early diagnosis 
and deliver care for cancer patients.
Table 6.1 
Six leading cancer causes of death globally, by sex, 2012, and trends in the death rates globally and by region, 2000–20121,52 
Global 
2012 
rank Cancer type Global AFR AMR SEAR EUR EMR WPR
High-
income 
OECD
Females
1 Breast cancer -8
2 Trachea, bronchus, lung cancers 9
3 Colon and rectum cancers -8
4 Cervix uteri cancer -12
5 Stomach cancer -21
6 Liver cancer 7
Males
1 Trachea, bronchus, lung cancers -4
2 Liver cancer -2
3 Stomach cancer -20
4 Colon and rectum cancers -7
5 Prostate cancer -8
6 Oesophagus cancer -8
  ASDR decreased by more than 5%
  ASDR increased by more than 5%
  Between -5% and 5% change in ASDR
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It is estimated that 9% of adults age 18 years and older has diabetes 
(Figure 6.10).13 The prevalence of diabetes is highest in the Eastern 
Mediterranean Region (14% for both sexes) and lowest (including 
high-income countries) in the European Region and the Western 
Pacific Region (8% and 9% for both sexes, respectively).13 In addition 
to the 1.5 million deaths for which diabetes was the underlying cause 
of death in 2012, diabetes was also a contributing factor for many 
deaths from CVD.1 
Improvements in diabetes epidemiology are hard to come by: diabetes 
prevalence increased in most regions of the world in recent years, 
and has not decreased in any region.12 Similarly, the prevalence of 
obesity has nearly doubled since 1980, with no decrease recorded in 
any region.12 It is encouraging to note that a few high-income countries 
have documented a levelling off of obesity prevalence in children,14,15 
which may eventually stabilize diabetes prevalence. Elsewhere, obesity 
is continuing to increase.
POSITIVE DEVELOPMENTS
Given the lack of progress in reducing obesity and diabetes prevalence, 
it would be inappropriate to talk of success. However, there is good 
evidence that type 2 diabetes can be prevented by adopting a healthy 
diet, engaging in regular physical activity and maintaining a normal body 
weight.67,68,69,70 Early diagnosis, which can be accomplished through 
relatively inexpensive blood testing, and appropriate treatment help 
to avoid complications. 
DIABETES
Type 2 diabetes accounts for 90% of diabetes cases,64 and is largely the result of excess body weight 
and physical inactivity. Previously only seen in adults, type 2 diabetes is now also occurring in children 
as a result of increasing childhood obesity and overweight.13 Over time, hyperglycaemia in uncontrolled 
diabetes leads to serious damage to many of the body’s systems. It increases the chance of foot ulcers and 
infection (which may eventually lead to limb amputation) and also increases the risk of blindness, heart 
disease and stroke.65 The overall risk of premature death among people with diabetes is at least double the 
risk of their non-diabetic peers.66
Figure 6.10 
Prevalence of raised fasting blood glucosea among people age 18 and older,b 2014113   
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Diabetes is an increasing challenge in all countries; the following are 
some contributing factors.
Unhealthy diet and the food industry: Processed foods and beverages 
that are high in sugar are associated with obesity which increases 
the risk of diabetes. 
Lack of political engagement: According to the WHO 2015 Country 
Capacity Survey, 72% of countries reported having an operational 
diabetes policy, strategy or action plan.27 Where a policy or plan is in 
place, too often it is not fully funded.
Lack of diabetes prevention: Nutrition and physical activity policies 
are also lacking, with just over half of countries reporting that they 
have operational policies.
Lack of timely diagnosis and appropriate diabetes treatment: Diabetes 
is frequently undetected.71,72,73 Once it is diagnosed, management of 
diabetes is complex and multifaceted, including a healthy lifestyle, 
self-management skills and frequent need for several medicines. 
Even in high-income settings the management of diabetes is often 
inadequate. In low-resource settings, essential medicines are frequently 
unavailable or unaffordable. 
Lack of monitoring and surveillance: Ability to measure and track 
the full extent of the diabetes epidemic is crucial to setting targets 
and monitoring progress. Some countries are only just beginning to 
monitor and collect data formally.
STRATEGIC PRIORITIES
Diabetes control is part of Target 3.4 on reducing premature mortality 
due to NCD by 2030. To push back against the twin epidemics of 
obesity and diabetes, a multisectoral population-based approach is 
required, focusing on prenatal and childhood health actions targeting 
the most vulnerable groups. This is acknowledged in the 2011 UN 
Political Declaration on NCDs4 and the WHO Global Action Plan for the 
Prevention and Control of NCDs 2013–20203 outlines the strategic 
priorities.
Policies should simultaneously address different sectors that contribute 
to the production, distribution and marketing of food, while concurrently 
supporting the development of a culture of healthy physical activity.74,75,76 
However, it is also important to develop the health services required 
to treat the associated health risks, notably the primary health-care 
services required for early detection and management. Treatment of 
diabetes involves lowering blood glucose and the levels of other known 
risk factors that damage blood vessels. Moderate blood glucose control 
is both cost saving and feasible in developing countries. People with 
type 2 diabetes can be treated with oral medication, but may also 
require insulin injections. Blood pressure and lipid control, foot care 
and screening for microvascular complications are an integral part 
of diabetes management.23 Regular monitoring of the prevalence of 
obesity and diabetes should also be instituted as part of routine NCD 
surveillance.
The setting of an international target for diabetes, such as “to halt 
the rise in diabetes and obesity”,3  is of tremendous significance for 
the global diabetes community and hopefully heralds a new era of 
diabetes action.
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The global prevalence of tobacco smoking among people age 15 years 
and older is estimated to have declined from 27% in 2000 to 21% in 
2013.79 Globally, smoking prevalence declined in both men and women. 
Declines were largest for men in the high-income OECD countries, 
and in low-, middle- and non-OECD high-income countries in the 
European Region and the Region of the Americas (all with declines of 
around 10%) (Figure 6.11).
POSITIVE DEVELOPMENTS
Global action: The WHO FCTC has stimulated many countries to 
implement tobacco control measures. The WHO FCTC Secretariat, 
civil society and WHO have been instrumental in advocating for and 
operationalizing of the FCTC into country tobacco control policies and 
programmes (Box 6.2).
Reducing demand: In 2008, WHO identified six evidence based tobacco 
control measures that are the most effective in reducing tobacco use, 
to assist countries with implementing selected WHO FCTC obligations. 
Known as MPOWER, these measures that correspond to one or more 
of the demand reduction provisions of the WHO FCTC are: 
• Monitoring tobacco use and tobacco control policies;
• Protect people from tobacco use; 
• Offer help to quit tobacco use; 
• Warn about the dangers of tobacco; 
• Enforce bans on tobacco advertising, promotion and sponsorship; 
• Raise taxes on tobacco. 
Today, more than half of the world’s countries, representing nearly 
40% of the world’s population – 2.8 billion people – has implemented 
at least one of these tobacco control demand reduction measures at 
the highest level of achievement (Figure 6.12).19 This progress more 
than doubles the number of countries and nearly triples the number 
of people covered since 2007.
Specific actions by countries: There has been steady progress in 
global tobacco-control efforts in recent years, both in terms of the 
number of countries protecting their people and the number of people 
worldwide protected by effective tobacco-control measures. By 
2014, 49 countries had introduced comprehensive, smoke-free laws 
covering all public places and workplaces; 24 countries were offering 
adequate help to quit tobacco use; 42 countries had mandated large 
graphic warning labels on their cigarette packaging; 29 countries 
had a comprehensive ban on all tobacco advertising, promotion and 
sponsorship, and 33 countries had taxes representing 75% of the price 
of a packet of cigarettes. These achievements were realized in the 
face of interference and threats from the tobacco industry. Success 
depended on high level political leadership in government and civil 
society support to champion tobacco control efforts. 
TOBACCO USE
It is estimated that there are 1.1 billion tobacco smokers worldwide.19 In 2013, high-income OECD 
countries accounted for around 200 million smokers, and non-OECD countries accounted for 900 million 
smokers. Tobacco use currently causes almost 6 million deaths per year. More than 5 million of those 
deaths are the result of direct tobacco use77, while over 600 000 deaths are the result of non-smokers 
being exposed to second-hand smoke (including 170 000 deaths among children).78 Other types of tobacco 
use, such as chewing tobacco or snuff, cause additional cancer deaths.
Box 6.2 
WHO FCTC
The WHO FCTC, ratified by 180 Parties – representing 90% of the global population 
– is the first public health treaty negotiated under the auspices of WHO and is 
designed to counter the tobacco epidemic. The WHO FCTC requires its Parties to 
implement policies designed to reduce both demand and supply of tobacco products 
thus addressing social determinants of health. These interventions include, among 
others, raising taxes on tobacco; banning smoking in public places; pictorial health 
warnings; bans on tobacco advertising; controlling illicit trade of tobacco products; 
identifying alternative crops to tobacco farming and preventing sales to and by 
minors, and collecting and sharing data on tobacco use and prevention efforts. In 
February 2015, Parties to the FCTC celebrated 10 years of its entry into force. The WHO 
FCTC offers a model for addressing the negative effects of globalization on health.
Figure 6.11 
Prevalence of tobacco smoking among people age 15 years and older, by region 
and sex, 2000–20258,80
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CHALLENGES
Increasing use in some regions: Even though tobacco smoking 
prevalence is declining worldwide and in many countries, it appears 
to be increasing in the African Region and the Eastern Mediterranean 
Region.31 In the European Region, the Western Pacific Region and the 
South-East Asia Region, prevalence of tobacco smoking is still high 
and efforts must be intensified to reduce it. Other forms of tobacco 
use also need to be addressed. 
Industry interference and industry tactics: The tobacco industry is 
fiercely challenging the implementation of pictorial health warnings 
and plain packaging in multiple countries, arguing that the packaging 
regulations impinge upon trademark and intellectual property rights. 
International trade and investment agreements are being used by the 
tobacco industry to challenge tobacco control measures in countries. 
New products, including Electronic Nicotine Delivery Systems (ENDS), 
and the growth in the use of existing products in new settings, such 
as water pipes, are presenting new challenges to tobacco control 
policymakers and regulatory bodies. 
Illicit trade: Illicit trade is a significant challenge to the reduction of 
tobacco use: one in 10 tobacco products available worldwide has been 
illicitly traded. Contraband cigarettes not only reduce governments’ 
tax revenues, but are also more affordable to vulnerable populations 
such as youth and low-income groups. In some instances, illicit trade 
has been supported by tobacco companies as a way of getting a 
foothold in markets.
Farmers and agriculture: Supply reduction cannot be forced upon 
farmers who depend on tobacco crops for their livelihoods. However, 
economically viable alternative crops should be explored: tobacco 
growing is harmful to health in itself,82 and support needs to be available 
for farmers wishing to switch to alternative crops.
Equity: An analysis of the association between smoking prevalence 
and wealth within countries, using survey data from 2002 to 2004 
in 48 low- and middle-income countries, found that current smoking 
was generally more prevalent in the poorer wealth quintiles, with the 
exception of women in some middle-income countries.83
STRATEGIC PRIORITIES
Tobacco control is a critical measure to achieve SDG Target 3.4 on 
reducing premature mortality due to NCD, being one of the leading 
risk factors for NCD. In addition, one of the health targets is specifically 
about tobacco control: “Strengthen the implementation of the World 
Health Organization Framework Convention on Tobacco Control in all 
countries, as appropriate”.
The MPOWER measures for tobacco control, in line with the WHO FCTC, 
are listed in the WHO Global Action Plan for the Prevention and Control 
of NCDs 2013–2020,3 including the most cost-effective interventions 
(“best buys”) for tobacco control.84 Evidence shows that the most 
cost-effective reduction measures for reducing tobacco use are:  
• reducing the affordability of tobacco products by increasing tobacco 
excise taxes; 
• creating by law completely smoke-free environments in all indoor 
workplaces, indoor public places and public transport; 
• alerting people to the dangers of tobacco and tobacco smoke 
through effective health warnings and mass media campaigns; 
• banning all forms of tobacco advertising, promotion and sponsorship. 
The measures are far more likely to be effective where implemented 
as part of a comprehensive approach, as envisaged by the WHO 
FCTC. Full implementation of the WHO FCTC involves adopting other 
demand reduction measures such as helping tobacco users to quit and 
regulating tobacco products. These provisions should be implemented 
via national tobacco control legislation and countries should ensure 
effective law enforcement. Integrating the implementation of the WHO 
FCTC with national health and development strategies and plans is 
also fundamental. Because tobacco control is a multisectoral issue, it 
requires an increase in multisectoral discussions and actions, including, 
for example, setting up and financing a functional multisectoral 
coordination mechanism, a focus on the relation between tobacco 
control and international trade or alternative livelihoods for tobacco 
farmers. When implementing the WHO FCTC, the infrastructures and 
capacities dedicated for broader tobacco control efforts should be 
integrated with other communicable and NCD programmes, such as 
for tuberculosis or respiratory diseases. 
Figure 6.12 
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TRENDS 
Indoor and outdoor air pollution are jointly responsible for about 7 million 
premature deaths annually (Figure 6.13),86 the vast majority occurring 
in low- and middle-income countries. Worldwide, 3.7 million premature 
deaths were attributable to outdoor pollution in 2012. About 88% of 
these deaths occurred in low- and middle-income countries, which 
represent 82% of the world population. The South-East Asia Region 
and the Western Pacific Region bear most of the burden of outdoor 
air pollution with 936 000 and 1.74 million deaths, respectively.87
Between 1980 and 2012, there was a significant decrease in the 
proportion of households primarily relying on solid fuels for cooking, 
the fraction dropping from 62% in 1980 to 41% in 2012.88 However, 
the absolute number of people relying on solid fuel use primarily for 
cooking has remained relatively constant over the last three decades 
at around 3 billion people. One of the most striking success stories 
for household air pollution is in China, where a national improved 
cookstoves programme distributed over 130 million improved chimney 
cookstoves in the 1990s. This programme led to a decreased risk of 
lung cancer, COPD and pneumonia in adults.89
Little or no improvement in outdoor air quality has been made over the 
last decade. In 2012, roughly three quarters of the global population 
was exposed to particulate matter in concentrations exceeding WHO Air 
Quality Guidelines, a figure that remained unchanged since 1998–2000 
(Figure 6.14). There are, however, important regional variations. For 
example, in many high-income countries, including in Europe and North 
America, air pollution has decreased markedly over the past decades 
due to efforts to reduce smog-forming emissions and particulate 
matter. These gains are balanced by significant declines in air quality 
in south and east Asia, largely as a result of population growth (and 
increasing population density in the regions’ highly polluted cities) 
and increasing industrialization.33
POSITIVE DEVELOPMENTS
Clean air policies: Air pollution levels can be reduced through 
investments in sustainable policy options for transport (including mass 
transit development and encouraging walking and cycling), clean and 
renewable energy, energy efficient buildings, waste reduction and 
recycling (to avoid the burning of solid and agricultural waste) and 
energy efficient industry. The use of health impact assessments and 
cost–benefit analysis of the policies has stimulated the selection of 
policy options that are most beneficial for air quality and for health. 
Norms and standards: National and international emissions benchmarks 
have created a level playing field that has enabled industry to develop 
and use more efficient and less polluting products. Examples include 
internationally recognized air pollution targets, clean fuel standards 
and emission rates targets for household fuel combustion,91 all of 
which have helped guide the development and implementation of 
effective policies.
Tracking progress, monitoring and evaluation: Comparative risk 
assessment estimates have been a major factor in raising awareness 
and motivating the engagement of development actors. Databases on 
household energy, household air pollution92 and ambient air quality 
in cities93 are integral to the design, implementation and monitoring 
of policies and interventions to reduce air pollution, and serve as key 
information resources for robust disease burden estimates and global 
initiatives on energy and climate. 
Partnerships and conventions: International initiatives, such as the UN 
Secretary-General Sustainable Energy for All Initiative, the Climate and 
Clean Air Coalition, the Convention on Long-Range Transboundary Air 
Pollution, the Partnership for Clean Indoor Air, the Global Alliance for 
Clean Cookstoves, and the Partnership for Clean Fuels and Vehicles, 
have spurred major actions with benefits for air quality and health.
AIR POLLUTION
SDG Target 3.9 aims to reduce deaths and illnesses from hazardous chemicals and air, water and soil 
pollution and contamination. Exposure to air pollution is discussed here because of its strong link to NCDs; 
water-related issues are discussed in Chapter 5, and other environmental risks in Chapter 2. Exposure 
to indoor (household, due to burning of solid fuels such as wood and charcoal) and outdoor (ambient) air 
pollution is a major risk factor for NCDs such as heart disease, stroke, COPD and lung cancer. Exposure to 
indoor air pollution is particularly high among women and young children, who spend the most time near 
the domestic hearth.85
Figure 6.13 
Distribution of 7 million deaths attributable to the joint effects of household and 
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CHALLENGES
Air pollution remains a problem everywhere, but low- and middle-
income countries carry the greatest air pollution burden. The following 
are the principal challenges to be faced.
• Uncontrolled urban expansion: Cities are growing fast, but most 
in an uncontrolled manner or based on outdated models of urban 
development that lead to pollution and ill-health. Sustainability and 
a Health-in-All-Policies18 approach need to be mainstreamed into 
urban development. 
• Lack of multisectoral policy-making: Working across the many 
sectors that relate to health and air pollution presents challenges. 
The polluting sectors are largely unaware of the potential health 
benefits cleaner policies could bring, and the health sector often lacks 
access to the knowledge, tools and skills to support multisectoral 
action to tackle air pollution. 
• Lack of finance for research and development: Resources are needed 
to support investments in technology improvements to tackle the 
sources of air pollution in low- and middle-income countries. 
• Lack of monitoring: Comprehensive monitoring of air pollutants and 
their sources is still lacking in many countries, limiting decision-
makers’ ability to assess risk, set targets and measure progress. 
• Exposure to and health burden from air pollution: Both of these are 
highest in low-and middle-income countries where governments 
are faced with many other competing health and development 
challenges and limited resources. 
STRATEGIC PRIORITIES
The SDG targets pay considerable attention to the need to address air 
quality, as part of a target on the health consequences of contamination 
and pollution under the health goal (Target 3.9) and as a component 
of several other goals such as those on safe, sustainable cities and 
human settlements (SDG 11), sustainable energy (SDG 7),sustainable 
industrialization (SDG 9), and combating climate change (SG13). In May 
2015, the World Health Assembly resolution “Addressing the health 
impacts of air pollution”, adopted unanimously by the 194 Member 
States, aimed to further strengthen efforts and international cooperation 
to address air pollution. Key strategic priorities for the future include: 
developing new energy efficient and affordable technologies such as 
induction stoves that can reduce household air pollution and related 
health risks; strengthening health sector capacity to contribute to 
multisectoral policy-making that benefits health and air quality; and 
improving the monitoring of air quality and identification of pollution 
sources, including through satellite remote sensing, portable monitors, 
data mining and crowd sourcing.
Figure 6.14 
Exposure to particulate matter with an aerodynamic diameter of 10 µm or less (PM10) in 1600 urban areas,a 2008–201390
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SUMMARY
Unlike the MDGs, the SDGs include mental health and substance use disorders that, together with neurological and 
developmental disorders, are responsible for over 10% of the global disease burden.  
SDG Target 3.4 calls for the promotion of mental health and well-being. Depression and suicide take a major toll on the 
health of the population. Nearly one in 10 people in the world suffer from a mental disorder. An estimated 804 000 
deaths due to suicide occurred worldwide in 2012. Treatment coverage for mental disorders is very poor in many countries 
and significant scale-up will be required. Evidence-based guidelines for the management of depression and suicide are 
available, and the WHO Mental Health Action Plan 2013–2020 calls for a 20% increase in service coverage for severe 
mental disorders.
Dementia has become a major global health issue because it affects many people and their families (it is estimated that over 
46 million people are living with dementia in 2015, a number expected to reach almost 75 million by 2030) and imposes 
major financial costs on societies (globally US$ 604 billion in 2010). Momentum is gathering with regard to the need 
to understand the causes of dementia and to develop appropriate prevention strategies and treatments. A broad public 
health approach is needed to improve the care and quality of life of people with dementia and family caregivers, articulated 
in a stand-alone dementia policy or plan, or integrated into existing health, mental health or old-age policies and plans.
SDG Target 3.5 calls for strengthening the prevention and treatment of substance abuse, including narcotic drug abuse and 
harmful use of alcohol. Almost 2% of the global burden of disease is estimated to be associated with alcohol and other 
substance use disorders. Alcohol use is one of the major risks for NCDs and a target of reducing harmful use by 10% over 
the next 15 years has been set. The WHO global strategy on reducing the harmful use of alcohol calls for national policies 
to strengthen the public health response to harmful use and build capacity for prevention and treatment of substance use 
disorders and associated health conditions. 
In 2013, some 27 million people worldwide suffered from drug use disorders; almost 50% injected drugs, and an estimated 
1.65 million were living with HIV. Since 2006, the number of people using illicit drugs has increased by 38 million, reaching 
246 million in 2013. The number of problem users has remained fairly constant at 27 million since 2008. Treatment 
coverage for drug use disorders continues to be low. A special session of the UN General Assembly will be held in 2016 
to address the world drug problem.
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29. In both cases, the burden declines rapidly after age 
50, although alcohol use disorders continue to impose a 
significant disease burden up to age 70 and older. Harmful 
use of alcohol is among the top five risk factors contributing 
to the global burden of disease. Alcohol-attributable disease 
burden, which includes but is not limited to, alcohol use 
disorders, amounts to 5.1% of the global burden of disease 
and injury. Illicit drug use continues to constitute a serious 
threat to public health and to people’s safety and well-
being – particularly that of children, young people and their 
families.
 Alcohol use disorders    Drug use disorders   
Figure 7.3 
DALYs for substance use disorders by region and globally, 20121,2
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Needless to say, the burden imposed by mental and 
substance use disorders, goes beyond the immediate health 
impact of the diseases themselves, notably in terms of the 
responsibilities shouldered by family members in care-
giving roles. Mental and substance use disorders also have 
an important economic impact. According to one recent 
study, the total economic output lost to these disorders in 
2010 alone was US$ 8.5 billion worldwide, an annual sum 
expected to nearly double by 2030, barring a concerted 
response.5 Concerning economic costs attributable to 
alcohol use and alcohol use disorders alone, a separate 
study estimated a loss equivalent to 1.3–3.3% of GDP in 
a range of high- and middle-income countries, with over 
Mental disorders, including dementias, are among the 
leading causes of disease worldwide, accounting for around 
6.2% of the total disease burden as measured in DALYs.1 The 
burden of mental disorders, including dementia, is highest 
in the high-income OECD countries, partly reflecting the 
higher proportion of elderly people in the population relative 
to other countries (Figure 7.1). Low-, middle- and non-OECD 
high-income countries in the Region of the Americas, the 
European Region, and the Eastern Mediterranean Region 
also carry burdens above the global DALYs average. 
In terms of years of life lived with disability (YLD), mental 
disorders impose an even greater burden, over one fifth of 
YLD being due to this cause. A large proportion of mental 
disorders is caused by depression and anxiety and people 
between age 15 and 59 are most affected.  
Figure 7.1 
DALYs for mental disorders by region and globally, 20121,2
 Unipolar depressive disorders    Bipolar disorder    Schizophrenia    Anxiety disorders 
 Eating disorders    Pervasive developmental disorders    
 Childhood behavioural disorders    Idiopathic intellectual disability    
 Other mental and behavioural disorders    Alzheimer’s disease and other dementias
DA
LY
s 
pe
r 1
00
 0
00
 p
op
ul
at
io
n
AFR High- 
income 
OECD
AMR SEAR EUR EMR WPR
3500
1000
500
2000
1500
3000
2500
0
Global
The level of premature mortality among people living 
with mental disorders is more than twice that of those 
without mental disorders.3 The main causes are suicide 
and unaddressed physical health conditions such as 
cardiovascular disease, aggravated by poor access to and 
quality of health-care services, lifestyle factors and other 
social determinants of health such as poverty. In 2012, there 
were over 800 000 estimated suicide deaths worldwide 
with suicide rates varying considerably by region and by 
sex (Figure 7.2).4
Approximately 1.8% of the worldwide disease burden is 
attributable to substance use disorders (1.2% to alcohol 
use disorders and 0.6% to drug use disorders). The burden 
due to substance use disorders varies considerably by 
region (Figure 7.3). For example, the DALY rate for the 
low-, middle- and non-OECD high-income countries in 
the European Region is five times higher than that of the 
Eastern Mediterranean Region, where the consumption of 
alcohol is banned in many countries. The disease burden 
peaks between ages 30 and 49, while the burden of drug 
use disorders occurs maximally between ages 15 and 
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Suicide death rates by region, 20121,2
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two thirds of the loss accounted for by lost productivity.6 
The global cost of dementia was estimated to be US$ 604 
billion in 2010.7 
Despite their significance as public health issues in all 
regions, mental and substance use disorders did not figure 
in the MDGs. The SDGs, on the other hand, address the 
issues as part of the broader NCD target (3.4), which calls 
for efforts to promote mental health and well-being, and 
in Target 3.5, which explicitly targets substance abuse 
and focuses on narcotic drugs and harmful use of alcohol 
(Figure 7.4). In addition, the UHC target (3.8) has clear 
implications for the provision of effective health promotion, 
illness prevention, curative, rehabilitative and palliative 
interventions to all people living with mental and substance 
use disorders.
Figure 7.4 
MDG and SDG targets related to mental and substance use disorders
MDG
No MDG target for either 
mental health or substance 
use disorders
SDG
SDG Target 3.4
By 2030, reduce by one 
third premature mortality 
from noncommunicable 
diseases through prevention 
and treatment and promote 
mental health and well-
being
SDG Target 3.5
Strengthen the prevention 
and treatment of substance 
abuse, including narcotic 
drug abuse and harmful use 
of alcohol
TRENDS
There was a 9% decrease in the estimated global number 
of suicides between 2000 and 2012.1 The global age-
standardized suicide rate fell by 26% over the same period, 
and has declined in all regions except the African Region, 
among men in the Eastern Mediterranean Region, excluding 
high-income OECD countries, and women in the high-
income OECD countries.
With regard to depression, while it is known to be common, 
data are not adequate to provide reliable estimates of 
global and regional trends. Treatment coverage is low. 
According to an analysis of the World Mental Health 
Surveys, even in high-resource settings, only 50% of 
people living with depression get any treatment, and about 
40% get treatment that would be considered to be only 
minimally adequate.8,9
The number of people living with dementia worldwide 
has been increasing during the past decades, linked with 
the rapidly ageing world population. It is estimated that 
there were over 46 million people living with dementia in 
2015, a number that is expected to almost double every 
20 years.10 There are marked differences in the levels of the 
incidence of dementia between regions, with high-income 
countries having much higher incidence rates than low-
income countries.
Data availability for alcohol use has only recently improved, 
and past global and regional trends are difficult to assess. In 
2012, about 6% of all deaths worldwide was attributable to 
the consequences of alcohol consumption, with a significant 
proportion of those deaths being due to cardiovascular 
diseases and injuries. It has been estimated that 38% of 
the world population age 15 or older had drunk alcohol in 
the past 12 months, and 16% engaged in heavy episodic 
drinking.11 
The estimated number of people using illicit drugs has 
increased by 38 million to 246 million over the period of 
2006–2013, while the number of problem users, who use 
drugs in a high-risk manner, has remained fairly constant at 
27 million since 2008. Almost half of problem users (12.2 
million) injects drugs, and an estimated 1.65 million have 
been infected with HIV, also as a result of unsafe injection 
practices such as needle sharing in 2013.12
POSITIVE DEVELOPMENTS
A major reason for the progress in some areas has been the 
increasing recognition of the importance of mental health 
and well-being, as well as healthy lifestyles, for successful 
human, social and economic development. Not only has the 
motto of “no health without mental health” struck a chord 
with national health ministries and international partners, 
but the consequences of inaction for economic growth are 
now better appreciated by public policy-makers. 
From the landmark 2001 World Health Report on mental 
health,13 the publication of two Lancet series drawing 
attention to the fact that up to nine out of 10 people living 
with mental disorders do not get even basic care in many 
countries around the world,14,15 to the launch of the WHO 
Mental Health Gap Action Programme (mhGAP)16 and the 
Grand Challenges in Global Mental Health supporting new 
research, there has been an important sharpening of focus 
on mental disorders. A major milestone was reached with 
the development and endorsement of the WHO Mental 
Health Action Plan 2013–2020 by Member States.17 Other 
milestones include the development and endorsement of 
the WHO global strategy to reduce the harmful effects of 
alcohol in 2010,18 and the development and implementation 
of the joint WHO and United Nations Office on Drugs 
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and Crime (UNODC) Programme on Drug Dependence 
Treatment and Care (currently operational in more than 
15 less-resourced countries), as well as the generation 
of new WHO guidelines and tools on identification and 
management of substance use disorders.19,20,21,22,23
Mental disorders were not included in the WHO Global 
Action Plan for the Prevention and Control of NCDs 2013–
2020 or the political declaration arising from the United 
Nations High-level Meeting on NCDs.24 Their absence in 
these strategically important documents was a factor in the 
decision of a number of WHO Member States to push for 
the development of a dedicated WHO action plan on mental 
health.17 The political declaration, however, recognized the 
important contribution of harmful use of alcohol as one of 
the four major risk factors for NCDs and the WHO Action 
Plan for the Prevention and Control of NCDs 2013–2020 
reinforced the WHO global strategy by calling for at least 
a 10% reduction by 2025 in the harmful use of alcohol 
compared to 2010. The UN General Assembly has also 
passed a resolution to hold a special session on the world 
drug problem in 2016.
Progress is also being driven by the emerging global 
consensus regarding which evidence-based interventions 
should be singled out for prioritized scale-up, based 
on an analysis of their cost-effectiveness, affordability 
and feasibility. For example, evidence that the cost of 
delivering a treatment package for conditions such as 
depression, bipolar disorder and schizophrenia would 
require only a modest investment is driving the scale-
up of key interventions.25,26 Similarly, evidence regarding 
the effectiveness of task sharing by non-specialist health 
workers working with specialist mental health professionals 
is suggesting new approaches to health workforce capacity 
development.27,28,29 
WHO has supported these trends by providing guidance 
regarding interventions for mental, neurological and 
substance use disorders in non-specialized health 
settings,30 which presents a series of protocols and tools 
which are currently being implemented to a greater or 
lesser extent in over 80 countries.31 There has also been a 
substantial increase in the funding of global mental health 
research, about US$ 50 million in the last five years alone, 
which has enabled the generation and dissemination of 
new evidence on the impact and viability of a range of 
intervention strategies for addressing mental disorders 
in low- and middle-income countries.32,33 That national 
governments are also taking note is borne out by the most 
recent WHO Mental Health Atlas survey,34 which shows 
that over two thirds of countries now have a specific policy 
or plan for mental health, and that over half have a stand-
alone mental health law. 
There has also been progress on the monitoring front, 
notably with regard to the epidemiology of mental 
disorders using common instruments for assessment and 
consistent analytical methods; several major multicountry 
initiatives are in progress.35 These studies have provided 
more comparable estimates of the extent, distribution 
and nature of mental disorders in all regions of the world, 
thereby helping to define the burden better, and have 
also contributed to better classification of mental health 
conditions.36,37,38,39
CHALLENGES 
Despite the achievements mentioned above and the factors 
that have contributed to the successes, several significant 
challenges remain. 
Lack of funding: While the political will to invest in mental 
health continues to grow, it is still far from adequate. Public 
spending on mental health continues to be very low at 
2% or less of total health-care spending in most low- and 
middle-income countries, or less than US$ 2 per capita.35 
This funding is mainly spent on inpatient care. Similarly, 
while development assistance for mental health increased 
between 2007 and 2013, both in relative and absolute 
terms, reaching US$ 134 million annually on average, as a 
proportion of overall development assistance for health it 
was less than 1%.40
Global dementia epidemic: Prevalence and incidence 
projections indicate that the number of people with 
dementia will continue to grow, particularly among the 
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oldest old, and countries in demographic transition will 
experience the greatest growth.7 The huge cost to health 
systems will be just one aspect of the challenge faced. 
For 2010, the costs were estimated at US$ 604 billion per 
year41 and costs are set to expand even faster than dementia 
prevalence.
Lack of quality data: Country health information systems 
do not routinely collect data on a core set of mental health 
indicators in over two thirds of countries, and are unable 
to provide reliable information on the extent of service 
coverage for even severe mental disorders.
Stigmatization: Negative attitudes to people living with 
mental and substance use disorders abound, both among 
the general public and health-care providers.42 Such 
attitudes have been compounded by the lack of “objective” 
markers or diagnostic tests for mental illnesses, which is 
often interpreted as evidence for these not being “real” 
diseases. There is a lack of awareness and understanding 
of dementia in most countries, resulting in stigmatization 
and barriers to diagnosis and care, which negatively impact 
both the affected person and their families.
Lack of advocacy: The lack of strong advocacy groups, such 
as the civil society organization movements that have been 
remarkably successful for HIV, prevents mental health 
issues being brought to the fore. 
Health workforce: The human resource challenges remain 
immense with regard to mental and substance use disorders, 
and in particular with regard to dementia. Investments are 
needed in training carers to recognize mental disorders, 
and in particular in supporting the non-specialist health-
care workers that are essential for the full integration of a 
package of interventions in primary or general health-care 
settings. Developing these collaborative care models for 
mental disorders and dementia with shifting tasks to non-
specialists with the right skills to scale up services will be 
a huge challenge.
Ease of access: In the particular case of alcohol use, an 
additional challenge relates to “profit driven disease” as 
policies and regulations that govern commercial interests 
interfere with public health objectives. The constantly 
changing market of illicit drugs and transit routes, along 
with new psychoactive substances regularly being reported, 
pose additional challenges in tackling this problem.12
STRATEGIC PRIORITIES
The way forward for mental health and substance use 
primarily lies in the appropriate and effective implementation 
of the already approved WHO Mental Health Action Plan 
2013–2020 and the global strategy to reduce the harmful 
use of alcohol. Concerning other drug use, the 2016 United 
Nations special session devoted to the world drug problem 
is expected to provide the strategic direction and actions 
for the years to come. 
While investment in mental health research has grown over 
the last five years, in making the case for mental health 
with regard to sustainable development, it is necessary 
to undertake more nuanced research and analyses of the 
relationship between mental health, poverty and inequality 
leading to the development of what has been referred to 
as the “political economy of mental health”. The effects of 
poverty on mental health in settings of particular inequality 
need to be studied, and the impact of poverty alleviation 
strategies on mental health better understood.43 
The WHO Mental Health Action Plan 2013–2020 has the 
following objectives and targets: 
• To strengthen effective leadership and governance for 
mental health:
 - Target: 80% of countries will have developed or 
updated their policies/plans for mental health in 
line with international and regional human rights 
instruments (by 2020).
 - Target: 50% of countries will have developed or 
updated their laws for mental health in line with 
international and regional human rights instruments 
(by 2020).
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• To provide comprehensive, integrated and responsive 
mental health and social care services in community-
based settings:
 - Target: service coverage for severe mental disorders 
will have increased by 20% (by 2020).
• To implement strategies for promotion and prevention 
in mental health:
 - Target: 80% of countries will have at least two 
functioning national, multisectoral promotion and 
prevention programmes in mental health (by 2020).
 - Target: the rate of suicide in countries will be reduced 
by 10% (by 2020).
• To strengthen information systems, evidence and 
research for mental health:
 - Target: 80% of countries will be routinely collecting 
and reporting at least a core set of mental health 
indicators every two years through their national 
health and social information systems (by 2020).
A broad public health approach is needed to improve the 
care and quality of life of people with dementia and family 
caregivers. The key strategic priorities set out in “Dementia: 
a public health priority”,7 which was developed jointly 
developed by WHO and Alzheimer’s Disease International 
are:
• promoting a dementia-friendly society; 
• making dementia a national public health and social care 
priority worldwide; 
• improving public and professional attitudes to, and 
understanding of, dementia; 
• investing in health and social systems to improve care and 
services for people with dementia and their caregivers;
• increasing the priority given to dementia in the public 
health research agenda.
The clear recognition of the substance use issue under 
SDG Target 3.5 is a major step forward. The main approach 
to strengthen the reduction of the harmful use of alcohol 
and its health and social consequences will be based on 
implementation of the WHO global strategy to reduce 
the harmful effects of alcohol and its suggested policy 
options for national action.18 Public health advocacy and 
partnerships, increased technical support and capacity-
building, strengthened international activities on production 
and dissemination of knowledge, and mobilization and 
pooling of available resources to support global and national 
action to reduce harmful use of alcohol will form the key 
elements going forward to reduce the individual and societal 
impacts of harmful use of alcohol. 
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With regard to substance use (other than alcohol) and 
drug use disorders, action will need to be based on 
strengthening public health responses to the world drug 
problem and increasing engagement of the health sector in 
the prevention of non-medicinal drug use and prevention 
and treatment of drug use disorders. It is expected that 
by 2030, countries will have developed or revised their 
relevant national policies and programs to increase 
treatment coverage for substance use disorders. Key 
activities should include raising awareness of the disease 
burden due to harmful substance use and promotion of 
an integrated health service response to substance use 
disorders through primary health care and community-
based specialized health and social services.18 All this 
will need to be backed by a strong political commitment 
that will possibly be demonstrated at the planned United 
Nations Special Session on the world drug problem 
in 2016.
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DEPRESSION AND SUICIDE
Mental disorders occur in all regions and cultures of the world, the most prevalent being depression and 
anxiety, which are estimated to affect nearly one in 10 people on the planet (676 million cases).44 The 
prevalence of depression among women is substantially higher than among men.45 At its worst, depression 
can lead to suicide. An estimated 804 000 suicide deaths occurred worldwide in 2012, an annual global 
suicide death rate of 11.4 per 100 000 population, and for every suicide there are many more suicide 
attempts. 
TRENDS 
There has been a 9% decrease in the number of global suicide deaths 
from 2000 to 2012, at the same time as the global population has 
increased.1 The global age-standardized suicide mortality rate has 
fallen 26% between 2000 and 2012 and rates have fallen in all regions 
except in the African Region, among men in the Eastern Mediterranean 
Region and women in the high-income OECD countries. (Figure 7.5).
Just over 75% of all suicide deaths occur in low- and middle-income 
countries. Globally, among young adults between ages 15 and 29, 
suicide accounts for 8.5% of all deaths and is ranked as the second 
leading cause of death (after road traffic injuries). In high-income 
countries, three times as many men die of suicide than women; in 
low- and middle-income countries the male to female ratio is 1.5.4
Despite the serious health impact of mental disorders very few of the 
people who need treatment receive it. According to the World Mental 
Health Surveys,36 even in high-resource settings only one half of those 
with depression get any treatment and about 40% get treatment that 
would be considered to be minimally adequate, while in low-income 
countries coverage is much lower. In Nigeria, for example, only one 
fifth of those with a depressive episode get any treatment and only 
1 in 50 gets treatment that is minimally adequate (Figure 7.6).
The incidence and prevalence of depression and other common mental 
disorders peak in the middle years of adulthood, and lead to a significant 
loss of productive years.39 Estimates suggest that households with 
people with a mental disorder have earnings that are between 16% 
and 33% lower than the median level of income in countries,46 and 
people living with such disorders lose roughly a month every year off 
work.38 Common mental disorders such as depression also frequently 
occur together, and at least two thirds of those with a mental disorder 
have at least one chronic disease.47,48,49
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POSITIVE DEVELOPMENTS
Country actions: In the past half-century, the decriminalization of 
suicide in many countries has made it possible for those with suicidal 
behaviours to seek help, if available. Comprehensive national strategies 
or action plans, especially in high-income countries,50 and, in some 
countries, restriction of access to means of suicide such as pesticides 
or legislation restricting firearm ownership have also contributed to 
the improvements.
Global standards: The development and dissemination of depression 
treatment and suicide prevention guidance as part of the mhGAP 
Intervention Guide, which is based on systematic reviews of the relevant 
international literature and is now being used in over 80 countries 
worldwide.51 This includes a better understanding of strategies to 
prevent suicide.52,53,54
Advocacy and awareness: In some countries, increased rates of 
awareness about and treatment of depression and alcohol use 
disorders are aided, for example, by special articles in high-impact 
global periodicals and multimedia products such as “I had a black 
dog; his name was depression” (which has had more hits than any 
other WHO webpage).55
Research funding: Increased research funding into mental health 
services research, including randomized controlled trials of interventions 
to manage depression in resource-constrained settings.
Better treatments: New treatments have become available for 
depression, both for acute episodes and relapse prevention, in terms 
of medications and psychological interventions that are effective and 
produce fewer side effects.56,57,58 
CHALLENGES
Poor detection of mental illness: Low rates of recognition of depression, 
both by people suffering from it and by health-care providers.
Stigma: High rates of stigma around depression and suicide, which 
impedes help-seeking by individuals and the development of services 
by health authorities. Around 25 countries still have laws or sanctions 
that may be applied for attempted suicide, potentially deterring people 
from seeking help.
Lack of preventive action: Unwillingness or difficulties in restricting 
access to the means of suicide (especially access to firearms, but 
also pesticides).
Lack of access to treatment: Many facilities in low- and middle-income 
countries do not have the capacity to provide basic treatment for 
depression, as health workers are not trained in mental health issues 
and medicines are not available.34
STRATEGIC PRIORITIES
SDG Target 3.5 aims to promote mental health and well-being. Moderate 
and severe depression are included within the Mental Health Action Plan 
2013–2020 target to increase service coverage for people with severe 
mental disorders by 20% by 2020. Member States have committed to 
developing and providing comprehensive, integrated and responsive 
mental health and social services in community-based settings.59 
Suicide prevention is also an integral component of the Action Plan, 
with the target of reducing the rate of suicide in countries by 10% 
by 2020.17 For national responses to be effective, a comprehensive 
multisectoral suicide prevention strategy is needed, including: 
• improving coverage of mental health services and access to treatment 
for mental and substance use disorders, early identification and 
effective management of suicidal risk, as well as follow-up and 
community support of those who attempted suicide;
• reducing harmful use of alcohol;
• restricting access to the most common means, including pesticides, 
firearms and certain medications;
• responsible media reporting and social media and crisis helplines;
• public awareness programmes to raise awareness and reduce 
stigma;
• targeted prevention strategies for vulnerable groups.
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DEMENTIA
The world’s population is ageing. Improvements in health care in the past century have contributed to 
people living longer and healthier lives. However, it has also resulted in an increase in the number of 
people with NCDs. Even though dementia mainly affects older people, it is not a normal part of ageing. 
A syndrome rather than a single illness, dementia is caused by a variety of brain illnesses that affect 
memory, thinking, behaviour and the ability to perform everyday activities. 
TRENDS 
The number of people living with dementia worldwide was estimated at 
46.8 million in 2015, a number that is estimated to reach 74.7 million 
in 2030 and to 131.5 million by 2050.60 The incidence of dementia 
increases exponentially with increasing age. A recent review concluded 
that the incidence of dementia doubled with every 5.9 years’ increase 
in age, from 3.1 for every 1000 person years at age 60–64 to 175 for 
every 1000 person years at age 95 and over (Figure 7.7).61 There are 
marked differences in the levels of the incidence of dementia between 
regions, with high-income countries having much higher incidence 
rates than low- and middle-income countries. 
POSITIVE DEVELOPMENTS
Global advocacy and awareness: Increased recognition of the importance 
of the issue, as exemplified by the world’s first G8 dementia summit 
held in London in December 2013,62 which led to increased awareness 
and investments in dementia research, is encouraging as was the 
first WHO Ministerial Conference on Global Action Against Dementia 
held in March 2015.63 
Country action: The development of national dementia strategies 
leading to prioritization and action at the country level is also a 
marker of success. There is a growing movement to enhance the 
public understanding of dementia through advocacy campaigns such 
as “dementia friends”.64 These efforts are intended to provide people 
with more information about dementia and encourage more people 
to help those with dementia in the community improve their lives.
Better data: With improved efforts at harmonization and coordinated data 
collection efforts, there is increasing understanding of the epidemiology, 
burden and impact of dementia especially in low- and middle-income 
countries. The collaboration between research networks across the 
globe holds promise for generating more comparable data over time.65 
Prevention: Recent advances in the understanding of dementia suggest 
that several modifiable risk factors contribute to dementia prevalence. 
An examination of the dietary and life style risk factors suggests that 
minimizing saturated and trans fats, replacing meat and dairy products 
with vegetables and legumes, ensuring minimal intake of vitamin B12, 
aerobic exercise, reducing stress and engaging in leisure activities 
may all reduce the risk of dementia.66,67,68
Setting standards: The development of clinical assessment and 
management guidelines for non-specialists as part of the WHO mhGAP 
Intervention Guide and its implementation across the world has also 
ensured that people with dementia get the appropriate care within 
primary care settings.69
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CHALLENGES
Global dementia epidemic: Prevalence and incidence projections 
indicate that the number of people with dementia will continue to 
grow, particularly among the oldest old, and countries in demographic 
transition will experience the greatest growth.7
Stigmatization: There is a lack of awareness and understanding of 
dementia in most countries, resulting in stigmatization and barriers to 
diagnosis and care. For those who are living with dementia (both the 
person and their family) stigma contributes to social isolation and to 
delays in seeking diagnosis and help. Improving the awareness and 
understanding of dementia across all levels of society is needed to 
decrease discrimination and to improve the quality of life for people 
with dementia and their caregivers.
Lack of effective treatment: While considerable progress has been 
made in the understanding of the underlying mechanisms for dementia 
in terms of what has been called the amyloid cascade, this has not 
led to the development of drug treatments of substantial impact.70 
Currently available medications for dementia only provide some relief 
of symptoms and possibly slow down progression.71
Escalating cost: The huge cost of the disease will challenge health 
systems to deal with the predicted future increase of prevalence. The 
costs were estimated at US$ 604 billion per year in 201072 and are 
set to increase even more quickly than the prevalence. The costs are 
driven mainly by social care needs. Health-care costs account for a 
small proportion of the total, given the low diagnosis rate, limited 
therapeutic options and the underutilization of existing evidence-based 
interventions (Figure 7.8). In low- and middle-income countries, where 
nearly two thirds of people with dementia live, most of the caregiving 
burden is borne by informal caregivers such as family members. 
Going forward, it will be necessary to develop policies involving all 
stakeholders focused on improved health and social care services that 
include chronic disease management and long-term care.7
Lack of support for carers: Caring for dementia patients is overwhelming 
for caregivers. The stresses include physical, emotional and economic 
pressures. Caregivers require support from the health, social, financial 
and legal systems.
STRATEGIC PRIORITIES
A broad public health approach is needed to improve the care and 
quality of life of people with dementia and family caregivers. The 
aims and objectives of the approach should either be articulated in 
a stand-alone dementia policy or plan or be integrated into existing 
health, mental health or old-age policies and plans. Some high-income 
countries have launched policies, plans, strategies or frameworks to 
respond to the impact of dementia.7
The principal goals for dementia care are:
• diagnosing cases early;
• optimizing physical health, cognition, activity and well-being;
• detecting and treating behavioural and psychological symptoms; 
• providing information and long-term support to caregivers.
The key strategic priorities set out in “Dementia: a public health priority”, 
which was developed jointly developed by WHO and Alzheimer’s 
Disease International are: 7
• promoting a dementia friendly society; 
• making dementia a national public health and social care priority 
worldwide; 
• improving public and professional attitudes to, and understanding 
of, dementia; 
• investing in health and social systems to improve care and services 
for people with dementia and their caregivers;
• increasing the priority given to dementia in the public health research 
agenda.
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SUBSTANCE USE AND SUBSTANCE USE 
DISORDERS
Psychoactive substance use (including alcohol and illicit drugs) is an important risk factor for poor health 
globally.11,73 The use of dependence producing substances may result in development of substance use 
disorders. The intoxicating effects of psychoactive substances, or their toxic effects on organs and tissues, 
or the mode of their administration, are also contributing factors to the development of diseases, injuries 
and other health conditions.12
TRENDS 
In 2012, 5.9% of all deaths worldwide was attributable to alcohol 
consumption with a significant proportion of alcohol-attributable deaths 
from cardiovascular diseases and injuries (Figure 7.9). Worldwide alcohol 
consumption in 2010 was 6.2 litres of pure alcohol per person age 
15 or older: 38% of the world population age 15 or older had drunk 
alcohol in the past 12 months, and 16% engaged in heavy episodic 
drinking.11 There is considerable global variation (Figure 7.10), but 
no clear global trend between 2005 and 2010 could be observed in 
alcohol per capita consumption.
It is estimated that in 2013, some 27 million people in the world 
suffered from drug use disorders, and almost half of them (12.2 million) 
injected drugs of which an estimated 1.65 million were living with 
HIV.12 About 5% of the population between ages 15 and 64 used illicit 
drugs in 2013. Since 2006, the number of people using illicit drugs has 
increased by 38 million, while the number of problem users remained 
fairly constant at 27 million since 2008.
Figure 7.9 
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POSITIVE DEVELOPMENTS
Political will: Increasing political will, as reflected by global agreements 
on reducing the harmful use of alcohol and the UN General Assembly 
resolutions to address the drug problem globally, including the resolution 
to hold a special session of the UN General Assembly on the world 
drug problem in 2016. 
Linking with the NCD agenda: Recognition of the harmful use of alcohol 
as a key risk factor for NCDs and endorsement of the global target of 
10% relative reduction in the harmful use of alcohol by 2025 in the 
NCD Global Monitoring Framework. 
Better data: Gradually, more data are becoming available on alcohol 
and illicit drug use in the world through WHO and UNODC databases 
and global reports, leading to increased awareness and supporting 
data on the impact of alcohol and drug use on population health and 
development.
Interagency collaboration: Within the UN system and beyond on 
addressing the harmful use of alcohol and the world drug problem, 
for instance, WHO and UNODC developed a programme on drug 
dependence treatment and care.75
CHALLENGES
Stigma and neglect: Stigmatization of substance use disorders and 
low priority given to these conditions in health systems in spite of 
the scope of preventable disease and social burden associated with 
psychoactive substance use. 
Lack of resources and response capacity: Limited capacity of 
international institutions and limited investment in public health 
responses to substance use disorders at all levels. There is limited 
involvement of the public health sector in drug policy development 
and implementation in many countries and poor interaction between 
drug control and public health governmental sectors.
Data gap: Insufficient quality data on levels and patterns of substance 
use, especially for illicit drugs and especially in low- and middle-
income countries.
Commercial interests: Interfering with public health interests with 
regard to policies and regulations for legally traded substances such 
as alcohol and prescription drugs.
Prescription drug abuse: Increased non-medical use of prescription 
medicines. 
STRATEGIC PRIORITIES
The clear recognition of the substance use issue under SDG Target 
3.5 (strengthen the prevention and treatment of substance abuse, 
including narcotic drug abuse and harmful use of alcohol) is a 
major achievement. Going forward, strategies will be based on the 
implementation of global policy frameworks and action plans with 
a focus on public health policies and health systems, including the 
implementation of the WHO global strategy on harmful use of alcohol. 
Key activities will include: 
• public health advocacy and partnerships to strengthen commitment 
and capacity of governments and relevant parties at all levels to 
reduce the harmful use of alcohol worldwide; 
• increased technical support and capacity-building to create, enforce 
and sustain the necessary policy and legal frameworks;
• strengthened international activities regarding the production and 
dissemination of knowledge on trends in alcohol consumption, 
alcohol-attributable harm and the societal responses;
• mobilization and pooling of available resources to support global 
and national action to reduce harmful use of alcohol in identified 
priority areas.
With regard to other psychoactive substance use and drug use disorders, 
action will be based on strengthening public health responses to the 
world drug problem and increasing engagement of the health sector in 
the prevention and treatment of substance use disorders. It is expected 
that by 2030 countries will have developed or revised their relevant 
national policies and programmes to increase treatment coverage for 
substance use disorders. Key activities will include:18
• articulating ethical and effective policy options to reduce harmful use 
of substances and the associated health and social consequences, 
while ensuring access to controlled medicines for medical purposes; 
• raising awareness of the disease burden due to harmful psychoactive 
substance use;
• strengthening partnerships and international collaboration and 
information exchange; 
• disseminating evidence of effectiveness and cost-effectiveness of 
strategies and interventions in primary prevention, early intervention, 
treatment, rehabilitation and social reintegration; 
• providing normative guidance, technical support and capacity-
building in the area of prevention and treatment of substance use 
disorders and associated health conditions;
• promoting an integrated health service response to substance use 
disorders, including primary health care and community-based 
specialized health and social services; 
• supporting the production and dissemination of knowledge on the 
epidemiology of substance use and its health consequences; 
• maintaining and further developing the global information system on 
prevention and treatment resources for substance use disorders.76
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SUMMARY
Unlike the MDGs, the SDGs include targets for reductions in injuries and violence, which are associated with more than 
5 million deaths, or one in 11 deaths. This chapter focuses on road traffic injuries, violence, war and conflict, and natural 
disasters.
There is an explicit SDG target on road traffic deaths under the health goal and a target on access to safe transport systems 
which includes improving road safety. Currently about 1.25 million deaths annually are due to road traffic crashes and 
collisions, which is 23% higher than in 2000. The past decade has shown that implementing a range of interventions, 
from legislation and driver behaviour change to vehicle design, reduces the risk of injury and death due to road traffic 
accidents. But because of the increase in numbers of vehicles (90% increase since 2000 to over 1.5 billion and a further 
47% increase expected by 2030), halting further increases in road traffic deaths will, in itself, be a major achievement. 
Further, major reductions in the numbers of road traffic deaths will require an extraordinary effort in all countries.
There are also 1.5 million deaths and many more nonfatal injuries due to other unintentional injuries, including falls, 
drowning, burns and poisonings, which should be addressed to reach the overall health SDGs.
The SDGs have four targets on reducing deaths and injuries due to violence in goals other than health. Nearly half a million 
people died from interpersonal violence in 2012, mostly men, with half of murders committed with firearms. Compared to 
the global rate, homicide rates are four times higher in the low- and middle-income countries of the Americas and more 
than three times lower in the low- and middle-income countries of the Western Pacific Region. Globally, homicide rates 
have declined by nearly 17% since 2000.
Physical or sexual violence against women, harmful practices such as child marriage and female genital mutilation, and 
violence against children, are common in many countries and specific SDG targets to address these issues have been 
set for 2030. Preventing homicide and nonfatal violence requires a multisectoral approach that addresses underlying 
causes, such as gender, social and economic inequalities, cultural norms that support violence, easy access and misuse 
of alcohol, drugs and firearms.
SDG 16 promotes peaceful and inclusive societies for sustainable development, which cuts across all sectors, including 
health. There has been a long-term decline in the number and intensity of wars and conflict since the end of the Second 
World War. Since 2011, however, there has been an upturn in conflict deaths, notably due to the increased level of conflict 
in the Middle East, putting many populations at additional health risk due to increased transmission of infectious diseases, 
poor nutrition and deteriorating health services, and jeopardizing global efforts to eradicate diseases such has polio.
The SDGs also include several targets that aim to reduce exposure, vulnerability, resilience and adaptive capacity in relation 
to disasters. Between 2000 and 2014 there were on average 865 000 deaths due to natural and technological disasters. 
Since 2000, three major disasters that were associated with more than 100 000 deaths have dominated the mortality 
trend, the Indian Ocean tsunami in 2004, the Myanmar cyclone in 2008 and the Haiti earthquake in 2010. The global 
numbers of forcibly displaced people as a result of persecution, conflict, generalized violence or human rights violations 
have reached unprecedented numbers (almost 60 million) in 2014, with further increases in 2015.
173INJURIES AND VIOLENCE
Injuries, whether sustained accidentally or as a result of 
intentional acts of violence, kill more than 5 million people 
worldwide annually, accounting for 9% of global mortality, 
which is nearly 1.7 times the number of fatalities that result 
from HIV/AIDS, tuberculosis and malaria combined. In 
addition, tens of millions of people suffer nonfatal injuries 
that require treatment and may result in temporary or 
permanent disability. For many injuries and some types of 
violence, there exist effective, evidence-based initiatives 
that can help reduce incidence and mitigate impact. There 
is thus a strong case for including injuries in the SDGs, both 
in terms of the burden of disease they represent and the 
solutions available to tackle them. 
The leading cause of injury deaths is road traffic injury, 
followed by suicide, falls and interpersonal violence. Other 
important causes of injuries include drowning,1 fires and 
burns, poisonings, and war and conflict (Figure 8.1). This 
chapter focuses on fatal and nonfatal injuries resulting from 
road traffic accidents, interpersonal violence, conflict and 
natural disasters. Injuries related to self-harm are addressed 
in Chapter 7, which deals with mental health disorders. 
Figure 8.1 
Leading causes among 5.1 million global deaths due to injuries and violence, 20122
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Every year, 1.25 million people die from road traffic injuries, 
and another 20–50 million people sustain nonfatal injuries 
as a result of road traffic collisions or crashes.3 Road traffic 
injuries are a top 10 cause of death globally, and the leading 
cause of death for people age 15–29. A significant cause 
of suffering and death, road crashes also impose a heavy 
economic burden, costing more than US$ 1800 billion or 
3% of GDP globally, with low- and middle-income countries 
losing around 5% of their GDP.4 
Homicide and collective violence account for around 10% 
of global, injury-related death. In 2012, there were an 
estimated 475 000 murders. Four fifths of homicide victims 
are men, and 60% of victims, males age 15–44.5 The 
low- and middle-income countries of the Region of the 
Americas has the most homicides, with 28.5 per 100 000 
population, while the lowest murder rate, almost 14 times 
lower (2.1 per 100 000 population), is found in the low- and 
middle-income countries of the Western Pacific Region. 
One of the main drivers of homicide rates is access to 
guns, with approximately half of all homicides committed 
with a firearm. Among women, intimate partner homicide 
accounts for almost 38% of all murders as compared to 
6% of murders of men. While homicide grabs headlines, 
far more people suffer severe health consequences as a 
result of nonfatal assaults, often sustaining serious injuries 
requiring emergency care and in some cases resulting in 
lifelong disability. 
There are substantial regional differences in injury 
burden (Figure 8.2). The African Region and the Eastern 
Mediterranean Region have the highest per capita burdens, 
but the Region of the Americas, excluding high-income 
OECD countries, has the highest injury burden as a 
proportion of total disease burden (15%), largely due to 
the very high levels of interpersonal violence and homicide.
Unlike the MDGs, the SDGs have several targets for 
injuries and violence , including an explicit target for road 
traffic deaths in the health goal (Target 3.6: “By 2020, 
halve the number of global deaths and injuries from road 
traffic accidents”) and Target 11.2 regarding access to safe, 
affordable, accessible and sustainable transport systems 
for all and improving road safety. The four SDG targets 
addressing the issue of interpersonal violence range from 
loosely defined targets (Target 16.1: Significantly reduce all 
forms of violence and related death rates everywhere) to 
specific targets on elimination of violence against all women 
and girls (Target 5.2, discussed in Chapter 4), elimination of 
harmful practices such as child marriage and female genital 
mutilation (Target 5.3, discussed in Chapter 4) and violence 
against children (Target 16.2). 
Four fifths of deaths from homicide, and nine tenths of 
deaths from war impact men.7 That said, there is clearly 
a case for highlighting violence experienced by women 
and children, which is often hidden, stigmatized and 
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perpetrated by someone known to the victim. For example, 
based on data from 79 countries and two territories, one 
in three women worldwide have experienced physical 
and or sexual violence by an intimate partner or sexual 
violence by perpetrators other than partners.8 This form of 
violence appears to be common in all regions. With regard 
to children, physical violence and abuse is experienced by 
both boys and girls. One quarter of all adults report having 
been physically abused as children, and around 20% of 
women and 5–10% of men report having been sexually 
abused as a child.5 Older people are also victims of violence, 
as indicated by some studies reporting that 6% of older 
adults report abuse in the past month. However, data are 
limited on the prevalence of elder abuse, particularly from 
low- and middle-income countries.9
Natural disasters were not mentioned in the MDGs, but 
are referred to several times in the SDGs (Targets 1.5, 3.d, 
11.5 and 13.1). As part of the goal on cities and human 
settlements, Target 11.5 states: “By 2030, significantly 
reduce the number of deaths and the number of people 
affected and substantially decrease the direct economic 
losses relative to global gross domestic product caused by 
disasters, including water-related disasters, with a focus 
on protecting the poor and people in vulnerable situations.” 
Target 13.1 refers to climate-related disasters: “Strengthen 
resilience and adaptive capacity to climate-related hazards 
and natural disasters in all countries”.
Annually, there were an average 656 reported disasters and 
86 500 deaths during 2000–2014, excluding epidemics.10 
Overall, the largest numbers of deaths are associated with 
earthquakes and tsunamis, but storms also take a heavy toll. 
The economic losses of disasters vary considerably and, in 
absolute terms, are usually much higher in high-income 
countries. However, expressed as a percentage of GDP, the 
direct economic losses from natural disasters in low-income 
countries between 1980 and 2011 were found to be more 
than 14 times higher than in high-income countries. 
TRENDS
Globally, mortality rates due to all major cause groups of 
injuries have fallen since 2000, but, because the world 
population is growing, this has not translated into fewer 
annual deaths (Figure 8.3). Since 2000, global road traffic 
deaths have increased by 23%, and are currently running 
at an annual rate of about 1.25 million deaths.2 Recent 
estimates suggest a lower rise of 13% over the period 
2000–2013.3 One of the main drivers of this trend is the 
increase in traffic, the number of registered vehicles having 
grown by 90% since 2000. It is encouraging to note, 
however, that the mortality rate has remained fairly flat in 
recent years, despite the increase in traffic. 
During 2000–2012, homicide rates are estimated to have 
dropped by almost 17% globally and by an impressive 39% 
in high-income countries. In the low- and middle-income 
countries of the European Region, homicide rates have seen 
an even steeper decline, falling by more than 50% since 
2000. In other low- and middle-income countries, progress 
has been less pronounced, the rate falling 13% in middle-
income countries and 10% in low-income countries.5 
Whether this decline is fully reflected in broader violence 
statistics is unclear.
It is not yet possible to establish global or regional trends 
for the incidence of violence against women and children 
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due to limited data. However, the surveys that have been 
undertaken – usually collecting data from adults on past 
violence and abuse – often show very high rates.
WHO estimates of global direct conflict deaths (injury 
deaths) vary substantially by year, but there has been a 
statistically significant decline during 1990–2010 of 2% 
per year, if the Rwandan genocide of 1994 is excluded. 
There has also been a long-term decline in the number and 
intensity of wars and conflict since the end of the Second 
World War.11,12 Since 2011, however, there has been an 
upturn in conflict deaths, notably due to the increased level 
of conflict in the Middle East.13
According to estimates of mortality directly associated 
with disasters produced by the Centre for Research on 
Epidemiology of Disasters (CRED), during 2000–2014, 
an annual average of about 86 500 people were killed by 
natural and technological disasters.11 Since 2000, three 
major natural disasters that were associated with more than 
100 000 deaths have dominated the picture: the Indian 
Ocean tsunami in 2004; the Myanmar cyclone in 2008; 
and the Haiti earthquake in 2010 (Figure 8.4). The number 
of disasters has been declining in the last decade and the 
number of people affected reached its lowest levels since 
2000 in 2012 and 2013.
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POSITIVE DEVELOPMENTS
Mortality due to road traffic injuries has remained fairly flat, 
despite the increases in numbers of vehicles and population, 
suggesting that interventions to improve global road safety are 
working. Given the existence of well-established road safety 
interventions, the prospects for mitigating the damage done 
by cars, trucks and motorcycles are good. No fewer than 76 
countries3 have already reduced the number of deaths on their 
roads during 2000–2013, demonstrating that improvement is 
possible, and that many more lives could be saved.
Several factors have contributed to these positive trends: 
• Effective, enforceable legislation: The introduction of 
enforceable legislation, coupled with social marketing, 
regarding speed, seat belts and child restraints, 
motorcycle helmets, and drinking and driving has already 
made a difference in a number of countries. 
• Safer roads: The same is true of improvements in the 
construction of new roads, with increased emphasis on 
the needs of vulnerable road users, including pedestrians, 
motorcyclists and cyclists. 
• Safer vehicles: Vehicles too have been made much safer 
and continuing improvements in vehicle design and 
safety, such as strengthened front-end design, air bags 
and computerized braking systems, will be essential 
components of any post-2015 campaign to bring about 
a drop in road traffic injuries and deaths. 
Drops in homicide may be associated with improvements 
in country policies and strategies to reduce violence and its 
consequences. Roughly one third of countries are currently 
implementing such strategies, including support for safe, 
stable and nurturing relationships between children and 
parents or caregivers, reducing the availability and harmful 
use of alcohol, reducing access to guns, and knives, and 
promoting gender equality.14 It is, however, unknown to 
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what extent these strategies have been a factor in the 
estimated decrease in the homicide rate.
During 2005–2015, the Hyogo Framework for Action 2005–
201515 promoted a strategic and systematic approach 
to reducing disaster risks, and underscored the need for 
building the resilience of nations and communities to 
disasters. The Hyogo Framework was instrumental in 
stimulating countries, development partners and other 
agencies to take action to reduce disaster risk, and may have 
helped decrease mortality rates in the case of some hazards, 
such as floods, for example, which, despite increasing 
frequency, are killing fewer people. Many countries (85%) 
have a national emergency preparedness and response 
policy and two thirds of countries have a policy in place 
for health sector emergency preparedness and response.16
CHALLENGES
Increase in vehicles: Based on current trends, and unless 
urgent action is taken, road traffic death is expected to rise 
on the list of leading causes of death. The main challenge 
is to bring road traffic deaths down at a time of rapidly 
increasing motorization, especially in low- and middle-
income countries. A matter of particular concern is the rapid 
increase in traffic volume without a concomitant investment 
in road safety strategies. 
Access to guns: One of the main drivers of homicide incidence 
is access to guns, approximately half of all homicides being 
committed with a firearm. It appears unlikely that access to 
firearms will decline in the coming years in most countries. 
Gender inequality: Violence against women and children 
is embedded in gender inequality and discrimination 
against women and girls. Increased and sustained efforts 
are needed to bring about changes in gender norms to: 
(i) empower women and girls, notably through improved 
access to education and safe, adequately remunerated 
employment; ii) mobilize communities and institutions to 
reduce the acceptability of violence, promote egalitarian 
gender norms and (iii) reform and effectively enforce laws 
to address sexual violence and intimate partner violence 
against women, as well as other laws that limit women’s 
rights regarding marriage, divorce, child custody and 
property and inheritance.
Increasing risks for some types of disasters: Natural hazards 
such as hydrometeorological disasters may increase in 
frequency and intensity as a result of climate change, 
significantly impeding progress towards sustainable 
development (see Chapter 2). These risks may be 
exacerbated by population growth and unsustainable use 
of natural resources.
Disabilities: Millions of people who do not die as a result of 
injuries and violence suffer serious injuries and, in some cases, 
lifelong disabilities as well as mental trauma. Greater investment 
for the prevention, treatment and rehabilitation of functioning 
loss due to injuries is critical.
Other injuries – falls: The SDGs focus on road traffic injury and 
violence, but other key injury areas are also of concern. An 
estimated 693 000 fatal falls occurred in 2012, making it the 
second leading cause of unintentional injury death, after road 
traffic injuries. There are also tens of millions of falls that, while 
not fatal, are severe enough to require medical attention. Older 
people who suffer falls are also at risk for subsequent long-term 
care and institutionalization.
Other injuries – burns: Fire-related injuries are another concern, 
with the majority occurring in low- and middle-income countries. 
They are often associated with unsafe cooking methods, 
including cooking with open fires, and with violence against 
women. Women and children are particularly at risk. Largely 
preventable, in high-income OECD countries burns have been 
reduced to almost negligible levels. 
Other injuries – drowning: An estimated 372 000 people died from 
drowning in 2012, and over half of the world’s drowning occurs 
in the South-East Asia Region and the Western Pacific Region. 
Many deaths due to drowning could be averted by barriers to 
control access to water, ensuring constant adult supervision for 
preschool children, teaching school children basic swimming 
and safe rescue skills as well as improving flood risk reduction 
strategies. 
Conflict: As noted in the SDG declaration spiralling conflict, 
violent extremism, terrorism and related humanitarian crises 
and forced displacement of people threaten to reverse much 
of the development progress made in recent decades. It will be 
a major challenge to reverse current trends and provide more 
effective support to conflict and post-conflict countries in all 
sectors including health. 
STRATEGIC PRIORITIES
Given the complexity of the determinants of injuries and violence, 
establishing development targets that are both simple and 
compelling enough to focus attention, but also specific enough 
to facilitate the drawing up and implementation of effective 
policy, is fraught with difficulty. However, certain targets look 
promising. Road traffic deaths, for instance, are an example of a 
specific target that is relevant to all countries, a serious problem 
that is easily defined and measured, while also being something 
that we can make progress on, using well-established, evidence-
based interventions. The target of halving the global number of 
road traffic deaths by 2020 is much more ambitious than the 
target set at the Decade of Action for Road Safety 2011–2020, 
which was endorsed by the UN General Assembly in 2010, 
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aiming to stop the predicted increase at about current 
levels.17 Given the projected increase in road vehicles (47% 
by 2030), it will be a substantial achievement to hold 
global road traffic deaths to the current level, let alone 
achieve a decrease. The key strategies are to roll out and 
implement effective behaviour change interventions such 
as legislation, enforcement and social marketing; improve 
road infrastructure, bearing in mind vulnerable road users; 
and encourage the uptake of good vehicle design measures.
Reducing interpersonal violence, particularly against 
women and children, is also a priority with considerable 
global support, notably among UN agencies, including 
the UN General Assembly, the UNESCO, the United 
Nations Development Programme (UNDP), the UNICEF, 
United Nations Entity for Gender Equality and Women’s 
Empowerment (UN Women) and WHO. In 2014, the World 
Health Assembly drew attention to the important role of 
health systems in addressing violence, in particular against 
women and girls and against children, and called upon the 
WHO Director-General to develop a global plan of action 
to strengthen the role of the health system in addressing 
interpersonal violence.18 
The global violence prevention field’s vision for the post-
2015 era is one of cutting worldwide levels of interpersonal 
violence by half within the next 30 years.19,20 While not 
as ambitious as the SDG targets, which aim to eliminate 
several forms of violence in the next 15 years, this vision 
aligns well with SDGs 5 and 16 that explicitly target violence 
reduction. A 15-year global plan of action on strengthening 
the role of the health sector in addressing interpersonal 
violence, in particular against women and children, will 
be considered by WHO Member States at the May 2016 
World Health Assembly. 
To date, few countries have implemented the social, 
economic and educational policy measures needed to 
address important risk factors for violence. This is a 
particular matter of concern in regard to violence against 
women, which is an issue for all regions and countries, and 
is worse in settings where familial violence against women 
and against children is considered socially acceptable. As 
noted above, access to guns is another major concern, and 
while nearly all countries have national laws to regulate 
firearm possession and use, there is wide variation in the 
adequacy and enforcement of these laws. 
The SDGs provide a framework for the focus on preventing 
conflict and more effective assistance to conflict and post-
conflict countries. Better integration of humanitarian and 
development assistance is essential. Health will have to 
continue and strengthen working closely with other sectors 
to reduce the impact of conflict on people’s health and 
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well-being. In each area of concern, from intimate partner and 
other family violence, sexual violence to human trafficking, 
policy responses and effective interventions already exist. 
The SDGs are an important opportunity to steer decision-
makers towards them, as part of global, regional and country 
efforts to address these pressing issues.
The main strategy for managing the health risks associated 
with disasters in the post-2015 era is supported by the 
Sendai Framework for Disaster Risk Reduction 2015–2030.21 
The Framework identifies four priorities for action that 
involve national, regional and global participation:
1. Understanding disaster risk: in all its dimensions of 
vulnerability, capacity, exposure of persons and assets, 
hazard characteristics, and the environment.
2. Strengthening disaster risk governance to manage 
disaster risk: for prevention, mitigation, preparedness, 
response, recovery and rehabilitation.
3. Investing in disaster risk reduction for resilience: for the 
enhancement of the economic, social, health and cultural 
resilience of people, communities, countries and their 
assets as well as the environment.
4. Enhancing disaster preparedness for effective response 
and to “build back better” in recovery, rehabilitation and 
reconstruction. 
WHO’s Six-year Strategic Plan to Minimize the Health 
Impact of Emergencies and Disasters 2014–2019 
outlines the policies and programmatic implications for 
the health sector.22 Effective emergency and disaster risk 
management health policies and programmes should be 
guided by a comprehensive approach across the emergency 
management cycle: prevention/mitigation; preparedness; 
response and recovery. Policies and programmes should also 
be designed to address common issues and build essential 
capacities in an “all-hazard approach”, supplemented 
by hazard-specific elements such as outbreaks, floods, 
earthquakes, radiological hazards and conflict.
While the health sector will lead in managing the risk of 
infectious diseases (chapters 3 and 5), for most types 
of hazards and events other sectors will play a key role. 
Intersectoral collaboration is thus crucial to building health 
security capacity. It should also be remembered that 
community members are central to effective emergency 
and disaster risk management, as they are the primary 
responders – and victims – of any emergency. The resilience 
of communities can be strengthened by helping them 
identify relevant hazards and vulnerabilities, and by building 
their capacities to mitigate, prepare for, respond to and 
recover from emergencies.
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ROAD TRAFFIC INJURIES
Every year, approximately 1.25 million people die, and another 20–50 million people sustain nonfatal 
injuries, as a result of road traffic collisions. Road traffic injuries are the ninth leading cause of death 
globally, and the leading cause of death for people age 15–29.3 Almost 60% of road traffic deaths are 
among people age 15–44. Based on current trends, and unless urgent action is taken, road traffic deaths 
will become the fifth leading cause of death by 2030.
TRENDS 
While the number of registered vehicles increased by no less than 
90% between 2000 and 2012,3 the increase in numbers of deaths 
due to road traffic injuries was much less dramatic (Figure 8.5), 
suggesting that interventions to improve global road safety have had 
some impact on mortality statistics. Indeed, 76 countries3 reduced the 
number of deaths on their roads between 2000 and 2013, showing 
that improvements are possible, and that many more lives could be 
saved if countries took further action.
POSITIVE DEVELOPMENTS
There are positive developments for several interventions from 
legislation to vehicle design that contribute to positive trends, such as:3
• Comprehensive legislation: While considerable effort is still needed 
to bring legislation into line with best practice, progress is being 
made. Between 2011 and 2014, 17 countries, representing 409 
million people; amended their road safety laws on one or more 
behaviour risk factors to make them comprehensive. Criteria used 
to assess comprehensive legislation are being refined and made 
stricter as the epidemiological evidence relating to particular risk 
factors evolves.
• Speed limit laws: 26% of countries have adopted comprehensive 
urban speed laws.
• Comprehensive seat belt laws: Covering occupants in both front and 
rear seats; 58% of countries have passed this kind of legislation. 
• Drinking and driving laws: Almost 20% of countries have such 
laws in place, based on blood alcohol concentration, with a limit 
of 0.05 g/dl or less for the general population 0.02 g/dl for young 
drivers, which is in line with best practice.
• Motorcycle helmet laws: Comprehensive laws are in place in a 
quarter of countries. 
• Child restraints: A third of all countries have comprehensive laws 
for child restraints.
• Attention to all road users: Increased attention to the needs of all 
road users when constructing new roads, with increased emphasis 
on the needs of vulnerable road users (pedestrians, cyclists and 
motorcyclists). Safety ratings are available that rate roads according 
to different categories of road users. 
• Vehicle safety: Continuing improvements in vehicle design and 
safety, such as strengthened front-end design, electronic stability 
control, ensuring seat belt fixture and anchorage points. These offer 
huge potential to reduce the likelihood of crashes and the severity 
of injury from road crashes. 
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CHALLENGES
Elevated mortality rates in low-, middle- and non-OECD high-income 
countries: Over 90% of road traffic deaths occur in low-, middle- and 
non-OECD high-income countries, which account for 85% of the 
world’s population, but only 56% of the world’s registered vehicles. 
Several factors are at work, including: poor or poorly implemented 
regulations; inadequate road and vehicle quality; a higher proportion 
of vulnerable road users; and increasing vehicle numbers.
Increasing road traffic death rates in some regions: This is partly 
attributable to the rapid rate of motorization in many developing 
countries that has occurred without a concomitant investment in road 
safety strategies (Figure 8.6). 
High mortality among younger adult men: More than one third of all 
road traffic deaths are among men age 15–44, the group that is often 
least likely to pay attention to public health messages (Figure 8.7).
Vulnerable road users: Half of the world’s road traffic deaths occur 
among motorcyclists (23%), pedestrians (22%) and cyclists (4%). In 
most low- and middle-income countries, a much higher proportion 
of road users are pedestrians, cyclists and users of motorized two- or 
three-wheeled vehicles than in high-income countries. 
Lack of legislation meeting best practice on key behavioural risk 
factors: As indicated above, many countries lag behind on adopting 
best practice legislation relating to speed and drink-driving, and the 
use of motorcycle helmets, seat belts and child restraints. 
Lack of law enforcement: While an increasing number of countries 
have enacted laws relating to key risk factors for road traffic injuries, 
in the vast majority of countries the enforcement is lacking. For 
example, only one quarter of countries rate their enforcement of seat 
belt laws as good.
STRATEGIC PRIORITIES
SDG Target 3.6 aims to halve the global number of road traffic deaths 
by 2020. This is much more ambitious than the target set at the Decade 
of Action for Road Safety 2011–2020, which was endorsed by the UN 
General Assembly in 2010, aiming to stop the predicted increase at 
about current levels.17 Given the projected increase in road vehicles 
(47% by 2030), it will be a substantial achievement to hold global 
road traffic deaths to the current level, let alone achieve a decrease. 
If current trends continue, and nothing is done to address the various 
challenges faced, then global road traffic deaths may increase to around 
1.5 million per year. Under an optimistic scenario, where increases in 
vehicles per capita are associated with fatality rates falling to those 
observed in high-income countries over the last two decades, global 
deaths will decrease to around 1 million per year by 2030. Substantial 
additional efforts will be required to make progress towards the SDG 
target of 625 000. There is a strong evidence base on the kinds of 
interventions and government actions that are effective; the key is to 
ensure their implementation. The most recent UN General Assembly 
resolution,23 which acknowledges the coordinating role of WHO for 
the UN system, and the Decade of Action for Road Safety 2011–2020 
outline the strategic priorities for making progress towards the SDG 
targets on road safety as the following:
• Enacting and enforcing comprehensive legislation on key risk factors: 
Laws to address speeding and drink-driving and to ensure the use 
of motorcycle helmets, seat belts and child restraints need to be 
enacted and enforced, supported by government commitment and 
funding.
• Making road infrastructure safer for pedestrians and cyclists: The 
needs of road users must be taken into consideration in road safety 
policy, transport planning and land use. In particular, governments 
need to consider how non-motorized forms of transport can be 
integrated into more sustainable and safer transport systems.
• Improving vehicle standards: Governments should focus on ensuring 
that vehicles in circulation are well maintained and meet international 
standards, including crash-testing standards. 
• Improving post crash care: The way victims of road traffic crashes 
are dealt with following a crash determines their chances and quality 
of survival. Prompt communication and activation of the response 
system, prompt response and effective assessment, treatment and 
transport of injured people to formal health-care facilities (where 
necessary) are essential. 
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VIOLENCE AND HOMICIDE
There were an estimated 475 000 deaths globally in 2012 as a result of interpersonal violence (homicide).5 
Four out of five homicide deaths were men, most of them age 15–44, which makes homicide the third 
leading cause of death in this age group. Globally, as many as 38% of homicides occurring in women are 
committed by their male partners; by comparison, only 6% of homicides in men are committed by their 
female partners.5,24 There is very large variation in homicide rates between regions. 
Victims of nonfatal violence far outnumber victims of homicide. While young to middle-aged men generally 
experience higher rates of nonfatal violence than others, women, children and elderly people also suffer 
from the nonfatal consequences of physical violence and sexual and psychological abuse. Nearly one 
quarter of all adults report having been physically abused as children, while 18% of women report having 
been sexually abused as children.5 Violence against women is all too common and takes many forms, 
including violence committed by an intimate partner, sexual violence by any perpetrator, trafficking for 
purposes of sex, murders in the name of honour or dowry, and early child and forced marriage (see also 
Chapter 4). About one in three women report having been a victim of physical or sexual violence by an 
intimate partner at some point in their lives.25 
TRENDS 
During 2000–2012, there has been a marked decline in homicide rates 
(Figure 8.8), which are estimated to have fallen by around 17% globally 
(from 8.0 to 6.7 per 100 000 population), and by an impressive 39% in 
high-income countries (from 6.2 to 3.8 per 100 000 population). In the 
low- and middle-income countries of the European Region, homicide 
rates have seen an even steeper decline, falling by more than one half 
since 2000. In several other regions, modest declines were observed 
with the exception of the low- and middle-income countries of the 
Region of the Americas, where homicide rates continue to be very high. 
The differences in levels between regions are striking. The low- and 
middle-income countries of the Region of the Americas has 28.5 
homicides per 100 000 population. This is four times higher than 
the global average and almost 14 times higher than in the low- and 
middle-income countries in the low- and middle-income countries 
of the Western Pacific Region, where murders occur at a rate of 2.1 
per 100 000 population per year. Organized criminal violence and 
violence related to illicit drugs have been important contributors to 
rising homicide rates in some countries of Latin and Central America.12 
Globally, approximately half of homicides are committed with a firearm, 
but murder methods vary markedly by region. For example, firearm 
homicides account for 75% of all homicides in the low- and middle-
income countries of the Region of the Americas, but only 23% in the 
low- and middle-income countries of the Western Pacific Region. 
POSITIVE DEVELOPMENTS
Roughly one third of countries are undertaking steps to implement 
promising strategies to reduce violence, including:14 
• increasing safe, stable and nurturing relationships between children 
and their parents and caregivers;
• developing life skills in children and adolescents; 
• reducing availability and harmful use of alcohol; 
• reducing access to guns, knives and poisons (particularly pesticides); 
• promoting gender equality and the empowerment of women; 
• changing cultural norms that support violence; 
• victim identification, care and support;
• identification and prosecution of perpetrators in order to reduce 
the “culture of impunity”. 
It is unknown to what extent interventions such as these have contributed 
to the observed declines in homicide since 2000. Homicide as well 
as most forms of interpersonal violence are strongly associated with 
social determinants such as social norms, gender inequality, poverty 
and unemployment, and other cross-cutting risk factors.5
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Figure 8.8 
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CHALLENGES
The Global Status Report on Violence Prevention 2014 and the Report 
on Global and Regional Estimates of Violence Against Women 2013 
identified several core concerns:
• Continued extremely high homicide rates in the low- and middle-
income countries of the Region of the Americas;
• Few countries are implementing social, economic and educational 
policy measures to address the social, cultural and economic risk 
factors for violence;
• Violence prevention laws are widely enacted, but enforcement is 
often inadequate;
• While nearly all countries have national laws to regulate firearms, 
enforcement is often inadequate, and few countries report having 
special firearms control programmes such as gun buy-backs and 
firearms collection and destruction programmes;
• Availability of services to identify, refer, protect and support victims 
varies markedly;
• Prevalence estimates for intimate partner violence are substantially 
higher in the low- and middle-income countries of the African 
Region, the Eastern Mediterranean Region and the South-East Asia 
Region, compared to other regions of the world (Figure 8.9), but 
only half of countries in these regions are implementing wide-scale 
social and cultural norm-change strategies to address sexual and 
intimate partner violence;
• In many settings, intimate partner violence against women and 
child maltreatment are considered socially acceptable and are 
often condoned;
• Discrimination against women and girls, including in legislation, 
continues to detract from efforts to address violence against women 
and girls;
• National surveys of violence against children conducted in Africa 
have documented high rates of childhood physical, sexual and 
emotional abuse;
• Violence prevention requires a multisectoral response, but few 
countries report the existence of lead agencies to coordinate the 
activities of different sectors and report periodically on progress.
STRATEGIC PRIORITIES
The global violence prevention field’s vision for the post-2015 era is to 
cut worldwide levels of interpersonal violence by half within the next 
30 years.19,20 While not as ambitious as the SDG targets, which aim 
to eliminate several forms of violence in the next 15 years, this vision 
aligns well with SDGs 5 and 16, that explicitly target violence reduction.
Several UN agencies have focussed on violence reduction as a priority, 
including WHO, UNESCO, UNODC, UNDP, UNICEF and UN Women as 
well as the UN General Assembly.
In 2014, the World Health Assembly drew attention to the important 
role of health systems in addressing violence, in particular against 
women and girls and against children, and called upon the WHO 
Director-General to develop a global plan of action to strengthen the 
role of the health system in addressing interpersonal violence, in 
particular against women and girls and against children.18
A 15-year global plan of action on strengthening the role of the health 
system in addressing interpersonal violence, in particular against women 
and girls and against children, will be considered by WHO Member 
States at the May 2016 World Health Assembly. It will include actions 
to address four strategic directions to address violence, in particular 
against women and girls and against children: 
• strengthening leadership and governance of the health system; 
• strengthening health service delivery and the capacity of health 
workers to respond to violence; 
• strengthening programming for prevention; 
• improving research and information. 
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WAR AND CONFLICT
In 2012, an estimated 164 000 people died related to war and conflict, corresponding with about 3% of 
global deaths, and increasing to over 200 000 conflict deaths in 2014.2,26  These estimates do not include 
deaths due to the indirect effects of war and conflict on the spread of diseases, poor nutrition and collapse 
of health services. 
TRENDS 
Between 1990 and 2011 there was a decline in the number and 
intensity of wars and conflicts.11,12 According to the Human Security 
Report 2013, the total number of conflicts dropped 40% from 1992 
to 2011. High-intensity conflicts declined by more than half after the 
end of the Cold War, while terrorism, genocide and homicide numbers 
were also down.12
WHO estimates of global direct conflict deaths (injury deaths) vary 
substantially by year, but there is a statistically significant average 
decline during 1990–2010 of 2% per year, if the Rwandan genocide 
of 1994 is excluded (Figure 8.10). 
Since 2011, however, there has been an upturn in conflict deaths, 
notably due to the increased level of conflict in the Middle East (Figure 
8.11).13,26 It appears likely that conflict mortality levels for 2015 may 
be similar to or exceed those for 1990. It is estimated that in 2014, 
there were at least 17 conflicts that killed more than 1000 people 
each, compared to 15 in 2013.26 Ongoing conflict in Afghanistan, 
Iraq and the Syrian Arab Republic accounts for significant numbers 
of conflict-related deaths, with these three countries accounting for 
an estimated two thirds of global conflict deaths in 2014. Nigeria’s 
ongoing conflicts were the fourth deadliest, doubling on the previous 
year as the conflict with a militant group, Boko Haram, intensified. Sudan 
and South Sudan are also suffering from conflict as are an increased 
number of African countries. There is increasing documentation and 
evidence on high rates of sexual violence against women in conflict 
situations.27
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Figure 8.11 
Trends in injury deaths due to conflict by region, 1990–20146,26
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POSITIVE DEVELOPMENTS
Notwithstanding the recent increase in violent conflict, it is possible to 
point to a number of reasons for the long-term decline in the numbers 
of wars and the level of conflict-related violence since the end of the 
Second World War.11
• Global partnership: The strong normative proscription against 
the use of military force – except in self‐defence, or sanctioned 
by the UN Security Council. This also includes more emphasis on 
peacekeeping, peace-building and peace-making initiatives. 
• Economic factors: Increased economic interdependence (globalization) 
and increased economic development.
• Increased democratization: This may be associated with reduced 
national willingness to wage wars of offence.
• Enhanced state capacity: This means access to greater resources 
to address grievances and deter violence.
• Fewer conflicts of global scale: Examples include the Second World 
War, anti-colonialism and the Cold War.
CHALLENGES
Fragile and conflict/post-conflict situations: These situations present 
the most profound challenges to development in the world today. In 
both fragile and conflict-affected states, poverty levels are usually high 
and welfare levels low. The stability and social cohesion necessary 
for development are frequently lacking. And often there are no strong 
and legitimate institutions to address poverty and manage conflict. 
Violent conflict is more likely to re-emerge in such areas, leading to 
further impoverishment, undercutting social cohesion and eroding 
institutions.28,29 Each conflict is slightly different, but important factors 
include the longstanding and intractable Middle East crisis, remnants 
of the Cold War and sectarian religious divisions. Many conflicts are 
also driven by underlying causes, including poverty, poor governance 
and neglect, and local grievances.
Sociopolitical factors: These include the upturn in the number and 
intensity of conflicts in the last five years, both in the African Region 
and the Eastern Mediterranean Region. It also involves the religious 
extremist component in many of the conflicts, including the transnational 
upsurge of belligerence associated with certain manifestations of Islam, 
which may in turn be in part stimulated by economic stagnation and 
unemployment, along with increased globalization. Risks of nuclear 
or chemical terrorism are likely to have increased.
Adverse impact on disease control and nutrition: War and conflict 
impede the maintenance of public health interventions and health 
services and are major obstacles in efforts to eradicate, eliminate or 
control diseases such as malaria and HIV. Polio is a particularly telling 
example: the battle against the virus has become entirely focused on 
conflict zones such as in Afghanistan and Pakistan. War and conflict 
also adversely affect the economy and people’s livelihoods and may 
cause serious malnutrition and famines.
STRATEGIC PRIORITIES
SDG 16 is to “Promote peaceful and inclusive societies for sustainable 
development, provide access to justice for all and build effective, 
accountable and inclusive institutions at all levels”. Its first two 
targets are to:
• significantly reduce all forms of violence and related death rates 
everywhere;
• end abuse, exploitations, trafficking and all forms of violence against 
and torture of children.
To break cycles of insecurity and reduce the risk of their recurrence, 
national reformers and their international partners need to build 
legitimate institutions that can provide a sustained level of citizen 
security, justice and jobs – offering a stake in society to groups that 
may otherwise receive more respect and recognition from engaging 
in armed violence than in lawful activities, and punishing infractions 
capably and fairly.29
In May 1998, the Fifty-first World Health Assembly accepted the role 
of WHO in health as a bridge for peace in the Health for All in the 21st 
century strategies. In fragile and conflict-affected settings, health can 
serve as an important entry point around which all stakeholders can 
unite. Health investments can potentially contribute to state-building 
and, perhaps, to enhanced national and local legitimacy. It is essential 
to work with local communities and with non-state actors in order 
to rebuild or preserve the functioning of the health system, ensure 
disease control, address the needs of affected groups such as women 
and children, provide access to comprehensive services, including 
sexual and reproductive health and mental health and psychosocial 
care, maintain health financing and protect health-care workers. 
The SDGs provide a global framework for greater focus and action in 
conflict and post-conflict countries. This requires greater integration 
efforts of health and other sectors, and of humanitarian and development 
support. 
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DISASTERS
Disasters are often associated with hazards that include hydrological (floods and landslides), 
meteorological (extreme temperatures and storms), climatological (droughts and wildfires) and geophysical 
phenomena (earthquakes/tsunamis, volcanic eruptions and dry mass movements). Hydrological and 
meteorological disasters accounted for 47% and 36%, respectively, of all natural disasters in 2014. 
Globally, 324 natural disasters were registered in 2014, which were associated with 141 million victims 
and 7 823 deaths.30 Technological disasters, including industrial and transport disasters, accounted for 
almost 40% of all types of disasters in 2014, but affect smaller numbers of people as they tend to be more 
localized. 
TRENDS 
During 2000–2014, an average 86 500 people were killed each year 
by natural disasters (not including biological hazards). Since 2000, 
there have been on average 656 natural and technological disasters 
each year, with slightly lower figures during 2012–2014. In 2013, 
the number of people affected reached its lowest point since 1997 
(Figure 8.12).
The number of total deaths was the lowest in 2014, but the long-term 
mortality trend is dominated by major events (Figure 8.13).30 Several 
major natural disasters stood out, each killing more than 50 000 
people in a single year: the Indian Ocean tsunami in 2004 and the 
Haiti earthquake in 2010, the cyclone in Myanmar in 2008, and the 
extreme temperatures in Europe in 2003 and 2010. 
Out of over one million disaster-related deaths during 2000–2014, 
61% occurred in Asia where 60% of the global population live, and 
20% in the Americas. Africa (6%) and Oceania (less than 1% of deaths) 
had much smaller proportions.
Figure 8.13 
Trends in number of people reported killed due to disasters, with disaster type 
of phenomenon if deaths exceeded 50 000 in a single year, 2000–201410
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POSITIVE DEVELOPMENTS
Global framework for action: The Hyogo Framework for Action 
2005–2015 provided the basis for risk management embedded 
inside health systems that ensured a greater focus on prevention, 
including exposure and vulnerability reduction, while also addressing 
preparedness, response and recovery. International mechanisms for 
strategic advice, coordination and partnership development for disaster 
risk reduction, such as the Global Platform for Disaster Risk Reduction 
and the regional platforms for disaster risk reduction, as well as other 
relevant international and regional forums for cooperation, have been 
instrumental in the development of country policies and strategies and 
the advancement of knowledge and mutual learning.
Country action: Many countries (85%) have a national emergency 
preparedness and response policy and two thirds of countries have a 
policy in place for health sector emergency preparedness and response.16 
In their reporting to WHO, 130 Member States indicated that they 
have “emergency preparedness and response programmes” in place. 
Globally 79 countries have reported they are implementing the Safe 
Hospital Initiative, which provides concrete actions towards the 
implementation of the Sendai Framework for Disaster Risk Reduction 
2015–2030. WHO has been promoting safer hospitals for more 
than 20 years31 and there is evidence of success. For instance, the 
hospitals in the Kathmandu valley were functioning immediately after 
the earthquake in Nepal (April and May 2015), helping to save lives. 
While the number of floods has been increasing, mortality has fallen. 
This likely reflects improvements in development conditions in low- 
and middle-income countries and better early warning, disaster 
preparedness and response in health and other sectors.32
CHALLENGES
Disasters occur frequently: On average there is about one major disaster 
recorded on the global databases every day on earth, and intensity 
may be increasing, in some cases as a result of climate change. 
Large economic impact: Many countries – especially low- and middle-
income countries, where the mortality and economic losses from 
disasters are disproportionately higher – are struggling to meet the 
financial, logistical and humanitarian needs for recovery from disasters.
Lack of country policies and poor emergency care services: One third 
of countries do not have any type of policy in place for health sector 
emergency preparedness and response.16
Tackle disaster risk drivers: Further efforts are needed to reduce 
exposure and vulnerability and to tackle underlying disaster risk 
drivers, such as the consequences of poverty and inequality, climate 
change and variability, unplanned and rapid urbanization, and poor 
land management.
STRATEGIC PRIORITIES
The post-2015 development agenda provides the international 
community with a unique opportunity to enhance coherence across 
policies, institutions, goals, indicators and measurement systems for 
implementation. SDG Target 3.d calls for strengthening of country 
capacity for early warning, risk reduction and management of 
national and global health risks, which aligns with the application of 
a comprehensive all-hazards approach to the development of country 
capacities for emergency and disaster risk management for health. 
This links with several WHO resolutions that called for Member States 
to strengthen national emergency prevention, preparedness, response 
and recovery programmes, and the resilience of health systems.33,34 
The Sendai Framework for Disaster Risk Reduction 2015–2030, as part 
of the post-2015 development agenda, aims to substantially reduce 
disaster risk and loss through integrated and multisectoral actions to 
prevent new disasters, mitigate existing disaster risk, reduce hazard 
exposure and enhance preparedness for response and recovery.21 The 
Framework puts health at the centre of global policy and action to 
reduce disaster risks35,36 and takes an all-hazards approach, including 
epidemics and pandemics within its scope as well.
To enhance the resilience of national health systems, the Sendai 
Framework recommends that disaster risk reduction strategies be 
integrated into all aspects of health-care provision (primary, secondary 
and tertiary). WHO has worked with Member States and stakeholders 
on the development of an Emergency Disaster Risk Management for 
Health (EDRM-H) policy framework, based on a comprehensive and 
integrated risk management approach, referring to a series of closely 
interrelated steps of prevention/mitigation, preparedness, response 
and recovery.37 It is intended to serve as an overarching policy across 
all types of hazards. 
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SUMMARY
In September 2015, heads of state and governments met at the UN in New York to agree on a new generation of 17 SDGs 
and 169 targets to succeed the MDGs and to guide global development over the 15 years to 2030.1  
A product of extensive global consultation, and prolonged negotiation, the SDGs have been welcomed by many for their 
comprehensiveness, universal applicability and breadth of ambition. But they have also been criticized for lacking precision 
and for proposing an unattainable utopia.2 While these and other schools of thought will be represented among WHO 
Member States, a pragmatic middle ground is possible, which uses the SDGs as an opportunity to accelerate progress in 
health, universal coverage and human development. 
The SDGs represent a potentially important and exciting opportunity for global health. Forging a clear narrative that 
clearly articulates the opportunities, challenges and the practical significance of the SDGs for health is therefore urgent. 
This final chapter briefly summarizes the development of the SDGs, highlighting key differences with the MDGs. It also 
outlines key elements of a strategic position for WHO and the health sector in general, in recognition of the fact that the 
SDGs will have significant implications for the work of WHO, ministries of health and global and regional health partners.
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THE LEGACY OF THE MDGs
It is generally agreed that the MDGs have been a success. 
Certainly they have been more influential and achieved wider 
public recognition than any other attempt at international 
target setting in the field of development. The period of 
their currency – 2000 to 2015 – has also seen significant 
increases in development financing, particularly for health: 
development assistance for health more than tripled after 
2000, accompanied by strong growth in domestically 
sourced financing. 
Their success is generally attributed to the fact that they 
galvanized concerted action around a limited number of 
time-bound, measurable and easy to communicate goals. 
While criticized for ignoring many aspects of development 
(not least sustainable economic growth and health system 
strengthening) and focusing on aggregate rather than equitable 
achievement, the MDG targets were nevertheless widely 
accepted as a measure of progress in the developing world.
The degree to which the remarkable progress in health 
outcomes over the last 15 years, and the increase in 
resources that have made these achievements possible, 
is directly attributable to the existence of MDGs per 
se is debatable.3 However, there have been significant 
achievements. Global MDG targets for HIV, TB and malaria 
have been met. Child mortality has fallen by 53% since the 
MDG statistical baseline year 1990 and maternal mortality 
by 44%. Even though these latter figures fall short of the 
two thirds and three quarters declines that were targeted, 
they are still cause for celebration. 
While it is hard to isolate specific causal effects, it seems 
reasonable to suppose that the intensity of focus (and 
investment) has been a key driver of innovation, enabling 
the scale-up of new interventions, such as ART, LLINs, 
ACTs, vaccines against pneumonia and diarrhoeal disease, 
and new and better diagnostic tests for multiple diseases.
It can also be argued that without the influence of the 
MDGs on promoting measurement, and the development 
of monitoring systems, the world would not be in a position 
to track progress with the degree of confidence that is 
now possible. Moreover, the focus on measurement has 
encouraged political leaders in several countries to make 
public commitments to achieving specific targets in areas 
such as maternal or child mortality.  These commitments 
not only put pressure on ministries of health, but also 
provide a way for civil society, parliament and the media 
to hold health providers accountable for their performance. 
Beyond the health sector, the broader determinants of 
health have shown similar improvements. Extreme poverty, 
as measured by the number of people living on less than 
US$ 1.25 per day, has declined by more than half. The 
proportion of under-nourished people in developing 
countries has fallen significantly. Primary school enrolment, 
for girls and boys equally, has exceeded 90% and, in 2015, 
91% of the global population are using improved drinking-
water sources.
However, there remain several targets where progress 
has been limited (for example, use of family planning and 
improved sanitation) and there remains an “unfinished 
agenda” to complete work on the current health MDGs.  It 
is also evident that progress within and between individual 
countries is highly variable. This unfinished MDG agenda 
is reflected in the SDGs and has been enhanced to include 
new and more ambitious targets such as ending epidemics 
of HIV, TB and malaria and all preventable maternal and 
child deaths – all with a greater focus on equity. 
THE BIRTH OF THE SDGs
Member States of the UN gave a first mandate to start 
work on the post-2015 development agenda in 2010, five 
years before the completion of the MDGs. In response, the 
Secretary-General convened a High-level Panel of Eminent 
Persons (HLP) in 2012 that submitted a report one year 
later, proposing 12 goals and 54 targets. Concurrently, the 
UN Development Group agencies, including WHO, led a 
“global conversation” to solicit views through web-based 
portals and innumerable face-to-face thematic and sectoral 
meetings at national, regional and global level. While the 
impact of the HLP’s work has been limited, their report 
served to build confidence at a time when many feared that 
it might be impossible to reach any consensus at all, given 
the vast range of issues competing for attention. 
A second mandate was agreed at the UN Conference 
on Sustainable Development in Rio de Janeiro in 2012 
(Rio+20). The Rio+20 outcome document – The future we 
want – established an open working group (OWG) of UN 
Member States to develop a set of sustainable development 
goals that would be presented to the UN General Assembly 
for consideration. It also stipulated that the SDGs should 
be aligned with and integrated into the UN development 
agenda post-2015. The OWG, following its own consultative 
process, duly presented its proposals in 2014, at which point 
it was agreed that they would provide the main basis for 
negotiation of a final set of goals to be agreed by heads of 
state and governments in September 2015.
A final text for adoption by the UN General Assembly, 
which takes into account the outcome of other global 
meetings in 2015 (the Sendai Framework for Disaster 
Risk Reduction and the Addis Ababa Action Agenda on 
Financing for Development), was published in August 
2015. The goals were endorsed by resolution at the UN 
Sustainable Development Summit in September 2015.
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A 10-page declaration precedes the main body of the 
document that sets out 17 goals and 169 targets. A full 
list of goals is found in Table 1.2. The main sections of the 
SDG declaration focus on the new agenda, the means of 
implementation and follow-up and review.
The goals will come into effect on 1 January 2016.  Thereafter, 
two processes will be completed. First, work is underway to 
develop a global indicator framework under the auspices of 
the UN Statistical Commission, involving an Inter-Agency 
and Expert Group on SDG indicators (IAEG-SDG) with 28 
Member States as members and UN agencies as observers. 
A proposal from the UN Statistical Commission to the UN 
Economic and Social Council (ECOSOC) is expected in 
March 2016. This should include the full set of indicators 
for SDG monitoring.
Second, while the SDG goals and targets are global in nature 
and universally applicable, the declaration envisages a 
situation with “each government setting its own national 
targets guided by the global level of ambition but taking 
into account national circumstances”. How this will work 
in practice and what will be the role of global and regional 
institutions in helping countries to set such targets remains 
to be seen.
Once an indicator framework is agreed, a complex and 
intensive reporting, follow-up and review process will begin. 
The Secretary-General, with support from the UN system, 
will produce an annual SDG Progress Report. The report will 
inform the High Level Political Forum (HLPF) for Sustainable 
Development, under the auspices of ECOSOC, which will also 
receive a Global Sustainable Development Report (frequency 
to be decided). Every four years “under the auspices of the UN 
General Assembly, the HPLF will provide high level political 
guidance on the SDG agenda and its implementation”. 
Review mechanisms will also be established at regional and 
national level and are likely to be more active and relevant 
than has been the case for the MDGs.
CHILDREN OF THEIR TIME: 
THE SDGs ARE DIFFERENT
The transition from MDGs to SDGs cannot be seen solely as 
the exchange of a shortlist of goals and targets for a longer 
one. The SDGs are fundamentally different to the MDGs, as 
is the political context in which they have been developed 
and in which they will be implemented. 
The MDGs had a consistent and more or less singular purpose. 
Emerging from a series of global development conferences 
in the 1990s, they were about the achievement of improved 
human development outcomes (primarily in terms of poverty, 
education and health) in developing countries. 
They were also framed as a compact between developed 
and developing countries, with Goal 8 specifying what the 
rich world could do to help low-income countries achieve 
goals 1 to 7. They were closely associated with aid spending, 
and have been a key determinant of aid budgets for health, 
with inevitable consequences for priority setting in both 
donor and recipient countries. 
The Millennium Declaration adopted by the UN General 
Assembly in 2000 was similar in breadth and ambition 
to the text of Transforming Our World: the 2030 Agenda for 
Sustainable Development. The big difference in 2000 was 
that following the adoption of the declaration, a technocratic 
process led by the UN resulted in a selected list of goals and 
targets. The SDGs, by contrast, reflect the breadth and 
ambition of the declaration of which they are part.
The SDGs in the words of the declaration are, “integrated 
and indivisible, global in nature and universally applicable”. 
The SDGs seek to be relevant to all countries. They are 
therefore about development, but not just about developing 
countries (although each reference to universality in the 
SDG declaration is qualified by phrases such as “taking 
into account national realities, capacities, policies and 
priorities”). 
The second major difference is the breadth of the proposed 
agenda; the SDGs are “unprecedented in scope and 
significance”. While the MDGs were about a limited set of 
human development targets, the SDGs cover the economic, 
environmental and social pillars of sustainable development 
with a strong focus on equity – expressed most frequently in 
the phrase, “no one will be left behind”. While the breadth 
and ambition of the agenda has attracted much critical 
comment, one can argue that the range of topics covered 
in the SDGs more closely reflects the range of issues with 
which a government in reality has to contend, than the 
narrow agenda encompassed by the MDGs.
The MDGs were silent about the impact of political 
factors in countries. Yet, most of the countries in which 
targets are farthest from being met are those that have 
gone through a period of sustained political turbulence 
requiring humanitarian and developmental support.  Goal 
16 of the SDG explicitly recognizes the importance of 
peace and security as necessary conditions for sustainable 
development. 
 
“We recognize that each country has primary responsibility 
for its own economic and social development.” This 
sentence from the declaration points to another difference 
that is worthy of consideration: the positioning of the SDGs 
in relation to development assistance. A complex issue, 
it can be expressed in simple terms: if the SDG agenda 
is genuinely universal and relevant to all countries, then 
the close link between development goals and financing 
from donors should become less important. The outcome 
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of the UN Conference on Financing for Development held 
in Addis Ababa points in the same direction, emphasizing 
the importance of domestic and private financing, and 
highlighting the role of international public finance, including 
ODA, in catalysing additional finance from other sources. 
There is a growing consensus that over the next 15 years, 
development assistance will remain important, but for a 
decreasing number of poor and often fragile countries. 
Such conceptual tendencies aside, the SDG/development 
assistance issue is likely to remain ambivalent. In Addis 
Ababa a clear difference between some donor and recipient 
countries on the importance of development assistance 
in financing SDG-related efforts became apparent. While 
not meant to be a pledging event, one of the few concrete 
targets to be agreed on was the reaffirmation of the “… 
commitment by many developed countries to achieve the 
target of 0.7% of ODA/GNI and 0.15 to 0.2% of ODA/GNI 
to LDCs.” 
Finally, it is worth noting that in attracting both aid money 
and political attention the MDGs fuelled intense competition 
during the period of consultation and implementation. 
A wide range of interest groups, including international 
agencies, lobbied intensely to ensure that their priorities 
were supported – with little concern for the coherence 
of the agenda as a whole. While this competition and 
fragmentation is likely to continue, the SDG declaration 
stresses the crucial importance of inter-linkages and the 
integrated nature of the goals to ensure that the purpose 
of the new Agenda is realized.
Overall, the MDGs were forged in an atmosphere of greater 
global optimism, in which the prospects for increases in 
development assistance spending were bright (and indeed 
were realized). The political context is now very different. 
Economic insecurity, cuts in public services and growing 
inequality in much of the western, rich world reduces 
political interest in international development and increases 
public hostility to aid. Indeed, it has been argued that only 
if the governments of developed countries do more to 
tackle inequality and insecurity at home, as part of their 
contribution to the SDGs, will they have the political space 
to pursue the idea of global solidarity that underpins the 
new agenda.4 
TOWARDS A WHO POSITION 
ON HEALTH AND THE SDGs
Several health targets follow on from the unfinished MDG 
agenda, and many of the other health targets are derived 
from World Health Assembly resolutions and related action 
plans. Much of the critique (around feasibility, precision, 
measurability etc.) that has been directed at the SDGs as 
a whole can be relatively easily dealt with when it comes 
to health, even though the agenda is now much more 
ambitious. 
At the same time, it is important to recognize the breadth of 
the new agenda: one that sees health not only as ensuring 
healthy lives and promoting well-being for all at all ages, but 
also one in which health and its determinants influence, and 
are influenced by, other goals and targets as an integral part 
of sustainable development. 
The following section sets out 10 points that will contribute 
to an organizational position on health and the SDGs. They 
are grouped under five broad headings.
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THE PLACE OF HEALTH IN THE SDGs
1 Having one health goal is enough
Goal 3 on health – Ensure healthy lives and promote well-being for all at all ages – is one goal among the 17. Some 
commentators have suggested that health has either lost out or been demoted from its place in the MDGs, where 
three out of eight goals were concerned with health. This should not be a matter of concern. Goal 3 is drafted in 
extremely broad terms and, in any case, the comparison, is flawed. The MDGs reflected a relatively narrow range of 
human development outcomes within which it is logical that health be prominent. The SDGs, by contrast, reflect a 
far wider range of environmental, economic and societal concerns. All the SDGs are designed to be cross-cutting and 
the inter-linkages and networks within the SDGs are as important as the individual goals themselves. Moreover, the 
importance of reducing “inequalities within and among countries” has been explicitly recognized as an SDG in itself 
(Goal 10), and applies to all other goals including health. Having only one goal is both logical and in no way detracts 
from the importance of health. Health is positioned as a major contributor to other SDGs: without health many other 
SDGs cannot be achieved. Health also benefits from progress towards the other SDGs.
2 There are some important health issues missing from the SDGs, but not many
The targets included under Goal 3 cover a great deal of ground. Almost all targets can be linked to strategies and 
global action plans that have been adopted by the World Health Assembly in recent years or are under development. 
Gaps are few. There is no mention of immunization coverage as a specific target, but it is integral to the achievement 
of at least four of those that are listed. Access to sexual and reproductive health care is included, but sexual and 
reproductive rights, violence and discrimination against women and girls are dealt with elsewhere (Goal 5). Older 
people are mentioned in Goal 2 on nutrition, and in Goal 11 on cities (safer environments). The implications of 
population ageing as a global trend with important implications for health systems is absent, except indirectly through 
its impact on NCDs and mental health. It therefore needs to be seen as integral to progress on UHC. 
One of the few issues that appear in WHO’s leadership priorities that is missing is antimicrobial resistance. It has been 
squeezed in as an afterthought in the health paragraph of the declaration, but is omitted from the specific targets. 
The omission is indicative of one of the main failings of the health targets, namely that they perpetuate current ways 
of thinking and working within the health sector, and give insufficient attention to issues like antimicrobial resistance 
that, by their very nature, cut across diseases and sectors.5
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HEALTH SYSTEMS ARE CENTRAL TO THE NEW AGENDA
3 The health targets have a logical relationship
Goal 3 has nine substantive targets and four additional points, which are also targets, but are listed as “means of 
implementation”. The full text of all 13 is found at Table 1.3. The order in which the targets are listed gives no sense of 
their relationship, but the declaration endorsed by heads of government in the section on “the New Agenda” provides 
more direction: 
“To promote physical and mental health and well-being and to extend life expectancy for all, we must achieve 
universal health coverage and access to quality health care. No one must be left behind. We commit to…” (thereafter 
follows a brief summary of health targets).
This places UHC as the target that underpins and is key to the achievement of all the others. Placing UHC as the target 
to which all the others contribute also shows how UHC can serve to increase coherence, reduce fragmentation in the 
health sector, and contribute to the development of strong health systems. Figure 9.1 presents the targets under Goal 3 
in a way that distinguishes those that have been carried forward and enhanced from the MDGs, those that have been 
added, and the means of implementation. Goal 17 is a cross-cutting goal on means of implementation that is relevant 
to all the others. It covers financing, partnership, technology assessment and data, monitoring and accountability.
Figure 9.1
A framework for the SDG health goal and targets
INTERACTIONS WITH ECONOMIC, OTHER SOCIAL AND ENVIRONMENTAL SDGs AND SDG 17 ON MEANS OF IMPLEMENTATION
3.a: Strengthen implementation of 
framework convention on tobacco 
control
3.b: Provide access to medicines 
and vaccines for all, support R&D 
of vaccines and medicines for all 
3.c: Increase health financing and 
health workforce in developing 
countries
3.d: Strengthen capacity for 
early warning, risk reduction and 
management of health risks
SDG 3 MEANS OF 
IMPLEMENTATION TARGETSNEW SDG 3 TARGETS 
3.1: Reduce maternal mortality
3.2:  End preventable newborn 
and child deaths
3.3: End the epidemics of AIDS, TB, 
malaria and NTDs
and combat hepatitis, waterborne 
and other communicable diseases
3.7: Ensure universal access to 
sexual and reproductive health-
care services
MDG UNFINISHED  
AND EXPANDED AGENDA
3.4: Reduce mortality from 
NCDs and promote mental 
health
3.5: Strengthen prevention 
and treatment of substance 
abuse
3.6: Halve global deaths 
and injuries from road traffic 
accidents
3.9: Reduce deaths and 
illnesses from hazardous 
chemicals and air, water 
and soil pollution and 
contamination
SUSTAINABLE 
DEVELOPMENT 
GOAL 3 AND 
ITS TARGETS 
SDG 3: 
ENSURE HEALTHY LIVES AND PROMOTE 
WELL-BEING FOR ALL AT ALL AGES
TARGET 3.8: ACHIEVE UNIVERSAL HEALTH COVERAGE, INCLUDING FINANCIAL RISK PROTECTION,  
ACCESS TO QUALITY ESSENTIAL HEALTH-CARE SERVICES, MEDICINES AND VACCINES FOR ALL
4 Achieving the new health targets cannot rely on business as usual
 
One of the acknowledged problems of the MDG era was the fragmentation of country health systems that resulted 
from the establishment of separate programmes, each focusing on its own targets, with little consideration for the 
impact on the health system as a whole. This situation is exacerbated when each programme produces a separate 
estimate of financial needs – geared primarily towards advocacy rather than accurate budgeting. The net result is 
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THE SDGs CAN PUT HEALTH GOVERNANCE CENTRE STAGE
5 Used creatively, the SDGs can enhance governance for health
One of the basic principles underpinning the SDGs is that they are “integrated and indivisible”: progress in one area 
is dependent on progress in many others. Translating this insight into practical action is one of the key challenges for 
the new agenda. Many of the synergies are well known (such as those that exist between health, education, nutrition, 
social protection and conflict). Other links, however, while less immediate, are no less important – for example the links 
between sustainable consumption and NCD risk factors, or climate change and the spread of vector-borne diseases. 
One area of growing concern that the nexus of SDG links can help address is the impact of non-health policy sectors on 
health. The fundamental idea behind governance for health6 is that deliberate action is needed to influence governance 
in other policy arenas to promote and protect health. The integrated nature of the SDG agenda provides additional 
legitimacy for WHO to pursue a more active agenda in this domain. Areas of particular relevance, in which governance 
can have a positive impact on health, include trade and intellectual property, sustainable energy, income inequality, 
migration, food security, and sustainable consumption and production. While much of the attention on governance 
for health has focused on global issues, the SDG declaration points to the importance of governance for health at 
national and regional levels.
6 The SDGs should provoke a deeper debate about health architecture 
The MDGs have had a marked influence on the institutional landscape for global health. While they have been 
successful in mobilizing money and political attention, many of the mechanisms established over the last 15 years 
(the Global Fund; GAVI; the Partnership for Maternal, Newborn, and Child Health; and a wide range of other advocacy 
and fundraising partnerships etc.) have contributed to creating a competitive institutional landscape globally with 
fragmented delivery systems at country level. UN agencies, often encouraged by their major donors, have behaved 
in similar ways, claiming allegiance to or ownership of particular goals or targets. The result is that competition for 
funds (on behalf of one target or another) and for the limelight of public attention, too often outweighs collaboration 
on improving health as a whole with people rather than diseases as the centre of concern. 
With talk already starting about creating yet more purpose-specific funds aligned to specific health targets, it is evident 
that the new generation of goals could make the situation worse. But there is an alternative. The adoption of the SDGs 
offers an opportunity to take a fresh look at the institutional arrangements that are required to improve and maintain 
people’s health. Such an approach would widen the scope of the “global health architecture” discussion beyond the 
current debates on financing and institutional positioning. Instead there is now an opportunity to start thinking about 
what is needed in terms of institutional arrangements for financing and producing global public goods; for improving 
cross-border health security; for improving the relevance and coherence of the UN development agencies in the field 
of health; for addressing the causes of NCDs; and for enhancing standardized measurement and accountability. This 
lays the basis for the institutional arrangements for better governance for health. 
that health systems providing integrated, people-centred care, with realistic estimates of overall cost, and capable of 
achieving multiple targets have been hard to establish. 
With 13 health targets covering most national health concerns and the majority of WHO’s work programme areas, an 
approach to national health development that focuses on individual programmes in isolation will be counterproductive. 
It risks even greater fragmentation and competition than has been seen in the past. More critically, as noted above, 
it will fail to address the many cross-cutting issues that do not fit neatly into programme areas. 
This point has fundamental implications for work in WHO, particularly at country level. To respond to the new agenda, 
WHO will need to ensure that individual programme areas contribute to, and work within, the framework of a country’s 
overall health plan or strategy. This will require more active collaboration within and between programmes than has 
been the case in the past. It also raises important questions as to how planning, budgeting and resource allocation, 
can provide the incentives needed to drive more collaborative work across the organization.
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FINANCING THE SDGs
7 The SDGs are affordable…
Many critics point to the UN’s estimate that the SDGs will cost between US$ 3.3 and US$ 4.5 trillion a year to achieve 
as evidence of their unaffordability.7 However, the SDGs are affordable, but with important caveats. 
First, like any normative framework the aim is for progressive realization. Countries will proceed at their own pace 
given the availability of resources. In the case of the SDGs this point is reinforced by the emphasis on national target 
setting. Second, even though estimating the costs of some of the more aspirational targets will remain highly imprecise, 
some goals, including Goal 3, can and should be costed more accurately. Third, the SDGs will not be primarily financed 
from aid budgets (a concern that often prompts the affordability question in the first place). In fact, despite the large 
increases in development assistance for health during the MDG era, the average low-income country still financed 
75% of its total health expenditure from domestic resources. 
As noted above, development assistance will remain important for some countries, but their number is likely to 
decrease, so that aid spending in the coming years will be more concentrated in a few, fragile, least developed 
countries.8 Of growing concern in regard to these countries will be the better integration of humanitarian and 
development assistance. In too many instances, sustainable recovery and the development of more health systems 
that can mount an all-hazards approach to health security have been compromised by the hiatus that occurs when 
short-term humanitarian assistance ends and longer-term development is late or support fails to materialize. 
8 …but the jury is still out on how the SDGs will influence financing for health 
The economies of many low- and lower-middle-income countries are expected to continue relatively rapid growth 
rates in the foreseeable future. Country capacity to raise and spend funds domestically will be further enhanced if 
statements of intent made in Addis Ababa to make tax systems more efficient nationally are realized; if measures 
to combat tax evasion and illicit tax flows globally are effective; and if partnerships with private sector entities align 
investments with the principles of better health and sustainable development.
 
Looking at health more specifically, the key question is whether the SDGs will change established patterns of spending 
within the sector. While NCDs do not threaten global security, as AIDS or pandemics have been predicted to do, the 
increase in NCDs in low- and middle-income countries threatens to overwhelm fragile health systems unless rapid 
investments in prevention and promotion are made. So far, however, there are few signs of a shift in development 
assistance actually happening. NCDs are still seen as competing for health funds by development assistance agencies 
(despite the need for intersectoral action) and the growing interest in health systems arguably has more to do with 
concerns about health security than universal health coverage and people-centred care. 
A preliminary conclusion therefore is that if the SDGs are to cause a fundamental change in the pattern of health 
financing, the onus is on domestic budgets to make this happen. While this trend is desirable and consistent with the 
idea of self-reliance, growing pressures from global partnerships to increase “counterpart funding” in their specific 
areas of interest may limit governments’ financial room to manoeuvre. 
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FOLLOW-UP AND REVIEW
9 Monitoring the health goal is as important as monitoring individual targets
The annual review of progress by the HLPF for Sustainable Development under the ECOSOC and the four-yearly reviews 
by the UN General Assembly will be informed by reports on SDG progress prepared by the UN Secretary-General. 
If the purpose of this process is to enhance accountability for commitments made at the UN General Assembly, it is 
critical that the high-level picture is not lost in detailed reporting on targets and indicators. 
The process for follow-up and review is described in the SDG declaration. With 169 targets and potentially well over 
200 global indicators, including 20 or so for the health goal, this will inevitably be complex. A further risk, therefore, 
is that a legitimate concern for accountability results in too many demands for data, and that the process will fail 
to gain support, particularly in those countries that already feel over-burdened by existing reporting requirements. 
For the health goal, many existing reporting systems can be used to monitor individual targets. Moreover, the SDG 
agenda offers an opportunity to rationalize the reporting requirements contained in multiple WHA resolutions. The 
key risk, however, is that current efforts to develop indicators, assess progress and hold governments and others to 
account focus exclusively on individual targets, ignoring the big picture, the interrelations between goals and targets 
and, particularly, equity.
Several overarching indicators can serve the purpose of monitoring progress toward the health goal, including life 
expectancy, the number of deaths before age 70 years,9 and healthy life expectancy. If it could be measured reliably, 
healthy life expectancy captures both mortality and years of life lived in less than good health (that is, with a disability).10 
However, challenges remain with regard to the availability of data that are comparable over time and across populations, 
and which allow progress in reducing inequalities to be tracked.
 There will be a growing focus on accountability at country level 
Much of the world’s attention to the MDGs has been based on aggregate global and regional achievements. The 
declaration makes it clear, as noted above, that global monitoring will remain important for the SDGs – albeit posing 
major challenges to graphic artists, report designers and meeting organizers as to how it will be presented in a 
digestible fashion. 
In contrast to the MDGs however, the SDG declaration puts much greater emphasis on country and regional follow-up 
and review processes, as the basis for accountability and remedial action. Given the more political nature and breadth of 
the SDG agenda, one can assume that civil society and others will use the SDGs to hold their governments to account.11 
Again in contrast to the MDGs, it is inevitable that social media – through civil society and a hyper-connected 
generation of socially concerned advocates – will play an important role, initially in determining whether the SDGs 
gain public traction, and assuming that they do, in insisting on greater accountability.  
It is thus not hard to imagine how the SDGs, in addition to being the subject of country-level monitoring of specific 
health targets, will also be used to provoke debate about a country’s position on inequality of income or in health, on 
migration, on access to medicines and many other factors that impact on health. Whilst sticking to its concerns for 
health and equity, WHO needs to be ready to handle demands for more detailed scrutiny of country performance, 
and to provide the comprehensive analyses needed by national governments and regional bodies.
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FINAL REFLECTIONS
The SDG health goal and the 13 targets, as well as the 
multiple health-related targets in other SDGs, provide a 
good basis for discussion and actions to improve health 
for all at all ages in all countries. The set of health targets 
is comprehensive and builds upon a wide array of recent 
World Health Assembly resolutions, WHO and other global 
plans of action and current country health strategies. The 
health targets within the SDGs cover all the main priorities 
in the WHO 12th General Programme of Work 2014–2019. 
The health targets per se are likely to galvanize action in 
many programme areas. The achievement of individual 
targets will remain critical, but the higher ambition will 
require thinking about the SDGs as an “integrated and 
indivisible” agenda, in the way that they are intended. 
A focus on UHC, as the target that underpins all other 
targets, and greater emphasis on the strategic and 
operational interactions with the social, economic and 
environmental dimensions of sustainable development are 
two central pieces of the new health agenda. The SDGs also 
provide a new and exciting opportunity for strengthening 
governance for health and interaction with policy processes 
in other sectors at global, and increasingly, at regional and 
country level. It is also essential to revisit and reshape the 
architecture for global health, particularly in relation to 
health security and the development of global public goods.
The SDG agenda now requires that the focus of global 
health be geared to a broader set of national priorities 
in health and related sectors. This means that all global 
health partners should adapt the timing and the structure of 
planning to reflect a more country-driven agenda in health. 
This should also ensure adequate resource allocation for 
health governance, health systems development and cross 
sectoral work that is implied by the new agenda.
While WHO will continue to work closely with other partners 
in the UN family and beyond, and target-specific work is 
likely to continue and be strengthened, WHO is the only 
global agency with the mandate to cover the whole health 
agenda. This requires that WHO maintain and strengthen 
the core functions in the 12th General Programme of Work, 
particularly in terms of defining indicators and improving 
ways of measuring and reporting on progress; supporting 
countries to generate necessary funding; advising on best-
buy interventions, implementation and delivery strategies; 
and defining research priorities.
The breadth of the SDG health agenda under Goal 3 and the 
range of health determinants reflected in the full set of goals 
poses an importance governance challenge: how to tell a 
coherent story about whether health is improving? Within 
the overall UN framework for SDG follow-up and review of 
progress the WHO governing body meetings should play a 
key role. Using the MDG review methods that focused on 
target level achievements will be unwieldy for the SDG, even 
just for the 13 health targets. A framework for reporting by 
WHO in collaboration with relevant UN agencies and review 
with five components is suggested in Box 9.1. 
Box 9.1 
Summary framework for reporting on the health SDGs
Summary measures of health and well-being using healthy life expectancy or 
premature mortality as discussed earlier.
Progress toward universal health coverage underpins the achievement of all 
other health targets under Goal 3. UHC is relevant and an issue of concern in all 
countries, and there is now a framework that can be used to measure progress 
towards it using coverage and financial protection indicators disaggregated by 
socioeconomic and other key determinants. 
Progress in reducing health inequity across the life course drawing on overall 
data and data from specific targets.12
Progress towards the health targets, framed as part of an overall assessment 
of progress towards the SDGs.
Focus on selected determinants and trends that influence health, reflecting the 
linkages between health and other SDGs, including a summary of capacities related 
to health security, and a qualitative assessment of changes in health architecture 
and health governance.  This part of the framework can be customized annually to 
include issues deemed to be of particular regional and/or global relevance. 
Even though many of the SDGs do indeed lack precision, 
are hard to achieve, have a staggering number of targets, 
of which many are difficult to measure; importantly they 
reflect issues that are of critical importance to people and 
the planet. The SDGs may have profound implications for 
countries and regional and global agencies, including WHO. 
They provide an opportunity to demonstrate that the goal 
of healthy life and well-being for all at all ages is more than 
the sum of the individual targets that contribute to their 
achievement. The integrated nature of the SDGs provides 
new legitimacy for addressing the wider determinants of 
health, while offering a basis for discussing (among other 
issues) the importance of peace and security for health, the 
need for better governance, the impact on health of growing 
inequities, and the importance of putting people rather than 
diseases at the centre of strategies to improve health. 
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WHO regional groupings
WHO African Region: Algeria, Angola, Benin, Botswana, 
Burkina Faso, Burundi, Cabo Verde, Cameroon, Central 
African Republic, Chad, Comoros, Congo, Côte d’Ivoire, 
Democratic Republic of the Congo, Equatorial Guinea, 
Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-
Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, 
Mali, Mauritania, Mauritius, Mozambique, Namibia, 
Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, 
Seychelles, Sierra Leone, South Africa, South Sudan, 
Swaziland, Togo, Uganda, United Republic of Tanzania, 
Zambia, Zimbabwe.
WHO Region of the Americas: Antigua and Barbuda, 
Argentina, Bahamas, Barbados, Belize, Bolivia (Plurinational 
State of), Brazil, Canada, Chile, Colombia, Costa Rica, 
Cuba, Dominica, Dominican Republic, Ecuador, El Salvador, 
Grenada, Guatemala, Guyana, Haiti, Honduras, Jamaica, 
Mexico, Nicaragua, Panama, Paraguay, Peru, Saint Kitts 
and Nevis, Saint Lucia, Saint Vincent and the Grenadines, 
Suriname, Trinidad and Tobago, United States of America, 
Uruguay, Venezuela (Bolivarian Republic of).
WHO South-East Asia Region: Bangladesh, Bhutan, 
Democratic People’s Republic of Korea, India, Indonesia, 
Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-
Leste.
WHO European Region: Albania, Andorra, Armenia, 
Austria, Azerbaijan, Belarus, Belgium, Bosnia and 
Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, 
Denmark, Estonia, Finland, France, Georgia, Germany, 
Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, 
Kyrgyzstan, Latvia, Lithuania, Luxembourg, Malta, Monaco, 
Montenegro, Netherlands, Norway, Poland, Portugal, 
Republic of Moldova, Romania, Russian Federation, 
San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, 
Switzerland, Tajikistan, The former Yugoslav Republic of 
Macedonia, Turkey, Turkmenistan, Ukraine, the United 
Kingdom, Uzbekistan.
WHO Eastern Mediterranean Region: Afghanistan, 
Bahrain, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, 
Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, 
Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic, 
Tunisia, United Arab Emirates, Yemen.
WHO Western Pacific Region: Australia, Brunei 
Darussalam, Cambodia, China, Cook Islands, Fiji, Japan, 
Kiribati, Lao People’s Democratic Republic, Malaysia, 
Marshall Islands, Micronesia (Federated States of), 
Mongolia, Nauru, New Zealand, Niue, Palau, Papua New 
Guinea, Philippines, Republic of Korea, Samoa, Singapore, 
Solomon Islands, Tonga, Tuvalu, Vanuatu, Viet Nam.
WHO regional groupings with high-income 
OECD countries separated out1,2 
High-income OECD countries: Australia, Austria, Belgium, 
Canada, Chile, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Iceland, Ireland, Israel, Italy, 
Japan, Luxembourg, Netherlands, New Zealand, Norway, 
Poland, Portugal, Republic of Korea, Slovakia, Slovenia, 
Spain, Sweden, Switzerland, the United Kingdom, United 
States of America.
Low-, middle- and non-OECD high-income countries:
WHO African Region: Algeria, Angola, Benin, Botswana, 
Burkina Faso, Burundi, Cabo Verde, Cameroon, Central 
African Republic, Chad, Comoros, Congo, Côte d’Ivoire, 
Democratic Republic of the Congo, Equatorial Guinea, 
Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-
Bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, 
Mali, Mauritania, Mauritius, Mozambique, Namibia, 
Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, 
Seychelles, Sierra Leone, South Africa, South Sudan, 
Swaziland, Togo, Uganda, United Republic of Tanzania, 
Zambia, Zimbabwe.
WHO Region of the Americas: Antigua and Barbuda, 
Argentina, Bahamas, Barbados, Belize, Bolivia (Plurinational 
State of), Brazil, Colombia, Costa Rica, Cuba, Dominica, 
Dominican Republic, Ecuador, El Salvador, Grenada, 
Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, 
Nicaragua, Panama, Paraguay, Peru, Saint Kitts and Nevis, 
Saint Lucia, Saint Vincent and the Grenadines, Suriname, 
Trinidad and Tobago, Uruguay, Venezuela (Bolivarian 
Republic of).
1 WHO Member States that are member countries of the OECD and classified as high 
income according to the World Bank analytical income classification of economies (based 
on the 2013 Atlas estimates of gross national income per capita) are grouped together 
as “high-income OECD countries”. The remaining WHO Member States are grouped into 
the six WHO regions. 
2 Member States marked with an * have been classified into income groups using gross 
domestic product.
ANNEX 1. 
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WHO South-East Asia Region: Bangladesh, Bhutan, 
Democratic People’s Republic of Korea, India, Indonesia, 
Maldives, Myanmar, Nepal, Sri Lanka, Thailand, Timor-Leste.
WHO European Region: Albania, Andorra, Armenia, 
Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, 
Croatia, Cyprus, Georgia, Hungary, Kazakhstan, Kyrgyzstan, 
Latvia, Lithuania, Malta, Monaco, Montenegro, Republic of 
Moldova, Romania, Russian Federation, San Marino, Serbia, 
Tajikistan, The former Yugoslav Republic of Macedonia, 
Turkey, Turkmenistan, Ukraine, Uzbekistan.
WHO Eastern Mediterranean Region: Afghanistan, 
Bahrain, Djibouti, Egypt, Iran (Islamic Republic of), Iraq, 
Jordan, Kuwait, Lebanon, Libya, Morocco, Oman, Pakistan, 
Qatar, Saudi Arabia, Somalia, Sudan, Syrian Arab Republic, 
Tunisia, United Arab Emirates, Yemen.
WHO Western Pacific Region: Brunei Darussalam, 
Cambodia, China, Cook Islands*, Fiji, Japan, Kiribati, Lao 
People’s Democratic Republic, Malaysia, Marshall Islands, 
Micronesia (Federated States of), Mongolia, Nauru*, Niue*, 
Palau, Papua New Guinea, Philippines, Samoa, Singapore, 
Solomon Islands, Tonga, Tuvalu, Vanuatu, Viet Nam.
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